variant_id,cell_id,assay_strain,chembl_id,tissue_id,bao_format,src_assay_id,assay_category,assay_cell_type,assay_type,doc_id,assay_tax_id,tid,description,src_id,relationship_type,assay_id,assay_test_type,assay_organism,assay_tissue,confidence_score,assay_subcellular_fraction,curated_by
,,,CHEMBL618647,2113.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,1,N,7524,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL618648,2113.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,1,N,7525,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL618649,2113.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,1,N,7526,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL618650,2107.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,1,N,7527,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL618651,2107.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,1,N,7528,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL876497,2107.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,1,N,7529,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL618652,2048.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,1,N,7530,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL618653,2048.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,1,N,7531,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL618654,2048.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,1,N,7532,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL618655,,BAO_0000218,,,,A,6351,10116.0,50597,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,1,N,7533,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618656,,BAO_0000218,,,,A,1465,10116.0,50597,Compound was tested for solubility in water,1,N,7534,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618657,,BAO_0000100,,,,P,5182,,22229,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),1,U,7535,,,,0,,Intermediate
,,,CHEMBL618658,,BAO_0000218,,,,A,17847,10116.0,50597,Solubility was determined,1,N,7536,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618659,,BAO_0000218,,,,A,15339,10116.0,50597,solubility in water (ug/mL) at 37 degree C.,1,N,7537,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618660,,BAO_0000218,,,,A,5202,10116.0,50597,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,1,N,7538,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618661,,BAO_0000218,,,,A,1088,10116.0,50597,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,1,N,7539,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL873807,,BAO_0000218,,,,A,3169,10116.0,50597,Half life in rats,1,N,7540,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618662,,BAO_0000218,,,,A,5353,10116.0,50597,Half life in Dawley rat,1,N,7541,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618663,,BAO_0000218,,,,A,2864,10116.0,50597,Half life period after 3 mg/kg iv administration,1,N,7542,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618664,,BAO_0000218,,,,A,2864,10116.0,50597,Half life period after 3 mg/kg iv administration in rat,1,N,7543,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618665,,BAO_0000218,,,,A,2864,10116.0,50597,Half life period after 3 mg/kg iv administration in the rat,1,N,7544,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL876498,,BAO_0000218,,,,A,6362,10116.0,50597,Half life period in female Sprague-Dawley rats,1,N,7545,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618666,,BAO_0000218,,,,A,6249,10116.0,50597,Half life period in rat,1,N,7546,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620440,,BAO_0000218,,,,A,3169,10116.0,50597,Half-life in rats was determined,1,N,7547,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620441,,BAO_0000218,,,,A,3169,10116.0,50597,Half-life in rats with metabolic oxidation,1,N,7548,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620442,,BAO_0000218,,,,A,3169,10116.0,50597,Half-life in rats,1,N,7549,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620443,,BAO_0000218,,,,A,17260,10116.0,50597,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,1,N,7550,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620444,,BAO_0000218,,,,A,17260,10116.0,50597,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,1,N,7551,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620445,,BAO_0000218,,,,A,17260,10116.0,50597,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,1,N,7552,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620446,,BAO_0000218,,,,A,17260,10116.0,50597,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,1,N,7553,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620447,1969.0,BAO_0000218,,,,A,2879,10116.0,50597,Biological half-life measured in plasma of rat,1,N,7554,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL621129,1969.0,BAO_0000218,,,,A,2879,10116.0,50597,Biological half-life measured in plasma of rat; 22-25,1,N,7555,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL621130,1969.0,BAO_0000218,,,,A,2879,10116.0,50597,Biological half-life measured in plasma of rat; 9-16,1,N,7556,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL873808,,BAO_0000218,,,,A,3184,10116.0,50597,Compound was evaluated for its half life when administered intravenously in rat,1,N,7557,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL876598,,BAO_0000218,,,,A,4891,10116.0,50597,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,1,N,7558,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621131,,BAO_0000218,,,,A,429,10116.0,50597,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,1,N,7559,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621132,,BAO_0000218,,,,A,5656,10116.0,50597,Half life (T1/2) after oral administration in rat,1,N,7560,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621133,,BAO_0000218,,,,A,4413,10116.0,50597,Half life of compound after iv administration of 20 mg/kg dose in rat,1,N,7561,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621312,,BAO_0000218,,,,A,3598,10116.0,50597,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,1,N,7562,In vivo,Rattus norvegicus,,1,,Expert
,,,CHEMBL621313,,BAO_0000218,,,,A,17267,10116.0,50597,Half life of compound was determined in rat,1,N,7563,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621314,178.0,BAO_0000218,,,,A,4727,10116.0,50597,Half life of compound was determined in rat blood,1,N,7564,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL621315,,BAO_0000218,,,,A,17651,10116.0,50597,Half life at 1 mg/kg was determined in rat,1,N,7565,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621316,,BAO_0000218,,,,A,17651,10116.0,50597,Half life at 10 mg/kg was determined in rat,1,N,7566,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621317,,BAO_0000218,,,,A,401,10116.0,50597,Half life in rats,1,N,7567,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621318,,BAO_0000218,,,,A,4942,10116.0,50597,Half life in rats in hours,1,N,7568,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621319,,BAO_0000218,,,,A,17735,10116.0,50597,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,1,N,7569,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621377,,BAO_0000218,,,,A,6056,10116.0,50597,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,1,N,7570,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621378,,BAO_0000218,,,,A,5213,10116.0,50597,Half life was determined,1,N,7571,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL876599,,BAO_0000218,,,,A,6616,10116.0,50597,Half life after i.v. administration,1,N,7572,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621379,,BAO_0000218,,,,A,5937,10116.0,50597,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,1,N,7573,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621380,1969.0,BAO_0000218,,,,A,5819,10116.0,50597,Half life in rat plasma,1,N,7574,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL621381,1969.0,BAO_0000218,,,,A,5819,10116.0,50597,Half life in rat plasma; Not detected,1,N,7575,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL618515,,BAO_0000218,,,,A,6803,10116.0,50597,Half life in rats,1,N,7576,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618516,,BAO_0000218,,,,A,17804,10116.0,50597,Half life period of compound was determined after peroral administration,1,N,7577,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618517,,BAO_0000218,,,,A,17804,10116.0,50597,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,1,N,7578,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618518,,BAO_0000218,,,,A,5948,10116.0,50597,Half life period in rat,1,N,7579,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618519,,BAO_0000218,,,,A,1916,10116.0,50597,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,1,N,7580,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618698,,BAO_0000218,,,,A,1916,10116.0,50597,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,1,N,7581,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618862,,BAO_0000218,,,,A,1916,10116.0,50597,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,1,N,7582,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618863,,BAO_0000218,,,,A,4890,10116.0,50597,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,1,N,7583,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618864,,BAO_0000218,,,,A,17764,10116.0,50597,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,1,N,7584,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618865,,BAO_0000218,,,,A,4727,10116.0,50597,Half life time in rat the dose of 2 mg/kg,1,N,7585,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618866,,BAO_0000218,,,,A,17509,10116.0,50597,Half-life 24 hr after 10 mg/kg iv administration in rats,1,N,7586,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618867,,BAO_0000218,,,,A,17509,10116.0,50597,Half-life 24 hr after 2 mg/kg iv administration in rats,1,N,7587,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL875828,,BAO_0000218,,,,A,6597,10116.0,50597,Half-life consistent with the observed metabolic steady state in rats,1,N,7588,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618868,,BAO_0000218,,,,A,17735,10116.0,50597,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,1,N,7589,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618869,,BAO_0000218,,,,A,6597,10116.0,50597,Half-life for oxidative metabolic stability was determined using male human,1,N,7590,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618870,,BAO_0000218,,,,A,17670,10116.0,50597,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",1,N,7591,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618871,1969.0,BAO_0000218,,,,A,1696,10116.0,50597,Half-life in rat plasma,1,N,7592,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL618872,1969.0,BAO_0000218,,,,A,1742,10116.0,50597,Half-life in rat plasma was determined,1,N,7593,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL873816,,BAO_0000218,,,,A,17800,10116.0,50597,Half-life in rats was determined,1,N,7594,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618873,,BAO_0000218,,,,A,12923,,22224,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,1,U,7595,,,,0,,Autocuration
,,,CHEMBL621602,,BAO_0000019,,,,A,11954,,22224,Area under curve after oral dose of 0.1 mg//kg,1,U,7596,,,,0,,Autocuration
,,,CHEMBL621603,,BAO_0000218,,,,A,11954,,22224,Area under curve after oral dose of 0.3 mg/kg,1,U,7597,,,,0,,Autocuration
,,,CHEMBL621604,,BAO_0000218,,,,A,11954,,22224,Area under curve after oral dose of 1 mg/kg,1,U,7598,,,,0,,Autocuration
,,,CHEMBL621605,,BAO_0000218,,,,A,11954,,22224,Area under curve after oral dose of 10 mg/kg,1,U,7599,,,,0,,Autocuration
,,,CHEMBL621606,,BAO_0000218,,,,A,11954,,22224,Area under curve after oral dose of 23.4 mg/kg,1,U,7600,,,,0,,Autocuration
,,,CHEMBL621607,,BAO_0000218,,,,A,11954,,22224,Area under curve after oral dose of 3 mg/kg,1,U,7601,,,,0,,Autocuration
,,,CHEMBL621608,,BAO_0000218,,,,A,11954,,22224,Area under curve after oral dose of 3.87 mg/kg,1,U,7602,,,,0,,Autocuration
,,,CHEMBL621609,,BAO_0000019,,,,A,5237,,22224,Area under curve was determined,1,U,7603,,,,0,,Autocuration
,,,CHEMBL621610,,BAO_0000218,,,,A,4026,,22224,Area under curve at a dose of 10 mg/kg,1,U,7604,,,,0,,Autocuration
,,,CHEMBL621611,,BAO_0000218,,,,A,5237,10116.0,50597,Area under curve was determined; ND=No data,1,N,7605,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621612,,BAO_0000218,,,,A,14793,10116.0,50597,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,1,N,7606,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622308,,BAO_0000218,,,,A,14793,10116.0,50597,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,1,N,7607,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622309,,BAO_0000218,,,,A,14793,10116.0,50597,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,1,N,7608,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622310,,BAO_0000218,,,,A,14793,10116.0,50597,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,1,N,7609,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622311,,BAO_0000218,,,,A,14793,10116.0,50597,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,1,N,7610,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622312,,BAO_0000218,,,,A,14793,10116.0,50597,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,1,N,7611,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622931,,BAO_0000218,,,,A,14793,10116.0,50597,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,1,N,7612,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622932,,BAO_0000218,,,,A,14793,10116.0,50597,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,1,N,7613,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622736,1969.0,BAO_0000218,,,,A,14793,10116.0,50597,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,1,N,7614,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622737,1969.0,BAO_0000218,,,,A,14793,10116.0,50597,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,1,N,7615,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622738,1969.0,BAO_0000218,,,,A,14793,10116.0,50597,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,1,N,7616,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622739,1969.0,BAO_0000218,,,,A,14793,10116.0,50597,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,1,N,7617,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622740,1969.0,BAO_0000218,,,,A,14793,10116.0,50597,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,1,N,7618,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622741,1969.0,BAO_0000218,,,,A,14793,10116.0,50597,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,1,N,7619,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622742,1969.0,BAO_0000218,,,,A,14793,10116.0,50597,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,1,N,7620,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622743,1969.0,BAO_0000218,,,,A,14793,10116.0,50597,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,1,N,7621,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622744,1969.0,BAO_0000218,,,,A,11637,10090.0,50594,AUC in mice,1,N,7622,,Mus musculus,Plasma,1,,Intermediate
,,,CHEMBL624134,,BAO_0000019,,,,A,11149,,22224,Area under curve was measured from the graph obtained from concentration Vs time,1,U,7623,,,,0,,Autocuration
,,,CHEMBL624135,,BAO_0000019,,,,A,10016,,22224,Area under curve value of compound per hour after oral administration,1,U,7624,,,,0,,Autocuration
,,,CHEMBL624136,,BAO_0000218,,,,A,17796,10116.0,50597,Area under curve was determined after oral administration in rats,1,N,7625,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624137,,BAO_0000218,,,,A,17796,10116.0,50597,Area under curve was determined after oral administration in rats; No data,1,N,7626,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624320,,BAO_0000218,,,,A,17796,10116.0,50597,Area under curve was determined after oral administration in rats;No data,1,N,7627,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624321,,BAO_0000218,,,,A,12923,9615.0,50588,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,1,N,7628,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624322,,BAO_0000218,,,,A,15372,10116.0,50597,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,1,N,7629,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624323,,BAO_0000218,,,,A,15372,10116.0,50597,Area under curve was determined for the compound after iv dose of 5.06 in rats,1,N,7630,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624324,,BAO_0000218,,,,A,15372,10116.0,50597,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,1,N,7631,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624325,,BAO_0000218,,,,A,15372,10116.0,50597,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,1,N,7632,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624326,,BAO_0000218,,,,A,15372,10116.0,50597,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,1,N,7633,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624327,,BAO_0000218,,,,A,15372,10116.0,50597,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,1,N,7634,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624328,,BAO_0000218,,,,A,15372,10116.0,50597,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,1,N,7635,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627848,,BAO_0000218,,,,A,14169,9615.0,50588,Area under curve was determined in Dogs after peroral administration,1,N,7636,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL627849,,BAO_0000218,,,,A,14169,10116.0,50597,Area under curve was determined in Rats after peroral administration,1,N,7637,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627850,,BAO_0000218,,,,A,14258,10116.0,50597,Area under curve was determined in carotid blood of rat when administered intradermally,1,N,7638,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627851,,BAO_0000218,,,,A,14258,10116.0,50597,Area under curve was determined in portal blood of rat when administered intradermally,1,N,7639,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627852,,BAO_0000218,,,,A,15011,10090.0,50594,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,1,N,7640,,Mus musculus,,1,,Intermediate
,,,CHEMBL627853,,BAO_0000218,,,,A,15011,10090.0,50594,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,1,N,7641,,Mus musculus,,1,,Intermediate
,,,CHEMBL627854,,BAO_0000218,,,,A,15011,10090.0,50594,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),1,N,7642,,Mus musculus,,1,,Intermediate
,,,CHEMBL627855,,BAO_0000218,,,,A,15011,10090.0,50594,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,1,N,7643,,Mus musculus,,1,,Intermediate
,,,CHEMBL627856,,BAO_0000218,,,,A,15011,10090.0,50594,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),1,N,7644,,Mus musculus,,1,,Intermediate
,,,CHEMBL875339,,BAO_0000218,,,,A,15011,10090.0,50594,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,1,N,7645,,Mus musculus,,1,,Intermediate
,,,CHEMBL627857,,BAO_0000218,,,,A,15011,10090.0,50594,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),1,N,7646,,Mus musculus,,1,,Intermediate
,,,CHEMBL627858,2106.0,BAO_0000218,,,,A,11195,10116.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,1,N,7647,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL627859,178.0,BAO_0000218,,,,A,10130,10116.0,50597,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,1,N,7648,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627860,955.0,BAO_0000218,,,,A,10130,10116.0,50597,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,1,N,7649,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL627019,948.0,BAO_0000218,,,,A,10130,10116.0,50597,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,1,N,7650,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL627020,2107.0,BAO_0000218,,,,A,10130,10116.0,50597,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,1,N,7651,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL627021,2048.0,BAO_0000218,,,,A,10130,10116.0,50597,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,1,N,7652,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627022,2385.0,BAO_0000218,,,,A,10130,10116.0,50597,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,1,N,7653,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL627023,,BAO_0000218,,,,A,10130,10116.0,50597,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,1,N,7654,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627024,2106.0,BAO_0000218,,,,A,10130,10116.0,50597,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,1,N,7655,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL627025,2046.0,BAO_0000218,,,,A,10130,10116.0,50597,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,1,N,7656,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL627026,2113.0,BAO_0000218,,,,A,10130,10116.0,50597,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,1,N,7657,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL627027,178.0,BAO_0000218,,,,A,10130,10116.0,50597,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,1,N,7658,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627028,955.0,BAO_0000218,,,,A,10130,10116.0,50597,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,1,N,7659,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL627029,948.0,BAO_0000218,,,,A,10130,10116.0,50597,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,1,N,7660,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL627030,2113.0,BAO_0000218,,,,A,10130,10116.0,50597,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,1,N,7661,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL627031,2107.0,BAO_0000218,,,,A,10130,10116.0,50597,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,1,N,7662,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL627032,2048.0,BAO_0000218,,,,A,10130,10116.0,50597,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,1,N,7663,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627033,2385.0,BAO_0000218,,,,A,10130,10116.0,50597,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,1,N,7664,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL627034,,BAO_0000218,,,,A,10130,10116.0,50597,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,1,N,7665,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627035,2106.0,BAO_0000218,,,,A,10130,10116.0,50597,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,1,N,7666,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL627036,2046.0,BAO_0000218,,,,A,10130,10116.0,50597,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,1,N,7667,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL875340,178.0,BAO_0000218,,,,A,10130,10116.0,50597,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,1,N,7668,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627037,948.0,BAO_0000218,,,,A,10130,10116.0,50597,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,1,N,7669,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL627038,2113.0,BAO_0000218,,,,A,10130,10116.0,50597,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,1,N,7670,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL627039,2107.0,BAO_0000218,,,,A,10130,10116.0,50597,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,1,N,7671,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL627040,2385.0,BAO_0000218,,,,A,10130,10116.0,50597,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,1,N,7672,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL624663,2106.0,BAO_0000218,,,,A,10130,10116.0,50597,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,1,N,7673,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL625963,2046.0,BAO_0000218,,,,A,10130,10116.0,50597,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,1,N,7674,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL876799,955.0,BAO_0000218,,,,A,10130,10116.0,50597,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,1,N,7675,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL626133,2048.0,BAO_0000218,,,,A,10130,10116.0,50597,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,1,N,7676,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL626134,,BAO_0000218,,,,A,10130,10116.0,50597,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,1,N,7677,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626135,,BAO_0000218,,,,A,6295,10116.0,50597,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,1,N,7678,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626136,,BAO_0000218,,,,A,6296,10116.0,50597,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,1,N,7679,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626137,,BAO_0000218,,,,A,6296,10116.0,50597,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,1,N,7680,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626138,,BAO_0000218,,,,A,6295,10116.0,50597,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,1,N,7681,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626139,,BAO_0000218,,,,A,6296,10116.0,50597,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,1,N,7682,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626140,,BAO_0000218,,,,A,17260,10116.0,50597,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,1,N,7683,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626141,,BAO_0000218,,,,A,17260,10116.0,50597,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,1,N,7684,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626142,,BAO_0000218,,,,A,17686,10116.0,50597,C24h in rat p.o. at 20 mg/kg concentration,1,N,7685,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627930,2385.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,1,N,7686,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL627931,2385.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,1,N,7687,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL627932,2385.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,1,N,7688,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL627933,2106.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,1,N,7689,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL627934,2106.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,1,N,7690,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL627935,2106.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,1,N,7691,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL627936,178.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,1,N,7692,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627937,178.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,1,N,7693,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627938,178.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,1,N,7694,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627939,178.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,1,N,7695,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627940,178.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,1,N,7696,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627941,178.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,1,N,7697,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL876800,178.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,1,N,7698,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627942,178.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,1,N,7699,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627943,178.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,1,N,7700,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627944,178.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,1,N,7701,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627945,178.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,1,N,7702,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL628584,178.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,1,N,7703,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL628585,178.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat blood in the presence of GdDTPA at 15 min,1,N,7704,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL628586,178.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,1,N,7705,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL628587,178.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat blood in the presence of GdDTPA at 30 min,1,N,7706,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL628588,178.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,1,N,7707,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL628589,178.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,1,N,7708,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL625304,178.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,1,N,7709,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL625305,178.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,1,N,7710,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL625306,178.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,1,N,7711,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL625307,178.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,1,N,7712,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL625308,178.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,1,N,7713,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627740,178.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,1,N,7714,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627741,178.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,1,N,7715,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627742,178.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,1,N,7716,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627743,178.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,1,N,7717,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627744,178.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,1,N,7718,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627745,10000001.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,1,N,7719,In vivo,Rattus norvegicus,Bone,1,,Intermediate
,,,CHEMBL627746,10000001.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,1,N,7720,In vivo,Rattus norvegicus,Bone,1,,Intermediate
,,,CHEMBL627747,10000001.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,1,N,7721,In vivo,Rattus norvegicus,Bone,1,,Intermediate
,,,CHEMBL876810,10000001.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,1,N,7722,In vivo,Rattus norvegicus,Bone,1,,Intermediate
,,,CHEMBL627748,10000001.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,1,N,7723,In vivo,Rattus norvegicus,Bone,1,,Intermediate
,,,CHEMBL627749,10000001.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,1,N,7724,In vivo,Rattus norvegicus,Bone,1,,Intermediate
,,,CHEMBL627750,10000001.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,1,N,7725,In vivo,Rattus norvegicus,Bone,1,,Intermediate
,,,CHEMBL618728,10000001.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,1,N,7726,In vivo,Rattus norvegicus,Bone,1,,Intermediate
,,,CHEMBL618729,10000001.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,1,N,7727,In vivo,Rattus norvegicus,Bone,1,,Intermediate
,,,CHEMBL618730,10000001.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat bone in the presence of GdDTPA at 15 min,1,N,7728,In vivo,Rattus norvegicus,Bone,1,,Intermediate
,,,CHEMBL618731,10000001.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,1,N,7729,In vivo,Rattus norvegicus,Bone,1,,Intermediate
,,,CHEMBL618732,10000001.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat bone in the presence of GdDTPA at 30 min,1,N,7730,In vivo,Rattus norvegicus,Bone,1,,Intermediate
,,,CHEMBL618733,10000001.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,1,N,7731,In vivo,Rattus norvegicus,Bone,1,,Intermediate
,,,CHEMBL618734,10000001.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,1,N,7732,In vivo,Rattus norvegicus,Bone,1,,Intermediate
,,,CHEMBL618735,10000001.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,1,N,7733,In vivo,Rattus norvegicus,Bone,1,,Intermediate
,,,CHEMBL876602,10000001.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,1,N,7734,In vivo,Rattus norvegicus,Bone,1,,Intermediate
,,,CHEMBL618736,10000001.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,1,N,7735,In vivo,Rattus norvegicus,Bone,1,,Intermediate
,,,CHEMBL618737,10000001.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,1,N,7736,In vivo,Rattus norvegicus,Bone,1,,Intermediate
,,,CHEMBL618738,10000001.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,1,N,7737,In vivo,Rattus norvegicus,Bone,1,,Intermediate
,,,CHEMBL618739,10000001.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,1,N,7738,In vivo,Rattus norvegicus,Bone,1,,Intermediate
,,,CHEMBL618740,10000001.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,1,N,7739,In vivo,Rattus norvegicus,Bone,1,,Intermediate
,,,CHEMBL618741,10000001.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,1,N,7740,In vivo,Rattus norvegicus,Bone,1,,Intermediate
,,,CHEMBL618742,10000001.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,1,N,7741,In vivo,Rattus norvegicus,Bone,1,,Intermediate
,,,CHEMBL618743,10000001.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,1,N,7742,In vivo,Rattus norvegicus,Bone,1,,Intermediate
,,,CHEMBL618744,1969.0,BAO_0000218,,,,A,17752,10116.0,50597,Half-life from rat plasma at a single oral dose of 25 mg/kg,1,N,7743,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL618745,,BAO_0000218,,,,A,5610,10116.0,50597,Half-life in male rat,1,N,7744,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620479,,BAO_0000218,,,,A,5939,10116.0,50597,Half-life in rat after peroral administration at 10 mg/kg concentration,1,N,7745,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620480,,BAO_0000218,,,,A,5939,10116.0,50597,Half-life in rat after peroral administration at 5 mg/kg concentration,1,N,7746,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620481,,BAO_0000218,,,,A,17771,10116.0,50597,Half-life in rat at a dose of 3 mg/kg,1,N,7747,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620482,,BAO_0000218,,,,A,1974,10116.0,50597,Half-life was evaluated in rats,1,N,7748,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL876603,,BAO_0000218,,,,A,4239,10116.0,50597,Half-life was measured in rat,1,N,7749,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620483,,BAO_0000218,,,,A,6681,10116.0,50597,Half-life period for the compound was determined in rats at 50 mg/kg dose,1,N,7750,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620484,,BAO_0000218,,,,A,17752,10116.0,50597,Half-life period in rats after intravenous administration at 5 mg/kg,1,N,7751,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620485,,BAO_0000218,,,,A,6046,10116.0,50597,Half-life period in rat at 10 mg/kg,1,N,7752,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620486,,BAO_0000218,,,,A,6685,10116.0,50597,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",1,N,7753,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620487,,BAO_0000218,,,,A,6685,10116.0,50597,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",1,N,7754,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620488,,BAO_0000218,,,,A,6685,10116.0,50597,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",1,N,7755,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620489,,BAO_0000218,,,,A,4727,10116.0,50597,Half-life time in rat the dose of 2 mg/kg,1,N,7756,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620490,,BAO_0000218,,,,A,1088,10116.0,50597,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,1,N,7757,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620491,,BAO_0000218,,,,A,5610,10116.0,50597,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,1,N,7758,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL876604,1969.0,BAO_0000218,,,,A,3032,10116.0,50597,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",1,N,7759,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL620492,,BAO_0000218,,,,A,5199,10116.0,50597,Oral half life was determined,1,N,7760,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620493,,BAO_0000218,,,,A,14941,10116.0,50597,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",1,N,7761,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620494,,BAO_0000218,,,,A,4408,10116.0,50597,Pharmacokinetic property (t1/2) in rat,1,N,7762,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620495,1969.0,BAO_0000218,,,,A,2552,10116.0,50597,Plasma elimination half-life was determined,1,N,7763,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL620496,1969.0,BAO_0000218,,,,A,5199,10116.0,50597,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,1,N,7764,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL620497,1969.0,BAO_0000218,,,,A,15662,10116.0,50597,Plasma half life was observed after intravenous administration in rat,1,N,7765,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL620498,1969.0,BAO_0000218,,,,A,1465,10116.0,50597,Plasma half-life was determined,1,N,7766,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL620499,1969.0,BAO_0000218,,,,A,1446,10116.0,50597,Plasma half-life following oral administration in Fisher rats,1,N,7767,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL620500,1969.0,BAO_0000218,,,,A,6824,10116.0,50597,Plasma half-life in rat,1,N,7768,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL873809,1969.0,BAO_0000218,,,,A,17533,10116.0,50597,Plasmatic Half-life after intravenous administration to rat,1,N,7769,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL620501,,BAO_0000218,,,,A,5979,10116.0,50597,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,1,N,7770,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620502,,BAO_0000218,,,,A,4689,10116.0,50597,Terminal half life after intravenous administration (1 mg/kg) in rat,1,N,7771,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620503,,BAO_0000218,,,,A,4689,10116.0,50597,Terminal half life in Rat at a oral dose of 5 mg/kg,1,N,7772,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620504,,BAO_0000218,,,,A,2463,10116.0,50597,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,1,N,7773,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL876605,,BAO_0000218,,,,A,4883,10116.0,50597,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,1,N,7774,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620505,,BAO_0000218,,,,A,4883,10116.0,50597,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,1,N,7775,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL873811,1969.0,BAO_0000218,,,,A,15662,10116.0,50597,plasma half life was observed after intravenous administration in rat,1,N,7776,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL624016,,BAO_0000218,,,,A,3598,10116.0,50597,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,1,N,7777,In vivo,Rattus norvegicus,,1,,Expert
,,,CHEMBL624017,,BAO_0000218,,,,A,4576,10116.0,50597,Half life of compound determined in rat,1,N,7778,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624018,,BAO_0000218,,,,A,4576,10116.0,50597,Mean residence time determined in rat,1,N,7779,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624019,,BAO_0000218,,,,A,4576,10116.0,50597,Plasma half life determined in rat,1,N,7780,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624020,955.0,BAO_0000218,,,,A,4910,10116.0,50597,Compound was evaluated for Tmax in brain after intravenous administration in male rats,1,N,7781,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL624201,,BAO_0000218,,,,A,4891,10116.0,50597,Compound was evaluated for pharmacokinetic parameter maximum time period,1,N,7782,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL872528,,BAO_0000218,,,,A,429,10116.0,50597,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,1,N,7783,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624202,,BAO_0000218,,,,A,5974,10116.0,50597,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,1,N,7784,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624203,,BAO_0000218,,,,A,5974,10116.0,50597,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,1,N,7785,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624350,,BAO_0000218,,,,A,5974,10116.0,50597,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,1,N,7786,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621320,,BAO_0000218,,,,A,5974,10116.0,50597,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,1,N,7787,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621321,,BAO_0000218,,,,A,17582,10116.0,50597,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,1,N,7788,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621322,,BAO_0000218,,,,A,4026,10116.0,50597,Maximum time (Tmax) required to reach Cmax in rats,1,N,7789,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621323,,BAO_0000218,,,,A,4890,10116.0,50597,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,1,N,7790,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621324,,BAO_0000218,,,,A,6571,10116.0,50597,Maximum time of clearance of compound in rats after peroral administration,1,N,7791,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621325,,BAO_0000218,,,,A,4727,10116.0,50597,Maximum time at the dose of 2 mg/kg in rat,1,N,7792,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL875837,1969.0,BAO_0000218,,,,A,17651,10116.0,50597,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,1,N,7793,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL621326,1969.0,BAO_0000218,,,,A,17651,10116.0,50597,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,1,N,7794,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL621327,,BAO_0000218,,,,A,14465,10116.0,50597,Tmax in Guinea pig (PO dose),1,N,7795,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621328,,BAO_0000218,,,,A,14941,10116.0,50597,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",1,N,7796,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621329,,BAO_0000218,,,,A,5960,10116.0,50597,Pharmacokinetic parameter (Tmax) in rat,1,N,7797,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621330,,BAO_0000218,,,,A,5022,10116.0,50597,Pharmacokinetic parameter (Tmax) was estimated,1,N,7798,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621331,,BAO_0000218,,,,A,4408,10116.0,50597,Pharmacokinetic property (Tmax) in rat,1,N,7799,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621332,,BAO_0000218,,,,A,5983,10116.0,50597,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,1,N,7800,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621333,,BAO_0000218,,,,A,4689,10116.0,50597,T max in Rat at a oral dose of 5 mg/kg,1,N,7801,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621334,,BAO_0000218,,,,A,2792,10116.0,50597,T max was determined at 10 mg/kg po dose in rats,1,N,7802,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621335,,BAO_0000218,,,,A,15011,10090.0,50594,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),1,N,7803,,Mus musculus,,1,,Intermediate
,,,CHEMBL621336,,BAO_0000218,,,,A,14180,9615.0,50588,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,1,N,7804,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL621337,,BAO_0000218,,,,A,14180,10116.0,50597,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,1,N,7805,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621338,,BAO_0000218,,,,A,14599,9615.0,50588,Area under curve was measured after i.v. administration into Beagle dog.,1,N,7806,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL875838,,BAO_0000218,,,,A,14599,9615.0,50588,Area under curve was measured after iv administration into Beagle dog,1,N,7807,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL621339,,BAO_0000218,,,,A,14599,9615.0,50588,Area under curve was measured after po administration into Beagle dog,1,N,7808,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL621340,,BAO_0000218,,,,A,14599,9615.0,50588,Area under curve was measured after po administration into Beagle dog.,1,N,7809,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL621341,,BAO_0000218,,,,A,15675,,22224,Area under curve was measured at peroral dose of 3 mg/kg,1,U,7810,,,,0,,Autocuration
,,,CHEMBL621342,,BAO_0000019,,,,A,12706,,22224,Area under curve was measured by using concentration Vs time,1,U,7811,,,,0,,Autocuration
,,,CHEMBL621343,,BAO_0000019,,,,A,12706,,22224,Area under curve was measured by using concentration Vs time; not tested,1,U,7812,,,,0,,Autocuration
,,,CHEMBL621344,,BAO_0000218,,,,A,9750,10090.0,50594,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),1,N,7813,,Mus musculus,,1,,Intermediate
,,,CHEMBL621345,,BAO_0000218,,,,A,9750,10090.0,50594,Area under curve(AUC) was measured in mice after oral administration.,1,N,7814,,Mus musculus,,1,,Intermediate
,,,CHEMBL621346,,BAO_0000019,,,,A,14691,,22224,Area under curve(AUC) value of the compound,1,U,7815,,,,0,,Autocuration
,,,CHEMBL621347,,BAO_0000218,,,,A,14691,,22224,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,1,U,7816,,,,0,,Autocuration
,,,CHEMBL621348,,BAO_0000218,,,,A,14691,9615.0,50588,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,1,N,7817,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL621349,178.0,BAO_0000019,,,,A,2939,,22224,Area under curve(carotid artery) was determined by the availability in blood,1,U,7818,,,Blood,0,,Autocuration
,,,CHEMBL621350,178.0,BAO_0000019,,,,A,2939,,22224,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,1,U,7819,,,Blood,0,,Autocuration
,,,CHEMBL875839,178.0,BAO_0000019,,,,A,2939,,22224,Area under curve(carotid artery) was determined by the availability in blood; No data,1,U,7820,,,Blood,0,,Autocuration
,,,CHEMBL620211,178.0,BAO_0000019,,,,A,2939,,22224,Area under curve(portal vein) was determined by the availability in blood,1,U,7821,,,Blood,0,,Autocuration
,,,CHEMBL620212,178.0,BAO_0000019,,,,A,2939,,22224,Area under curve(portal vein) was determined by the availability in blood; ND means no data,1,U,7822,,,Blood,0,,Autocuration
,,,CHEMBL620213,178.0,BAO_0000019,,,,A,2939,,22224,Area under curve(portal vein) was determined by the availability in blood; No data,1,U,7823,,,Blood,0,,Autocuration
,,,CHEMBL620214,1969.0,BAO_0000218,,,,A,9552,9544.0,50797,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",1,N,7824,,Macaca mulatta,Plasma,1,,Intermediate
,,,CHEMBL620215,1969.0,BAO_0000218,,,,A,9552,9544.0,50797,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",1,N,7825,,Macaca mulatta,Plasma,1,,Intermediate
,,,CHEMBL620216,1969.0,BAO_0000218,,,,A,9552,9544.0,50797,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,1,N,7826,,Macaca mulatta,Plasma,1,,Intermediate
,,,CHEMBL620888,1969.0,BAO_0000218,,,,A,9552,9615.0,50588,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",1,N,7827,,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL620889,1969.0,BAO_0000218,,,,A,9552,9615.0,50588,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",1,N,7828,,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL620890,1969.0,BAO_0000019,,,,A,9552,,22224,Area under plasma concentration vs time curve observed in rats for 0-3 h,1,U,7829,,,Plasma,0,,Autocuration
,,,CHEMBL620891,1969.0,BAO_0000218,,,,A,11911,10116.0,50597,Area under plasma time curve determined in male rat,1,N,7830,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL620892,,BAO_0000019,,,,A,16618,,22224,Area under the MAP curve measured over 5 min.,1,U,7831,,,,0,,Autocuration
,,,CHEMBL621079,,BAO_0000218,,,,A,14387,10090.0,50594,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,1,N,7832,,Mus musculus,,1,,Intermediate
,,,CHEMBL621080,,BAO_0000218,,,,A,14387,10090.0,50594,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,1,N,7833,,Mus musculus,,1,,Intermediate
,,,CHEMBL621081,,BAO_0000218,,,,A,12836,9615.0,50588,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,1,N,7834,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL621082,,BAO_0000218,,,,A,12836,10026.0,100712,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,1,N,7835,,Cricetinae,,1,,Intermediate
,,,CHEMBL621083,,BAO_0000218,,,,A,12836,10116.0,50597,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,1,N,7836,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621084,,BAO_0000218,,,,A,14339,9615.0,50588,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,1,N,7837,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL621085,,BAO_0000218,,,,A,14339,9615.0,50588,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,1,N,7838,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL621086,,BAO_0000218,,,,A,14339,9615.0,50588,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,1,N,7839,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL621087,,BAO_0000218,,,,A,10524,9615.0,50588,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),1,N,7840,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL622607,,BAO_0000218,,,,A,9994,9615.0,50588,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),1,N,7841,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL622608,,BAO_0000218,,,,A,11325,9615.0,50588,Serum AUC in marmosets (IV dose),1,N,7842,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624481,,BAO_0000019,,,,A,12536,,22224,Area under the curve after intravenous administration at a dose of 10 umol/kg,1,U,7843,,,,0,,Autocuration
,,,CHEMBL624482,,BAO_0000019,,,,A,12536,,22224,Area under the curve after intravenous administration at a dose of 2 umol/kg,1,U,7844,,,,0,,Autocuration
,,,CHEMBL624483,,BAO_0000019,,,,A,12536,,22224,Area under the curve after intravenous administration at a dose of 4 umol/kg,1,U,7845,,,,0,,Autocuration
,,,CHEMBL624484,,BAO_0000019,,,,A,12536,,22224,Area under the curve after intravenous administration at a dose of 40 umol/kg,1,U,7846,,,,0,,Autocuration
,,,CHEMBL624485,,BAO_0000019,,,,A,12536,,22224,Area under the curve after intravenous administration at a dose of 5 umol/kg,1,U,7847,,,,0,,Autocuration
,,,CHEMBL624486,,BAO_0000218,,,,A,15556,10116.0,50597,Area under the curve for fumarate salt was evaluated in F344 Rats.,1,N,7848,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624487,,BAO_0000019,,,,A,2809,,22224,Area under the curve for the compound was calculated.,1,U,7849,,,,0,,Autocuration
,,,CHEMBL624488,,BAO_0000019,,,,A,9511,,22224,Area under the curve in concentration/ time,1,U,7850,,,,0,,Autocuration
,,,CHEMBL624489,,BAO_0000218,,,,A,12818,10116.0,50597,Area under the curve administered intraintestinal in rats.,1,N,7851,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625184,,BAO_0000218,,,,A,12818,10116.0,50597,Area under the curve administered intravenously in rats.,1,N,7852,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625185,,BAO_0000019,,,,A,15118,,22224,Area under the curve during intravenous administration,1,U,7853,,,,0,,Autocuration
,,,CHEMBL875954,,BAO_0000019,,,,A,15118,,22224,Area under the curve during intravenous administration; Not determined,1,U,7854,,,,0,,Autocuration
,,,CHEMBL625186,,BAO_0000019,,,,A,15118,,22224,Area under the curve during systemic administration,1,U,7855,,,,0,,Autocuration
,,,CHEMBL625187,,BAO_0000019,,,,A,15118,,22224,Area under the curve during systemic administration; Not determined,1,U,7856,,,,0,,Autocuration
,,,CHEMBL625188,,BAO_0000019,,,,A,2632,,22224,Area under the curve was calculated for the compound.,1,U,7857,,,,0,,Autocuration
,,,CHEMBL625189,,BAO_0000218,,,,A,14346,9615.0,50588,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,1,N,7858,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625190,,BAO_0000218,,,,A,14346,9615.0,50588,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,1,N,7859,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL621733,,BAO_0000218,,,,A,14346,10116.0,50597,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,1,N,7860,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621734,,BAO_0000218,,,,A,14346,10116.0,50597,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,1,N,7861,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621735,,BAO_0000218,,,,A,11149,10116.0,50597,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,1,N,7862,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621736,1969.0,BAO_0000218,,,,A,17796,10116.0,50597,Clearance of the drug was measured in the plasma of rat; No data,1,N,7863,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL621737,1969.0,BAO_0000218,,,,A,5247,10116.0,50597,The pharmacokinetic parameter plasma clearance in vivo in rats,1,N,7864,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL621738,,BAO_0000218,,,,A,4727,10116.0,50597,Plasma clearance at the dose of 2 mg/kg in rat,1,N,7865,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622806,,BAO_0000218,,,,A,5654,10116.0,50597,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,1,N,7866,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623519,,BAO_0000218,,,,A,5654,10116.0,50597,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,1,N,7867,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623520,,BAO_0000218,,,,A,17260,10116.0,50597,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,1,N,7868,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623521,,BAO_0000218,,,,A,17065,10116.0,50597,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,1,N,7869,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623522,,BAO_0000218,,,,A,17671,10116.0,50597,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,1,N,7870,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623523,,BAO_0000218,,,,A,6672,10116.0,50597,Clearance rate in rat,1,N,7871,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623690,,BAO_0000218,,,,A,6673,10116.0,50597,Clearance rate in rat,1,N,7872,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623691,,BAO_0000218,,,,A,5978,10116.0,50597,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,N,7873,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623692,,BAO_0000218,,,,A,5978,10116.0,50597,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,N,7874,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623693,,BAO_0000218,,,,A,5978,10116.0,50597,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,N,7875,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623694,,BAO_0000218,,,,A,5978,10116.0,50597,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,N,7876,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623695,,BAO_0000218,,,,A,4413,10116.0,50597,Clearance of compound after iv administration of 20 mg/kg dose in rat,1,N,7877,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623696,,BAO_0000218,,,,A,2661,10116.0,50597,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,1,N,7878,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623697,,BAO_0000218,,,,A,2661,10116.0,50597,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,1,N,7879,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623698,1969.0,BAO_0000218,,,,A,5005,9544.0,22224,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,1,U,7880,In vivo,Macaca mulatta,Plasma,0,,Intermediate
,,,CHEMBL623699,1969.0,BAO_0000218,,,,A,5005,10116.0,22224,Compound was tested for its plasma clearance rate in Sprague Dawley rats,1,U,7881,In vivo,Rattus norvegicus,Plasma,0,,Intermediate
,,,CHEMBL623700,,BAO_0000218,,,,A,15765,10116.0,50597,Mean (%CV) PK parameters for CL(mL/min/kg).,1,N,7882,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623701,,BAO_0000218,,,,A,3747,10116.0,50597,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,1,N,7883,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623702,1969.0,BAO_0000218,,,,A,16366,10116.0,50597,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,1,N,7884,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623703,,BAO_0000218,,,,A,4199,10116.0,50597,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,1,N,7885,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623704,,BAO_0000218,,,,A,17267,10116.0,50597,Plasma clearance in rat was determined,1,N,7886,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623705,,BAO_0000218,,,,A,6535,10116.0,50597,Plasma clearance in rat after administration of 2 mg/kg iv,1,N,7887,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623706,,BAO_0000218,,,,A,6535,10116.0,50597,Plasma clearance in rat after administration of 2 mg/kg iv,1,N,7888,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623707,,BAO_0000218,,,,A,5041,10116.0,50597,Plasma clearance was determined,1,N,7889,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623708,,BAO_0000218,,,,A,5960,10116.0,50597,Plasma clearance in rat,1,N,7890,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623709,,BAO_0000218,,,,A,5937,10116.0,50597,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,1,N,7891,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623710,,BAO_0000218,,,,A,5871,10116.0,50597,Plasma clearance in rat by iv administration,1,N,7892,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623711,,BAO_0000218,,,,A,5874,10116.0,50597,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,1,N,7893,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623712,,BAO_0000218,,,,A,6504,10116.0,50597,Plasma clearance in rat p.o.,1,N,7894,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623713,,BAO_0000218,,,,A,6803,10116.0,50597,Plasma clearance in rats,1,N,7895,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623714,,BAO_0000218,,,,A,5041,10116.0,50597,Plasma clearance was determined; ND denotes no data,1,N,7896,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623715,,BAO_0000218,,,,A,5041,10116.0,50597,Plasma clearance was determined; ND denotes not determined,1,N,7897,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623716,,BAO_0000218,,,,A,1916,10116.0,50597,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,1,N,7898,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622980,,BAO_0000218,,,,A,5199,10116.0,50597,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,1,N,7899,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622981,,BAO_0000218,,,,A,16367,10116.0,50597,Plasma administration to rats,1,N,7900,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622982,,BAO_0000218,,,,A,6362,10116.0,50597,Plasma clearance of the compound in female Sprague-Dawley rats,1,N,7901,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622983,,BAO_0000218,,,,A,15662,10116.0,50597,Plasma clearance was observed after intravenous administration in rat,1,N,7902,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622984,,BAO_0000218,,,,A,6215,10116.0,50597,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,1,N,7903,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622985,,BAO_0000218,,,,A,1466,10116.0,50597,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,1,N,7904,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623631,1969.0,BAO_0000218,,,,A,15662,10116.0,50597,plasma clearance was observed after intravenous administration in rat,1,N,7905,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623632,,BAO_0000218,,,,A,4723,10116.0,50597,In vivo CL/F determined,1,N,7906,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623633,1969.0,BAO_0000218,,,,A,2792,10116.0,50597,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,1,N,7907,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623634,1969.0,BAO_0000218,,,,A,2792,10116.0,50597,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,1,N,7908,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623635,,BAO_0000218,,,,A,5213,10116.0,50597,Compound was tested for the lower blood clearance in rat,1,N,7909,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621195,,BAO_0000218,,,,A,4687,10116.0,50597,Evaluated for the low clearance in rat (in vivo),1,N,7910,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621196,,BAO_0000218,,,,A,3371,10116.0,50597,Pharmacokinetic property (CLb)of the compound was determined in rat,1,N,7911,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL875287,,BAO_0000218,,,,A,4690,10116.0,50597,Rapid clearance after intravenous administration in rat was determined,1,N,7912,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621197,,BAO_0000218,,,,A,5702,10116.0,50597,Clearance measured in rat,1,N,7913,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621198,1969.0,BAO_0000218,,,,A,740,10116.0,50597,Compound was evaluated for plasma clearance in rat,1,N,7914,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL621199,1969.0,BAO_0000218,,,,A,4853,10116.0,50597,Low plasma clearance was calculated in rat,1,N,7915,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL621200,,BAO_0000218,,,,A,5789,10116.0,50597,Pharmacokinetic property (Clp) in rat,1,N,7916,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621201,,BAO_0000218,,,,A,4527,10116.0,50597,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,1,N,7917,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621202,,BAO_0000218,,,,A,4527,10116.0,50597,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,1,N,7918,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621203,,BAO_0000218,,,,A,6518,10116.0,50597,Plasma clearance after IV dosing at 0.5 mg/kg in rat,1,N,7919,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621204,,BAO_0000218,,,,A,6518,10116.0,50597,Plasma clearance after IV dosing at 1 mg/kg in rat,1,N,7920,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621205,948.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,1,N,7921,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL621206,948.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,1,N,7922,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL621207,948.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,1,N,7923,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL621208,948.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,1,N,7924,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL621209,948.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,1,N,7925,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL876484,948.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,1,N,7926,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL621210,948.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,1,N,7927,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL621211,948.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,1,N,7928,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL621212,948.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,1,N,7929,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL621213,948.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat heart in the presence of GdDTPA at 15 min,1,N,7930,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL621214,948.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,1,N,7931,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL621215,948.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat heart in the presence of GdDTPA at 30 min,1,N,7932,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL621216,948.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,1,N,7933,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL621217,948.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,1,N,7934,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL621218,948.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,1,N,7935,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL621219,948.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,1,N,7936,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL621220,948.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,1,N,7937,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL621221,948.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,1,N,7938,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL621222,948.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,1,N,7939,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL621223,948.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,1,N,7940,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL876485,948.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,1,N,7941,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL621224,948.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,1,N,7942,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL621225,948.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,1,N,7943,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL621226,948.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,1,N,7944,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL621227,2113.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,1,N,7945,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL621228,2113.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,1,N,7946,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL621229,2113.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,1,N,7947,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL621230,2113.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,1,N,7948,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL621231,2113.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,1,N,7949,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL621232,2113.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,1,N,7950,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL621233,2113.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,1,N,7951,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL621234,2113.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,1,N,7952,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL621235,2113.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,1,N,7953,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL621236,2113.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,1,N,7954,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL621237,2113.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,1,N,7955,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL876486,2113.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,1,N,7956,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL622436,160.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,1,N,7957,In vivo,Rattus norvegicus,Intestine,1,,Intermediate
,,,CHEMBL622437,160.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,1,N,7958,In vivo,Rattus norvegicus,Intestine,1,,Intermediate
,,,CHEMBL622438,160.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,1,N,7959,In vivo,Rattus norvegicus,Intestine,1,,Intermediate
,,,CHEMBL622439,2107.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,1,N,7960,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622440,2107.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,1,N,7961,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622441,2107.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,1,N,7962,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622442,2107.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,1,N,7963,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622443,2107.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,1,N,7964,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622444,2107.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,1,N,7965,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622445,2107.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,1,N,7966,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622446,2107.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,1,N,7967,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622447,2107.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,1,N,7968,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622448,2107.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,1,N,7969,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622449,2107.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,1,N,7970,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622450,2107.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,1,N,7971,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622451,2107.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,1,N,7972,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622452,2107.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat liver in the presence of GdDTPA at 15 min,1,N,7973,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622453,2107.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,1,N,7974,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622454,2107.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat liver in the presence of GdDTPA at 30 min,1,N,7975,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622455,2107.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,1,N,7976,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL876024,2107.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,1,N,7977,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622456,,BAO_0000218,,,,A,2792,10116.0,50597,T max was determined at 3 mg/kg po dose in rats,1,N,7978,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622457,,BAO_0000218,,,,A,15078,10116.0,50597,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",1,N,7979,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622458,,BAO_0000218,,,,A,15078,10116.0,50597,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",1,N,7980,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622459,,BAO_0000218,,,,A,15022,10116.0,50597,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,1,N,7981,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL873343,,BAO_0000218,,,,A,15022,10116.0,50597,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,1,N,7982,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622460,,BAO_0000218,,,,A,15022,10116.0,50597,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,1,N,7983,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622461,1969.0,BAO_0000218,,,,A,4576,10116.0,50597,Time for maximum plasma concentration determined in rat,1,N,7984,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622462,1969.0,BAO_0000218,,,,A,6681,10116.0,50597,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,1,N,7985,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622463,,BAO_0000218,,,,A,16365,10116.0,50597,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,1,N,7986,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622464,,BAO_0000218,,,,A,16365,10116.0,50597,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,1,N,7987,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622465,,BAO_0000218,,,,A,16365,10116.0,50597,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,1,N,7988,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622466,,BAO_0000218,,,,A,16365,10116.0,50597,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,1,N,7989,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622467,,BAO_0000218,,,,A,16365,10116.0,50597,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,1,N,7990,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622468,1969.0,BAO_0000218,,,,A,6824,10116.0,50597,Time of maximum plasma concentration in rat,1,N,7991,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL876025,1969.0,BAO_0000218,,,,A,6685,10116.0,50597,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",1,N,7992,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622469,1969.0,BAO_0000218,,,,A,6685,10116.0,50597,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",1,N,7993,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622470,1969.0,BAO_0000218,,,,A,6685,10116.0,50597,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",1,N,7994,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622471,,BAO_0000218,,,,A,15662,10116.0,50597,Time required to reach maximum concentration (Cmax) after oral administration in rat,1,N,7995,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622472,1969.0,BAO_0000218,,,,A,1742,10116.0,50597,Time required to reach maximum concentration in rat plasma,1,N,7996,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622473,1969.0,BAO_0000218,,,,A,2774,10116.0,50597,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,1,N,7997,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL624282,1969.0,BAO_0000218,,,,A,5199,10116.0,50597,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,1,N,7998,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL624283,1969.0,BAO_0000218,,,,A,12873,10116.0,50597,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,1,N,7999,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL624284,1969.0,BAO_0000218,,,,A,12873,10116.0,50597,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,1,N,8000,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL624285,1969.0,BAO_0000218,,,,A,1916,10116.0,50597,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,1,N,8001,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL624286,,BAO_0000218,,,,A,16367,10116.0,50597,Time to reach Cmax after oral administration to rats,1,N,8002,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624287,,BAO_0000218,,,,A,16366,10116.0,50597,Time to reach Cmax when a dose of 1 mg/kg is administered orally,1,N,8003,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624288,,BAO_0000218,,,,A,216,10116.0,50597,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,1,N,8004,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624289,1969.0,BAO_0000218,,,,A,6410,10116.0,50597,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,1,N,8005,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL873344,1969.0,BAO_0000218,,,,A,6410,10116.0,50597,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,1,N,8006,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL619623,,BAO_0000218,,,,A,6215,10116.0,50597,Tmax after peroral administration (10 mg/kg) was determined in rat,1,N,8007,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621399,,BAO_0000218,,,,A,3598,10116.0,50597,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,1,N,8008,In vivo,Rattus norvegicus,,1,,Expert
,,,CHEMBL621400,,BAO_0000218,,,,A,4527,10116.0,50597,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,1,N,8009,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621401,,BAO_0000218,,,,A,17670,10116.0,50597,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",1,N,8010,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621402,,BAO_0000218,,,,A,1465,10116.0,50597,Tmax was determined,1,N,8011,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621403,,BAO_0000218,,,,A,2552,10116.0,50597,Tmax was determined,1,N,8012,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621121,,BAO_0000218,,,,A,5656,10116.0,50597,Tmax after oral administration in rat,1,N,8013,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL872525,,BAO_0000218,,,,A,17764,10116.0,50597,Tmax after peroral administration in rats at 2.4 uM/kg,1,N,8014,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621122,,BAO_0000218,,,,A,5610,10116.0,50597,Tmax in male rat,1,N,8015,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621123,,BAO_0000218,,,,A,6046,10116.0,50597,Tmax in rat at 10 mg/kg,1,N,8016,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621124,,BAO_0000218,,,,A,5874,10116.0,50597,Tmax in rat by po administration at a dose of 40 mg/kg,1,N,8017,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621125,,BAO_0000218,,,,A,17596,10116.0,50597,Tmax in rats,1,N,8018,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621126,,BAO_0000218,,,,A,17804,10116.0,50597,Tmax was measured in rats after peroral administration at 5 mg/kg,1,N,8019,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621127,,BAO_0000218,,,,A,1908,10116.0,50597,Tmax value after oral dose at a dose of 10 mg/kg in rats.,1,N,8020,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621128,,BAO_0000218,,,,A,2959,10116.0,50597,Tmax value after administration of 20 mg/Kg oral dose in rat,1,N,8021,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618263,,BAO_0000218,,,,A,6757,10116.0,50597,Tmax value at a dose of 10 mg/kg in male SD rats,1,N,8022,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618264,,BAO_0000218,,,,A,6757,10116.0,50597,Tmax value at a dose of 100 mg/kg in male SD rats,1,N,8023,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618265,,BAO_0000218,,,,A,6757,10116.0,50597,Tmax value at a dose of 50 mg/kg in male SD rats,1,N,8024,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618266,1969.0,BAO_0000218,,,,A,4186,10116.0,50597,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,1,N,8025,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL618267,,BAO_0000218,,,,A,15662,10116.0,50597,time required to reach maximum concentration (Cmax) after oral administration in rat,1,N,8026,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618450,1088.0,BAO_0000218,,,,A,429,10116.0,50597,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),1,N,8027,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL618451,1088.0,BAO_0000218,,,,A,429,10116.0,50597,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),1,N,8028,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL618452,,BAO_0000218,,,,A,5546,10116.0,50597,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,1,N,8029,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618453,1088.0,BAO_0000218,,,,A,3173,10116.0,50597,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,1,N,8030,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL618454,1088.0,BAO_0000218,,,,A,3173,10116.0,50597,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,1,N,8031,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL618455,1088.0,BAO_0000218,,,,A,3173,10116.0,50597,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,1,N,8032,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL618456,,BAO_0000218,,,,A,4257,10116.0,50597,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,1,N,8033,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618457,,BAO_0000218,,,,A,6011,10116.0,50597,Compound distribution in rat tissues was determined,1,N,8034,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618458,,BAO_0000218,,,,A,5472,10116.0,50597,Volume of distribution was evaluated in rat,1,N,8035,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618459,,BAO_0000218,,,,A,14346,10116.0,50597,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,1,N,8036,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL876733,,BAO_0000218,,,,A,14346,10116.0,50597,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,1,N,8037,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618460,,BAO_0000218,,,,A,14346,9615.0,50588,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,1,N,8038,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL618461,,BAO_0000218,,,,A,14346,10116.0,50597,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,1,N,8039,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618462,,BAO_0000019,,,,A,15469,,22224,Area under the curve was determined after oral administration (300 uM/Kg),1,U,8040,,,,0,,Autocuration
,,,CHEMBL618463,,BAO_0000218,,,,A,14346,10116.0,50597,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,1,N,8041,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618464,,BAO_0000218,,,,A,14346,10116.0,50597,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,1,N,8042,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618465,,BAO_0000218,,,,A,14346,10116.0,50597,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,1,N,8043,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618466,,BAO_0000218,,,,A,14346,10116.0,50597,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,1,N,8044,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618467,,BAO_0000218,,,,A,14346,10116.0,50597,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,1,N,8045,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618468,,BAO_0000218,,,,A,15372,10116.0,50597,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,1,N,8046,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618469,1969.0,BAO_0000218,,,,A,12935,9615.0,50588,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,1,N,8047,,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL618470,1969.0,BAO_0000218,,,,A,12935,9615.0,50588,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,1,N,8048,,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL618471,,BAO_0000218,,,,A,14813,,22224,Plasma drug AUC in rat (PO dose),1,U,8049,,,,0,,Autocuration
,,,CHEMBL618472,,BAO_0000218,,,,A,15792,10090.0,50594,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,1,N,8050,,Mus musculus,,1,,Intermediate
,,,CHEMBL618473,,BAO_0000218,,,,A,3579,,22224,Area under was determined at a dose of 30 mg/kg,1,U,8051,,,,0,,Autocuration
,,,CHEMBL621699,,BAO_0000218,,,,A,12487,9669.0,50506,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,1,N,8052,,Mustela putorius furo,,1,,Intermediate
,,,CHEMBL621700,,BAO_0000218,,,,A,12487,10116.0,50597,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,1,N,8053,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621701,,BAO_0000218,,,,A,12487,10116.0,50597,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,1,N,8054,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621702,,BAO_0000218,,,,A,12487,9669.0,50506,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,1,N,8055,,Mustela putorius furo,,1,,Intermediate
,,,CHEMBL621703,,BAO_0000218,,,,A,12487,9615.0,50588,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,1,N,8056,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL621704,,BAO_0000218,,,,A,12487,9615.0,50588,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,1,N,8057,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624259,,BAO_0000218,,,,A,12902,10116.0,50597,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",1,N,8058,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624260,,BAO_0000218,,,,A,12902,10116.0,50597,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",1,N,8059,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624430,,BAO_0000218,,,,A,12902,10116.0,50597,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",1,N,8060,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624431,,BAO_0000218,,,,A,12902,10116.0,50597,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",1,N,8061,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624432,,BAO_0000218,,,,A,12902,10116.0,50597,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",1,N,8062,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624433,,BAO_0000218,,,,A,12902,10116.0,50597,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",1,N,8063,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624434,,BAO_0000218,,,,A,12902,10116.0,50597,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",1,N,8064,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624435,,BAO_0000218,,,,A,12902,10116.0,50597,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",1,N,8065,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618570,,BAO_0000218,,,,A,12745,10090.0,50594,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,1,N,8066,,Mus musculus,,1,,Intermediate
,,,CHEMBL618571,,BAO_0000218,,,,A,12745,10090.0,50594,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),1,N,8067,,Mus musculus,,1,,Intermediate
,,,CHEMBL618572,,BAO_0000218,,,,A,12745,10090.0,50594,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,1,N,8068,,Mus musculus,,1,,Intermediate
,,,CHEMBL618573,,BAO_0000218,,,,A,12745,10090.0,50594,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),1,N,8069,,Mus musculus,,1,,Intermediate
,,,CHEMBL619267,,BAO_0000218,,,,A,12745,10090.0,50594,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,1,N,8070,,Mus musculus,,1,,Intermediate
,,,CHEMBL619431,,BAO_0000218,,,,A,12745,10090.0,50594,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),1,N,8071,,Mus musculus,,1,,Intermediate
,,,CHEMBL619432,,BAO_0000218,,,,A,12745,10090.0,50594,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,1,N,8072,,Mus musculus,,1,,Intermediate
,,,CHEMBL619433,,BAO_0000218,,,,A,12745,10090.0,50594,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),1,N,8073,,Mus musculus,,1,,Intermediate
,,,CHEMBL619434,1969.0,BAO_0000218,,,,A,13298,,22224,AUC in mice after oral dose (50 mg/kg),1,U,8074,,,Plasma,0,,Autocuration
,,,CHEMBL619435,1977.0,BAO_0000218,,,,A,12226,10090.0,50594,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,1,N,8075,,Mus musculus,Serum,1,,Intermediate
,,,CHEMBL619436,1969.0,BAO_0000019,,,,A,12634,,22224,AUC (0-4 hr) ug/ml/h,1,U,8076,,,Plasma,0,,Autocuration
,,,CHEMBL619437,,BAO_0000218,,,,A,14810,10116.0,50597,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,1,N,8077,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL619438,,BAO_0000218,,,,A,13889,,22224,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,1,U,8078,,,,0,,Autocuration
,,,CHEMBL619439,,BAO_0000218,,,,A,10018,10090.0,50594,Compound was evaluated for Area under curve in mice,1,N,8079,,Mus musculus,,1,,Intermediate
,,,CHEMBL619440,,BAO_0000218,,,,A,8758,10116.0,50597,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,1,N,8080,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL619441,,BAO_0000218,,,,F,8758,,22224,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,1,U,8081,,,,0,,Autocuration
,,,CHEMBL619442,,BAO_0000218,,,,A,8758,10116.0,50597,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,1,N,8082,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL875156,,BAO_0000019,,,,A,2249,,22224,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,1,U,8083,,,,0,,Autocuration
,,,CHEMBL619443,,BAO_0000019,,,,A,2249,,22224,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,1,U,8084,,,,0,,Autocuration
,,,CHEMBL619444,,BAO_0000019,,,,A,2249,,22224,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,1,U,8085,,,,0,,Autocuration
,,,CHEMBL623464,,BAO_0000019,,,,A,2249,,22224,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,1,U,8086,,,,0,,Autocuration
,,,CHEMBL623465,,BAO_0000218,,,,A,15115,10090.0,50594,Compound was evaluated for area under curve when administered through oral route in mouse,1,N,8087,,Mus musculus,,1,,Intermediate
,,,CHEMBL623466,,BAO_0000218,,,,A,6518,10116.0,50597,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,1,N,8088,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623467,,BAO_0000218,,,,A,6518,10116.0,50597,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,1,N,8089,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623468,,BAO_0000218,,,,A,6249,10116.0,50597,Plasma clearance in rat,1,N,8090,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622660,,BAO_0000218,,,,A,2463,10116.0,50597,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,1,N,8091,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622661,,BAO_0000218,,,,A,4969,10116.0,50597,Plasma clearance rate in Sprague-Dawley rats,1,N,8092,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622662,,BAO_0000218,,,,F,17720,10116.0,50597,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,1,N,8093,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622663,,BAO_0000218,,,,A,3457,10116.0,50597,Pharmacokinetic property (total body clearance) in rat,1,N,8094,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622664,,BAO_0000218,,,,A,5983,10116.0,50597,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,1,N,8095,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622665,,BAO_0000218,,,,A,6295,10116.0,50597,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,1,N,8096,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622666,,BAO_0000218,,,,A,6296,10116.0,50597,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,1,N,8097,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621615,,BAO_0000218,,,,A,17686,10116.0,50597,Cl in rat i.v. at 2 mg/kg concentration,1,N,8098,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621616,,BAO_0000218,,,,A,17764,10116.0,50597,Clearance of compound after intravenous administration in rats at 24 uM/kg,1,N,8099,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621617,,BAO_0000218,,,,A,5503,10116.0,50597,Clearance was determined,1,N,8100,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621618,,BAO_0000218,,,,A,4368,10116.0,50597,Clearance by intravenous administration of 3.4 mg/kg in rat,1,N,8101,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621619,,BAO_0000218,,,,A,6005,10116.0,50597,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,1,N,8102,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621620,,BAO_0000218,,,,A,5031,10116.0,50597,Clearance rate after i.v. administration in rats,1,N,8103,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621786,,BAO_0000218,,,,A,4890,10116.0,50597,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,1,N,8104,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621787,,BAO_0000218,,,,A,5182,10116.0,50597,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,1,N,8105,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621788,,BAO_0000218,,,,A,5979,10116.0,50597,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,1,N,8106,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621789,,BAO_0000218,,,,A,5656,10116.0,50597,Clearance (Cl) after oral administration in rat,1,N,8107,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621790,,BAO_0000218,,,,A,17804,10116.0,50597,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,1,N,8108,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621791,1969.0,BAO_0000218,,,,A,4839,10116.0,50597,Compound was tested for plasma clearance in rat,1,N,8109,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL621792,,BAO_0000218,,,,A,5041,10116.0,50597,In vitro microsome metabolism clearance in rat was determined,1,N,8110,In vitro,Rattus norvegicus,,1,Microsomes,Intermediate
,,,CHEMBL621793,,BAO_0000218,,,,A,5041,10116.0,50597,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,1,N,8111,In vitro,Rattus norvegicus,,1,Microsomes,Intermediate
,,,CHEMBL621794,,BAO_0000218,,,,A,5974,10116.0,50597,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,1,N,8112,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621795,1969.0,BAO_0000218,,,,A,5496,10116.0,50597,In vivo plasma clearance was determined,1,N,8113,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL621796,,BAO_0000218,,,,A,5739,10116.0,50597,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,1,N,8114,In vivo,Rattus norvegicus,,1,,Intermediate
,401.0,,CHEMBL621797,2107.0,BAO_0000218,,,Hepatocyte,A,5676,10116.0,50597,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,1,N,8115,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL621798,,BAO_0000218,,,,A,4239,10116.0,50597,Pharmacokinetic property (Plasma clearance) was measured in rat,1,N,8116,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621799,,BAO_0000218,,,,A,5676,10116.0,50597,Pharmacokinetic property (clearance) in rat i.v.,1,N,8117,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621800,,BAO_0000218,,,,A,1918,10116.0,50597,"Plasma Clearance was evaluated in rats, iv",1,N,8118,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621801,,BAO_0000218,,,,A,17800,10116.0,50597,Plasma clearance (in vivo) in rats was determined,1,N,8119,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621802,,BAO_0000218,,,,A,6056,10116.0,50597,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,1,N,8120,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618596,,BAO_0000218,,,,A,5496,10116.0,50597,Plasma clearance was determined,1,N,8121,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618597,,BAO_0000218,,,,A,5939,10116.0,50597,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,1,N,8122,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618598,,BAO_0000218,,,,A,5939,10116.0,50597,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,1,N,8123,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618599,,BAO_0000218,,,,A,17752,10116.0,50597,Plasma clearance in rats,1,N,8124,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618600,,BAO_0000218,,,,A,4576,10116.0,50597,Plasma clearance rate determined in rat,1,N,8125,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618601,,BAO_0000218,,,,A,6011,10116.0,50597,Plasma clearance was determined in rat,1,N,8126,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618602,,BAO_0000218,,,,A,5510,10116.0,50597,Plasma clearance was determined,1,N,8127,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618603,,BAO_0000218,,,,A,5948,10116.0,50597,Plasma clearance value in rat,1,N,8128,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618604,2107.0,BAO_0000218,,,,A,6125,10116.0,50597,Clearance rate constant using isolated perfused rat liver (IPRL) assay,1,N,8129,Ex vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL618605,,BAO_0000218,,,,A,4839,10116.0,50597,Clearance in rat,1,N,8130,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618606,,BAO_0000218,,,,A,17686,10116.0,50597,Total body clearance in rat i.v. at 2 mg/kg concentration,1,N,8131,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618607,,BAO_0000218,,,,A,6571,10116.0,50597,Clearance of compound in rats after intravenous administration,1,N,8132,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618608,,BAO_0000218,,,,A,3364,10116.0,50597,Clearance after iv administration to rats,1,N,8133,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618609,,BAO_0000218,,,,A,13569,10116.0,50597,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,1,N,8134,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618610,,BAO_0000218,,,,A,13569,10116.0,50597,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,1,N,8135,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618611,,BAO_0000218,,,,A,13569,10116.0,50597,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,1,N,8136,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618612,,BAO_0000218,,,,A,13569,10116.0,50597,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,1,N,8137,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618613,,BAO_0000218,,,,A,13569,10116.0,50597,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,1,N,8138,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621076,,BAO_0000218,,,,A,13569,10116.0,50597,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,1,N,8139,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621077,,BAO_0000218,,,,A,13569,10116.0,50597,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,1,N,8140,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621078,,BAO_0000218,,,,A,17670,10116.0,50597,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",1,N,8141,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621251,,BAO_0000218,,,,A,5970,10116.0,50597,Clearance in rat,1,N,8142,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621252,,BAO_0000218,,,,A,6495,10116.0,50597,Clearance in rat after oral administration at 10 mg/kg,1,N,8143,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621253,,BAO_0000218,,,,A,4590,10116.0,50597,Clearance in rat.,1,N,8144,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621254,,BAO_0000218,,,,A,6193,10116.0,50597,Clearance rate following an oral dose of 20 mg/kg in rats,1,N,8145,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621255,,BAO_0000218,,,,A,2832,10116.0,50597,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,1,N,8146,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621256,1969.0,BAO_0000218,,,,A,1052,10116.0,50597,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,1,N,8147,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL621257,2107.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,1,N,8148,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL621258,2107.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,1,N,8149,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL621259,2107.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,1,N,8150,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL621260,2107.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,1,N,8151,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL876494,2107.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,1,N,8152,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL621261,2107.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,1,N,8153,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL621262,2107.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,1,N,8154,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL621263,2107.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,1,N,8155,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL621264,2107.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,1,N,8156,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL621265,2385.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,1,N,8157,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL621266,2385.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,1,N,8158,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL621267,2385.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,1,N,8159,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL621268,2385.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,1,N,8160,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL621269,2385.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,1,N,8161,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL621270,2385.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,1,N,8162,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL621271,2385.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,1,N,8163,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL621272,2385.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,1,N,8164,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL621273,2385.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,1,N,8165,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL621274,2385.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,1,N,8166,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL876495,2385.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,1,N,8167,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL621275,2385.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,1,N,8168,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL621276,2385.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,1,N,8169,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL621277,2385.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,1,N,8170,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL621278,160.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,1,N,8171,In vivo,Rattus norvegicus,Intestine,1,,Intermediate
,,,CHEMBL621279,160.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,1,N,8172,In vivo,Rattus norvegicus,Intestine,1,,Intermediate
,,,CHEMBL621280,160.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),1,N,8173,In vivo,Rattus norvegicus,Intestine,1,,Intermediate
,,,CHEMBL621281,2106.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,1,N,8174,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL621282,2106.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,1,N,8175,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL621283,2106.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,1,N,8176,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL621284,2106.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,1,N,8177,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL621285,2106.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,1,N,8178,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL621286,2106.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,1,N,8179,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL623220,2106.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,1,N,8180,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL623221,2106.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,1,N,8181,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL876029,2106.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,1,N,8182,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL623222,945.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,1,N,8183,In vivo,Rattus norvegicus,Stomach,1,,Intermediate
,,,CHEMBL623223,945.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,1,N,8184,In vivo,Rattus norvegicus,Stomach,1,,Intermediate
,,,CHEMBL621445,945.0,BAO_0000218,,,,A,9866,10116.0,50597,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,1,N,8185,In vivo,Rattus norvegicus,Stomach,1,,Intermediate
,,,CHEMBL621446,178.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,N,8186,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL621447,178.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,1,N,8187,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL619681,178.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,N,8188,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL619682,178.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,1,N,8189,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL619683,178.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,N,8190,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL619684,955.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,N,8191,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL619685,955.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,1,N,8192,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL619686,955.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,N,8193,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL619687,955.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,1,N,8194,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL619688,955.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,N,8195,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL619689,948.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,N,8196,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL619690,948.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,1,N,8197,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL619691,948.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,N,8198,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL619692,,BAO_0000218,,,,A,6062,10116.0,50597,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,1,N,8199,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL619693,,BAO_0000218,,,,A,3598,10116.0,50597,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,1,N,8200,,Rattus norvegicus,,1,,Expert
,,,CHEMBL619694,,BAO_0000218,,,,A,1908,10116.0,50597,Vc value after IV dose at a dose of 5 mg/kg in rats.,1,N,8201,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL619695,,BAO_0000218,,,,A,17596,10116.0,50597,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,1,N,8202,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL619696,,BAO_0000218,,,,A,4891,10116.0,50597,Compound was evaluated for pharmacokinetic parameter volume of distribution,1,N,8203,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL619697,,BAO_0000218,,,,A,740,10116.0,50597,Compound was evaluated for volume of distribution in rat,1,N,8204,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL619698,,BAO_0000218,,,,A,16366,10116.0,50597,Steady state volume distribution was determined; steady state(ss),1,N,8205,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL619699,,BAO_0000218,,,,A,3364,10116.0,50597,Steady state volume of distribution after iv administration to rats,1,N,8206,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL619700,,BAO_0000218,,,,A,2552,10116.0,50597,Steady state volume of distribution dosing at 3 mg/kg iv,1,N,8207,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL619701,,BAO_0000218,,,,A,406,10116.0,50597,The compound was evaluated for volume of distribution in rat,1,N,8208,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL619702,,BAO_0000218,,,,A,12500,10116.0,50597,The compound was tested for volume of distribution in rat,1,N,8209,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620335,,BAO_0000218,,,,A,12500,10116.0,50597,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,1,N,8210,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620336,,BAO_0000218,,,,A,5656,10116.0,50597,Volume distribution (VD) after oral administration in rat,1,N,8211,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620337,,BAO_0000218,,,,A,17671,10116.0,50597,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,1,N,8212,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620520,,BAO_0000218,,,,A,1094,10116.0,50597,Volume distribution in rat,1,N,8213,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620521,,BAO_0000218,,,,A,5833,10116.0,50597,Volume distribution in rat,1,N,8214,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL875825,,BAO_0000218,,,,A,5939,10116.0,50597,Volume distribution in rat after peroral administration at 10 mg/kg,1,N,8215,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620522,,BAO_0000218,,,,A,5939,10116.0,50597,Volume distribution in rat after peroral administration at 5 mg/kg,1,N,8216,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620523,,BAO_0000218,,,,A,6005,10116.0,50597,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,1,N,8217,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620524,,BAO_0000218,,,,A,1696,10116.0,50597,Volume of distribution in rat.,1,N,8218,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620525,,BAO_0000218,,,,A,6672,10116.0,50597,Volume of distribution in rat,1,N,8219,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620526,,BAO_0000218,,,,A,6673,10116.0,50597,Volume of distribution in rat,1,N,8220,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620527,,BAO_0000218,,,,A,5871,10116.0,50597,Volume of distribution in rat by iv administration,1,N,8221,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620528,,BAO_0000218,,,,A,6803,10116.0,50597,Volume of distribution in rats,1,N,8222,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620529,,BAO_0000218,,,,A,5199,10116.0,50597,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,1,N,8223,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620530,,BAO_0000218,,,,A,4727,10116.0,50597,Volume distribution at the dose of 2 mg/kg in rat,1,N,8224,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620531,,BAO_0000218,,,,A,16367,10116.0,50597,Steady state volume of distribution was determined,1,N,8225,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620532,,BAO_0000218,,,,A,5005,9544.0,22224,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,1,U,8226,In vivo,Macaca mulatta,,0,,Intermediate
,,,CHEMBL620533,,BAO_0000218,,,,A,5005,10116.0,22224,Compound was tested for its plasma volume distribution in Sprague Dawley rats,1,U,8227,In vivo,Rattus norvegicus,,0,,Intermediate
,,,CHEMBL620534,,BAO_0000218,,,,A,5005,10116.0,22224,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,1,U,8228,In vivo,Rattus norvegicus,,0,,Intermediate
,,,CHEMBL620535,,BAO_0000218,,,,A,15765,10116.0,50597,Mean (%CV) PK parameters for Vdss(mL/kg).,1,N,8229,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL875826,,BAO_0000218,,,,A,2792,10116.0,50597,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,1,N,8230,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620536,,BAO_0000218,,,,A,2792,10116.0,50597,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,1,N,8231,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620537,,BAO_0000218,,,,A,5334,10116.0,50597,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,1,N,8232,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618526,,BAO_0000218,,,,A,5334,10116.0,50597,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,1,N,8233,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618527,,BAO_0000218,,,,A,5739,10116.0,50597,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,1,N,8234,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618528,,BAO_0000218,,,,A,5789,10116.0,50597,Pharmacokinetic property (Vdss) in rat,1,N,8235,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618529,,BAO_0000218,,,,A,4239,10116.0,50597,Pharmacokinetic property (vdss) was measured in rat,1,N,8236,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618530,,BAO_0000218,,,,A,4709,10116.0,50597,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,1,N,8237,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618531,,BAO_0000218,,,,A,6642,10116.0,50597,Volume of distribution in rat,1,N,8238,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618532,,BAO_0000218,,,,A,5247,10116.0,50597,The pharmacokinetic parameter volume of distribution in vivo in rats,1,N,8239,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618533,,BAO_0000218,,,,F,17720,10116.0,50597,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,1,N,8240,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618534,,BAO_0000218,,,,A,17686,10116.0,50597,Vdss in rat i.v. at 2 mg/kg concentration,1,N,8241,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618535,,BAO_0000218,,,,A,4689,10116.0,50597,Volume distribution after intravenous administration (1 mg/kg) in rat,1,N,8242,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618536,,BAO_0000218,,,,A,5654,10116.0,50597,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,1,N,8243,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618537,,BAO_0000218,,,,A,5654,10116.0,50597,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,1,N,8244,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618538,,BAO_0000218,,,,A,4527,10116.0,50597,Volume distribution at a dose of 10 uM/kg in rat was determined,1,N,8245,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618539,,BAO_0000218,,,,A,4521,10116.0,50597,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,1,N,8246,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618540,,BAO_0000218,,,,A,6057,10116.0,50597,Volume distribution was calculated in rat,1,N,8247,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618541,,BAO_0000218,,,,A,5510,10116.0,50597,Volume distribution was determined,1,N,8248,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618542,,BAO_0000218,,,,A,2938,10116.0,50597,Volume of distribution after intravenous administration was evaluated in rat,1,N,8249,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622544,,BAO_0000218,,,,A,6679,10116.0,50597,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,1,N,8250,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622545,,BAO_0000218,,,,A,6685,10116.0,50597,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",1,N,8251,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622546,,BAO_0000218,,,,A,6685,10116.0,50597,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",1,N,8252,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622547,,BAO_0000218,,,,A,6685,10116.0,50597,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",1,N,8253,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622548,,BAO_0000218,,,,A,5145,10116.0,50597,Volume of distribution in steady state was determined in rat,1,N,8254,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622549,,BAO_0000218,,,,A,6467,10116.0,50597,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,1,N,8255,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622550,,BAO_0000218,,,,A,6467,10116.0,50597,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,1,N,8256,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622551,,BAO_0000218,,,,A,15115,10090.0,50594,Compound was evaluated for area under curve when administered through oral route to mouse,1,N,8257,,Mus musculus,,1,,Intermediate
,,,CHEMBL622552,,BAO_0000218,,,,A,8758,10116.0,50597,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,1,N,8258,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622553,,BAO_0000218,,,,A,8758,10116.0,50597,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,1,N,8259,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622554,,BAO_0000218,,,,F,8267,,22224,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,1,U,8260,In vivo,,,0,,Autocuration
,,,CHEMBL622555,,BAO_0000218,,,,A,8267,9615.0,50588,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,1,N,8261,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL622556,,BAO_0000218,,,,A,14239,10090.0,50594,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,1,N,8262,,Mus musculus,,1,,Intermediate
,,,CHEMBL622557,,BAO_0000218,,,,A,14239,10090.0,50594,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,1,N,8263,,Mus musculus,,1,,Intermediate
,,,CHEMBL622558,178.0,BAO_0000218,,,,A,10754,10090.0,50594,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,1,N,8264,,Mus musculus,Blood,1,,Intermediate
,,,CHEMBL622559,178.0,BAO_0000218,,,,A,10754,10090.0,50594,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,1,N,8265,,Mus musculus,Blood,1,,Intermediate
,,,CHEMBL622560,,BAO_0000218,,,,A,10754,9615.0,50588,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,1,N,8266,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL622561,,BAO_0000218,,,,A,14681,10116.0,50597,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,1,N,8267,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622562,,BAO_0000218,,,,A,14681,10116.0,50597,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,1,N,8268,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622563,,BAO_0000218,,,,A,14681,10116.0,50597,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,1,N,8269,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622564,,BAO_0000019,,,,A,13118,,22224,Concentration of compound in Central nervous system,1,U,8270,,,,0,,Autocuration
,,,CHEMBL622565,,BAO_0000019,,,,A,13118,,22224,Concentration of compound in Central nervous system; Not detectable,1,U,8271,,,,0,,Autocuration
,,,CHEMBL622566,,BAO_0000218,,,,A,13318,10090.0,50594,"Concentration of diester in the blood, following oral administration in mice",1,N,8272,,Mus musculus,,1,,Intermediate
,,,CHEMBL624515,,BAO_0000218,,,,A,13318,10090.0,50594,"Concentration of monoester in the blood, following oral administration in mice",1,N,8273,,Mus musculus,,1,,Intermediate
,,,CHEMBL624516,,BAO_0000218,,,,A,13318,10090.0,50594,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,1,N,8274,,Mus musculus,,1,,Intermediate
,,,CHEMBL624517,,BAO_0000019,,,,A,15692,,22224,Evaluated for Pharmacokinetic property: Area under the curve,1,U,8275,,,,0,,Autocuration
,,,CHEMBL624518,,BAO_0000218,,,,A,14839,10090.0,50594,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,1,N,8276,,Mus musculus,,1,,Intermediate
,,,CHEMBL624519,,BAO_0000218,,,,A,14839,9541.0,100710,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,1,N,8277,,Macaca fascicularis,,1,,Intermediate
,,,CHEMBL624520,,BAO_0000218,,,,A,14839,9541.0,100710,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,1,N,8278,,Macaca fascicularis,,1,,Intermediate
,,,CHEMBL624521,,BAO_0000218,,,,A,14839,9541.0,100710,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,1,N,8279,,Macaca fascicularis,,1,,Intermediate
,,,CHEMBL624522,,BAO_0000218,,,,A,14839,9541.0,100710,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,1,N,8280,,Macaca fascicularis,,1,,Intermediate
,,,CHEMBL624523,,BAO_0000218,,,,A,14839,9541.0,100710,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,1,N,8281,,Macaca fascicularis,,1,,Intermediate
,,,CHEMBL624409,,BAO_0000218,,,,A,14839,9541.0,100710,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",1,N,8282,,Macaca fascicularis,,1,,Intermediate
,,,CHEMBL624410,,BAO_0000218,,,,A,14839,9541.0,100710,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",1,N,8283,,Macaca fascicularis,,1,,Intermediate
,,,CHEMBL624411,,BAO_0000218,,,,A,14839,9541.0,100710,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",1,N,8284,,Macaca fascicularis,,1,,Intermediate
,,,CHEMBL623531,,BAO_0000218,,,,A,14839,9541.0,100710,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",1,N,8285,,Macaca fascicularis,,1,,Intermediate
,,,CHEMBL623532,,BAO_0000218,,,,A,14839,9541.0,100710,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",1,N,8286,,Macaca fascicularis,,1,,Intermediate
,,,CHEMBL623533,,BAO_0000218,,,,A,14839,9541.0,100710,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",1,N,8287,,Macaca fascicularis,,1,,Intermediate
,,,CHEMBL623534,,BAO_0000218,,,,A,14839,9541.0,100710,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",1,N,8288,,Macaca fascicularis,,1,,Intermediate
,,,CHEMBL623535,,BAO_0000218,,,,A,14839,10090.0,50594,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,1,N,8289,,Mus musculus,,1,,Intermediate
,,,CHEMBL623536,,BAO_0000218,,,,A,14839,10090.0,50594,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,1,N,8290,,Mus musculus,,1,,Intermediate
,,,CHEMBL623537,,BAO_0000218,,,,A,14839,10090.0,50594,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,1,N,8291,,Mus musculus,,1,,Intermediate
,,,CHEMBL623538,,BAO_0000218,,,,A,14839,10090.0,50594,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,1,N,8292,,Mus musculus,,1,,Intermediate
,,,CHEMBL623539,,BAO_0000218,,,,A,14839,10090.0,50594,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,1,N,8293,,Mus musculus,,1,,Intermediate
,,,CHEMBL623540,,BAO_0000218,,,,A,14839,10090.0,50594,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,1,N,8294,,Mus musculus,,1,,Intermediate
,,,CHEMBL623541,,BAO_0000218,,,,A,14839,10090.0,50594,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",1,N,8295,,Mus musculus,,1,,Intermediate
,,,CHEMBL623542,,BAO_0000218,,,,A,14839,10090.0,50594,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",1,N,8296,,Mus musculus,,1,,Intermediate
,,,CHEMBL623543,,BAO_0000218,,,,A,14839,10090.0,50594,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",1,N,8297,,Mus musculus,,1,,Intermediate
,,,CHEMBL623544,,BAO_0000218,,,,A,14839,10090.0,50594,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",1,N,8298,,Mus musculus,,1,,Intermediate
,,,CHEMBL623545,,BAO_0000218,,,,A,14839,10090.0,50594,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",1,N,8299,,Mus musculus,,1,,Intermediate
,,,CHEMBL623546,,BAO_0000218,,,,A,14839,10090.0,50594,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",1,N,8300,,Mus musculus,,1,,Intermediate
,,,CHEMBL623547,1969.0,BAO_0000218,,,,A,5408,10116.0,50597,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,1,N,8301,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623548,,BAO_0000218,,,,A,6827,10116.0,50597,High i.v. clearance in Dawley rats,1,N,8302,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623549,2107.0,BAO_0000218,,,,A,17538,10116.0,50597,In vitro clearance in rat liver microsomes,1,N,8303,In vitro,Rattus norvegicus,Liver,1,Microsomes,Intermediate
,,,CHEMBL623550,2107.0,BAO_0000218,,,,A,6331,10116.0,50597,Intrinsic clearance in rat liver microsomes was determined,1,N,8304,In vitro,Rattus norvegicus,Liver,1,Microsomes,Intermediate
,401.0,,CHEMBL875276,2107.0,BAO_0000218,,,Hepatocyte,A,5948,10116.0,50597,Intrinsic clearance in rat hepatocytes was determined,1,N,8305,In vitro,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL621872,,BAO_0000218,,,,A,4026,10116.0,50597,Plasma Clearance was determined,1,N,8306,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621873,,BAO_0000218,,,,A,6647,10116.0,50597,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,1,N,8307,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621874,,BAO_0000218,,,,A,1696,10116.0,50597,Plasma clearance in rat.,1,N,8308,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621875,,BAO_0000218,,,,A,6597,10116.0,50597,Plasma clearance in rats,1,N,8309,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621876,,BAO_0000218,,,,A,347,10116.0,50597,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,1,N,8310,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621877,,BAO_0000218,,,,A,16423,10116.0,50597,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,1,N,8311,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621878,,BAO_0000218,,,,A,2879,10116.0,50597,Plasma clearance was measured in rat,1,N,8312,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621879,,BAO_0000218,,,,A,4883,10116.0,50597,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,1,N,8313,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621880,1969.0,BAO_0000218,,,,A,5328,10116.0,50597,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",1,N,8314,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL621881,,BAO_0000218,,,,A,5160,10116.0,50597,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,1,N,8315,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621882,,BAO_0000218,,,,A,17582,10116.0,50597,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,1,N,8316,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL875283,,BAO_0000218,,,,A,17651,10116.0,50597,Total clearance at 1 mg/kg was determined in rat,1,N,8317,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621883,,BAO_0000218,,,,A,17651,10116.0,50597,Total clearance at 10 mg/kg was determined in rat,1,N,8318,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621884,,BAO_0000218,,,,A,6596,10116.0,50597,Clearance in rat,1,N,8319,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621885,,BAO_0000218,,,,A,4796,10116.0,50597,Plasma clearance rate determined in rats,1,N,8320,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621886,,BAO_0000218,,,,A,6850,10116.0,50597,Clearance of compound in rat was evaluated,1,N,8321,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621887,1969.0,BAO_0000218,,,,A,5932,10116.0,50597,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,1,N,8322,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL621888,,BAO_0000218,,,,A,3371,10116.0,50597,Pharmacokinetic property (blood clearance) in rat,1,N,8323,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621889,,BAO_0000218,,,,A,2083,10116.0,50597,Plasma clearance in rat,1,N,8324,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621890,,BAO_0000218,,,,A,4942,10116.0,50597,Plasma clearance in rats,1,N,8325,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621891,2107.0,BAO_0000218,,,,A,6838,10116.0,50597,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,1,N,8326,In vitro,Rattus norvegicus,Liver,1,Microsomes,Intermediate
,,,CHEMBL621892,,BAO_0000218,,,,A,5353,10116.0,50597,Clearance in Dawley rat,1,N,8327,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621893,,BAO_0000218,,,,A,6641,10116.0,50597,Clearance rat,1,N,8328,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621894,,BAO_0000218,,,,A,6641,10116.0,50597,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),1,N,8329,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621895,,BAO_0000218,,,,A,6641,10116.0,50597,Clearance rat; Not determined,1,N,8330,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL875284,,BAO_0000218,,,,A,6444,10116.0,50597,Clearance rate was determined in rat at a dose of 1 mpk i.v.,1,N,8331,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618699,,BAO_0000218,,,,A,6444,10116.0,50597,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,1,N,8332,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618700,,BAO_0000218,,,,A,6444,10116.0,50597,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,1,N,8333,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618701,,BAO_0000218,,,,A,6211,10116.0,50597,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,1,N,8334,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL876600,1969.0,BAO_0000218,,,,A,12873,10116.0,50597,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",1,N,8335,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL618702,,BAO_0000218,,,,A,6570,10116.0,50597,Clearance of compound in rat after 1 mg/kg i.v. administration,1,N,8336,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618703,,BAO_0000218,,,,A,3341,10116.0,50597,Compound was evaluated for Hepatic clearance in rat,1,N,8337,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618704,,BAO_0000218,,,,A,4891,10116.0,50597,In vivo clearance after 5 mg/kg dose,1,N,8338,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618705,1969.0,BAO_0000218,,,,A,1094,10116.0,50597,Compound was tested for plasma clearance in rats,1,N,8339,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL618706,,BAO_0000218,,,,A,2938,10116.0,50597,Hepatic clearance after intravenous administration was evaluated in rat,1,N,8340,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618707,,BAO_0000218,,,,A,17853,10116.0,50597,Lower clearance in rat (i.v.) at 0.5 mpk,1,N,8341,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618708,1969.0,BAO_0000218,,,,A,6049,10116.0,50597,Pharmacokinetic parameter expressed as plasma clearance in rat,1,N,8342,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL618709,,BAO_0000218,,,,A,5789,10116.0,50597,Pharmacokinetic property (Clp) in rat,1,N,8343,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618710,,BAO_0000218,,,,A,4514,10116.0,50597,Plasma clearance in Sprague-Dawley rats,1,N,8344,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618711,,BAO_0000218,,,,A,6448,10116.0,50597,Plasma clearance (Clp) in rat,1,N,8345,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618712,,BAO_0000218,,,,A,6062,10116.0,50597,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,1,N,8346,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618713,,BAO_0000218,,,,A,5710,10116.0,50597,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,1,N,8347,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618714,,BAO_0000218,,,,A,4709,10116.0,50597,Plasma clearance after intravenous administration of 1 mg/kg in rat,1,N,8348,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618715,,BAO_0000218,,,,A,4521,10116.0,50597,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,1,N,8349,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618716,,BAO_0000218,,,,A,1742,10116.0,50597,Plasma clearance in rat was determined,1,N,8350,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL876601,,BAO_0000218,,,,A,6057,10116.0,50597,Plasma clearance measured in rat,1,N,8351,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618717,,BAO_0000218,,,,A,6057,10116.0,50597,Plasma clearance was calculated in rat,1,N,8352,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618718,,BAO_0000218,,,,A,5145,10116.0,50597,Plasma clearance in rat,1,N,8353,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618719,,BAO_0000218,,,,A,5833,10116.0,50597,Plasma clearance in rat,1,N,8354,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618720,,BAO_0000218,,,,A,6453,10116.0,50597,Plasma clearance in rat,1,N,8355,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618721,,BAO_0000218,,,,A,6640,10116.0,50597,Plasma clearance in rat,1,N,8356,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621477,,BAO_0000218,,,,A,6305,10116.0,50597,Plasma clearance in rats,1,N,8357,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621478,,BAO_0000218,,,,A,6642,10116.0,50597,Plasma clearance in rat,1,N,8358,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621479,,BAO_0000218,,,,A,5472,10116.0,50597,Plasma clearance was evaluated in rat,1,N,8359,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621480,,BAO_0000218,,,,A,5472,10116.0,50597,Plasma clearance was evaluated in rat; Not tested,1,N,8360,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621481,,BAO_0000218,,,,A,5144,10116.0,50597,Plasma clearance rate was determined for the compound in rat,1,N,8361,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621482,,BAO_0000218,,,,A,6685,10116.0,50597,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",1,N,8362,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621483,,BAO_0000218,,,,A,6685,10116.0,50597,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",1,N,8363,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621484,,BAO_0000218,,,,A,6685,10116.0,50597,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",1,N,8364,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621485,948.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,1,N,8365,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL621486,948.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,N,8366,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL621487,160.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,N,8367,In vivo,Rattus norvegicus,Intestine,1,,Intermediate
,,,CHEMBL621488,160.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,1,N,8368,In vivo,Rattus norvegicus,Intestine,1,,Intermediate
,,,CHEMBL621489,160.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,N,8369,In vivo,Rattus norvegicus,Intestine,1,,Intermediate
,,,CHEMBL621490,160.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,1,N,8370,In vivo,Rattus norvegicus,Intestine,1,,Intermediate
,,,CHEMBL621491,160.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,N,8371,In vivo,Rattus norvegicus,Intestine,1,,Intermediate
,,,CHEMBL621492,2113.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,N,8372,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL621493,2113.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,1,N,8373,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL621494,2113.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,N,8374,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL621495,2113.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,1,N,8375,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL621496,2113.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,N,8376,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL621497,2107.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,N,8377,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL621498,2107.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,1,N,8378,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL621499,2107.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,N,8379,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL618634,2107.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,1,N,8380,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL618635,2107.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,N,8381,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL618636,2048.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,N,8382,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL619737,2048.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,1,N,8383,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL619738,2048.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,N,8384,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL624329,2048.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,1,N,8385,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL624330,2048.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,N,8386,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL624331,2385.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,N,8387,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL624332,2385.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,1,N,8388,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL624333,2385.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,N,8389,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL624334,2385.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,1,N,8390,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL624335,2385.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,N,8391,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL620016,2106.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,N,8392,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL620169,2106.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,1,N,8393,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL620170,2106.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,N,8394,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL620171,2106.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,1,N,8395,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL620172,2106.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,N,8396,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL620173,945.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,N,8397,In vivo,Rattus norvegicus,Stomach,1,,Intermediate
,,,CHEMBL620174,945.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,1,N,8398,In vivo,Rattus norvegicus,Stomach,1,,Intermediate
,,,CHEMBL620175,945.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,N,8399,In vivo,Rattus norvegicus,Stomach,1,,Intermediate
,,,CHEMBL620176,945.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,1,N,8400,In vivo,Rattus norvegicus,Stomach,1,,Intermediate
,,,CHEMBL620177,945.0,BAO_0000218,,,,A,13950,10116.0,50597,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,N,8401,In vivo,Rattus norvegicus,Stomach,1,,Intermediate
,,,CHEMBL620178,2037.0,BAO_0000218,,,,A,13950,10116.0,50597,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,1,N,8402,,Rattus norvegicus,Cerebellum,1,,Intermediate
,,,CHEMBL620179,2037.0,BAO_0000218,,,,A,13950,10116.0,50597,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,1,N,8403,,Rattus norvegicus,Cerebellum,1,,Intermediate
,,,CHEMBL620180,,BAO_0000218,,,,A,13950,10116.0,50597,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,1,N,8404,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620181,,BAO_0000218,,,,A,6570,10116.0,50597,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,1,N,8405,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620182,,BAO_0000218,,,,A,6571,10116.0,50597,Volume of distribution of compound in rats after intravenous administration,1,N,8406,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620183,,BAO_0000218,,,,A,6453,10116.0,50597,Volume of distribution in rat,1,N,8407,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620184,,BAO_0000218,,,,A,6444,10116.0,50597,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,1,N,8408,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620185,,BAO_0000218,,,,A,6444,10116.0,50597,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,1,N,8409,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620186,,BAO_0000218,,,,A,6444,10116.0,50597,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,1,N,8410,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620187,,BAO_0000218,,,,A,5353,10116.0,50597,Volume of distribution was determined in Dawley rat,1,N,8411,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620188,,BAO_0000218,,,,A,5334,10116.0,50597,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,1,N,8412,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620189,,BAO_0000218,,,,A,5334,10116.0,50597,Volume of distribution was reported in Sprague-Dawley rat,1,N,8413,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620190,,BAO_0000218,,,,A,6641,10116.0,50597,Volumes of distribution in rat after peroral administration,1,N,8414,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620191,,BAO_0000218,,,,A,6641,10116.0,50597,Volumes of distribution in rat after po administration,1,N,8415,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620192,,BAO_0000218,,,,A,6641,10116.0,50597,Volumes of distribution in rat after po administration; Not determined,1,N,8416,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620193,,BAO_0000218,,,,A,5676,10116.0,50597,Pharmacokinetic property (Volume) in rat i.v.,1,N,8417,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620194,,BAO_0000218,,,,A,6410,10116.0,50597,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,1,N,8418,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL876730,,BAO_0000218,,,,A,17670,10116.0,50597,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",1,N,8419,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620195,,BAO_0000218,,,,A,6495,10116.0,50597,Volume distribution in rat after oral administration at 10 mg/kg,1,N,8420,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620196,,BAO_0000218,,,,A,5408,10116.0,50597,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,1,N,8421,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620197,,BAO_0000218,,,,A,4883,10116.0,50597,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,1,N,8422,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620198,,BAO_0000218,,,,A,6647,10116.0,50597,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,1,N,8423,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620199,,BAO_0000218,,,,A,6495,10116.0,50597,Volume of distribution in rats,1,N,8424,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620200,,BAO_0000218,,,,A,2661,10116.0,50597,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,1,N,8425,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620201,,BAO_0000218,,,,A,2661,10116.0,50597,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,1,N,8426,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620202,,BAO_0000218,,,,A,5974,10116.0,50597,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,1,N,8427,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620203,,BAO_0000218,,,,A,5974,10116.0,50597,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,1,N,8428,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620204,,BAO_0000218,,,,A,5974,10116.0,50597,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,1,N,8429,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620205,,BAO_0000218,,,,A,5974,10116.0,50597,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,1,N,8430,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624664,,BAO_0000218,,,,A,5960,10116.0,50597,Pharmacokinetic parameter (Vss) in rat,1,N,8431,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624665,,BAO_0000218,,,,A,5676,10116.0,50597,Pharmacokinetic property (Volume) in rat i.v.,1,N,8432,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624666,,BAO_0000218,,,,A,5948,10116.0,50597,Pharmacokinetic property (Vss) in rat,1,N,8433,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624667,,BAO_0000218,,,,A,5979,10116.0,50597,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,1,N,8434,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624668,,BAO_0000218,,,,A,5978,10116.0,50597,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,1,N,8435,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624669,,BAO_0000218,,,,A,5978,10116.0,50597,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,N,8436,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624670,,BAO_0000218,,,,A,5978,10116.0,50597,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,N,8437,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624671,,BAO_0000218,,,,A,5978,10116.0,50597,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,N,8438,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624672,,BAO_0000218,,,,A,6448,10116.0,50597,Steady state volume distribution in rat,1,N,8439,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624673,1969.0,BAO_0000218,,,,A,12873,10116.0,50597,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",1,N,8440,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL624674,,BAO_0000218,,,,A,4576,10116.0,50597,Steady state volume of distribution determined in rat,1,N,8441,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624675,,BAO_0000218,,,,A,17582,10116.0,50597,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,1,N,8442,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621728,,BAO_0000218,,,,A,1466,10116.0,50597,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,1,N,8443,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621729,,BAO_0000218,,,,A,5182,10116.0,50597,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,1,N,8444,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621730,,BAO_0000218,,,,A,5182,10116.0,50597,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,1,N,8445,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621731,,BAO_0000218,,,,A,6535,10116.0,50597,Volume distribution in rat after administration of 2 mg/kg iv,1,N,8446,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621732,,BAO_0000218,,,,A,6535,10116.0,50597,Volume distribution in rat after administration of 2 mg/kg iv,1,N,8447,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621908,,BAO_0000218,,,,A,5041,10116.0,50597,Volume in steady state distribution value was determined,1,N,8448,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL875347,,BAO_0000218,,,,A,5041,10116.0,50597,Volume in steady state distribution value was determined; ND denotes no data,1,N,8449,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621909,,BAO_0000218,,,,A,5041,10116.0,50597,Volume in steady state distribution value was determined; ND denotes not determined,1,N,8450,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621910,,BAO_0000218,,,,A,17065,10116.0,50597,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,1,N,8451,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621911,,BAO_0000218,,,,A,6597,10116.0,50597,Volume of distribution at steady state was evaluated in rats,1,N,8452,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621912,,BAO_0000218,,,,A,15662,10116.0,50597,Volume of distribution at steady state was observed after intravenous administration in rat,1,N,8453,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621913,,BAO_0000218,,,,A,6485,10116.0,50597,Volume of distribution in steady state was determined in rat,1,N,8454,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621914,,BAO_0000218,,,,A,17655,10116.0,50597,Volume of distribution in steady state was determined in rat,1,N,8455,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621915,,BAO_0000218,,,,A,6616,10116.0,50597,Volume of distribution after i.v. administration,1,N,8456,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621916,,BAO_0000218,,,,A,1916,10116.0,50597,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,1,N,8457,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621917,2107.0,BAO_0000218,,,,A,16438,10090.0,50594,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",1,N,8458,In vivo,Mus musculus,Liver,1,,Intermediate
,,,CHEMBL621918,2107.0,BAO_0000218,,,,A,16438,10090.0,50594,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",1,N,8459,In vivo,Mus musculus,Liver,1,,Intermediate
,,,CHEMBL621919,2106.0,BAO_0000218,,,,A,16438,10090.0,50594,Biodistribution of compound (oxidized form) in spleen tissue,1,N,8460,In vivo,Mus musculus,Spleen,1,,Intermediate
,,,CHEMBL621920,2106.0,BAO_0000218,,,,A,16438,10090.0,50594,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",1,N,8461,In vivo,Mus musculus,Spleen,1,,Intermediate
,,,CHEMBL621921,2106.0,BAO_0000218,,,,A,16438,10090.0,50594,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",1,N,8462,In vivo,Mus musculus,Spleen,1,,Intermediate
,,,CHEMBL622401,2106.0,BAO_0000218,,,,A,16438,10090.0,50594,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",1,N,8463,In vivo,Mus musculus,Spleen,1,,Intermediate
,,,CHEMBL875348,2106.0,BAO_0000218,,,,A,16438,10090.0,50594,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",1,N,8464,In vivo,Mus musculus,Spleen,1,,Intermediate
,,,CHEMBL622402,2106.0,BAO_0000218,,,,A,16438,10090.0,50594,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",1,N,8465,In vivo,Mus musculus,Spleen,1,,Intermediate
,,,CHEMBL622403,178.0,BAO_0000218,,,,A,16438,10090.0,50594,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,1,N,8466,In vivo,Mus musculus,Blood,1,,Intermediate
,,,CHEMBL622404,178.0,BAO_0000218,,,,A,16438,10090.0,50594,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",1,N,8467,In vivo,Mus musculus,Blood,1,,Intermediate
,,,CHEMBL622405,955.0,BAO_0000218,,,,A,16438,10090.0,50594,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,1,N,8468,In vivo,Mus musculus,Brain,1,,Intermediate
,,,CHEMBL622406,955.0,BAO_0000218,,,,A,16438,10090.0,50594,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",1,N,8469,In vivo,Mus musculus,Brain,1,,Intermediate
,,,CHEMBL622407,955.0,BAO_0000218,,,,A,16438,10090.0,50594,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",1,N,8470,In vivo,Mus musculus,Brain,1,,Intermediate
,,,CHEMBL622408,948.0,BAO_0000218,,,,A,16438,10090.0,50594,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,1,N,8471,In vivo,Mus musculus,Heart,1,,Intermediate
,,,CHEMBL622409,948.0,BAO_0000218,,,,A,16438,10090.0,50594,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",1,N,8472,In vivo,Mus musculus,Heart,1,,Intermediate
,,,CHEMBL622410,948.0,BAO_0000218,,,,A,16438,10090.0,50594,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",1,N,8473,In vivo,Mus musculus,Heart,1,,Intermediate
,,,CHEMBL622411,2113.0,BAO_0000218,,,,A,16438,10090.0,50594,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,1,N,8474,In vivo,Mus musculus,Kidney,1,,Intermediate
,,,CHEMBL627864,2113.0,BAO_0000218,,,,A,16438,10090.0,50594,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",1,N,8475,In vivo,Mus musculus,Kidney,1,,Intermediate
,,,CHEMBL627865,2113.0,BAO_0000218,,,,A,16438,10090.0,50594,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",1,N,8476,In vivo,Mus musculus,Kidney,1,,Intermediate
,,,CHEMBL627866,2107.0,BAO_0000218,,,,A,16438,10090.0,50594,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,1,N,8477,In vivo,Mus musculus,Liver,1,,Intermediate
,,,CHEMBL627751,2107.0,BAO_0000218,,,,A,16438,10090.0,50594,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",1,N,8478,In vivo,Mus musculus,Liver,1,,Intermediate
,,,CHEMBL627752,2106.0,BAO_0000218,,,,A,16438,10090.0,50594,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,1,N,8479,In vivo,Mus musculus,Spleen,1,,Intermediate
,,,CHEMBL627753,2106.0,BAO_0000218,,,,A,16438,10090.0,50594,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",1,N,8480,In vivo,Mus musculus,Spleen,1,,Intermediate
,,,CHEMBL627754,2106.0,BAO_0000218,,,,A,16438,10090.0,50594,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",1,N,8481,In vivo,Mus musculus,Spleen,1,,Intermediate
,,,CHEMBL627755,,BAO_0000218,,,,A,12467,10090.0,50594,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,1,N,8482,,Mus musculus,,1,,Intermediate
,,,CHEMBL627756,955.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),1,N,8483,In vivo,Mus musculus,Brain,1,,Intermediate
,,,CHEMBL627757,955.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),1,N,8484,In vivo,Mus musculus,Brain,1,,Intermediate
,,,CHEMBL627758,955.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),1,N,8485,In vivo,Mus musculus,Brain,1,,Intermediate
,,,CHEMBL627759,955.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),1,N,8486,In vivo,Mus musculus,Brain,1,,Intermediate
,,,CHEMBL627760,955.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),1,N,8487,In vivo,Mus musculus,Brain,1,,Intermediate
,,,CHEMBL627761,955.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),1,N,8488,In vivo,Mus musculus,Brain,1,,Intermediate
,,,CHEMBL876811,948.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),1,N,8489,In vivo,Mus musculus,Heart,1,,Intermediate
,,,CHEMBL627762,948.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),1,N,8490,In vivo,Mus musculus,Heart,1,,Intermediate
,,,CHEMBL627763,948.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),1,N,8491,In vivo,Mus musculus,Heart,1,,Intermediate
,,,CHEMBL627764,948.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),1,N,8492,In vivo,Mus musculus,Heart,1,,Intermediate
,,,CHEMBL627765,948.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),1,N,8493,In vivo,Mus musculus,Heart,1,,Intermediate
,,,CHEMBL627766,948.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),1,N,8494,In vivo,Mus musculus,Heart,1,,Intermediate
,,,CHEMBL627767,2113.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),1,N,8495,In vivo,Mus musculus,Kidney,1,,Intermediate
,,,CHEMBL627768,2113.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),1,N,8496,In vivo,Mus musculus,Kidney,1,,Intermediate
,,,CHEMBL628422,2113.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),1,N,8497,In vivo,Mus musculus,Kidney,1,,Intermediate
,,,CHEMBL628423,2113.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),1,N,8498,In vivo,Mus musculus,Kidney,1,,Intermediate
,,,CHEMBL628424,,BAO_0000218,,,,A,5089,10116.0,50597,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,1,N,8499,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628425,,BAO_0000218,,,,A,5089,10116.0,50597,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,1,N,8500,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628426,,BAO_0000218,,,,A,4257,10116.0,50597,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,1,N,8501,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628427,,BAO_0000218,,,,A,6679,10116.0,50597,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,1,N,8502,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626938,,BAO_0000218,,,,A,5546,10116.0,50597,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,1,N,8503,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626939,,BAO_0000218,,,,A,6141,10116.0,50597,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,1,N,8504,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626940,,BAO_0000218,,,,A,5334,10116.0,50597,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,1,N,8505,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626941,,BAO_0000218,,,,A,5334,10116.0,50597,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,1,N,8506,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626942,,BAO_0000218,,,,A,5334,10116.0,50597,Plasma clearance was reported in Sprague-Dawley rat,1,N,8507,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL876812,,BAO_0000218,,,,A,4689,10116.0,50597,Plasma clearance after intravenous administration (1 mg/kg) in rat,1,N,8508,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626943,,BAO_0000218,,,,A,6848,10116.0,50597,Plasma clearance of compound in rats was evaluated,1,N,8509,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626944,,BAO_0000218,,,,A,6848,10116.0,50597,Plasma clearance of compound in rats was evaluated; ND indicates not determined,1,N,8510,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626945,,BAO_0000218,,,,A,6467,10116.0,50597,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,1,N,8511,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626946,,BAO_0000218,,,,A,6467,10116.0,50597,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,1,N,8512,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626856,,BAO_0000218,,,,A,4956,10116.0,50597,Plasma clearance rate in Sprague-Dawley rats,1,N,8513,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626857,,BAO_0000218,,,,A,5529,10116.0,50597,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),1,N,8514,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626858,1969.0,BAO_0000218,,,,A,406,10116.0,50597,The compound was evaluated for plasma clearance in rat,1,N,8515,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL627018,1969.0,BAO_0000218,,,,A,17655,10116.0,50597,Total plasma clearance in rat,1,N,8516,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL625331,178.0,BAO_0000218,,,,A,3293,10116.0,50597,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,1,N,8517,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL625332,178.0,BAO_0000218,,,,A,4075,10116.0,50597,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,1,N,8518,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL877590,,BAO_0000218,,,,A,2792,10116.0,50597,C max was determined at 10 mg/kg po dose in rats,1,N,8519,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625333,,BAO_0000218,,,,A,2792,10116.0,50597,C max was determined at 3 mg/kg po dose in rats,1,N,8520,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625334,,BAO_0000218,,,,A,17594,10116.0,50597,Cmax after repeated oral dose of compound at 1 mg/kg in rats,1,N,8521,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625335,,BAO_0000218,,,,A,17594,10116.0,50597,Cmax after single intravenous bolus of 1 mg/kg in rats,1,N,8522,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625336,,BAO_0000218,,,,A,4762,10116.0,50597,Cmax of compound at 5 mg/kg after po administration was determined in rat,1,N,8523,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625337,,BAO_0000218,,,,A,17509,10116.0,50597,Cmax 24 hr after 10 mg/kg oral administration in rats,1,N,8524,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625338,,BAO_0000218,,,,A,17509,10116.0,50597,Cmax 24 hr after 2 mg/kg oral administration in rats,1,N,8525,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625339,1969.0,BAO_0000218,,,,A,1466,10116.0,50597,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,1,N,8526,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL625340,,BAO_0000218,,,,A,6535,10116.0,50597,Cmax in rat after administration of 2 mg/kg iv,1,N,8527,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625341,,BAO_0000218,,,,A,6535,10116.0,50597,Cmax in rat after administration of 2 mg/kg iv,1,N,8528,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622687,,BAO_0000218,,,,A,3169,10116.0,50597,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,1,N,8529,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622688,1969.0,BAO_0000218,,,,A,6515,10116.0,50597,Cmax wa determined in rat plasma at 30 mg/kg after po administration,1,N,8530,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622689,178.0,BAO_0000218,,,,A,11149,10116.0,50597,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,1,N,8531,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL620295,178.0,BAO_0000218,,,,A,11149,10116.0,50597,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,1,N,8532,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL620296,,BAO_0000218,,,,A,17858,10116.0,50597,Cmax after 10 mg/kg oral administration in rat,1,N,8533,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620297,,BAO_0000218,,,,A,6518,10116.0,50597,Cmax after IV dosing at 0.5 mg/kg in rat; no data,1,N,8534,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620298,,BAO_0000218,,,,A,6518,10116.0,50597,Cmax after IV dosing at 1 mg/kg in rat; no data,1,N,8535,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620299,,BAO_0000218,,,,A,4426,10116.0,50597,Cmax after oral administration at 20 mpk in rats,1,N,8536,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620300,,BAO_0000218,,,,A,4426,10116.0,50597,Cmax after oral administration at 20 mpk in rats; Not performed.,1,N,8537,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620301,,BAO_0000218,,,,A,4426,10116.0,50597,Cmax after oral administration at 20 mpk in rats d; Not performed.,1,N,8538,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620302,,BAO_0000218,,,,A,5656,10116.0,50597,Cmax after oral administration in rat,1,N,8539,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620303,,BAO_0000218,,,,A,6518,10116.0,50597,Cmax after oral administration at a dose of 2 mg/kg in rat,1,N,8540,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620304,,BAO_0000218,,,,A,6518,10116.0,50597,Cmax after oral administration at a dose of 4 mg/kg in rat,1,N,8541,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620305,,BAO_0000218,,,,A,6113,10116.0,50597,Cmax in rats after 20 mg/kg oral dose,1,N,8542,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620306,,BAO_0000218,,,,A,17764,10116.0,50597,Cmax after peroral administration in rats at 2.4 uM/kg,1,N,8543,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620307,,BAO_0000218,,,,A,4756,10116.0,50597,Cmax at the dose of 2 mg/Kg administered perorally in rats,1,N,8544,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620308,,BAO_0000218,,,,A,4756,10116.0,50597,Cmax at the dose of 5 mg/Kg administered perorally in rats,1,N,8545,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620309,,BAO_0000218,,,,A,6402,10116.0,50597,Cmax by administering at 20 mg/kg p.o. in rats,1,N,8546,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620310,,BAO_0000218,,,,A,5610,10116.0,50597,Cmax in male rat,1,N,8547,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620311,,BAO_0000218,,,,A,5207,10116.0,50597,Cmax in rat,1,N,8548,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620312,,BAO_0000218,,,,A,6011,10116.0,50597,Cmax in rat,1,N,8549,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620313,,BAO_0000218,,,,A,6504,10116.0,50597,Cmax in rat,1,N,8550,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620314,,BAO_0000218,,,,A,6046,10116.0,50597,Cmax in rat at 10 mg/kg,1,N,8551,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620315,,BAO_0000218,,,,A,6504,10116.0,50597,Cmax in rat at the dose of 1 mg/kg i.v.,1,N,8552,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620316,,BAO_0000218,,,,A,5874,10116.0,50597,Cmax in rat by po administration at a dose of 40 mg/kg,1,N,8553,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620317,,BAO_0000218,,,,A,17686,10116.0,50597,Cmax in rat p.o. at 20 mg/kg concentration,1,N,8554,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620318,,BAO_0000218,,,,A,5836,10116.0,50597,Cmax in rats,1,N,8555,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620319,,BAO_0000218,,,,A,17596,10116.0,50597,Cmax in rats,1,N,8556,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620320,,BAO_0000218,,,,A,16423,10116.0,50597,Cmax was evaluated after 20 uM/kg of peroral administration,1,N,8557,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620321,,BAO_0000218,,,,A,17804,10116.0,50597,Cmax was measured in rats after peroral administration at 3 mg/kg,1,N,8558,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620322,,BAO_0000218,,,,A,1908,10116.0,50597,Cmax value after oral dose at a dose of 10 mg/kg in rats.,1,N,8559,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620323,,BAO_0000218,,,,A,13950,10116.0,50597,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,1,N,8560,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620324,1870.0,BAO_0000218,,,,A,13950,10116.0,50597,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,1,N,8561,,Rattus norvegicus,Frontal cortex,1,,Intermediate
,,,CHEMBL620325,1870.0,BAO_0000218,,,,A,13950,10116.0,50597,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,1,N,8562,,Rattus norvegicus,Frontal cortex,1,,Intermediate
,,,CHEMBL620326,10000000.0,BAO_0000218,,,,A,13950,10116.0,50597,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,1,N,8563,,Rattus norvegicus,Hippocampus,1,,Intermediate
,,,CHEMBL620327,10000000.0,BAO_0000218,,,,A,13950,10116.0,50597,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,1,N,8564,,Rattus norvegicus,Hippocampus,1,,Intermediate
,,,CHEMBL620328,,BAO_0000218,,,,A,13950,10116.0,50597,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,1,N,8565,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620329,,BAO_0000218,,,,A,13950,10116.0,50597,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,1,N,8566,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620330,1891.0,BAO_0000218,,,,A,13950,10116.0,50597,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,1,N,8567,,Rattus norvegicus,Midbrain,1,,Intermediate
,,,CHEMBL875286,1891.0,BAO_0000218,,,,A,13950,10116.0,50597,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,1,N,8568,,Rattus norvegicus,Midbrain,1,,Intermediate
,,,CHEMBL620331,,BAO_0000218,,,,A,13950,10116.0,50597,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,1,N,8569,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620332,,BAO_0000218,,,,A,13950,10116.0,50597,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,1,N,8570,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620333,2435.0,BAO_0000218,,,,A,13950,10116.0,50597,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,1,N,8571,,Rattus norvegicus,Striatum,1,,Intermediate
,,,CHEMBL620334,2435.0,BAO_0000218,,,,A,13950,10116.0,50597,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,1,N,8572,,Rattus norvegicus,Striatum,1,,Intermediate
,,,CHEMBL621015,178.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,N,8573,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL621016,178.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,N,8574,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL621191,178.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,N,8575,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL621192,178.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,N,8576,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL621193,178.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,N,8577,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL621194,178.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,N,8578,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL624204,178.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,N,8579,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL624205,178.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,1,N,8580,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL624206,178.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,N,8581,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL624207,178.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,N,8582,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL624208,178.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,N,8583,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL624209,178.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,N,8584,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL624210,178.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,N,8585,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL624211,178.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,N,8586,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL624212,178.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,N,8587,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL624213,178.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,N,8588,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL876611,178.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,N,8589,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL624214,178.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,1,N,8590,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL624215,178.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,N,8591,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL624216,178.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,N,8592,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL624217,178.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,N,8593,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL624218,178.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,N,8594,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL624219,178.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,N,8595,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL624220,178.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,N,8596,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL624221,178.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,N,8597,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL624222,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,N,8598,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624223,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,N,8599,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624224,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,N,8600,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624225,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,N,8601,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622420,,BAO_0000218,,,,A,17764,10116.0,50597,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,1,N,8602,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622421,,BAO_0000218,,,,A,5031,10116.0,50597,Volume of steady state distribution after i.v. administration in rats,1,N,8603,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622422,,BAO_0000218,,,,A,6215,10116.0,50597,Vss after intravenous administration (5.0 mg/kg) was determined in rat,1,N,8604,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622423,,BAO_0000218,,,,A,17671,10116.0,50597,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,1,N,8605,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622424,,BAO_0000218,,,,A,17752,10116.0,50597,Vss was determined,1,N,8606,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622425,,BAO_0000218,,,,A,6596,10116.0,50597,Vss in rat,1,N,8607,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL876612,,BAO_0000218,,,,A,16423,10116.0,50597,Vss was evaluated after 10 uM/kg of intra arterial administration,1,N,8608,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622426,,BAO_0000218,,,,A,15662,10116.0,50597,volume of distribution at steady state was observed after intravenous administration in rat,1,N,8609,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622427,,BAO_0000218,,,,A,6062,10116.0,50597,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,1,N,8610,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622428,,BAO_0000218,,,,A,5874,10116.0,50597,Pharmacokinetic (PK) parameter Vz in rat,1,N,8611,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622429,,BAO_0000218,,,,A,4942,10116.0,50597,Volume distribution in rats,1,N,8612,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622430,,BAO_0000218,,,,A,17796,10116.0,50597,Volume of distribution in rat; No data,1,N,8613,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622431,,BAO_0000218,,,,A,4890,10116.0,50597,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,1,N,8614,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622432,2116.0,BAO_0000218,,,,A,15765,10116.0,50597,% absorption predicted from in vitro rat ileum transport studies,1,N,8615,,Rattus norvegicus,Ileum,1,,Intermediate
,,,CHEMBL622433,,BAO_0000218,,,,A,13569,10116.0,50597,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,1,N,8616,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622434,,BAO_0000218,,,,A,13569,10116.0,50597,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,1,N,8617,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622435,,BAO_0000218,,,,A,13569,10116.0,50597,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,1,N,8618,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618748,,BAO_0000218,,,,A,13569,10116.0,50597,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),1,N,8619,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618749,,BAO_0000218,,,,A,13569,10116.0,50597,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,1,N,8620,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618750,,BAO_0000218,,,,A,13569,10116.0,50597,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,1,N,8621,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618751,,BAO_0000218,,,,A,13569,10116.0,50597,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,1,N,8622,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618752,,BAO_0000218,,,,A,13569,10116.0,50597,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,1,N,8623,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618753,,BAO_0000218,,,,A,4576,10116.0,50597,Oral bioavailability in rat,1,N,8624,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618754,1969.0,BAO_0000218,,,,A,750,10116.0,50597,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,1,N,8625,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL618755,,BAO_0000218,,,,A,750,10116.0,50597,Oral bioavailability in rat,1,N,8626,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618756,,BAO_0000218,,,,A,4590,10116.0,50597,Oral bioavailability in rat,1,N,8627,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618757,,BAO_0000218,,,,A,1716,10116.0,50597,Oral bioavailability in rat,1,N,8628,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618758,,BAO_0000218,,,,A,1974,10116.0,50597,Bioavailability in rat,1,N,8629,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621088,,BAO_0000218,,,,A,4502,10116.0,50597,Oral bioavailability in rat (dose 30 mg/kg),1,N,8630,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621089,,BAO_0000218,,,,A,3371,10116.0,50597,Pharmacokinetic property (cLogP) in rat,1,N,8631,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621090,178.0,BAO_0000218,,,,F,9099,10116.0,50597,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,1,N,8632,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL621091,178.0,BAO_0000218,,,,F,9099,10116.0,50597,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,1,N,8633,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL876731,,BAO_0000218,,,,A,4590,10116.0,50597,Clearance in rat.,1,N,8634,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621092,,BAO_0000218,,,,A,3184,10116.0,50597,Compound was evaluated for its clearance when administered intravenously in rat,1,N,8635,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621093,,BAO_0000218,,,,A,16456,10116.0,50597,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,1,N,8636,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621094,,BAO_0000218,,,,A,4199,10116.0,50597,Blood: Brain distribution ratio is determined in rat,1,N,8637,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621095,,BAO_0000218,,,,A,4199,10116.0,50597,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,1,N,8638,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621096,,BAO_0000218,,,,A,4199,10116.0,50597,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,1,N,8639,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621097,2113.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,N,8640,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL621098,,BAO_0000218,,,,F,7449,10116.0,50597,Percent dose excreted in 0-48 hours administered ip to male rat,1,N,8641,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621099,2037.0,BAO_0000218,,,,A,11977,10116.0,50597,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,N,8642,,Rattus norvegicus,Cerebellum,1,,Intermediate
,,,CHEMBL621100,2037.0,BAO_0000218,,,,A,11977,10116.0,50597,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,N,8643,,Rattus norvegicus,Cerebellum,1,,Intermediate
,,,CHEMBL621101,2037.0,BAO_0000218,,,,A,11977,10116.0,50597,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,N,8644,,Rattus norvegicus,Cerebellum,1,,Intermediate
,,,CHEMBL621102,2037.0,BAO_0000218,,,,A,11977,10116.0,50597,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,N,8645,,Rattus norvegicus,Cerebellum,1,,Intermediate
,,,CHEMBL876732,2037.0,BAO_0000218,,,,A,11977,10116.0,50597,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,N,8646,,Rattus norvegicus,Cerebellum,1,,Intermediate
,,,CHEMBL621103,,BAO_0000218,,,,A,11977,10116.0,50597,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,N,8647,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621104,,BAO_0000218,,,,A,11977,10116.0,50597,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,N,8648,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621105,,BAO_0000218,,,,A,11977,10116.0,50597,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,N,8649,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621106,,BAO_0000218,,,,A,11977,10116.0,50597,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,N,8650,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621107,,BAO_0000218,,,,A,11977,10116.0,50597,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,N,8651,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621108,,BAO_0000218,,,,A,11977,10116.0,50597,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,N,8652,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621109,,BAO_0000218,,,,A,11977,10116.0,50597,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,N,8653,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621110,2113.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),1,N,8654,In vivo,Mus musculus,Kidney,1,,Intermediate
,,,CHEMBL621111,2113.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),1,N,8655,In vivo,Mus musculus,Kidney,1,,Intermediate
,,,CHEMBL622541,2107.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),1,N,8656,In vivo,Mus musculus,Liver,1,,Intermediate
,,,CHEMBL622542,2107.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),1,N,8657,In vivo,Mus musculus,Liver,1,,Intermediate
,,,CHEMBL622543,2107.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),1,N,8658,In vivo,Mus musculus,Liver,1,,Intermediate
,,,CHEMBL624412,2107.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),1,N,8659,In vivo,Mus musculus,Liver,1,,Intermediate
,,,CHEMBL624413,2107.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),1,N,8660,In vivo,Mus musculus,Liver,1,,Intermediate
,,,CHEMBL624414,2107.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),1,N,8661,In vivo,Mus musculus,Liver,1,,Intermediate
,,,CHEMBL624415,2048.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),1,N,8662,In vivo,Mus musculus,Lung,1,,Intermediate
,,,CHEMBL624416,2048.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),1,N,8663,In vivo,Mus musculus,Lung,1,,Intermediate
,,,CHEMBL624417,2048.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),1,N,8664,In vivo,Mus musculus,Lung,1,,Intermediate
,,,CHEMBL624418,2048.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),1,N,8665,In vivo,Mus musculus,Lung,1,,Intermediate
,,,CHEMBL624419,2048.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),1,N,8666,In vivo,Mus musculus,Lung,1,,Intermediate
,,,CHEMBL624420,2048.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),1,N,8667,In vivo,Mus musculus,Lung,1,,Intermediate
,,,CHEMBL624421,2385.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),1,N,8668,In vivo,Mus musculus,Muscle tissue,1,,Intermediate
,,,CHEMBL624422,2385.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),1,N,8669,In vivo,Mus musculus,Muscle tissue,1,,Intermediate
,,,CHEMBL624423,2385.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),1,N,8670,In vivo,Mus musculus,Muscle tissue,1,,Intermediate
,,,CHEMBL625123,2385.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),1,N,8671,In vivo,Mus musculus,Muscle tissue,1,,Intermediate
,,,CHEMBL625124,2385.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),1,N,8672,In vivo,Mus musculus,Muscle tissue,1,,Intermediate
,,,CHEMBL625125,2385.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),1,N,8673,In vivo,Mus musculus,Muscle tissue,1,,Intermediate
,,,CHEMBL625126,14.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),1,N,8674,In vivo,Mus musculus,Zone of skin,1,,Intermediate
,,,CHEMBL626947,14.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),1,N,8675,In vivo,Mus musculus,Zone of skin,1,,Intermediate
,,,CHEMBL626948,14.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),1,N,8676,In vivo,Mus musculus,Zone of skin,1,,Intermediate
,,,CHEMBL626949,14.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),1,N,8677,In vivo,Mus musculus,Zone of skin,1,,Intermediate
,,,CHEMBL626950,14.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),1,N,8678,In vivo,Mus musculus,Zone of skin,1,,Intermediate
,,,CHEMBL626951,14.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),1,N,8679,In vivo,Mus musculus,Zone of skin,1,,Intermediate
,,,CHEMBL626952,2106.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),1,N,8680,In vivo,Mus musculus,Spleen,1,,Intermediate
,,,CHEMBL626953,2106.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),1,N,8681,In vivo,Mus musculus,Spleen,1,,Intermediate
,,,CHEMBL626954,2106.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),1,N,8682,In vivo,Mus musculus,Spleen,1,,Intermediate
,,,CHEMBL626955,2106.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),1,N,8683,In vivo,Mus musculus,Spleen,1,,Intermediate
,,,CHEMBL626956,2106.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),1,N,8684,In vivo,Mus musculus,Spleen,1,,Intermediate
,,,CHEMBL626957,2106.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),1,N,8685,In vivo,Mus musculus,Spleen,1,,Intermediate
,,,CHEMBL626958,178.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),1,N,8686,In vivo,Mus musculus,Blood,1,,Intermediate
,,,CHEMBL626959,178.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),1,N,8687,In vivo,Mus musculus,Blood,1,,Intermediate
,,,CHEMBL626960,178.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),1,N,8688,In vivo,Mus musculus,Blood,1,,Intermediate
,,,CHEMBL626961,178.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),1,N,8689,In vivo,Mus musculus,Blood,1,,Intermediate
,,,CHEMBL627589,178.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),1,N,8690,In vivo,Mus musculus,Blood,1,,Intermediate
,,,CHEMBL627590,178.0,BAO_0000218,,,,A,17208,10090.0,50594,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),1,N,8691,In vivo,Mus musculus,Blood,1,,Intermediate
,,,CHEMBL627591,,BAO_0000218,,,,A,3132,10090.0,50594,Time taken for EC90 was determined when tested in mouse,1,N,8692,,Mus musculus,,1,,Intermediate
,,,CHEMBL627592,,BAO_0000218,,,,A,3132,10090.0,50594,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,1,N,8693,,Mus musculus,,1,,Intermediate
,,,CHEMBL627593,,BAO_0000218,,,,A,16597,10090.0,50594,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),1,N,8694,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL627594,,BAO_0000218,,,,A,5727,10090.0,50594,Half life in mice,1,N,8695,,Mus musculus,,1,,Intermediate
,,,CHEMBL876813,,BAO_0000218,,,,A,5302,10090.0,50594,Half life period in mouse after 10 mg/Kg dose,1,N,8696,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL627595,,BAO_0000218,,,,A,5302,10090.0,50594,Half life period in mouse after 10 mg/kg dose,1,N,8697,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL627596,,BAO_0000218,,,,A,6348,10090.0,50594,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,1,N,8698,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL627597,,BAO_0000218,,,,A,5964,10116.0,50597,Cmax value at 5 mg/kg po was determined in rat,1,N,8699,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627598,,BAO_0000218,,,,A,6078,10116.0,50597,Cmax value evaluated in rat,1,N,8700,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627599,955.0,BAO_0000218,,,,A,5206,10116.0,50597,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,1,N,8701,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL627600,,BAO_0000218,,,,A,2959,10116.0,50597,Cmax value after administration of 20 mg/Kg oral dose in rat,1,N,8702,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627601,,BAO_0000218,,,,A,5964,10116.0,50597,Cmax value at 1 mg/kg po in rat,1,N,8703,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627776,,BAO_0000218,,,,A,5964,10116.0,50597,Cmax value at 5 mg/kg po in rat,1,N,8704,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627777,,BAO_0000218,,,,A,6757,10116.0,50597,Cmax value at a dose of 10 mg/kg in male SD rats,1,N,8705,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627778,,BAO_0000218,,,,A,6757,10116.0,50597,Cmax value at a dose of 100 mg/kg in male SD rats,1,N,8706,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627779,,BAO_0000218,,,,A,6757,10116.0,50597,Cmax value at a dose of 50 mg/kg in male SD rats,1,N,8707,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL876814,,BAO_0000218,,,,A,17617,10116.0,50597,Cmax value in rats at 10 mg/kg,1,N,8708,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627780,,BAO_0000218,,,,A,1445,10116.0,50597,Cmax value was evaluated in rats at a dose of 20 mg/kg,1,N,8709,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627781,,BAO_0000218,,,,A,6082,10116.0,50597,Cmax value was determined after peroral administration of 20 mg/kg in rat,1,N,8710,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627782,,BAO_0000218,,,,A,1446,10116.0,50597,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,1,N,8711,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627783,1969.0,BAO_0000218,,,,A,5407,10116.0,50597,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,1,N,8712,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL627784,1969.0,BAO_0000218,,,,A,2690,10116.0,50597,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,1,N,8713,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL627785,,BAO_0000218,,,,A,2661,10116.0,50597,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,1,N,8714,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627786,,BAO_0000218,,,,A,2661,10116.0,50597,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,1,N,8715,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627787,1969.0,BAO_0000218,,,,A,4891,10116.0,50597,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,1,N,8716,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL627788,1969.0,BAO_0000218,,,,A,2807,10116.0,50597,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,1,N,8717,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626579,1969.0,BAO_0000218,,,,A,2807,10116.0,50597,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,1,N,8718,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626580,1969.0,BAO_0000218,,,,A,2807,10116.0,50597,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,1,N,8719,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL876815,,BAO_0000218,,,,A,3634,10116.0,50597,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,1,N,8720,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626581,1969.0,BAO_0000218,,,,A,1881,10116.0,50597,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,1,N,8721,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626582,1969.0,BAO_0000218,,,,A,1881,10116.0,50597,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,1,N,8722,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626583,,BAO_0000218,,,,A,429,10116.0,50597,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,1,N,8723,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626205,,BAO_0000218,,,,A,5974,10116.0,50597,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,1,N,8724,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626206,,BAO_0000218,,,,A,5974,10116.0,50597,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,1,N,8725,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626207,,BAO_0000218,,,,A,5974,10116.0,50597,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,1,N,8726,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623882,,BAO_0000218,,,,A,5974,10116.0,50597,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,1,N,8727,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623883,,BAO_0000218,,,,A,17582,10116.0,50597,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,1,N,8728,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623884,,BAO_0000218,,,,A,17582,10116.0,50597,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,1,N,8729,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623885,1969.0,BAO_0000218,,,,A,3032,10116.0,50597,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",1,N,8730,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623886,1969.0,BAO_0000218,,,,A,6295,10116.0,50597,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,1,N,8731,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623887,,BAO_0000218,,,,A,6619,10116.0,50597,Maximal concentration in rat was determined,1,N,8732,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623888,,BAO_0000218,,,,A,6616,10116.0,50597,Maximal concentration after i.v. administration,1,N,8733,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623889,1969.0,BAO_0000218,,,,A,3249,10116.0,50597,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,1,N,8734,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623890,1969.0,BAO_0000218,,,,A,17791,10116.0,50597,Maximal plasma concentration in rat after oral administration at 50 mg/kg,1,N,8735,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623891,1969.0,BAO_0000218,,,,A,17791,10116.0,50597,Cmax in rat plasma after oral dose (50 mg/Kg),1,N,8736,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623892,1969.0,BAO_0000218,,,,A,1360,10116.0,50597,Maximal plasma concentration was determined.,1,N,8737,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623893,1969.0,BAO_0000218,,,,A,2552,10116.0,50597,Maximal plasma drug concentration was determined,1,N,8738,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL877616,,BAO_0000218,,,,A,6571,10116.0,50597,Maximal concentration in rats after peroral administration,1,N,8739,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623894,,BAO_0000218,,,,A,6570,10116.0,50597,Maximum concentration in rat after 2 mg/kg peroral administration,1,N,8740,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623895,1969.0,BAO_0000218,,,,A,6567,10116.0,50597,Maximum concentration in rat plasma after 5 mg/kg oral gavage,1,N,8741,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623896,,BAO_0000218,,,,A,3031,10116.0,50597,Maximum concentration of compound in rat was evaluated.,1,N,8742,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623897,,BAO_0000218,,,,A,3436,10116.0,50597,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,1,N,8743,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623898,,BAO_0000218,,,,A,3436,10116.0,50597,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,1,N,8744,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623899,,BAO_0000218,,,,A,2083,10116.0,50597,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,1,N,8745,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623900,,BAO_0000218,,,,A,3436,10116.0,50597,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,1,N,8746,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623901,,BAO_0000218,,,,A,4527,10116.0,50597,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,1,N,8747,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623902,,BAO_0000218,,,,A,1974,10116.0,50597,Maximum concentration was evaluated in rats,1,N,8748,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623903,1359.0,BAO_0000218,,,,A,3307,10116.0,50597,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,1,N,8749,In vivo,Rattus norvegicus,Cerebrospinal fluid,1,,Intermediate
,,,CHEMBL623904,1969.0,BAO_0000218,,,,A,3307,10116.0,50597,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,1,N,8750,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL877617,1969.0,BAO_0000218,,,,A,1916,10116.0,50597,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,1,N,8751,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623905,,BAO_0000218,,,,A,1500,10116.0,50597,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,1,N,8752,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623906,,BAO_0000218,,,,A,1500,10116.0,50597,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,1,N,8753,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623907,1969.0,BAO_0000218,,,,A,4186,10116.0,50597,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,1,N,8754,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623908,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,N,8755,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623909,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,1,N,8756,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623910,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,N,8757,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623911,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,1,N,8758,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623912,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,N,8759,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624616,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,N,8760,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624617,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,N,8761,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624618,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,N,8762,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624619,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,N,8763,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624794,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,N,8764,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624795,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,N,8765,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623921,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,N,8766,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623922,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,N,8767,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623923,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,1,N,8768,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623924,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,N,8769,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623925,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,N,8770,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623926,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,N,8771,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623927,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,N,8772,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623928,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,N,8773,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623929,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,N,8774,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623930,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,N,8775,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623931,955.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,N,8776,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL622165,955.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,N,8777,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL621249,955.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,N,8778,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL621250,955.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,N,8779,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL621448,955.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,N,8780,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL621449,955.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,N,8781,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL621450,955.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,N,8782,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL621451,955.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,1,N,8783,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL621452,955.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,N,8784,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL621453,955.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,N,8785,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL621454,955.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,N,8786,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL621455,955.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,N,8787,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL621456,955.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,N,8788,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL625145,955.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,N,8789,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL875847,955.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,N,8790,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL625146,955.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,N,8791,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL625147,955.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,N,8792,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL625148,955.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,1,N,8793,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL625149,955.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,N,8794,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL625150,955.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,N,8795,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL625151,955.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,N,8796,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL625152,955.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,N,8797,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL625153,955.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,N,8798,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL625154,955.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,N,8799,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL625155,955.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,N,8800,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL625156,,BAO_0000218,,,,A,11977,10116.0,50597,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,N,8801,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624354,,BAO_0000218,,,,A,11977,10116.0,50597,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,N,8802,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624355,10000000.0,BAO_0000218,,,,A,11977,10116.0,50597,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,N,8803,,Rattus norvegicus,Hippocampus,1,,Intermediate
,,,CHEMBL624356,10000000.0,BAO_0000218,,,,A,11977,10116.0,50597,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,N,8804,,Rattus norvegicus,Hippocampus,1,,Intermediate
,,,CHEMBL624357,10000000.0,BAO_0000218,,,,A,11977,10116.0,50597,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,N,8805,,Rattus norvegicus,Hippocampus,1,,Intermediate
,,,CHEMBL624358,10000000.0,BAO_0000218,,,,A,11977,10116.0,50597,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,N,8806,,Rattus norvegicus,Hippocampus,1,,Intermediate
,,,CHEMBL624359,2435.0,BAO_0000218,,,,A,11977,10116.0,50597,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,N,8807,,Rattus norvegicus,Striatum,1,,Intermediate
,,,CHEMBL624360,2435.0,BAO_0000218,,,,A,11977,10116.0,50597,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,N,8808,,Rattus norvegicus,Striatum,1,,Intermediate
,,,CHEMBL624361,2435.0,BAO_0000218,,,,A,11977,10116.0,50597,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,N,8809,,Rattus norvegicus,Striatum,1,,Intermediate
,,,CHEMBL624362,2435.0,BAO_0000218,,,,A,11977,10116.0,50597,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,N,8810,,Rattus norvegicus,Striatum,1,,Intermediate
,,,CHEMBL624363,2435.0,BAO_0000218,,,,A,11977,10116.0,50597,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,N,8811,,Rattus norvegicus,Striatum,1,,Intermediate
,,,CHEMBL624364,178.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,N,8812,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL624365,178.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,N,8813,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL624366,178.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,N,8814,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL624367,178.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,N,8815,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL624368,955.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,N,8816,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL624369,955.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,N,8817,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL624370,955.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,N,8818,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL625069,955.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,N,8819,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL625070,955.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,N,8820,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL626051,948.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,N,8821,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL626052,948.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,N,8822,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL626053,948.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,N,8823,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL626054,948.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,N,8824,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL626055,948.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,N,8825,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL626056,2113.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,N,8826,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL626057,2113.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,N,8827,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL625193,2113.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,N,8828,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL625194,2113.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,N,8829,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL625195,2107.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,N,8830,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625196,2107.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,N,8831,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625197,2107.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,N,8832,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625198,2107.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,N,8833,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL627929,2107.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,N,8834,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL627074,2048.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,N,8835,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627075,2048.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,N,8836,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627076,2048.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,N,8837,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627077,2048.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,N,8838,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627078,2048.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,N,8839,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627079,2385.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),1,N,8840,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL873824,,BAO_0000218,,,,A,4573,10090.0,50594,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,1,N,8841,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL627080,1969.0,BAO_0000218,,,,A,3132,10090.0,50594,Half life in mouse plasma was determined at dose 25 mg/kg,1,N,8842,In vivo,Mus musculus,Plasma,1,,Intermediate
,,,CHEMBL627081,,BAO_0000218,,,,A,17718,10090.0,50594,Half life was determined,1,N,8843,,Mus musculus,,1,,Intermediate
,,,CHEMBL627082,,BAO_0000218,,,,A,17728,10090.0,50594,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,1,N,8844,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL627083,,BAO_0000218,,,,A,5961,10090.0,50594,Half-life in male mice after 1 mg/kg intravenous dose,1,N,8845,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL627085,1969.0,BAO_0000218,,,,A,17731,10090.0,50594,Half life in mice plasma,1,N,8847,,Mus musculus,Plasma,1,,Intermediate
,,,CHEMBL627086,,BAO_0000218,,,,A,17592,10090.0,50594,Half life in mouse,1,N,8848,,Mus musculus,,1,,Intermediate
,,,CHEMBL627087,1969.0,BAO_0000218,,,,A,3132,10090.0,50594,Half life in mouse plasma at dose 25 mg/kg,1,N,8849,In vivo,Mus musculus,Plasma,1,,Intermediate
,,,CHEMBL627088,,BAO_0000218,,,,A,17729,10090.0,50594,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,1,N,8850,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL627089,,BAO_0000218,,,,A,17729,10090.0,50594,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,1,N,8851,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL627090,,BAO_0000218,,,,A,17729,10090.0,50594,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,1,N,8852,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL627091,,BAO_0000218,,,,A,3277,10090.0,50594,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),1,N,8853,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL627092,,BAO_0000218,,,,A,3760,10090.0,50594,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",1,N,8854,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL876785,,BAO_0000218,,,,A,3760,10090.0,50594,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",1,N,8855,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL627093,,BAO_0000218,,,,A,2862,10090.0,50594,Half-life by iv administration in mouse,1,N,8856,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL627094,,BAO_0000218,,,,A,2862,10090.0,50594,Half-life by oral administration in mouse,1,N,8857,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL627095,,BAO_0000218,,,,A,5980,10090.0,50594,Half-life in mice,1,N,8858,,Mus musculus,,1,,Intermediate
,,,CHEMBL627096,955.0,BAO_0000218,,,,A,6159,10090.0,50594,Half-life using mouse brain homogenate,1,N,8859,,Mus musculus,Brain,1,,Intermediate
,,,CHEMBL627097,,BAO_0000218,,,,A,6254,10090.0,50594,Half-life was measured in mice,1,N,8860,,Mus musculus,,1,,Intermediate
,,,CHEMBL627098,,BAO_0000218,,,,A,6062,10090.0,50594,Half-life was measured in mouse after an iv dose of 1 mg/kg,1,N,8861,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL627099,178.0,BAO_0000218,,,,A,1574,10090.0,50594,Half-life period was determined in mouse blood,1,N,8862,,Mus musculus,Blood,1,,Intermediate
,,,CHEMBL627100,955.0,BAO_0000218,,,,A,56,10090.0,50594,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",1,N,8863,,Mus musculus,Brain,1,,Intermediate
,,,CHEMBL627101,1969.0,BAO_0000218,,,,A,993,10090.0,50594,Plasma half life in mouse,1,N,8864,,Mus musculus,Plasma,1,,Intermediate
,,,CHEMBL627102,,BAO_0000218,,,,A,6652,10090.0,50594,Stability of the peptide in the presence of mouse serum,1,N,8865,,Mus musculus,,1,,Intermediate
,,,CHEMBL627103,,BAO_0000218,,,,A,17852,10090.0,50594,Terminal half life of compound was determined in mouse,1,N,8866,,Mus musculus,,1,,Intermediate
,,,CHEMBL627104,,BAO_0000218,,,,A,2675,10090.0,50594,Terminal half life was evaluated in mice after intravenous administration,1,N,8867,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL627105,,BAO_0000218,,,,A,2675,10090.0,50594,Terminal half life was evaluated in mice after oral administration,1,N,8868,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL876786,,BAO_0000218,,,,A,499,10090.0,50594,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,1,N,8869,,Mus musculus,,1,,Intermediate
,,,CHEMBL873825,,BAO_0000218,,,,A,499,10090.0,50594,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,1,N,8870,,Mus musculus,,1,,Intermediate
,,,CHEMBL627106,,BAO_0000218,,,,A,499,10090.0,50594,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,1,N,8871,,Mus musculus,,1,,Intermediate
,,,CHEMBL626336,,BAO_0000218,,,,A,14239,10090.0,50594,half life period is evaluated by administering intravenously at 25 mg/kg in mice,1,N,8872,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL877462,,BAO_0000218,,,,A,5506,10090.0,50594,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",1,N,8873,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL626337,,BAO_0000218,,,,A,5506,10090.0,50594,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",1,N,8874,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL626338,,BAO_0000218,,,,A,17734,10090.0,50594,Half life after intraperitoneal administration of 100 mg/kg in mice,1,N,8875,,Mus musculus,,1,,Intermediate
,,,CHEMBL626339,,BAO_0000218,,,,A,17728,10090.0,50594,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,1,N,8876,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL626340,,BAO_0000218,,,,A,17728,10090.0,50594,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,1,N,8877,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL625377,,BAO_0000218,,,,A,17728,10090.0,50594,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,1,N,8878,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL625378,,BAO_0000218,,,,A,17728,10090.0,50594,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,1,N,8879,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL625379,,BAO_0000218,,,,A,17728,10090.0,50594,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,1,N,8880,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL625380,,BAO_0000251,,,,A,14294,9823.0,22224,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),1,U,8881,,Sus scrofa,,0,Microsomes,Autocuration
,,,CHEMBL625381,,BAO_0000251,,,,A,14294,9823.0,22224,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),1,U,8882,,Sus scrofa,,0,Microsomes,Autocuration
,,,CHEMBL625382,,BAO_0000019,,,,A,6056,9823.0,22224,Stability to porcine renal DHP-I,1,U,8883,,Sus scrofa,,0,,Autocuration
,,,CHEMBL873828,,BAO_0000218,,,,A,1317,9823.0,22224,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,1,U,8884,In vivo,Sus scrofa,,0,,Autocuration
,,,CHEMBL625383,,BAO_0000218,,,,A,1317,9823.0,22224,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,1,U,8885,In vivo,Sus scrofa,,0,,Autocuration
,,,CHEMBL625384,,BAO_0000019,,,,A,5229,9823.0,22224,Half-life of the parent prodrug in porcine esterase solution,1,U,8886,,Sus scrofa,,0,,Autocuration
,,,CHEMBL625385,,BAO_0000019,,,,A,4231,9823.0,22224,"First order rate constant, k was determined in in pig liver Esterase",1,U,8887,,Sus scrofa,,0,,Autocuration
,,,CHEMBL625386,2107.0,BAO_0000221,,,,A,4231,9823.0,22224,Half life of the in pig liver Esterase,1,U,8888,,Sus scrofa,Liver,0,,Autocuration
,,,CHEMBL623571,2107.0,BAO_0000221,,,,A,5318,9823.0,22224,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,1,U,8889,,Sus scrofa,Liver,0,,Autocuration
,,,CHEMBL623572,2107.0,BAO_0000221,,,,A,5318,9823.0,22224,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,1,U,8890,,Sus scrofa,Liver,0,,Autocuration
,,,CHEMBL623573,2107.0,BAO_0000221,,,,A,5318,9823.0,22224,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,1,U,8891,,Sus scrofa,Liver,0,,Autocuration
,,,CHEMBL623574,2107.0,BAO_0000221,,,,A,3305,9823.0,22224,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,1,U,8892,,Sus scrofa,Liver,0,,Autocuration
,,,CHEMBL623575,2107.0,BAO_0000221,,,,A,3305,9823.0,22224,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,1,U,8893,,Sus scrofa,Liver,0,,Autocuration
,,,CHEMBL623749,2107.0,BAO_0000221,,,,A,2842,9823.0,22224,Half-life in the presence of pig liver esterase(PLE) was evaluated.,1,U,8894,,Sus scrofa,Liver,0,,Autocuration
,,,CHEMBL623750,2107.0,BAO_0000221,,,,A,2842,9823.0,22224,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,1,U,8895,,Sus scrofa,Liver,0,,Autocuration
,,,CHEMBL623751,2107.0,BAO_0000221,,,,A,889,9823.0,22224,Half-life in vitro in pig liver,1,U,8896,In vitro,Sus scrofa,Liver,0,,Autocuration
,,,CHEMBL623752,2107.0,BAO_0000221,,,,A,1904,9823.0,22224,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,1,U,8897,,Sus scrofa,Liver,0,,Autocuration
,,,CHEMBL623753,1969.0,BAO_0000218,,,,A,4186,10116.0,50597,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,1,N,8898,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623754,1969.0,BAO_0000218,,,,A,2774,10116.0,50597,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,1,N,8899,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623755,1969.0,BAO_0000218,,,,A,1742,10116.0,50597,Maximum concentration in rat plasma was determined,1,N,8900,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623756,,BAO_0000218,,,,A,3169,10116.0,50597,Maximum concentration in rats,1,N,8901,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623757,,BAO_0000218,,,,A,3169,10116.0,50597,Maximum concentration in rats at 1-2 hours,1,N,8902,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623758,,BAO_0000218,,,,A,2081,10116.0,50597,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,1,N,8903,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623759,955.0,BAO_0000218,,,,A,3307,10116.0,50597,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,1,N,8904,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL623760,,BAO_0000218,,,,A,4727,10116.0,50597,Maximum concentration at the dose of 2 mg/kg in rat,1,N,8905,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623761,,BAO_0000218,,,,A,6597,10116.0,50597,Maximum concentration was evaluated in rats,1,N,8906,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623762,1969.0,BAO_0000218,,,,A,16365,10116.0,50597,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,1,N,8907,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL877594,1969.0,BAO_0000218,,,,A,16365,10116.0,50597,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,1,N,8908,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623763,1969.0,BAO_0000218,,,,A,16365,10116.0,50597,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,1,N,8909,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623764,1969.0,BAO_0000218,,,,A,16365,10116.0,50597,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,1,N,8910,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623765,1969.0,BAO_0000218,,,,A,16365,10116.0,50597,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,1,N,8911,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623766,178.0,BAO_0000218,,,,A,2591,10116.0,50597,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,1,N,8912,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL623767,178.0,BAO_0000218,,,,A,2591,10116.0,50597,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,1,N,8913,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL623768,178.0,BAO_0000218,,,,A,2591,10116.0,50597,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,1,N,8914,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL623769,1969.0,BAO_0000218,,,,A,5978,10116.0,50597,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,1,N,8915,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623770,1969.0,BAO_0000218,,,,A,5978,10116.0,50597,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,1,N,8916,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623771,1969.0,BAO_0000218,,,,A,5978,10116.0,50597,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,1,N,8917,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623772,1969.0,BAO_0000218,,,,A,5978,10116.0,50597,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,1,N,8918,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623773,1969.0,BAO_0000218,,,,A,5978,10116.0,50597,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,1,N,8919,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623774,1969.0,BAO_0000218,,,,A,5978,10116.0,50597,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,1,N,8920,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623775,1969.0,BAO_0000218,,,,A,5978,10116.0,50597,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,1,N,8921,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623776,,BAO_0000218,,,,A,14465,10116.0,50597,Cmax in rat (PO dose),1,N,8922,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622191,1969.0,BAO_0000218,,,,A,4723,10116.0,50597,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,1,N,8923,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622192,1969.0,BAO_0000218,,,,A,4723,10116.0,50597,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,1,N,8924,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622193,1969.0,BAO_0000218,,,,A,4576,10116.0,50597,Maximum plasma concentration determined in rat,1,N,8925,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622194,1969.0,BAO_0000218,,,,A,12873,10116.0,50597,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,1,N,8926,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622195,1969.0,BAO_0000218,,,,A,12873,10116.0,50597,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,1,N,8927,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622196,1969.0,BAO_0000218,,,,A,6824,10116.0,50597,Maximum plasma concentration in rat,1,N,8928,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622197,1969.0,BAO_0000218,,,,A,17065,10116.0,50597,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,1,N,8929,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622198,1969.0,BAO_0000218,,,,A,2932,10116.0,50597,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,1,N,8930,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622199,1969.0,BAO_0000218,,,,A,2932,10116.0,50597,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,1,N,8931,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622200,1969.0,BAO_0000218,,,,A,2879,10116.0,50597,Maximum plasma concentration of compound was measured in rat,1,N,8932,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622201,1969.0,BAO_0000218,,,,A,2864,10116.0,50597,Maximum plasma concentration after 20 mg/kg oral administration in rat,1,N,8933,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623990,1969.0,BAO_0000218,,,,A,16367,10116.0,50597,Maximum plasma concentration after oral administration to rats,1,N,8934,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623991,1969.0,BAO_0000218,,,,A,17717,10116.0,50597,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,1,N,8935,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623992,1969.0,BAO_0000218,,,,A,17717,10116.0,50597,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",1,N,8936,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623993,1969.0,BAO_0000218,,,,A,17717,10116.0,50597,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,1,N,8937,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623994,1969.0,BAO_0000218,,,,A,17717,10116.0,50597,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,1,N,8938,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623995,1969.0,BAO_0000218,,,,F,17720,10116.0,50597,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,1,N,8939,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623996,1969.0,BAO_0000218,,,,F,17720,10116.0,50597,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,1,N,8940,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623997,1969.0,BAO_0000218,,,,F,17720,10116.0,50597,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,1,N,8941,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623998,1969.0,BAO_0000218,,,,A,4516,10116.0,50597,Maximum plasma concentration dosed orally in rats,1,N,8942,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623999,1969.0,BAO_0000218,,,,A,4516,10116.0,50597,Maximum plasma concentration dosed orally in rats after 6 hours,1,N,8943,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL624000,1969.0,BAO_0000218,,,,A,4516,10116.0,50597,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,1,N,8944,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL624001,1969.0,BAO_0000218,,,,A,5199,10116.0,50597,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,1,N,8945,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL624002,1969.0,BAO_0000218,,,,A,17538,10116.0,50597,Maximum plasma concentration in rat after po administration,1,N,8946,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL624003,1969.0,BAO_0000218,,,,A,6685,10116.0,50597,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",1,N,8947,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL624004,1969.0,BAO_0000218,,,,A,6685,10116.0,50597,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",1,N,8948,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL624005,948.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,N,8949,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL624006,948.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,N,8950,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL624007,948.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,N,8951,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL624008,948.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,N,8952,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL624009,948.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,N,8953,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL874387,948.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,N,8954,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL624010,948.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,N,8955,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL624011,948.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,1,N,8956,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL624012,948.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,N,8957,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL624013,948.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,N,8958,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL624736,948.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,N,8959,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL624737,948.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,N,8960,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL624738,948.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,N,8961,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL624739,948.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,1,N,8962,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL624740,948.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,N,8963,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL624896,948.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,N,8964,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL624897,948.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,N,8965,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL624108,948.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,N,8966,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL624109,948.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,N,8967,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL624110,948.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,N,8968,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL624111,948.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,N,8969,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL624112,948.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,N,8970,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL624113,948.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,N,8971,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL619709,948.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,N,8972,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL619710,948.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,N,8973,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL619711,2113.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,N,8974,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL619712,2113.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,N,8975,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL619713,2113.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,N,8976,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL619714,2113.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,N,8977,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL619715,2113.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,N,8978,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL619716,2113.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,N,8979,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL619717,2113.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,N,8980,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL619718,2113.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,1,N,8981,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL619719,2113.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,N,8982,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL875329,2113.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,N,8983,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL619720,2113.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,N,8984,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL619721,2113.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,N,8985,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL619722,2113.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,N,8986,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL619723,2113.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,N,8987,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL619724,2113.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,N,8988,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL619725,2113.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,N,8989,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL619726,2113.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,N,8990,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL619727,2113.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,1,N,8991,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL619728,2113.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,N,8992,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL619729,2113.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,N,8993,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL619730,2385.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,N,8994,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL619731,2385.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,N,8995,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL619732,2385.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,N,8996,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL619733,2385.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,N,8997,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL619734,2385.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,N,8998,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL619735,14.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,N,8999,In vivo,Rattus norvegicus,Zone of skin,1,,Intermediate
,,,CHEMBL875330,14.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,N,9000,In vivo,Rattus norvegicus,Zone of skin,1,,Intermediate
,,,CHEMBL628465,14.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,N,9001,In vivo,Rattus norvegicus,Zone of skin,1,,Intermediate
,,,CHEMBL628466,14.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,N,9002,In vivo,Rattus norvegicus,Zone of skin,1,,Intermediate
,,,CHEMBL628467,14.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,N,9003,In vivo,Rattus norvegicus,Zone of skin,1,,Intermediate
,,,CHEMBL628468,2106.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,N,9004,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL628469,2106.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,N,9005,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL628470,2106.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,N,9006,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL628471,2106.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,N,9007,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL628472,2106.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,N,9008,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL625191,2046.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,N,9009,In vivo,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL625192,2046.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,N,9010,In vivo,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL875337,2046.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,N,9011,In vivo,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL626341,2046.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,N,9012,In vivo,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL626342,2046.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,N,9013,In vivo,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL621943,2107.0,BAO_0000218,,,,A,11977,10116.0,50597,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,N,9014,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL621944,,BAO_0000218,,,,A,3748,10116.0,50597,Half life in rats,1,N,9015,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621945,,BAO_0000218,,,,A,15765,10116.0,50597,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,1,N,9016,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621946,,BAO_0000218,,,,A,4871,10116.0,50597,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),1,N,9017,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621947,,BAO_0000218,,,,A,4871,10116.0,50597,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,1,N,9018,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621948,,BAO_0000218,,,,A,4872,10116.0,50597,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),1,N,9019,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621949,,BAO_0000218,,,,A,4872,10116.0,50597,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,1,N,9020,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621950,,BAO_0000218,,,,A,5413,10116.0,50597,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),1,N,9021,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621951,,BAO_0000218,,,,A,5413,10116.0,50597,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,1,N,9022,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621952,178.0,BAO_0000218,,,,A,15272,10116.0,50597,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,1,N,9023,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL621953,2107.0,BAO_0000218,,,,A,4689,10116.0,50597,Stability (%) in rat liver microsomes,1,N,9024,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL621954,,BAO_0000218,,,,A,6057,10116.0,50597,Area under curve was calculated after intravenous administration,1,N,9025,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621955,,BAO_0000218,,,,A,6057,10116.0,50597,Area under the curve was calculated after iv administration in rat,1,N,9026,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621956,,BAO_0000218,,,,A,6057,10116.0,50597,Area under the curve was calculated in rat after peroral administration,1,N,9027,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621957,,BAO_0000218,,,,A,6211,10116.0,50597,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,1,N,9028,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621958,,BAO_0000218,,,,A,5710,10116.0,50597,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,1,N,9029,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621959,,BAO_0000218,,,,A,5710,10116.0,50597,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,1,N,9030,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621960,,BAO_0000218,,,,A,17853,10116.0,50597,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,1,N,9031,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621961,,BAO_0000218,,,,A,17853,10116.0,50597,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,1,N,9032,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621962,,BAO_0000218,,,,A,15765,10116.0,50597,p value of the compound,1,N,9033,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL876787,,BAO_0000218,,,,F,15765,10116.0,50597,p value of the compound,1,N,9034,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621963,,BAO_0000218,,,,A,15765,10116.0,50597,p value of the compound,1,N,9035,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622637,945.0,BAO_0000218,,,,A,6175,10116.0,50597,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),1,N,9036,,Rattus norvegicus,Stomach,1,,Intermediate
,,,CHEMBL622638,945.0,BAO_0000218,,,,A,6175,10116.0,50597,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),1,N,9037,,Rattus norvegicus,Stomach,1,,Intermediate
,,,CHEMBL626561,945.0,BAO_0000218,,,,A,6175,10116.0,50597,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),1,N,9038,,Rattus norvegicus,Stomach,1,,Intermediate
,,,CHEMBL626562,,BAO_0000019,,,,F,7991,9986.0,22224,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),1,U,9039,,Oryctolagus cuniculus,,0,,Autocuration
,,,CHEMBL626563,,BAO_0000218,,,,A,429,9986.0,22224,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),1,U,9040,,Oryctolagus cuniculus,,0,,Autocuration
,,,CHEMBL626564,,BAO_0000218,,,,A,429,9986.0,22224,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),1,U,9041,,Oryctolagus cuniculus,,0,,Autocuration
,,,CHEMBL626565,,BAO_0000218,,,,A,6253,9986.0,22224,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,1,U,9042,In vivo,Oryctolagus cuniculus,,0,,Autocuration
,,,CHEMBL626566,,BAO_0000218,,,,A,6253,9986.0,22224,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,1,U,9043,In vivo,Oryctolagus cuniculus,,0,,Autocuration
,,,CHEMBL626567,,BAO_0000218,,,,A,3615,9986.0,22224,Clearance rate in rabbits,1,U,9044,In vivo,Oryctolagus cuniculus,,0,,Autocuration
,,,CHEMBL626568,,BAO_0000218,,,,A,4059,9986.0,22224,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,1,U,9045,In vivo,Oryctolagus cuniculus,,0,,Autocuration
,,,CHEMBL626569,,BAO_0000218,,,,A,5124,9986.0,22224,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,1,U,9046,In vivo,Oryctolagus cuniculus,,0,,Autocuration
,,,CHEMBL626570,,BAO_0000218,,,,A,5124,9986.0,22224,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,1,U,9047,In vivo,Oryctolagus cuniculus,,0,,Autocuration
,,,CHEMBL626571,,BAO_0000218,,,,A,5124,9986.0,22224,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,1,U,9048,In vivo,Oryctolagus cuniculus,,0,,Autocuration
,,,CHEMBL626572,,BAO_0000218,,,,A,429,9986.0,22224,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,1,U,9049,In vivo,Oryctolagus cuniculus,,0,,Autocuration
,,,CHEMBL626573,1969.0,BAO_0000218,,,,A,4059,9986.0,22224,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,1,U,9050,In vivo,Oryctolagus cuniculus,Plasma,0,,Autocuration
,,,CHEMBL626574,2107.0,BAO_0000251,,,,A,9659,9986.0,22224,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,1,U,9051,,Oryctolagus cuniculus,Liver,0,Microsomes,Autocuration
,,,CHEMBL626575,2107.0,BAO_0000251,,,,A,9659,9986.0,22224,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,1,U,9052,,Oryctolagus cuniculus,Liver,0,Microsomes,Autocuration
,,,CHEMBL626576,,BAO_0000218,,,,A,3639,9986.0,22224,Dose at which bioavailability of intravenously administered compound was tested in rabbit,1,U,9053,,Oryctolagus cuniculus,,0,,Autocuration
,,,CHEMBL626577,,BAO_0000218,,,,A,3639,9986.0,22224,Dose at which bioavailability of perorally administered compound was tested in rabbit,1,U,9054,,Oryctolagus cuniculus,,0,,Autocuration
,,,CHEMBL626578,,BAO_0000218,,,,A,3639,9986.0,22224,The compound was tested for its bioavailability in rabbit (by oral dosage).,1,U,9055,In vivo,Oryctolagus cuniculus,,0,,Autocuration
,,,CHEMBL625263,,BAO_0000218,,,,A,5124,9986.0,22224,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,1,U,9056,In vivo,Oryctolagus cuniculus,,0,,Autocuration
,,,CHEMBL625264,,BAO_0000218,,,,A,5124,9986.0,22224,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,1,U,9057,In vivo,Oryctolagus cuniculus,,0,,Autocuration
,,,CHEMBL625265,,BAO_0000218,,,,A,5124,9986.0,22224,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,1,U,9058,In vivo,Oryctolagus cuniculus,,0,,Autocuration
,,,CHEMBL625266,,BAO_0000251,,,,A,14294,9986.0,22224,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),1,U,9059,,Oryctolagus cuniculus,,0,Microsomes,Autocuration
,,,CHEMBL876796,,BAO_0000251,,,,A,14294,9986.0,22224,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),1,U,9060,,Oryctolagus cuniculus,,0,Microsomes,Autocuration
,,,CHEMBL625267,,BAO_0000218,,,,A,429,9986.0,22224,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,1,U,9061,In vivo,Oryctolagus cuniculus,,0,,Autocuration
,,,CHEMBL625268,1969.0,BAO_0000218,,,,A,5124,9986.0,22224,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,1,U,9062,In vivo,Oryctolagus cuniculus,Plasma,0,,Autocuration
,,,CHEMBL625269,1969.0,BAO_0000218,,,,A,5124,9986.0,22224,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,1,U,9063,In vivo,Oryctolagus cuniculus,Plasma,0,,Autocuration
,,,CHEMBL624689,1969.0,BAO_0000218,,,,A,5124,9986.0,22224,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,1,U,9064,In vivo,Oryctolagus cuniculus,Plasma,0,,Autocuration
,,,CHEMBL624690,,BAO_0000218,,,,A,429,9986.0,22224,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,1,U,9065,In vivo,Oryctolagus cuniculus,,0,,Autocuration
,,,CHEMBL624691,1088.0,BAO_0000218,,,,A,429,9986.0,22224,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),1,U,9066,,Oryctolagus cuniculus,Urine,0,,Autocuration
,,,CHEMBL624692,1088.0,BAO_0000218,,,,A,429,9986.0,22224,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),1,U,9067,,Oryctolagus cuniculus,Urine,0,,Autocuration
,,,CHEMBL624693,,BAO_0000218,,,,A,4059,9986.0,22224,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,1,U,9068,In vivo,Oryctolagus cuniculus,,0,,Autocuration
,,,CHEMBL624694,,BAO_0000218,,,,A,4137,9986.0,22224,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,1,U,9069,In vivo,Oryctolagus cuniculus,,0,,Autocuration
,,,CHEMBL877596,,BAO_0000221,,,,A,11672,9986.0,22224,In vitro Biological half-life in crude homogenate of rabbit renal cortex,1,U,9070,In vitro,Oryctolagus cuniculus,,0,,Autocuration
,,,CHEMBL624695,,BAO_0000019,,,,A,12886,9986.0,22224,Time within which only 10% of the drug was degraded,1,U,9071,,Oryctolagus cuniculus,,0,,Autocuration
,,,CHEMBL624696,2107.0,BAO_0000221,,,,A,3853,9986.0,22224,Half life period in rabbit liver homogenate,1,U,9072,,Oryctolagus cuniculus,Liver,0,,Autocuration
,,,CHEMBL624697,,BAO_0000019,,,,A,3615,9986.0,22224,Half life value in rabbits,1,U,9073,,Oryctolagus cuniculus,,0,,Autocuration
,,,CHEMBL624698,178.0,BAO_0000218,,,,A,6253,9986.0,22224,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,1,U,9074,In vivo,Oryctolagus cuniculus,Blood,0,,Autocuration
,,,CHEMBL624699,178.0,BAO_0000218,,,,A,6253,9986.0,22224,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,1,U,9075,In vivo,Oryctolagus cuniculus,Blood,0,,Autocuration
,,,CHEMBL624700,,BAO_0000218,,,,A,6077,9986.0,22224,Half-life period in rabbits following intravenous administration at 2 mg/kg,1,U,9076,In vivo,Oryctolagus cuniculus,,0,,Autocuration
,,,CHEMBL622903,1969.0,BAO_0000218,,,,A,17617,10116.0,50597,AUC 0-8 hr value in rats at 10 mg/kg,1,N,9077,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622904,1969.0,BAO_0000218,,,,A,17594,10116.0,50597,AUC after administration at 2000 mg/kg/day in rats,1,N,9078,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622905,1969.0,BAO_0000218,,,,A,6149,10116.0,50597,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,1,N,9079,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622906,1969.0,BAO_0000218,,,,A,17260,10116.0,50597,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,1,N,9080,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622907,1969.0,BAO_0000218,,,,A,17260,10116.0,50597,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,1,N,9081,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622908,1969.0,BAO_0000218,,,,A,6644,10116.0,50597,AUC in rat after oral administration at 10.5 mg/kg dose,1,N,9082,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622909,1969.0,BAO_0000218,,,,A,6644,10116.0,50597,AUC in rat after oral administration at 11.2 mg/kg dose,1,N,9083,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622910,1969.0,BAO_0000218,,,,A,6644,10116.0,50597,AUC in rat after oral administration at 9.7 mg/kg dose,1,N,9084,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622911,955.0,BAO_0000218,,,,A,6495,10116.0,50597,AUC in rat brain after oral administration at 10 mg/kg,1,N,9085,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL622912,1969.0,BAO_0000218,,,,A,6504,10116.0,50597,AUC in rat p.o.,1,N,9086,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622913,1969.0,BAO_0000218,,,,A,17686,10116.0,50597,AUC in rat p.o. at 20 mg/kg concentration,1,N,9087,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622914,1969.0,BAO_0000218,,,,A,6495,10116.0,50597,AUC in rat plasma after oral administration at 10 mg/kg,1,N,9088,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622915,1969.0,BAO_0000218,,,,A,216,10116.0,50597,AUC in rats,1,N,9089,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622916,1969.0,BAO_0000218,,,,A,1908,10116.0,50597,AUC value after IV dose at a dose of 5 mg/kg in rats.,1,N,9090,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622917,1969.0,BAO_0000218,,,,A,1908,10116.0,50597,AUC value after oral dose at a dose of 10 mg/kg in rats.,1,N,9091,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622918,1969.0,BAO_0000218,,,,A,6685,10116.0,50597,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",1,N,9092,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622919,1969.0,BAO_0000218,,,,A,216,10116.0,50597,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,1,N,9093,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622920,1969.0,BAO_0000218,,,,A,6049,10116.0,50597,Maximum plasma concentration was evaluated in rat,1,N,9094,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622921,1969.0,BAO_0000218,,,,A,2463,10116.0,50597,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,1,N,9095,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622922,1969.0,BAO_0000218,,,,A,6679,10116.0,50597,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,1,N,9096,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622923,1969.0,BAO_0000218,,,,A,6681,10116.0,50597,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,1,N,9097,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL877604,1969.0,BAO_0000218,,,,A,4890,10116.0,50597,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,1,N,9098,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622924,1969.0,BAO_0000218,,,,A,6410,10116.0,50597,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,1,N,9099,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622925,1969.0,BAO_0000218,,,,A,6410,10116.0,50597,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,1,N,9100,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622926,1969.0,BAO_0000218,,,,A,16366,10116.0,50597,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,1,N,9101,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623625,1969.0,BAO_0000218,,,,A,6227,10116.0,50597,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,1,N,9102,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623626,1969.0,BAO_0000218,,,,A,3598,10116.0,50597,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,1,N,9103,In vivo,Rattus norvegicus,Plasma,1,,Expert
,,,CHEMBL623627,1969.0,BAO_0000218,,,,A,1465,10116.0,50597,Maximum plasma drug concentration was determined,1,N,9104,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623628,,BAO_0000218,,,,A,4368,10116.0,50597,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,1,N,9105,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623629,1969.0,BAO_0000218,,,,A,15662,10116.0,50597,Mean peak plasma concentration was observed after intravenous administration in rat,1,N,9106,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623630,1969.0,BAO_0000218,,,,A,15662,10116.0,50597,Mean peak plasma concentration was observed after oral administration in rat,1,N,9107,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623804,,BAO_0000218,,,,A,5355,10116.0,50597,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,1,N,9108,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623805,,BAO_0000218,,,,A,5355,10116.0,50597,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,1,N,9109,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623806,1969.0,BAO_0000218,,,,A,1567,10116.0,50597,Peak oral plasma concentration was determined in rats by oral administration,1,N,9110,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623807,1969.0,BAO_0000218,,,,A,4026,10116.0,50597,Peak plasma concentration (Cmax) was determined,1,N,9111,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623808,1969.0,BAO_0000218,,,,A,6193,10116.0,50597,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,1,N,9112,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623809,1969.0,BAO_0000218,,,,A,4026,10116.0,50597,Peak plasma concentration (Cmax) in rats,1,N,9113,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623810,1969.0,BAO_0000218,,,,A,6485,10116.0,50597,Peak plasma concentration at 1 mg/kg peroral administration,1,N,9114,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623811,1969.0,BAO_0000218,,,,A,17655,10116.0,50597,Peak plasma concentration in rat,1,N,9115,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623812,1969.0,BAO_0000218,,,,A,14941,10116.0,50597,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",1,N,9116,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL877605,,BAO_0000218,,,,A,5394,10116.0,50597,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,1,N,9117,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623813,,BAO_0000218,,,,A,4408,10116.0,50597,Pharmacokinetic property (Cmax) in rat,1,N,9118,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623814,,BAO_0000218,,,,A,5983,10116.0,50597,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,1,N,9119,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623815,,BAO_0000218,,,,A,4878,10116.0,50597,Cmax in rat after 3mg/kg oral dose,1,N,9120,In vivo,Rattus norvegicus,,1,,Intermediate
,,Sprague-Dawley,CHEMBL623816,,BAO_0000218,,,,A,5862,10116.0,50597,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,1,N,9121,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623145,,BAO_0000218,,,,A,4517,10116.0,50597,Cmax in rats after 20 mg/kg oral dose,1,N,9122,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623146,1969.0,BAO_0000218,,,,A,5932,10116.0,50597,Cmax in rat plasma after 30mg/kg oral dose,1,N,9123,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623147,1969.0,BAO_0000218,,,,A,5436,10116.0,50597,Plasma concentration after oral administration of 100 mg/kg to rats,1,N,9124,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623042,955.0,BAO_0000218,,,,A,4910,10116.0,50597,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,1,N,9125,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL623043,,BAO_0000218,,,,A,4950,10116.0,50597,Tested for the Cmax in rat at 10 mg/kg per orally,1,N,9126,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623044,,BAO_0000218,,,,A,15078,10116.0,50597,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",1,N,9127,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623045,,BAO_0000218,,,,A,15078,10116.0,50597,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",1,N,9128,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623046,,BAO_0000218,,,,A,3360,10116.0,50597,Bioavailability as oral Cmax in rats at 30 mins,1,N,9129,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623226,,BAO_0000218,,,,A,3360,10116.0,50597,Bioavailability as oral Cmax in rats at 6hr,1,N,9130,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623227,,BAO_0000218,,,,A,15022,10116.0,50597,The maximum concentration of compound was measured at the dose of 100 umol/kg,1,N,9131,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623228,,BAO_0000218,,,,A,15022,10116.0,50597,The maximum concentration of compound was measured at the dose of 300 umol/kg,1,N,9132,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623229,,BAO_0000218,,,,A,15022,10116.0,50597,The maximum concentration of compound was measured at the dose of 30 umol/kg,1,N,9133,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623230,1969.0,BAO_0000218,,,,A,5160,10116.0,50597,The maximum plasma levels for the compounds were determined by LC-MS.,1,N,9134,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623231,1969.0,BAO_0000218,,,,A,15662,10116.0,50597,mean peak plasma concentration was observed after intravenous administration in rat,1,N,9135,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623232,1969.0,BAO_0000218,,,,A,15662,10116.0,50597,mean peak plasma concentration was observed after oral administration in rat,1,N,9136,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623233,,BAO_0000218,,,,A,4709,10116.0,50597,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,1,N,9137,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623234,,BAO_0000218,,,,A,3535,10116.0,50597,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,1,N,9138,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623235,,BAO_0000218,,,,A,3535,10116.0,50597,Concentration in plasma (portal) following oral dose in rats at 1 hr,1,N,9139,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623236,,BAO_0000218,,,,A,3535,10116.0,50597,Concentration in plasma (portal) following oral dose in rats at 2 hr,1,N,9140,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623237,,BAO_0000218,,,,A,3535,10116.0,50597,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,1,N,9141,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623238,,BAO_0000218,,,,A,3535,10116.0,50597,Concentration in plasma (systemic) following oral dose in rats at 1 hr,1,N,9142,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623239,,BAO_0000218,,,,A,3535,10116.0,50597,Concentration in plasma (systemic) following oral dose in rats at 2 hr,1,N,9143,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623240,1969.0,BAO_0000218,,,,A,5005,10116.0,22224,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,1,U,9144,In vivo,Rattus norvegicus,Plasma,0,,Intermediate
,,,CHEMBL623241,1898.0,BAO_0000218,,,,A,6326,10116.0,50597,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",1,N,9145,,Rattus norvegicus,Hypothalamus,1,,Intermediate
,,,CHEMBL623242,1898.0,BAO_0000218,,,,A,6326,10116.0,50597,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",1,N,9146,,Rattus norvegicus,Hypothalamus,1,,Intermediate
,,,CHEMBL874394,,BAO_0000218,,,,A,6326,10116.0,50597,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",1,N,9147,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623243,,BAO_0000218,,,,A,6326,10116.0,50597,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",1,N,9148,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623244,,BAO_0000218,,,,A,17411,10116.0,50597,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,1,N,9149,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623245,2113.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,N,9150,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL623246,2113.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,N,9151,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL623247,2113.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,N,9152,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL623248,2113.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,N,9153,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL623249,2113.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,N,9154,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL625072,2107.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,N,9155,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625073,2107.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,N,9156,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625074,2107.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,N,9157,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625075,2107.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,N,9158,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625076,2107.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,1,N,9159,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625077,2107.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,N,9160,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625078,2107.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,N,9161,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL874395,2107.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,1,N,9162,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625079,2107.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,N,9163,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625080,2107.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,N,9164,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625081,2107.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,N,9165,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625082,2107.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,N,9166,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625083,2107.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,N,9167,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625084,2107.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,N,9168,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625085,2107.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,N,9169,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625086,2107.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,N,9170,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625087,2107.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,N,9171,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625088,2107.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,1,N,9172,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622205,2107.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,N,9173,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622206,2107.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,N,9174,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622207,2107.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,N,9175,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622366,2107.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,N,9176,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622367,2107.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,N,9177,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL875331,2107.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,N,9178,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622368,2107.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,N,9179,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622369,2048.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,N,9180,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL622370,2048.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,N,9181,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL622371,2048.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,N,9182,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL622372,2048.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,N,9183,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL622373,2048.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,N,9184,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL622374,2048.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,N,9185,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL622375,2048.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,N,9186,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL622376,2048.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,1,N,9187,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL622377,2048.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,N,9188,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL622378,2048.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,N,9189,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL622379,2048.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,N,9190,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL622380,2048.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,N,9191,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL622381,2048.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,N,9192,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL622382,2048.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,N,9193,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL622383,2048.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,1,N,9194,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL875332,945.0,BAO_0000218,,,,A,6175,10116.0,50597,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),1,N,9195,,Rattus norvegicus,Stomach,1,,Intermediate
,,,CHEMBL622384,945.0,BAO_0000218,,,,A,6175,10116.0,50597,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),1,N,9196,,Rattus norvegicus,Stomach,1,,Intermediate
,,,CHEMBL622385,945.0,BAO_0000218,,,,A,6175,10116.0,50597,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),1,N,9197,,Rattus norvegicus,Stomach,1,,Intermediate
,,,CHEMBL622386,945.0,BAO_0000218,,,,A,6175,10116.0,50597,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),1,N,9198,,Rattus norvegicus,Stomach,1,,Intermediate
,,,CHEMBL622387,,BAO_0000218,,,,A,10839,10116.0,50597,The compound was tested for the plasma binding in rat,1,N,9199,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622388,,BAO_0000218,,,,A,16459,10116.0,50597,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",1,N,9200,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622389,,BAO_0000218,,,,A,16459,10116.0,50597,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",1,N,9201,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622390,,BAO_0000218,,,,A,16459,10116.0,50597,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",1,N,9202,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622391,,BAO_0000218,,,,A,16459,10116.0,50597,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),1,N,9203,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622392,,BAO_0000218,,,,A,16459,10116.0,50597,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),1,N,9204,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622393,,BAO_0000218,,,,A,16459,10116.0,50597,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),1,N,9205,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622394,,BAO_0000218,,,,A,3278,10116.0,50597,Plasma level at 2 hr after administration of the compound,1,N,9206,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622395,,BAO_0000218,,,,A,3278,10116.0,50597,plasma level at 2 hr after administration of the compound,1,N,9207,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622396,1977.0,BAO_0000218,,,,A,4684,10116.0,50597,Stability in rat serum measured as % recovery at 1 min,1,N,9208,,Rattus norvegicus,Serum,1,,Intermediate
,,,CHEMBL624894,1977.0,BAO_0000218,,,,A,4684,10116.0,50597,Stability in rat serum measured as % recovery at 10 min,1,N,9209,,Rattus norvegicus,Serum,1,,Intermediate
,,,CHEMBL624895,1977.0,BAO_0000218,,,,A,4684,10116.0,50597,Stability in rat serum measured as % recovery at 10 mins,1,N,9210,,Rattus norvegicus,Serum,1,,Intermediate
,,,CHEMBL624058,1977.0,BAO_0000218,,,,A,4684,10116.0,50597,Stability in rat serum measured as % recovery at 2 hr,1,N,9211,,Rattus norvegicus,Serum,1,,Intermediate
,,,CHEMBL624059,1977.0,BAO_0000218,,,,A,4684,10116.0,50597,Stability in rat serum measured as % recovery at 3 min,1,N,9212,,Rattus norvegicus,Serum,1,,Intermediate
,,,CHEMBL624060,1977.0,BAO_0000218,,,,A,4684,10116.0,50597,Stability in rat serum measured as % recovery at 3 mins,1,N,9213,,Rattus norvegicus,Serum,1,,Intermediate
,,,CHEMBL624061,1977.0,BAO_0000218,,,,A,4684,10116.0,50597,Stability in rat serum measured as % recovery at 5 min,1,N,9214,,Rattus norvegicus,Serum,1,,Intermediate
,,,CHEMBL624062,1977.0,BAO_0000218,,,,A,4684,10116.0,50597,Stability in rat serum measured as % recovery at 5 mins,1,N,9215,,Rattus norvegicus,Serum,1,,Intermediate
,,,CHEMBL624063,,BAO_0000218,,,,A,16456,10116.0,50597,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,1,N,9216,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624064,,BAO_0000218,,,,A,16456,10116.0,50597,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,1,N,9217,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624065,1969.0,BAO_0000218,,,,A,723,10116.0,50597,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,1,N,9218,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL624066,1969.0,BAO_0000218,,,,A,723,10116.0,50597,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,1,N,9219,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL877490,,BAO_0000218,,,,A,5160,10116.0,50597,Half life tested in mature male rat at a dose of 30 mg/kg,1,N,9220,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL874442,,BAO_0000218,,,,A,4709,10116.0,50597,Half life after intravenous administration of 1 mg/kg in rat,1,N,9221,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626890,,BAO_0000218,,,,A,5633,10116.0,50597,Half life period after administration (30 mg/kg) in rat,1,N,9222,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626891,,BAO_0000218,,,,A,5302,10116.0,50597,Half life period in rat after 5 mg/Kg dose,1,N,9223,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626892,,BAO_0000218,,,,A,5302,10116.0,50597,Half life period in rat after 5 mg/kg dose,1,N,9224,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626893,,BAO_0000218,,,,A,17791,10116.0,50597,Half life period was determined,1,N,9225,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626894,,BAO_0000218,,,,A,17791,10116.0,50597,Half life period was evaluated in rat,1,N,9226,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626895,,BAO_0000218,,,,A,17791,10116.0,50597,Half life period was evaluated in rat; 0.5-1.0,1,N,9227,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626896,,BAO_0000218,,,,A,17791,10116.0,50597,Half life period was evaluated in rat; 5.9-7.5,1,N,9228,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626897,1969.0,BAO_0000218,,,,A,14512,10116.0,50597,Half-life in rat plasma,1,N,9229,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626898,,BAO_0000218,,,,A,6230,10116.0,50597,Half-life time in rat was determined,1,N,9230,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626899,,BAO_0000218,,,,A,3364,10116.0,50597,Terminal half-life after iv administration to rats,1,N,9231,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626900,,BAO_0000218,,,,A,6874,10116.0,50597,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,1,N,9232,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626901,,BAO_0000218,,,,A,857,10116.0,50597,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,1,N,9233,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626902,,BAO_0000218,,,,A,858,10116.0,50597,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),1,N,9234,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626903,,BAO_0000218,,,,A,858,10116.0,50597,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),1,N,9235,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL874443,,BAO_0000218,,,,A,5355,10116.0,50597,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,1,N,9236,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626904,,BAO_0000218,,,,A,5355,10116.0,50597,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,1,N,9237,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626905,,BAO_0000218,,,,A,6305,10116.0,50597,Half life in rats,1,N,9238,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL873830,1969.0,BAO_0000218,,,,A,13501,10116.0,50597,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,1,N,9239,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626906,,BAO_0000218,,,,A,17594,10116.0,50597,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,1,N,9240,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631076,1969.0,BAO_0000218,,,,A,4186,10116.0,50597,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,1,N,9241,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL631077,1969.0,BAO_0000218,,,,A,2932,10116.0,50597,Biological half-life was measured in plasma of rats,1,N,9242,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL631078,,BAO_0000218,,,,A,17065,10116.0,50597,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,1,N,9243,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631079,,BAO_0000218,,,,A,15765,10116.0,50597,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,1,N,9244,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631080,,BAO_0000218,,,,A,2713,10116.0,50597,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,1,N,9245,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631081,,BAO_0000218,,,,A,2661,10116.0,50597,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,1,N,9246,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631239,,BAO_0000218,,,,A,2661,10116.0,50597,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,1,N,9247,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631240,1969.0,BAO_0000218,,,,A,740,10116.0,50597,Compound was evaluated for plasma half life in rat,1,N,9248,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL631241,1969.0,BAO_0000218,,,,A,6597,10116.0,50597,AUC value at a dose of 5 mg/kg (p.o.) in rats,1,N,9249,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL631242,1969.0,BAO_0000218,,,,A,2959,10116.0,50597,AUC value after administration of 20 mg/Kg oral dose in rat,1,N,9250,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL631243,1969.0,BAO_0000218,,,,A,17594,10116.0,50597,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,1,N,9251,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL874444,1969.0,BAO_0000218,,,,A,17596,10116.0,50597,AUC0-96 after administration at 50 mg/kg,1,N,9252,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL631244,1969.0,BAO_0000218,,,,A,17594,10116.0,50597,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,1,N,9253,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL631245,,BAO_0000218,,,,A,3293,10116.0,50597,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",1,N,9254,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627162,,BAO_0000218,,,,A,6757,10116.0,50597,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,1,N,9255,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627163,,BAO_0000218,,,,A,6757,10116.0,50597,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,1,N,9256,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627164,,BAO_0000218,,,,A,6757,10116.0,50597,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,1,N,9257,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627165,2113.0,BAO_0000218,,,,A,5979,10116.0,50597,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,1,N,9258,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL627166,,BAO_0000218,,,,A,5979,10116.0,50597,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,1,N,9259,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627167,,BAO_0000218,,,,A,5979,10116.0,50597,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,1,N,9260,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627822,,BAO_0000218,,,,A,4026,10116.0,50597,Area under curve (AUC) at a dose of 30 mg/kg in rats,1,N,9261,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627823,,BAO_0000218,,,,A,5355,10116.0,50597,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,1,N,9262,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627824,,BAO_0000218,,,,A,5355,10116.0,50597,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,1,N,9263,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627825,,BAO_0000218,,,,A,5355,10116.0,50597,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,1,N,9264,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627826,,BAO_0000218,,,,A,5633,10116.0,50597,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,1,N,9265,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627827,,BAO_0000218,,,,A,1716,10116.0,50597,Area under curve (Pharmacokinetic property) was determined,1,N,9266,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627828,,BAO_0000218,,,,A,1716,10116.0,50597,Area under curve (Pharmacokinetic property) of the compound; Not determined,1,N,9267,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627829,,BAO_0000218,,,,A,4689,10116.0,50597,Area under curve after intravenous administration (1 mg/kg) in rat,1,N,9268,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627830,,BAO_0000218,,,,A,4527,10116.0,50597,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,1,N,9269,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627831,,BAO_0000218,,,,A,4527,10116.0,50597,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,1,N,9270,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627832,,BAO_0000218,,,,A,15662,10116.0,50597,Area under curve in male SD rats was observed after oral administration in rat,1,N,9271,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627833,,BAO_0000218,,,,A,4413,10116.0,50597,Area under curve of compound after iv administration of 20 mg/kg dose in rat,1,N,9272,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627834,,BAO_0000218,,,,A,3598,10116.0,50597,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,1,N,9273,,Rattus norvegicus,,1,,Expert
,,,CHEMBL628004,,BAO_0000218,,,,A,3598,10116.0,50597,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,1,N,9274,,Rattus norvegicus,,1,,Expert
,,,CHEMBL628005,,BAO_0000218,,,,A,5964,10116.0,50597,Area under curve at 5 mg/kg po was determined in rat,1,N,9275,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628006,,BAO_0000218,,,,A,4689,10116.0,50597,Area under curve in Rat at a oral dose of 5 mg/kg,1,N,9276,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628007,,BAO_0000218,,,,A,4186,10116.0,50597,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,1,N,9277,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625676,,BAO_0000218,,,,A,5510,10116.0,50597,Area under curve was determined,1,N,9278,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631309,,BAO_0000218,,,,A,17858,10116.0,50597,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,1,N,9279,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631310,,BAO_0000218,,,,A,17804,10116.0,50597,Area under curve after intravenous administration at 3 mg/kg,1,N,9280,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631311,,BAO_0000218,,,,A,6106,10116.0,50597,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,1,N,9281,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631312,,BAO_0000218,,,,A,5964,10116.0,50597,Area under curve at 4 hr in rat,1,N,9282,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631313,,BAO_0000218,,,,A,4026,10116.0,50597,Area under curve at a dose of 30 mg/kg,1,N,9283,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631314,,BAO_0000218,,,,A,4756,10116.0,50597,Area under curve at the dose of 2 mg/Kg administered perorally in rats,1,N,9284,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631315,,BAO_0000218,,,,A,4756,10116.0,50597,Area under curve at the dose of 5 mg/Kg administered perorally in rats,1,N,9285,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631316,,BAO_0000218,,,,A,5862,10116.0,50597,Area under curve for a 2-mpk po dose in SD rats,1,N,9286,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631317,,BAO_0000218,,,,A,5862,10116.0,50597,Area under curve in SD rats,1,N,9287,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL874471,,BAO_0000218,,,,A,6644,10116.0,50597,Area under curve in rat after oral administration at 13 mg/kg dose,1,N,9288,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631318,,BAO_0000218,,,,A,5871,10116.0,50597,Area under curve in rat by po administration at 0-24 hr,1,N,9289,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631319,1969.0,BAO_0000218,,,,A,5919,10116.0,50597,Area under curve in rat plasma,1,N,9290,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL631320,,BAO_0000218,,,,A,5939,10116.0,50597,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,1,N,9291,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631321,,BAO_0000218,,,,A,5939,10116.0,50597,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,1,N,9292,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631322,,BAO_0000218,,,,A,10,10116.0,50597,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,1,N,9293,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631323,,BAO_0000218,,,,A,11149,10116.0,50597,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,1,N,9294,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631324,,BAO_0000218,,,,A,5302,10116.0,50597,Area under curve value in rat at a dose of 5 mg/kg,1,N,9295,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631325,,BAO_0000218,,,,A,17796,10116.0,50597,Area under curve was determined after oral administration in rats,1,N,9296,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631326,,BAO_0000218,,,,A,4890,10116.0,50597,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,1,N,9297,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631327,,BAO_0000218,,,,A,6011,10116.0,50597,Area under curve was determined after peroral administration in rat,1,N,9298,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631328,,BAO_0000218,,,,A,5375,10116.0,50597,Area under curve was determined at a dose 30 mpk administered orally.,1,N,9299,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631329,,BAO_0000218,,,,A,17764,10116.0,50597,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,1,N,9300,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627217,,BAO_0000218,,,,A,4368,10116.0,50597,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,1,N,9301,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626352,,BAO_0000218,,,,A,5610,10116.0,50597,Area under curve was determined in male rat,1,N,9302,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626353,,BAO_0000218,,,,A,5833,10116.0,50597,Area under curve was determined in rat after PO administration,1,N,9303,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626354,,BAO_0000218,,,,A,4257,10116.0,50597,Area under curve was determined in rat after a 3 mg/kg of oral dose,1,N,9304,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626355,,BAO_0000218,,,,A,5937,10116.0,50597,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,1,N,9305,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626356,,BAO_0000218,,,,A,5932,10116.0,50597,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,1,N,9306,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626357,,BAO_0000218,,,,A,5932,10116.0,50597,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,1,N,9307,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626358,,BAO_0000218,,,,A,17411,10116.0,50597,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,1,N,9308,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626359,,BAO_0000218,,,,A,17411,10116.0,50597,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,1,N,9309,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626360,1969.0,BAO_0000218,,,,A,17771,10116.0,50597,Peak plasma concentration in rat at a dose of 3 mg/kg,1,N,9310,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626361,,BAO_0000218,,,,A,1628,10116.0,50597,Plasma concentration at 2 hr in rats was evaluated.,1,N,9311,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626362,,BAO_0000218,,,,A,1628,10116.0,50597,Plasma concentration at 2 hr in rats was evaluated; Not available,1,N,9312,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626363,,BAO_0000218,,,,A,17411,10116.0,50597,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,1,N,9313,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626970,,BAO_0000218,,,,A,4910,10116.0,50597,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,1,N,9314,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626971,,BAO_0000218,,,,A,4910,10116.0,50597,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,1,N,9315,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626972,1969.0,BAO_0000218,,,,A,4910,10116.0,50597,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,1,N,9316,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626973,1969.0,BAO_0000218,,,,A,4910,10116.0,50597,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,1,N,9317,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626974,1969.0,BAO_0000218,,,,A,4910,10116.0,50597,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,1,N,9318,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL874592,1969.0,BAO_0000218,,,,A,4910,10116.0,50597,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,1,N,9319,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626975,,BAO_0000218,,,,A,5510,10116.0,50597,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,1,N,9320,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626976,,BAO_0000218,,,,A,5510,10116.0,50597,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,1,N,9321,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626977,,BAO_0000218,,,,A,5510,10116.0,50597,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,1,N,9322,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626978,,BAO_0000218,,,,A,5510,10116.0,50597,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,1,N,9323,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626979,,BAO_0000218,,,,A,16427,10116.0,50597,PK study was carried to determine the relative absorption ranking in rat.,1,N,9324,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626980,1969.0,BAO_0000218,,,,A,4689,10116.0,50597,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,1,N,9325,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626981,178.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",1,N,9326,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL626982,178.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",1,N,9327,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL626983,178.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",1,N,9328,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL622522,178.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",1,N,9329,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL622523,178.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",1,N,9330,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL622524,178.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",1,N,9331,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL622525,955.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",1,N,9332,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL622526,955.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",1,N,9333,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL619849,955.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",1,N,9334,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL619850,955.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",1,N,9335,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL623864,955.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",1,N,9336,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL623865,955.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",1,N,9337,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL623866,948.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",1,N,9338,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL623867,948.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",1,N,9339,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL877615,948.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",1,N,9340,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL623868,948.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",1,N,9341,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL623869,948.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",1,N,9342,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL623870,948.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",1,N,9343,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL623871,2048.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,1,N,9344,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL623872,2048.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,N,9345,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL622129,2048.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,N,9346,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL622130,2048.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,N,9347,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL622131,2048.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,N,9348,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL622132,2048.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,N,9349,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL622133,2048.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,N,9350,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL622134,2048.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,N,9351,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL622135,2048.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,N,9352,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL622136,2048.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,N,9353,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL622137,2385.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,N,9354,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL622138,2385.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,N,9355,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL623017,2385.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,N,9356,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL623018,2385.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,N,9357,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL623019,2385.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,N,9358,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL623020,2385.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,N,9359,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL623021,2385.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,1,N,9360,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL623022,2385.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,1,N,9361,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL623023,2385.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,N,9362,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL623024,2385.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,N,9363,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL623025,2385.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,N,9364,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL620545,2385.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,N,9365,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL620546,2385.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,N,9366,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL620547,2385.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,N,9367,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL620548,2385.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,N,9368,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL620549,2385.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,N,9369,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL620550,2385.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,N,9370,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL620551,2385.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,1,N,9371,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL620552,2385.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,N,9372,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL620553,2385.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,N,9373,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL620554,2385.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,N,9374,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL875845,2385.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,N,9375,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL620555,2385.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,N,9376,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL620556,2385.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,N,9377,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL620557,2385.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,N,9378,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL620558,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,N,9379,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620559,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,N,9380,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622939,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,N,9381,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622940,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,N,9382,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622941,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,N,9383,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622942,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,N,9384,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622943,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,N,9385,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622944,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,1,N,9386,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622945,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,N,9387,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622946,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,N,9388,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622947,,BAO_0000218,,,,A,3341,10116.0,50597,Compound was evaluated for terminal half life in rat,1,N,9389,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622948,1969.0,BAO_0000218,,,,A,3634,10116.0,50597,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,1,N,9390,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622949,1969.0,BAO_0000218,,,,A,3634,10116.0,50597,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,1,N,9391,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622950,,BAO_0000218,,,,A,4839,10116.0,50597,Compound was tested for its half life in rat,1,N,9392,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622951,1969.0,BAO_0000218,,,,A,5005,9544.0,22224,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,1,U,9393,In vivo,Macaca mulatta,Plasma,0,,Intermediate
,,,CHEMBL622952,1969.0,BAO_0000366,,,,A,5005,10116.0,22224,Compound was tested for its plasma half life in Sprague Dawley rats,1,U,9394,,Rattus norvegicus,Plasma,0,,Intermediate
,,,CHEMBL622953,1969.0,BAO_0000366,,,,A,5005,10116.0,22224,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,1,U,9395,,Rattus norvegicus,Plasma,0,,Intermediate
,,,CHEMBL873818,1969.0,BAO_0000218,,,,A,1094,10116.0,50597,Compound was tested for plasma half-life period in rat,1,N,9396,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622954,,BAO_0000218,,,,A,5031,10116.0,50597,Elimination half life after i.v. administration of compound in rats,1,N,9397,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622955,,BAO_0000218,,,,A,6518,10116.0,50597,Elimination half-life after IV dosing at 0.5 mg/kg in rat,1,N,9398,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL875229,,BAO_0000218,,,,A,6518,10116.0,50597,Elimination half-life after IV dosing at 1 mg/kg in rat,1,N,9399,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622956,,BAO_0000218,,,,A,6518,10116.0,50597,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,1,N,9400,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622957,,BAO_0000218,,,,A,6518,10116.0,50597,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,1,N,9401,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622958,955.0,BAO_0000218,,,,A,5408,10116.0,50597,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,1,N,9402,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL622959,1969.0,BAO_0000218,,,,A,5408,10116.0,50597,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,1,N,9403,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622960,955.0,BAO_0000218,,,,A,5408,10116.0,50597,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,1,N,9404,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL622961,1969.0,BAO_0000218,,,,A,5408,10116.0,50597,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,1,N,9405,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622962,,BAO_0000218,,,,A,4687,10116.0,50597,Evaluated for the half life in rat (in vivo),1,N,9406,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622963,,BAO_0000218,,,,A,6640,10116.0,50597,Hafl life in rat,1,N,9407,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622964,,BAO_0000218,,,,A,6640,10116.0,50597,Hafl life rat,1,N,9408,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622965,,BAO_0000218,,,,A,6641,10116.0,50597,Hafl life rat,1,N,9409,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622966,,BAO_0000218,,,,A,6640,10116.0,50597,Hafl life rat; Not determined,1,N,9410,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622967,,BAO_0000218,,,,A,6641,10116.0,50597,Hafl life rat; Not determined,1,N,9411,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622968,2113.0,BAO_0000218,,,,A,17411,10116.0,50597,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,1,N,9412,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL622969,2107.0,BAO_0000218,,,,A,17411,10116.0,50597,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,1,N,9413,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL875327,2048.0,BAO_0000218,,,,A,17411,10116.0,50597,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,1,N,9414,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL628638,,BAO_0000218,,,,A,6570,10116.0,50597,Half life in rat after 1 mg/kg i.v. administration,1,N,9415,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628639,,BAO_0000218,,,,A,6570,10116.0,50597,Half life in rat after 2 mg/kg peroral administration,1,N,9416,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625840,,BAO_0000218,,,,A,17411,10116.0,50597,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,1,N,9417,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625841,,BAO_0000218,,,,A,4722,10116.0,50597,Half life of 10 mg/kg oral dose determined in rats,1,N,9418,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625842,,BAO_0000218,,,,A,5978,10116.0,50597,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,N,9419,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625843,,BAO_0000218,,,,A,5978,10116.0,50597,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,1,N,9420,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625844,,BAO_0000218,,,,A,5978,10116.0,50597,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,1,N,9421,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL873822,,BAO_0000218,,,,A,5978,10116.0,50597,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,1,N,9422,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625845,,BAO_0000218,,,,A,5978,10116.0,50597,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,N,9423,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627059,,BAO_0000218,,,,A,5978,10116.0,50597,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,N,9424,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627060,,BAO_0000218,,,,A,5978,10116.0,50597,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,1,N,9425,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627061,,BAO_0000218,,,,A,5978,10116.0,50597,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,N,9426,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627709,,BAO_0000218,,,,A,4762,10116.0,50597,Half life of compound at 5 mg/kg after po administration was determined in rat,1,N,9427,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627710,,BAO_0000218,,,,A,5327,10116.0,50597,Half life of compound determined after intravenous administration to rat,1,N,9428,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627711,,BAO_0000218,,,,A,4847,10116.0,50597,Half life of compound was determined in rat,1,N,9429,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627712,1969.0,BAO_0000218,,,,A,17720,10116.0,50597,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,1,N,9430,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL627713,,BAO_0000218,,,,A,4723,10116.0,50597,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,1,N,9431,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627714,,BAO_0000218,,,,A,4723,10116.0,50597,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,1,N,9432,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627889,,BAO_0000218,,,,A,4256,9541.0,22224,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,1,U,9433,In vivo,Macaca fascicularis,,0,,Intermediate
,,,CHEMBL627890,,BAO_0000218,,,,A,4256,10116.0,22224,Half life determined in rat by intravenous administration,1,U,9434,In vivo,Rattus norvegicus,,0,,Intermediate
,,,CHEMBL627891,,BAO_0000218,,,,A,4722,10116.0,50597,Half life determined in rats after iv administration,1,N,9435,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627892,1969.0,BAO_0000218,,,,A,6535,10116.0,50597,Half life in rat plasma after administration of 2 mg/kg iv,1,N,9436,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL627893,1969.0,BAO_0000218,,,,A,6535,10116.0,50597,Half life in rat plasma after administration of 2 mg/kg iv,1,N,9437,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL627894,1969.0,BAO_0000218,,,,A,1435,10116.0,50597,Half life in rat plasma was determined,1,N,9438,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL627895,1969.0,BAO_0000218,,,,A,1435,10116.0,50597,Half life in rat plasma was determined; NA means not applicable,1,N,9439,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL627896,,BAO_0000218,,,,A,5206,10116.0,50597,Half life in rat was tested,1,N,9440,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627897,1969.0,BAO_0000218,,,,A,6080,10116.0,50597,Half life measured in rat plasma,1,N,9441,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL627898,,BAO_0000218,,,,A,4449,10116.0,50597,Half life recorded in rats,1,N,9442,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627899,,BAO_0000218,,,,A,6057,10116.0,50597,Half life was calculated,1,N,9443,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL873823,,BAO_0000218,,,,A,6057,10116.0,50597,Half life was calculated in rat,1,N,9444,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627900,,BAO_0000218,,,,A,3747,10116.0,50597,Half life was determined,1,N,9445,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627901,,BAO_0000218,,,,A,17858,10116.0,50597,Half life after 10 mg/kg oral administration in rat,1,N,9446,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627902,,BAO_0000218,,,,A,16365,10116.0,50597,Half life after administering orally a dose of 10 mg/kg to a fasting rat,1,N,9447,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627903,,BAO_0000218,,,,A,16365,10116.0,50597,Half life after administering orally a dose of 30 mg/kg,1,N,9448,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627904,,BAO_0000218,,,,A,5031,10116.0,50597,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,1,N,9449,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627905,,BAO_0000218,,,,A,4722,10116.0,50597,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,1,N,9450,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627906,,BAO_0000218,,,,A,6078,10116.0,50597,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,1,N,9451,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627907,,BAO_0000218,,,,A,6078,10116.0,50597,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,1,N,9452,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL876783,,BAO_0000218,,,,A,6078,10116.0,50597,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,1,N,9453,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627908,,BAO_0000218,,,,A,6078,10116.0,50597,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,1,N,9454,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627909,,BAO_0000218,,,,A,17065,10116.0,50597,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,1,N,9455,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627910,,BAO_0000218,,,,A,1353,10116.0,50597,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,1,N,9456,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627911,,BAO_0000218,,,,A,1353,10116.0,50597,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),1,N,9457,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627912,,BAO_0000218,,,,A,1353,10116.0,50597,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),1,N,9458,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627913,,BAO_0000218,,,,A,1353,10116.0,50597,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),1,N,9459,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627914,,BAO_0000218,,,,A,1353,10116.0,50597,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),1,N,9460,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627915,,BAO_0000218,,,,A,16423,10116.0,50597,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,1,N,9461,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627916,,BAO_0000218,,,,A,16423,10116.0,50597,Area under the curve was evaluated after 20 uM/kg of peroral administration,1,N,9462,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627917,,BAO_0000218,,,,A,6062,10116.0,50597,Area under the curve was measured in rat after an iv dose of 1 mg/kg,1,N,9463,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627918,,BAO_0000218,,,,A,6056,10116.0,50597,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,1,N,9464,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627919,,BAO_0000218,,,,A,5182,10116.0,50597,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,1,N,9465,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627920,,BAO_0000218,,,,A,6410,10116.0,50597,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,1,N,9466,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627921,,BAO_0000218,,,,A,6410,10116.0,50597,Area under the curve was evaluated at an oral dose of 30 mg/kg,1,N,9467,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627922,,BAO_0000218,,,,A,4723,10116.0,50597,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,1,N,9468,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL876784,,BAO_0000218,,,,A,4723,10116.0,50597,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,1,N,9469,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627923,,BAO_0000218,,,,A,4723,10116.0,50597,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,1,N,9470,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626208,,BAO_0000218,,,,A,4723,10116.0,50597,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,1,N,9471,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626209,,BAO_0000218,,,,A,4723,10116.0,50597,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,1,N,9472,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626210,,BAO_0000218,,,,A,4723,10116.0,50597,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,1,N,9473,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627994,1969.0,BAO_0000218,,,,A,2463,10116.0,50597,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,1,N,9474,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL627995,,BAO_0000218,,,,A,4709,10116.0,50597,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,1,N,9475,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627996,,BAO_0000218,,,,A,4075,10116.0,50597,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,1,N,9476,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627997,,BAO_0000218,,,,A,5394,10116.0,50597,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,1,N,9477,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627998,,BAO_0000218,,,,A,2661,10116.0,50597,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,1,N,9478,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628640,,BAO_0000218,,,,A,2661,10116.0,50597,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,1,N,9479,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628641,,BAO_0000218,,,,A,2661,10116.0,50597,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,1,N,9480,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628642,,BAO_0000218,,,,A,2661,10116.0,50597,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,1,N,9481,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628643,,BAO_0000218,,,,A,17791,10116.0,50597,Compound was evaluated for area under the curve expressed as (h*ug/ml),1,N,9482,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628644,,BAO_0000218,,,,A,2591,10116.0,50597,Compound was tested for area under curve in rat,1,N,9483,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628645,,BAO_0000218,,,,A,6567,10116.0,50597,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,1,N,9484,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628646,,BAO_0000218,,,,A,6211,10116.0,50597,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,1,N,9485,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628647,,BAO_0000218,,,,A,5529,10116.0,50597,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),1,N,9486,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628648,,BAO_0000218,,,,A,5408,10116.0,50597,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,1,N,9487,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625358,,BAO_0000218,,,,A,5408,10116.0,50597,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,1,N,9488,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625359,,BAO_0000218,,,,A,5408,10116.0,50597,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,1,N,9489,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625360,,BAO_0000218,,,,A,5408,10116.0,50597,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,1,N,9490,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625361,,BAO_0000218,,,,A,429,10116.0,50597,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),1,N,9491,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625362,,BAO_0000218,,,,A,429,10116.0,50597,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),1,N,9492,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625363,,BAO_0000218,,,,A,429,10116.0,50597,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),1,N,9493,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625364,,BAO_0000218,,,,A,4796,10116.0,50597,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,1,N,9494,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625365,,BAO_0000218,,,,A,5974,10116.0,50597,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,1,N,9495,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625366,,BAO_0000218,,,,A,5974,10116.0,50597,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,1,N,9496,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625367,,BAO_0000218,,,,A,5974,10116.0,50597,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,1,N,9497,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625368,2113.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",1,N,9498,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL625369,2113.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",1,N,9499,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL625370,2113.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",1,N,9500,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL625371,2113.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",1,N,9501,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL625372,2113.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",1,N,9502,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL625373,2113.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",1,N,9503,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL625374,2107.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",1,N,9504,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL877593,2107.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",1,N,9505,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625375,2107.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",1,N,9506,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625376,2107.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",1,N,9507,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL621973,2107.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",1,N,9508,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL621974,2107.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",1,N,9509,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL621975,2048.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",1,N,9510,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL622166,2048.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",1,N,9511,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL622167,2048.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",1,N,9512,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL622168,2048.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",1,N,9513,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL622169,2048.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",1,N,9514,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL622170,2048.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",1,N,9515,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL622171,2046.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",1,N,9516,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL622172,2046.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",1,N,9517,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL622173,2046.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",1,N,9518,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL622174,2046.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",1,N,9519,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL622175,2046.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",1,N,9520,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL622176,2046.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",1,N,9521,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL622177,2046.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",1,N,9522,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL622178,2046.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",1,N,9523,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL622179,2046.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",1,N,9524,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL622180,2046.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",1,N,9525,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL622181,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,N,9526,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622182,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,N,9527,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622183,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,N,9528,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622184,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,N,9529,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622185,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,N,9530,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622186,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,N,9531,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622187,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,N,9532,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625002,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,1,N,9533,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622090,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,1,N,9534,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622091,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,N,9535,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622092,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,N,9536,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622093,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,N,9537,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622094,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,N,9538,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622095,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,N,9539,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622264,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,N,9540,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622265,2106.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,N,9541,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL622266,2106.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,N,9542,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL622267,2106.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,N,9543,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL622268,2106.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,N,9544,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL622269,2106.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,N,9545,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL625071,2106.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,N,9546,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL621621,2106.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,N,9547,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL621622,2106.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,1,N,9548,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL621623,2106.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,N,9549,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL621624,2106.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,N,9550,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL621625,2106.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,N,9551,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL621626,2106.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,N,9552,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL621627,2106.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,N,9553,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL621628,2106.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,N,9554,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL875328,2106.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,N,9555,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL621629,2106.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,N,9556,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL621630,2106.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,N,9557,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL621631,2106.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,1,N,9558,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL621632,2106.0,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,N,9559,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL621633,2106.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,N,9560,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL621634,2106.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,N,9561,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL621635,2106.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,N,9562,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL621636,2106.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,N,9563,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL621637,2106.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,N,9564,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL621638,2106.0,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,N,9565,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL618883,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,N,9566,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618884,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,N,9567,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628627,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,N,9568,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628628,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,N,9569,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628629,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,N,9570,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628630,,BAO_0000218,,,,A,16365,10116.0,50597,Half life after administering orally a dose of 3 mg/kg,1,N,9571,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628631,,BAO_0000218,,,,A,16365,10116.0,50597,Half life after administering orally a dose of 3 mg/kg to a fasting rat,1,N,9572,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628632,,BAO_0000218,,,,A,16365,10116.0,50597,Half life after administering intravenously a dose of 1 mg/kg,1,N,9573,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628633,,BAO_0000218,,,,A,526,10116.0,50597,Half life after oral dosing in rats,1,N,9574,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628634,,BAO_0000218,,,,A,16365,10116.0,50597,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,1,N,9575,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627789,,BAO_0000218,,,,A,4368,10116.0,50597,Half life by intravenous administration of 3.4 mg/kg in rat,1,N,9576,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627790,,BAO_0000218,,,,A,3371,10116.0,50597,Half life in rat,1,N,9577,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627791,,BAO_0000218,,,,A,6448,10116.0,50597,Half life in rat,1,N,9578,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627792,,BAO_0000218,,,,A,6453,10116.0,50597,Half life in rat,1,N,9579,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627793,,BAO_0000218,,,,A,4353,10116.0,50597,Half life in rat after intravenous administration of the compound,1,N,9580,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627794,1969.0,BAO_0000218,,,,A,4353,10116.0,50597,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,1,N,9581,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL627795,,BAO_0000218,,,,A,4353,10116.0,50597,Half life in rat after po administration of the compound,1,N,9582,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627796,,BAO_0000218,,,,A,4353,10116.0,50597,Half life in rat after po administration of the compound; ND means Not determined,1,N,9583,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL875335,1969.0,BAO_0000218,,,,A,4353,10116.0,50597,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,1,N,9584,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL627797,1969.0,BAO_0000218,,,,A,4353,10116.0,50597,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,1,N,9585,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL627798,,BAO_0000218,,,,A,5789,10116.0,50597,Half life in rat i.v.,1,N,9586,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627799,,BAO_0000218,,,,A,17686,10116.0,50597,Half life in rat i.v. at 2 mg/kg concentration,1,N,9587,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627800,,BAO_0000218,,,,A,6495,10116.0,50597,Half life in rats,1,N,9588,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627801,,BAO_0000218,,,,A,484,10116.0,50597,Half life in rats after intravenous administration,1,N,9589,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627802,,BAO_0000218,,,,A,6467,10116.0,50597,Half life in rats at the dose of 1.0 mpk by i.v. administration,1,N,9590,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627803,,BAO_0000218,,,,A,6642,10116.0,50597,Half life in rat,1,N,9591,,Rattus norvegicus,,1,,Expert
,,,CHEMBL873820,,BAO_0000218,,,,A,16367,10116.0,50597,Half life was evaluated after intravenous administration to rats,1,N,9592,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627804,,BAO_0000218,,,,A,1369,10116.0,50597,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),1,N,9593,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627805,,BAO_0000218,,,,A,5472,10116.0,50597,Half life was evaluated in rat,1,N,9594,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627806,,BAO_0000218,,,,A,6049,10116.0,50597,Half life was evaluated in rat,1,N,9595,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627107,,BAO_0000218,,,,A,5472,10116.0,50597,Half life was evaluated in rat; Not tested,1,N,9596,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627108,,BAO_0000218,,,,A,16366,10116.0,50597,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,1,N,9597,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627109,,BAO_0000218,,,,A,11149,10116.0,50597,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,1,N,9598,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627110,178.0,BAO_0000218,,,,A,11149,10116.0,50597,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,1,N,9599,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627111,,BAO_0000218,,,,A,2891,9443.0,22224,Half life was measured in monkey at dose of 10 mg/kg by po administration,1,U,9600,In vivo,Primates,,0,,Intermediate
,,,CHEMBL627112,,BAO_0000218,,,,A,2891,9443.0,22224,Half life was measured in monkey at dose of 10 mg/kg by po administration,1,U,9601,In vivo,Primates,,0,,Intermediate
,,,CHEMBL627113,,BAO_0000218,,,,A,2891,10116.0,22224,Half life was measured in rat at dose of 30 mg/kg by iv administration,1,U,9602,In vivo,Rattus norvegicus,,0,,Intermediate
,,,CHEMBL627114,,BAO_0000218,,,,A,2891,10116.0,22224,Half life was measured in rat at dose of 30 mg/kg by po administration,1,U,9603,In vivo,Rattus norvegicus,,0,,Intermediate
,,,CHEMBL627115,,BAO_0000218,,,,A,4026,10116.0,50597,Half life (t1/2) was determined,1,N,9604,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627116,,BAO_0000218,,,,A,4527,10116.0,50597,Half life period at a dose of 10 uM/kg in rat was determined,1,N,9605,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627117,,BAO_0000218,,,,A,4527,10116.0,50597,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,1,N,9606,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627118,,BAO_0000218,,,,A,5503,10116.0,50597,Half life period was determined,1,N,9607,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627119,,BAO_0000218,,,,A,4426,10116.0,50597,Half life period after intravenous administration at 20 mpk in rats,1,N,9608,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627120,,BAO_0000218,,,,A,4426,10116.0,50597,Half life period after intravenous administration at 20 mpk in rats; Not performed.,1,N,9609,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626922,,BAO_0000218,,,,A,6109,10116.0,50597,Half life period after intravenous administration in rat,1,N,9610,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626923,,BAO_0000218,,,,A,5654,10116.0,50597,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,1,N,9611,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626924,,BAO_0000218,,,,A,5654,10116.0,50597,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,1,N,9612,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626925,1969.0,BAO_0000218,,,,A,4755,10116.0,50597,Half life period in 80% rat plasma at 37 degree Centigrade,1,N,9613,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626926,,BAO_0000218,,,,A,5862,10116.0,50597,Half life period in SD rats,1,N,9614,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626927,1969.0,BAO_0000218,,,,A,1515,10116.0,50597,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),1,N,9615,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626928,1969.0,BAO_0000218,,,,A,1515,10116.0,50597,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),1,N,9616,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626929,1969.0,BAO_0000218,,,,A,1515,10116.0,50597,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,1,N,9617,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626930,1969.0,BAO_0000218,,,,A,1515,10116.0,50597,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,1,N,9618,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626931,,BAO_0000218,,,,A,5960,10116.0,50597,Half life period in rat,1,N,9619,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626932,,BAO_0000218,,,,A,6103,10116.0,50597,Half life period in rat,1,N,9620,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626933,,BAO_0000218,,,,A,6317,10116.0,50597,Half life period in rat,1,N,9621,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL873826,,BAO_0000218,,,,A,6644,10116.0,50597,Half life period in rat after oral administration at 10.5 mg/kg dose,1,N,9622,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626934,,BAO_0000218,,,,A,6644,10116.0,50597,Half life period in rat after oral administration at 11.2 mg/kg dose,1,N,9623,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626935,,BAO_0000218,,,,A,6644,10116.0,50597,Half life period in rat after oral administration at 13 mg/kg dose,1,N,9624,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626936,,BAO_0000218,,,,A,6644,10116.0,50597,Half life period in rat after oral administration at 9.7 mg/kg dose,1,N,9625,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626937,,BAO_0000218,,,,A,5974,10116.0,50597,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,1,N,9626,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625906,,BAO_0000218,,,,A,6295,10116.0,50597,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,1,N,9627,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625907,,BAO_0000218,,,,A,6296,10116.0,50597,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,1,N,9628,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625908,,BAO_0000218,,,,A,16427,10116.0,50597,PK study was carried to determine AUC (area under curve) value in rat,1,N,9629,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625909,,BAO_0000218,,,,A,16367,10116.0,50597,Pharmacokinetic parameter AUC after intravenous administration to rats,1,N,9630,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625910,,BAO_0000218,,,,A,16367,10116.0,50597,Pharmacokinetic parameter AUC after oral administration to rats,1,N,9631,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625911,,BAO_0000218,,,,A,16365,10116.0,50597,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,1,N,9632,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625912,,BAO_0000218,,,,A,16365,10116.0,50597,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,1,N,9633,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626538,,BAO_0000218,,,,A,16365,10116.0,50597,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,1,N,9634,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL876794,,BAO_0000218,,,,A,16365,10116.0,50597,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,1,N,9635,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626539,,BAO_0000218,,,,A,16365,10116.0,50597,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,1,N,9636,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626540,,BAO_0000218,,,,A,16365,10116.0,50597,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,1,N,9637,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626541,,BAO_0000218,,,,A,5394,10116.0,50597,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,1,N,9638,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626542,,BAO_0000218,,,,A,5394,10116.0,50597,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,1,N,9639,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626543,,BAO_0000218,,,,A,2792,10116.0,50597,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,1,N,9640,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626544,,BAO_0000218,,,,A,2792,10116.0,50597,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,1,N,9641,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626545,,BAO_0000218,,,,A,2792,10116.0,50597,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,1,N,9642,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626546,,BAO_0000218,,,,A,2792,10116.0,50597,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,1,N,9643,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626547,,BAO_0000218,,,,A,5334,10116.0,50597,Pharmacokinetic parameter area under curve was reported,1,N,9644,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626548,,BAO_0000218,,,,A,4408,10116.0,50597,Pharmacokinetic property (AUC) in rat,1,N,9645,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626549,,BAO_0000218,,,,A,5983,10116.0,50597,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,1,N,9646,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626550,,BAO_0000218,,,,A,4397,10116.0,50597,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,1,N,9647,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626551,,BAO_0000218,,,,A,4397,10116.0,50597,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,1,N,9648,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623777,,BAO_0000218,,,,A,5491,10116.0,50597,Pharmacokinetic property was determined,1,N,9649,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623778,,BAO_0000218,,,,A,5491,10116.0,50597,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,1,N,9650,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623779,,BAO_0000218,,,,A,5491,10116.0,50597,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,1,N,9651,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623780,1969.0,BAO_0000218,,,,A,4199,10116.0,50597,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,1,N,9652,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622015,1969.0,BAO_0000218,,,,A,4199,10116.0,50597,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,1,N,9653,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622016,1969.0,BAO_0000218,,,,A,4199,10116.0,50597,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,1,N,9654,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622017,,BAO_0000218,,,,A,5173,10116.0,50597,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",1,N,9655,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622018,,BAO_0000218,,,,A,5173,10116.0,50597,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",1,N,9656,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622019,,BAO_0000218,,,,A,5173,10116.0,50597,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",1,N,9657,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622020,,BAO_0000218,,,,A,5173,10116.0,50597,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",1,N,9658,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622021,,BAO_0000218,,,,A,16366,10116.0,50597,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,1,N,9659,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622022,,BAO_0000218,,,,A,16366,10116.0,50597,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,1,N,9660,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622023,,BAO_0000218,,,,A,5327,10116.0,50597,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,1,N,9661,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622024,,BAO_0000218,,,,A,6681,10116.0,50597,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,1,N,9662,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622693,,BAO_0000218,,,,A,12873,10116.0,50597,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),1,N,9663,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622694,,BAO_0000218,,,,A,12873,10116.0,50597,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),1,N,9664,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622695,,BAO_0000218,,,,A,6685,10116.0,50597,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",1,N,9665,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622696,,BAO_0000218,,,,A,6685,10116.0,50597,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",1,N,9666,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622697,,BAO_0000218,,,,A,6685,10116.0,50597,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",1,N,9667,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622874,,BAO_0000218,,,,A,6619,10116.0,50597,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",1,N,9668,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622875,,BAO_0000218,,,,A,6619,10116.0,50597,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",1,N,9669,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622876,,BAO_0000218,,,,A,10363,10116.0,50597,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,1,N,9670,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622877,,BAO_0000218,,,,A,4796,10116.0,50597,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,1,N,9671,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622878,,BAO_0000218,,,,A,4910,10116.0,50597,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,1,N,9672,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622879,1969.0,BAO_0000218,,,,A,4910,10116.0,50597,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,1,N,9673,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL877602,,BAO_0000218,,,,A,4839,10116.0,50597,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,1,N,9674,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622880,,BAO_0000218,,,,A,15078,10116.0,50597,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",1,N,9675,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622881,,BAO_0000218,,,,A,15078,10116.0,50597,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",1,N,9676,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622882,,BAO_0000218,,,,A,15078,10116.0,50597,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",1,N,9677,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622883,,BAO_0000218,,,,A,15078,10116.0,50597,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",1,N,9678,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622884,2046.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",1,N,9679,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL622885,2046.0,BAO_0000218,,,,A,11450,10116.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",1,N,9680,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL622886,,BAO_0000218,,,,A,8151,10116.0,50597,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,1,N,9681,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622887,,BAO_0000218,,,,A,8151,10116.0,50597,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,1,N,9682,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622888,1088.0,BAO_0000218,,,,A,8151,10116.0,50597,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,1,N,9683,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL622889,178.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,N,9684,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL622890,178.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,N,9685,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL622891,178.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,N,9686,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL877603,178.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,N,9687,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL622892,955.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,N,9688,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL622893,955.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,N,9689,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL622894,955.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,N,9690,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL622895,955.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,N,9691,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL622896,955.0,BAO_0000218,,,,A,8677,10116.0,50597,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,1,N,9692,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL622897,948.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,N,9693,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL622898,948.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,N,9694,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL622899,948.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,N,9695,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL622900,2113.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,N,9696,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL624114,2113.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,N,9697,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL624115,2113.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,N,9698,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL624116,2113.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,N,9699,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL624117,2107.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,N,9700,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL624118,2107.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,N,9701,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL624119,2107.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,N,9702,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL624120,2107.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,N,9703,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL624121,2048.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,N,9704,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL624122,2048.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,N,9705,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL624123,2048.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,N,9706,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL624124,2048.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,N,9707,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL624125,2385.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,N,9708,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL624126,2385.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,N,9709,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL624127,2385.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,N,9710,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL624128,2385.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,N,9711,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL624129,14.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,N,9712,In vivo,Rattus norvegicus,Zone of skin,1,,Intermediate
,,,CHEMBL624130,14.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,N,9713,In vivo,Rattus norvegicus,Zone of skin,1,,Intermediate
,,,CHEMBL622340,14.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,N,9714,In vivo,Rattus norvegicus,Zone of skin,1,,Intermediate
,,,CHEMBL622341,14.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,N,9715,In vivo,Rattus norvegicus,Zone of skin,1,,Intermediate
,,,CHEMBL622342,160.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,N,9716,In vivo,Rattus norvegicus,Intestine,1,,Intermediate
,,,CHEMBL622343,160.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,N,9717,In vivo,Rattus norvegicus,Intestine,1,,Intermediate
,,,CHEMBL622344,160.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,N,9718,In vivo,Rattus norvegicus,Intestine,1,,Intermediate
,,,CHEMBL622345,160.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,N,9719,In vivo,Rattus norvegicus,Intestine,1,,Intermediate
,,,CHEMBL622346,2106.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,N,9720,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL622347,2106.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,N,9721,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL622348,2106.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,N,9722,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL622349,2106.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,N,9723,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL622350,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,N,9724,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622351,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,N,9725,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622352,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,1,N,9726,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622353,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,N,9727,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622354,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,N,9728,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622355,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,N,9729,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622356,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,N,9730,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622357,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,N,9731,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622358,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,N,9732,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622359,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,N,9733,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL874393,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,N,9734,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622872,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,N,9735,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622873,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,1,N,9736,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623047,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,N,9737,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623048,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,N,9738,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623049,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,N,9739,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623050,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,N,9740,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623051,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,N,9741,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623052,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,N,9742,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626343,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,N,9743,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626344,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,N,9744,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626345,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,N,9745,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626346,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,N,9746,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626347,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,N,9747,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626348,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,1,N,9748,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626349,,BAO_0000218,,,,A,16434,10116.0,50597,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,N,9749,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626350,,BAO_0000218,,,,F,16435,10116.0,50597,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,N,9750,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626351,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,N,9751,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627650,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,N,9752,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627651,,BAO_0000218,,,,F,16435,10116.0,50597,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,N,9753,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627652,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,N,9754,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627653,,BAO_0000218,,,,A,16435,10116.0,50597,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,N,9755,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627654,,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,1,N,9756,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627835,,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,1,N,9757,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627836,,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,1,N,9758,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627837,,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,1,N,9759,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627838,,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,1,N,9760,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL875338,,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,1,N,9761,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627839,,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,1,N,9762,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627840,,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,1,N,9763,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627841,,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,1,N,9764,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627842,,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,1,N,9765,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627843,,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,1,N,9766,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627844,,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,1,N,9767,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627845,,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,1,N,9768,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627846,,BAO_0000218,,,,A,5874,10116.0,50597,Half life period in rat by iv administration at a dose of 3 mg/kg,1,N,9769,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627847,1969.0,BAO_0000218,,,,A,1515,10116.0,50597,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),1,N,9770,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL873821,1969.0,BAO_0000218,,,,A,1515,10116.0,50597,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),1,N,9771,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626079,1969.0,BAO_0000218,,,,A,1515,10116.0,50597,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,1,N,9772,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626080,1969.0,BAO_0000218,,,,A,1515,10116.0,50597,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,1,N,9773,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626081,1969.0,BAO_0000218,,,,A,5491,10116.0,50597,Half life period was evaluated in rat plasma,1,N,9774,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL875344,1969.0,BAO_0000218,,,,A,5491,10116.0,50597,Half life period was evaluated in rat plasma; Not tested,1,N,9775,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626082,,BAO_0000218,,,,A,1918,10116.0,50597,Half life period was evaluated in rats,1,N,9776,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626250,,BAO_0000218,,,,A,1918,10116.0,50597,"Half life period was evaluated in rats, iv",1,N,9777,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626251,,BAO_0000218,,,,A,6113,10116.0,50597,Half life period after intravenous administration at 5 mg/kg in rat,1,N,9778,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626252,,BAO_0000218,,,,A,5546,10116.0,50597,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,1,N,9779,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626253,,BAO_0000218,,,,A,5553,10116.0,50597,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,1,N,9780,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626254,1969.0,BAO_0000218,,,,A,4188,10116.0,50597,Half life stability of compound was evaluated in rat plasma,1,N,9781,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626255,,BAO_0000218,,,,A,6215,10116.0,50597,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,1,N,9782,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626256,,BAO_0000218,,,,A,6141,10116.0,50597,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,1,N,9783,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626257,,BAO_0000218,,,,A,5182,10116.0,50597,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,1,N,9784,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626258,,BAO_0000218,,,,A,5182,10116.0,50597,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,1,N,9785,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626259,,BAO_0000218,,,,A,5710,10116.0,50597,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,1,N,9786,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626260,,BAO_0000218,,,,A,5789,10116.0,50597,Half in rat i.v.,1,N,9787,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL875345,,BAO_0000218,,,,A,6011,10116.0,50597,Half period in rat after intravenous administration,1,N,9788,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626261,,BAO_0000218,,,,A,17594,10116.0,50597,Half-life after repeated oral dose of compound at 1 mg/kg in rats,1,N,9789,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626262,2107.0,BAO_0000218,,,,A,12357,10116.0,50597,Half-life measured in in vitro Cathepsin B assay in rat liver,1,N,9790,In vitro,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL626263,,BAO_0000218,,,,A,5210,10116.0,50597,Half-life of compound was determined in rats,1,N,9791,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625270,,BAO_0000218,,,,A,17596,10116.0,50597,Half-life at 10 mg/kg in rat upon intravenous administration,1,N,9792,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625271,,BAO_0000218,,,,A,6672,10116.0,50597,Half-life determined in rat,1,N,9793,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625272,,BAO_0000218,,,,A,6673,10116.0,50597,Half-life determined in rat,1,N,9794,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625273,955.0,BAO_0000218,,,,A,4910,10116.0,50597,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,1,N,9795,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL625274,1969.0,BAO_0000218,,,,A,3741,10116.0,50597,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",1,N,9796,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL625275,,BAO_0000218,,,,A,17671,10116.0,50597,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,1,N,9797,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625276,1969.0,BAO_0000218,,,,A,4910,10116.0,50597,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,1,N,9798,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL625277,1969.0,BAO_0000218,,,,A,17537,10116.0,50597,Half-life in rat plasma,1,N,9799,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL625278,1969.0,BAO_0000218,,,,A,4965,10116.0,50597,Half-life in rat plasma was determined,1,N,9800,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL625279,1969.0,BAO_0000218,,,,A,17537,10116.0,50597,Half-life in rat plasma; Not tested,1,N,9801,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL625280,1977.0,BAO_0000218,,,,A,6124,10116.0,50597,Half-life in rat serum,1,N,9802,,Rattus norvegicus,Serum,1,,Intermediate
,,,CHEMBL876797,1977.0,BAO_0000218,,,,A,6124,10116.0,50597,Half-life in rat serum; na is not available,1,N,9803,,Rattus norvegicus,Serum,1,,Intermediate
,,,CHEMBL625281,,BAO_0000218,,,,A,6078,10116.0,50597,Half-life was calculated in rat,1,N,9804,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL873827,1969.0,BAO_0000218,,,,A,17668,10116.0,50597,Half-life was calculated in rat plasma,1,N,9805,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL625282,,BAO_0000218,,,,A,3185,10116.0,50597,Half-life was determined,1,N,9806,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625283,,BAO_0000218,,,,A,4883,10116.0,50597,Half-life was determined,1,N,9807,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625284,,BAO_0000218,,,,A,2959,10116.0,50597,Half-life after administration of 20 mg/Kg oral dose in rat,1,N,9808,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625285,,BAO_0000218,,,,A,4029,10116.0,50597,Half-life after administration of 3.2 mg/kg intravenously in male rat,1,N,9809,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625286,,BAO_0000218,,,,A,4029,10116.0,50597,Half-life after intravenous administration in female rat,1,N,9810,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625287,,BAO_0000218,,,,A,4029,10116.0,50597,Half-life after intravenous administration in male rat,1,N,9811,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625288,,BAO_0000218,,,,A,6180,10116.0,50597,Half-life after intravenous dose in rat,1,N,9812,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625289,2107.0,BAO_0000218,,,,A,1557,10116.0,50597,Half-life in a rat liver homogenate preparation,1,N,9813,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625290,1969.0,BAO_0000218,,,,A,12500,10116.0,50597,Half-life in plasma of rat,1,N,9814,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL876798,1969.0,BAO_0000218,,,,A,12500,10116.0,50597,Half-life in plasma of rat at dose of 3-10 mgkg,1,N,9815,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL625291,,BAO_0000218,,,,A,5064,10116.0,50597,Half-life in rat,1,N,9816,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625292,,BAO_0000218,,,,A,5145,10116.0,50597,Half-life in rat,1,N,9817,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625293,,BAO_0000218,,,,A,5147,10116.0,50597,Half-life in rat,1,N,9818,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622832,,BAO_0000218,,,,A,5833,10116.0,50597,Half-life in rat,1,N,9819,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622833,,BAO_0000218,,,,A,6596,10116.0,50597,Half-life in rat,1,N,9820,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622834,,BAO_0000218,,,,A,17655,10116.0,50597,Half-life in rat,1,N,9821,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622835,,BAO_0000218,,,,A,6495,10116.0,50597,Half-life in rat after oral administration at 10 mg/kg,1,N,9822,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622836,,BAO_0000218,,,,A,17538,10116.0,50597,Half-life in rat after po administration at a dose of 10 mg/kg,1,N,9823,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622837,,BAO_0000218,,,,A,17538,10116.0,50597,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,1,N,9824,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622838,,BAO_0000218,,,,A,10,10116.0,50597,Half-life in rat at 3 mg/kg dose administered intravenously,1,N,9825,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622839,955.0,BAO_0000218,,,,A,17669,10116.0,50597,Half-life in rat brain homogenate,1,N,9826,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL622840,1969.0,BAO_0000218,,,,A,17065,10116.0,50597,Half-life in rat plasma,1,N,9827,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622841,,BAO_0000218,,,,A,4333,10116.0,50597,Half-life in rats,1,N,9828,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622842,,BAO_0000218,,,,A,6827,10116.0,50597,Half-life in Dawley rats,1,N,9829,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622843,1969.0,BAO_0000218,,,,A,889,10116.0,50597,Half-life in vitro in rat plasma,1,N,9830,In vitro,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622844,1969.0,BAO_0000218,,,,A,889,10116.0,50597,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,1,N,9831,In vitro,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622845,,BAO_0000218,,,,A,3747,10116.0,50597,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",1,N,9832,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622846,,BAO_0000218,,,,A,15022,10116.0,50597,The area under the curve of compound was measured at the dose of 100 umol/kg,1,N,9833,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622847,,BAO_0000218,,,,A,15022,10116.0,50597,The area under the curve of compound was measured at the dose of 300 umol/kg,1,N,9834,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622848,,BAO_0000218,,,,A,15022,10116.0,50597,The area under the curve of compound was measured at the dose of 30 umol/kg,1,N,9835,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622849,,BAO_0000218,,,,A,3360,10116.0,50597,Bioavailability as oral AUC in rats,1,N,9836,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622850,1969.0,BAO_0000218,,,,A,5334,10116.0,50597,The plasma concentration versus time curve (AUC) was determined,1,N,9837,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL876807,,BAO_0000218,,,,A,17411,10116.0,50597,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,1,N,9838,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622851,,BAO_0000218,,,,A,17411,10116.0,50597,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,1,N,9839,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622852,,BAO_0000218,,,,A,17411,10116.0,50597,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,1,N,9840,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622853,,BAO_0000218,,,,A,6570,10116.0,50597,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,1,N,9841,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622854,,BAO_0000218,,,,A,6570,10116.0,50597,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,1,N,9842,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622855,,BAO_0000218,,,,A,17411,10116.0,50597,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,1,N,9843,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622856,1969.0,BAO_0000218,,,,A,14941,10116.0,50597,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",1,N,9844,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622857,1969.0,BAO_0000218,,,,A,14941,10116.0,50597,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",1,N,9845,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622858,1969.0,BAO_0000218,,,,A,17538,10116.0,50597,AUC in rat after po administration at a dose of 10 mg/kg,1,N,9846,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622859,1969.0,BAO_0000218,,,,A,17752,10116.0,50597,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,1,N,9847,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622860,,BAO_0000218,,,,A,17509,10116.0,50597,Area under curve value 24 hr after 10 mg/kg iv administration in rats,1,N,9848,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622861,,BAO_0000218,,,,A,17509,10116.0,50597,Area under curve value 24 hr after 10 mg/kg oral administration in rats,1,N,9849,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622862,,BAO_0000218,,,,A,17509,10116.0,50597,Area under curve value 24 hr after 2 mg/kg iv administration in rats,1,N,9850,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622863,,BAO_0000218,,,,A,17509,10116.0,50597,Area under curve value 24 hr after 2 mg/kg oral administration in rats,1,N,9851,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623817,,BAO_0000218,,,,A,17509,10116.0,50597,Area under curve value 6 hr after po administration in rat,1,N,9852,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623818,,BAO_0000218,,,,A,17717,10116.0,50597,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,1,N,9853,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623819,,BAO_0000218,,,,A,17717,10116.0,50597,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",1,N,9854,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623820,,BAO_0000218,,,,A,17717,10116.0,50597,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,1,N,9855,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623821,,BAO_0000218,,,,A,17717,10116.0,50597,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,1,N,9856,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623822,1969.0,BAO_0000218,,,,A,6642,10116.0,50597,AUC normalized for dose (AUCN) in rat,1,N,9857,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623823,,BAO_0000218,,,,A,6640,10116.0,50597,Area under curve in rat after p.o. administration,1,N,9858,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623824,,BAO_0000218,,,,A,6641,10116.0,50597,Area under curve in rat after p.o. administration,1,N,9859,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623825,,BAO_0000218,,,,A,6641,10116.0,50597,Area under curve in rat after p.o. administration; Not determined,1,N,9860,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622070,,BAO_0000218,,,,A,6641,10116.0,50597,Area under curve in rat after peroral administration,1,N,9861,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622071,,BAO_0000218,,,,A,3603,10116.0,50597,Area under curve (carotid artery) value of the compound,1,N,9862,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622072,,BAO_0000218,,,,A,3550,10116.0,50597,Bioavailability expressed as the area under curve of rat carotid artery,1,N,9863,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622073,,BAO_0000218,,,,A,15662,10116.0,50597,Area under curve in male SD rats was observed after intravenous administration in rat,1,N,9864,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622074,,BAO_0000218,,,,A,17720,10116.0,50597,Area under curve of the compound was determined,1,N,9865,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622075,,BAO_0000218,,,,A,5407,10116.0,50597,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,1,N,9866,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622076,1969.0,BAO_0000218,,,,A,17752,10116.0,50597,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,1,N,9867,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622077,1969.0,BAO_0000218,,,,A,17752,10116.0,50597,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,1,N,9868,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622078,,BAO_0000218,,,,A,3603,10116.0,50597,Area under curve (portal vein) value of the compound,1,N,9869,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622079,,BAO_0000218,,,,A,3550,10116.0,50597,Bioavailability expressed as the area under curve of rat portal vein,1,N,9870,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622080,1969.0,BAO_0000218,,,,A,17655,10116.0,50597,Area Under plasma concentration time curve in rat upon peroral administration,1,N,9871,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL877612,,BAO_0000218,,,,A,17582,10116.0,50597,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,1,N,9872,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622081,,BAO_0000218,,,,A,17582,10116.0,50597,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,1,N,9873,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622082,,BAO_0000218,,,,A,17791,10116.0,50597,Compound was evaluated for oral bioavailability in rats,1,N,9874,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622083,,BAO_0000218,,,,A,17791,10116.0,50597,Compound was evaluated for oral bioavailability in rats after iv administration,1,N,9875,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622084,,BAO_0000218,,,,A,17791,10116.0,50597,Compound was evaluated for oral bioavailability in rats; 30-80,1,N,9876,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622085,,BAO_0000218,,,,A,17791,10116.0,50597,Compound was evaluated for oral bioavailability in rats; 50-60,1,N,9877,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622086,,BAO_0000218,,,,A,17791,10116.0,50597,Compound was evaluated for oral bioavailability in rats; no data,1,N,9878,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622087,,BAO_0000218,,,,A,17791,10116.0,50597,Compound was evaluated for oral bioavailability in rats; peptide,1,N,9879,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622088,178.0,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",1,N,9880,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL622089,178.0,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",1,N,9881,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL623685,178.0,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",1,N,9882,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL623686,178.0,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",1,N,9883,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL623687,945.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,N,9884,In vivo,Rattus norvegicus,Stomach,1,,Intermediate
,,,CHEMBL623688,945.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,N,9885,In vivo,Rattus norvegicus,Stomach,1,,Intermediate
,,,CHEMBL623689,945.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,N,9886,In vivo,Rattus norvegicus,Stomach,1,,Intermediate
,,,CHEMBL622485,945.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,N,9887,In vivo,Rattus norvegicus,Stomach,1,,Intermediate
,,,CHEMBL622486,2046.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,N,9888,In vivo,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL877613,2046.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,N,9889,In vivo,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL622487,2046.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,N,9890,In vivo,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL622488,2046.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,N,9891,In vivo,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL622489,948.0,BAO_0000218,,,,A,8677,10116.0,50597,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,N,9892,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL622490,1088.0,BAO_0000218,,,,A,6899,10116.0,50597,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,1,N,9893,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL622491,1088.0,BAO_0000218,,,,A,6899,10116.0,50597,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,1,N,9894,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL622492,2107.0,BAO_0000218,,,,A,6899,10116.0,50597,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,1,N,9895,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622493,1088.0,BAO_0000218,,,,A,6899,10116.0,50597,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,1,N,9896,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL622494,1088.0,BAO_0000218,,,,A,6899,10116.0,50597,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,1,N,9897,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL622495,2385.0,BAO_0000218,,,,A,8677,10116.0,50597,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,N,9898,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL622496,,BAO_0000218,,,,A,6899,10116.0,50597,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,1,N,9899,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622497,1088.0,BAO_0000218,,,,A,6899,10116.0,50597,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,1,N,9900,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL622498,,BAO_0000218,,,,A,2189,10116.0,50597,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,1,N,9901,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624918,1088.0,BAO_0000218,,,,A,2189,10116.0,50597,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,1,N,9902,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL624919,1088.0,BAO_0000218,,,,A,2189,10116.0,50597,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,1,N,9903,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL624920,178.0,BAO_0000218,,,,A,10839,10116.0,50597,Biodistribution of compound in rat blood after 5 min of administration,1,N,9904,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL624921,178.0,BAO_0000218,,,,A,10839,10116.0,50597,Biodistribution of compound in rat blood after 5 min of administration.,1,N,9905,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL624922,955.0,BAO_0000218,,,,A,10839,10116.0,50597,Biodistribution of compound in rat brain after 5 min of administration,1,N,9906,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL624923,948.0,BAO_0000218,,,,A,10839,10116.0,50597,Biodistribution of compound in rat heart after 5 min of administration,1,N,9907,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL624924,948.0,BAO_0000218,,,,A,10839,10116.0,50597,Biodistribution of compound in rat heart after 5 min of administration.,1,N,9908,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL624925,2113.0,BAO_0000218,,,,A,10839,10116.0,50597,Biodistribution of compound in rat kidney after 5 min of administration,1,N,9909,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL624926,2113.0,BAO_0000218,,,,A,10839,10116.0,50597,Biodistribution of compound in rat kidney after 5 min of administration.,1,N,9910,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL624927,2107.0,BAO_0000218,,,,A,10839,10116.0,50597,Biodistribution of compound in rat liver after 5 min of administration,1,N,9911,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL874402,2107.0,BAO_0000218,,,,A,10839,10116.0,50597,Biodistribution of compound in rat liver after 5 min of administration.,1,N,9912,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL624928,2048.0,BAO_0000218,,,,A,10839,10116.0,50597,Biodistribution of compound in rat lung after 5 min of administration,1,N,9913,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL624929,2048.0,BAO_0000218,,,,A,10839,10116.0,50597,Biodistribution of compound in rat lung after 5 min of administration.,1,N,9914,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL624930,2385.0,BAO_0000218,,,,A,10839,10116.0,50597,Biodistribution of compound in rat muscle after 5 min of administration,1,N,9915,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL624931,2385.0,BAO_0000218,,,,A,10839,10116.0,50597,Biodistribution of compound in rat muscle after 5 min of administration.,1,N,9916,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL624932,948.0,BAO_0000218,,,,A,4043,10116.0,50597,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,N,9917,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL624933,948.0,BAO_0000218,,,,A,4043,10116.0,50597,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,N,9918,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL624934,2107.0,BAO_0000218,,,,A,4043,10116.0,50597,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,N,9919,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL624935,2107.0,BAO_0000218,,,,A,4043,10116.0,50597,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,N,9920,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL624936,,BAO_0000218,,,,A,4043,10116.0,50597,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,N,9921,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624937,,BAO_0000218,,,,A,4043,10116.0,50597,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,N,9922,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624938,2106.0,BAO_0000218,,,,A,4043,10116.0,50597,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,N,9923,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL624939,2106.0,BAO_0000218,,,,A,4043,10116.0,50597,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,N,9924,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL624940,,BAO_0000218,,,,A,4043,10116.0,50597,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,N,9925,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL874403,,BAO_0000218,,,,A,4043,10116.0,50597,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,N,9926,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624941,,BAO_0000218,,,,A,1446,10116.0,50597,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,1,N,9927,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624942,1088.0,BAO_0000218,,,,A,9971,10116.0,50597,Dose required to lower urine osmolality to 300 mOsm/kg in rat,1,N,9928,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL624943,1088.0,BAO_0000218,,,,A,9971,10116.0,50597,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,1,N,9929,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL624944,,BAO_0000218,,,,A,5765,10116.0,50597,% Bioavailability after 1 day of the drug administration in rats,1,N,9930,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624945,,BAO_0000218,,,,A,5765,10116.0,50597,% Bioavailability after 4 day of the drug administration in rats,1,N,9931,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624946,,BAO_0000218,,,,A,4257,10116.0,50597,Absolute bioavailability was evaluated in rat,1,N,9932,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624947,,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,1,N,9933,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624948,,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,1,N,9934,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624949,,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,1,N,9935,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622025,2113.0,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,1,N,9936,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL622026,2113.0,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,1,N,9937,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL622027,2113.0,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,1,N,9938,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL622028,2113.0,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,1,N,9939,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL622029,2107.0,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,1,N,9940,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622208,2107.0,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,1,N,9941,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622209,2107.0,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,1,N,9942,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622210,2107.0,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,1,N,9943,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622211,,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,1,N,9944,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622212,,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,1,N,9945,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622213,,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,1,N,9946,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL874404,,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,1,N,9947,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620452,2385.0,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,1,N,9948,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL620453,2385.0,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,1,N,9949,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL620454,2385.0,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,1,N,9950,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL624067,2385.0,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,1,N,9951,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL624068,,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,1,N,9952,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624069,992.0,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,1,N,9953,,Rattus norvegicus,Female gonad,1,,Intermediate
,,,CHEMBL624070,992.0,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,1,N,9954,,Rattus norvegicus,Female gonad,1,,Intermediate
,,,CHEMBL624071,992.0,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,1,N,9955,,Rattus norvegicus,Female gonad,1,,Intermediate
,,,CHEMBL624072,995.0,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,1,N,9956,,Rattus norvegicus,Uterus,1,,Intermediate
,,,CHEMBL624073,995.0,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,1,N,9957,,Rattus norvegicus,Uterus,1,,Intermediate
,,,CHEMBL624788,995.0,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,1,N,9958,,Rattus norvegicus,Uterus,1,,Intermediate
,,,CHEMBL624789,995.0,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,1,N,9959,,Rattus norvegicus,Uterus,1,,Intermediate
,,,CHEMBL624790,,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,1,N,9960,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624791,,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,1,N,9961,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624792,,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,1,N,9962,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624793,,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,1,N,9963,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL877491,2385.0,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,1,N,9964,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL624957,2385.0,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,1,N,9965,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL624958,2385.0,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,1,N,9966,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL624959,2385.0,BAO_0000218,,,,A,13091,10116.0,50597,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,1,N,9967,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL624960,,BAO_0000218,,,,A,11977,10116.0,50597,Dissociation constant was determined,1,N,9968,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624961,,BAO_0000218,,,,A,14941,10116.0,50597,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",1,N,9969,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624962,,BAO_0000218,,,,A,15078,10116.0,50597,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",1,N,9970,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624963,,BAO_0000218,,,,A,15078,10116.0,50597,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",1,N,9971,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624964,,BAO_0000218,,,,A,4755,10116.0,50597,Observed rate constant in 80% rat plasma at 37 degree Centigrade,1,N,9972,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624965,,BAO_0000218,,,,A,589,10116.0,50597,LogP value was evaluated in the in situ rat gut perfusion assay,1,N,9973,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624966,,BAO_0000218,,,,A,17582,10116.0,50597,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,1,N,9974,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624967,,BAO_0000218,,,,A,5031,10116.0,50597,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,1,N,9975,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624968,,BAO_0000218,,,,A,17764,10116.0,50597,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,1,N,9976,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624969,,BAO_0000218,,,,A,17720,10116.0,50597,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,1,N,9977,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624970,,BAO_0000218,,,,F,2862,10116.0,50597,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,1,N,9978,,Rattus norvegicus,,1,,Expert
,,,CHEMBL624971,,BAO_0000218,,,,A,16423,10116.0,50597,Half-life was evaluated after 10 uM/kg of intra arterial administration,1,N,9979,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624972,,BAO_0000218,,,,A,16423,10116.0,50597,Half-life was evaluated after 20 uM/kg of peroral administration,1,N,9980,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624973,,BAO_0000218,,,,A,6005,10116.0,50597,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,1,N,9981,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624974,1969.0,BAO_0000218,,,,A,2938,10116.0,50597,Half-life was evaluated in plasma of rat,1,N,9982,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL624975,,BAO_0000218,,,,A,6410,10116.0,50597,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,1,N,9983,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL877492,,BAO_0000218,,,,A,6410,10116.0,50597,Half-life was evaluated in rats at an oral dose of 30 mg/kg,1,N,9984,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624976,,BAO_0000218,,,,A,6062,10116.0,50597,Half-life was measured in rat after an iv dose of 1 mg/kg,1,N,9985,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624977,,BAO_0000218,,,,A,6571,10116.0,50597,Half-life period of compound in rats after peroral administration,1,N,9986,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626848,1969.0,BAO_0000218,,,,A,3136,10116.0,50597,Half-life period of compound was measured in rat plasma.,1,N,9987,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626849,1969.0,BAO_0000218,,,,A,3136,10116.0,50597,Half-life period of compound was measured in rat plasma; ND is not determined,1,N,9988,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626850,1969.0,BAO_0000218,,,,A,3136,10116.0,50597,Half-life period of compound was measured in rat plasma; not determined,1,N,9989,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626851,,BAO_0000218,,,,A,4521,10116.0,50597,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,1,N,9990,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626852,,BAO_0000218,,,,A,5871,10116.0,50597,Half-life period in rat by iv administration,1,N,9991,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626853,,BAO_0000218,,,,A,6077,10116.0,50597,Half-life period in rats following intravenous administration at 2 mg/kg,1,N,9992,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626854,,BAO_0000218,,,,A,6679,10116.0,50597,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,1,N,9993,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627486,,BAO_0000218,,,,A,5144,10116.0,50597,Half-life period was determined for the compound in rat,1,N,9994,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627487,,BAO_0000218,,,,A,4498,10116.0,50597,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",1,N,9995,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627488,,BAO_0000218,,,,A,4498,10116.0,50597,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",1,N,9996,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627489,,BAO_0000218,,,,A,1908,10116.0,50597,Half-life value after IV dose at a dose of 5 mg/kg in rats.,1,N,9997,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627490,,BAO_0000218,,,,A,6211,10116.0,50597,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,1,N,9998,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL873829,,BAO_0000218,,,,A,5529,10116.0,50597,Half-life was determined in rat after intravenous administration (0.5 mg/kg),1,N,9999,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627655,,BAO_0000218,,,,A,6444,10116.0,50597,Half-life was determined in rat at a dose of 1 mpk i.v.,1,N,10000,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625994,,BAO_0000218,,,,A,6444,10116.0,50597,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,1,N,10001,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625995,,BAO_0000218,,,,A,6444,10116.0,50597,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,1,N,10002,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625996,,BAO_0000218,,,,A,5207,10116.0,50597,Half-life in rat,1,N,10003,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625850,1969.0,BAO_0000218,,,,A,530,10116.0,50597,In vitro half life in rat plasma,1,N,10004,In vitro,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL625851,1969.0,BAO_0000218,,,,A,1116,10116.0,50597,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",1,N,10005,In vitro,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL625852,,BAO_0000218,,,,A,3219,10116.0,50597,In vitro half life in rat,1,N,10006,In vitro,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625853,,BAO_0000218,,,,A,6109,10116.0,50597,In vivo half life period after intravenous administration in rat,1,N,10007,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625854,,BAO_0000218,,,,A,17582,10116.0,50597,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,1,N,10008,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL874450,,BAO_0000218,,,,A,17582,10116.0,50597,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,1,N,10009,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625855,,BAO_0000218,,,,A,5974,10116.0,50597,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,1,N,10010,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625856,,BAO_0000218,,,,A,5974,10116.0,50597,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,1,N,10011,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625857,,BAO_0000218,,,,A,5974,10116.0,50597,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,1,N,10012,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL873831,,BAO_0000218,,,,A,5974,10116.0,50597,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,1,N,10013,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625858,,BAO_0000218,,,,A,17853,10116.0,50597,Longer half-life in rat (i.v.) at 0.5 mpk,1,N,10014,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625859,,BAO_0000218,,,,A,17853,10116.0,50597,Longer half-life in rat (p.o.) at 2.0 mpk,1,N,10015,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625860,,BAO_0000218,,,,A,3457,10116.0,50597,Pharmacokinetic property (half life) in rat,1,N,10016,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625861,,BAO_0000218,,,,A,2792,10116.0,50597,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,1,N,10017,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625862,,BAO_0000218,,,,A,2792,10116.0,50597,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,1,N,10018,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625863,,BAO_0000218,,,,A,2792,10116.0,50597,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,1,N,10019,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625864,,BAO_0000218,,,,A,2792,10116.0,50597,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,1,N,10020,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625865,,BAO_0000218,,,,A,5739,10116.0,50597,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,1,N,10021,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625866,,BAO_0000218,,,,A,15765,10116.0,50597,Pharmacokinetic half time was determined intravenously in rats.,1,N,10022,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625867,1969.0,BAO_0000218,,,,A,6567,10116.0,50597,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,1,N,10023,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL625868,1969.0,BAO_0000218,,,,A,2448,10116.0,50597,Plasma half life of hydrolysis of the compound,1,N,10024,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL625869,1969.0,BAO_0000218,,,,A,5423,10116.0,50597,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,1,N,10025,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL874451,1969.0,BAO_0000218,,,,A,4853,10116.0,50597,Plasma half life period was calculated in rat,1,N,10026,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL625870,1969.0,BAO_0000218,,,,A,4514,10116.0,50597,Plasma half-life in Sprague-Dawley rats,1,N,10027,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL625871,1969.0,BAO_0000218,,,,A,4514,10116.0,50597,Plasma half-life in Sprague-Dawley rats; Not determined,1,N,10028,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL625872,1969.0,BAO_0000218,,,,A,1500,10116.0,50597,Plasma half-life in rats,1,N,10029,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL625873,1969.0,BAO_0000218,,,,A,1500,10116.0,50597,Plasma half-life in rats; <MQL,1,N,10030,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL625874,1969.0,BAO_0000218,,,,A,5334,10116.0,50597,Plasma half-life period (0-8 h) was determined,1,N,10031,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL625875,1969.0,BAO_0000218,,,,A,5334,10116.0,50597,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,1,N,10032,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL625876,1969.0,BAO_0000218,,,,A,5334,10116.0,50597,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,1,N,10033,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL631258,1969.0,BAO_0000218,,,,A,5334,10116.0,50597,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,1,N,10034,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL631259,1969.0,BAO_0000218,,,,A,4956,10116.0,50597,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,1,N,10035,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL631260,1969.0,BAO_0000218,,,,A,4956,10116.0,50597,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,1,N,10036,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL631261,178.0,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",1,N,10037,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631262,178.0,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",1,N,10038,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631263,178.0,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",1,N,10039,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631264,,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",1,N,10040,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631265,,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",1,N,10041,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631266,,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",1,N,10042,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631267,,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",1,N,10043,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631268,,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",1,N,10044,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631269,,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",1,N,10045,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631270,,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",1,N,10046,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631271,948.0,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",1,N,10047,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL631272,948.0,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",1,N,10048,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL631273,948.0,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",1,N,10049,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL631274,948.0,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",1,N,10050,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL631275,948.0,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",1,N,10051,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL626984,948.0,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",1,N,10052,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL626985,948.0,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",1,N,10053,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL626986,2107.0,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",1,N,10054,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL626987,2107.0,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",1,N,10055,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL626988,2107.0,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",1,N,10056,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL626989,2107.0,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",1,N,10057,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL626990,2107.0,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",1,N,10058,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL626991,2107.0,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",1,N,10059,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL626992,2107.0,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",1,N,10060,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL626993,2048.0,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",1,N,10061,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL874593,2048.0,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",1,N,10062,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL626994,2048.0,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",1,N,10063,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL626995,2048.0,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",1,N,10064,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL626190,2048.0,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",1,N,10065,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL626191,2048.0,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",1,N,10066,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL626364,2048.0,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",1,N,10067,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL626365,2046.0,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",1,N,10068,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL626366,2046.0,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",1,N,10069,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL626367,2046.0,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",1,N,10070,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL626368,2046.0,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",1,N,10071,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL626369,2046.0,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",1,N,10072,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL626370,2046.0,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",1,N,10073,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL626371,,BAO_0000218,,,,A,4498,10116.0,50597,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",1,N,10074,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626372,,BAO_0000218,,,,A,4498,10116.0,50597,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",1,N,10075,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626373,,BAO_0000218,,,,A,3603,10116.0,50597,Bioavailability after a dose of 10 mg/kg p.o.,1,N,10076,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626374,,BAO_0000218,,,,A,6215,10116.0,50597,Bioavailability after peroral administration (10 mg/kg) was determined in rat,1,N,10077,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626375,,BAO_0000218,,,,A,5710,10116.0,50597,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,1,N,10078,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626376,,BAO_0000218,,,,A,5710,10116.0,50597,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),1,N,10079,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626377,,BAO_0000218,,,,A,5676,10116.0,50597,Bioavailability in rat po was determined,1,N,10080,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626378,,BAO_0000218,,,,A,17667,10116.0,50597,Bioavailability of compound at 10 mg/kg in rat after oral administration,1,N,10081,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626379,,BAO_0000218,,,,A,17667,10116.0,50597,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,1,N,10082,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626380,,BAO_0000218,,,,A,6848,10116.0,50597,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),1,N,10083,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626381,,BAO_0000218,,,,A,6848,10116.0,50597,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),1,N,10084,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626382,,BAO_0000218,,,,A,17267,10116.0,50597,Bioavailability in rat,1,N,10085,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626383,,BAO_0000218,,,,A,6362,10116.0,50597,Bioavailability in rat (Sprague-Dawley) (female),1,N,10086,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL874652,,BAO_0000218,,,,A,17671,10116.0,50597,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,1,N,10087,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626384,,BAO_0000218,,,,A,17671,10116.0,50597,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),1,N,10088,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626385,,BAO_0000218,,,,A,4333,10116.0,50597,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,1,N,10089,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626386,,BAO_0000218,,,,A,6077,10116.0,50597,Bioavailability in rat at an oral dose of 2 mg/kg,1,N,10090,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626387,,BAO_0000218,,,,A,3278,10116.0,50597,Bioavailability in rat,1,N,10091,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626388,,BAO_0000218,,,,A,5964,10116.0,50597,Bioavailability in rat,1,N,10092,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626389,,BAO_0000218,,,,A,4884,10116.0,50597,Bioavailability in rat,1,N,10093,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626390,,BAO_0000218,,,,A,4905,10116.0,50597,Bioavailability in rat,1,N,10094,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626391,,BAO_0000218,,,,A,4884,10116.0,50597,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,1,N,10095,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626392,,BAO_0000218,,,,A,6850,10116.0,50597,Bioavailability in rat,1,N,10096,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626393,,BAO_0000218,,,,A,2864,10116.0,50597,Oral bioavailability in rat,1,N,10097,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623026,,BAO_0000218,,,,A,5780,10116.0,50597,Bioavailability was determined in rat,1,N,10098,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623027,,BAO_0000218,,,,A,1465,10116.0,50597,Bioavailability,1,N,10099,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623028,,BAO_0000218,,,,A,5199,10116.0,50597,Bioavailability,1,N,10100,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623029,,BAO_0000218,,,,A,5765,10116.0,50597,Bioavailability in rat after 1 day dosing,1,N,10101,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623030,,BAO_0000218,,,,A,5765,10116.0,50597,Bioavailability in rat after 4 day dosing,1,N,10102,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623031,,BAO_0000218,,,,A,6518,10116.0,50597,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,1,N,10103,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623032,,BAO_0000218,,,,A,6518,10116.0,50597,Bioavailability after IV dosing at 1 mg/kg in rat; no data,1,N,10104,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623033,,BAO_0000218,,,,A,6518,10116.0,50597,Bioavailability after oral administration at a dose of 2 mg/kg in rat,1,N,10105,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623034,,BAO_0000218,,,,A,6518,10116.0,50597,Bioavailability after oral administration at a dose of 4 mg/kg in rat,1,N,10106,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623035,,BAO_0000218,,,,A,2083,10116.0,50597,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,1,N,10107,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623036,,BAO_0000218,,,,A,17260,10116.0,50597,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,1,N,10108,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623037,,BAO_0000218,,,,A,4956,10116.0,50597,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),1,N,10109,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623038,,BAO_0000218,,,,A,4368,10116.0,50597,Bioavailability by intravenous administration of 3.4 mg/kg in rat,1,N,10110,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL874385,1969.0,BAO_0000218,,,,A,17752,10116.0,50597,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,1,N,10111,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623039,,BAO_0000218,,,,A,1446,10116.0,50597,Bioavailability in rat (Fisher) (fasted),1,N,10112,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623040,,BAO_0000218,,,,A,2891,9443.0,22224,Bioavailability in monkey after po administration of 10 mg/kg dose,1,U,10113,In vivo,Primates,,0,,Intermediate
,,,CHEMBL623041,,BAO_0000218,,,,A,2891,9443.0,22224,Oral bioavailability in monkey (dose 10 mg/kg),1,U,10114,In vivo,Primates,,0,,Intermediate
,,,CHEMBL623741,,BAO_0000218,,,,A,6672,10116.0,50597,Bioavailability in rat,1,N,10115,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623742,,BAO_0000218,,,,A,6673,10116.0,50597,Bioavailability in rat,1,N,10116,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623743,,BAO_0000218,,,,A,17655,10116.0,50597,Bioavailability in rat,1,N,10117,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623744,,BAO_0000218,,,,A,17796,10116.0,50597,Bioavailability in rat,1,N,10118,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623745,,BAO_0000218,,,,A,17853,10116.0,50597,Bioavailability in rat (dose 2.0 mg/kg p.o.),1,N,10119,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623746,,BAO_0000218,,,,A,4521,10116.0,50597,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),1,N,10120,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623747,,BAO_0000218,,,,A,4940,10116.0,50597,Oral bioavailability in rat (dose 5 mg/kg p.o.),1,N,10121,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623748,,BAO_0000218,,,,A,2891,10116.0,22224,Bioavailability in rat after po administration of 30 mg/kg dose,1,U,10122,In vivo,Rattus norvegicus,,0,,Intermediate
,,,CHEMBL623916,,BAO_0000218,,,,A,2891,10116.0,22224,Bioavailability in rat after po administration of 30 mg/kg dose,1,U,10123,In vivo,Rattus norvegicus,,0,,Intermediate
,,,CHEMBL623917,,BAO_0000218,,,,A,4521,10116.0,50597,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,1,N,10124,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623918,,BAO_0000218,,,,A,17686,10116.0,50597,Bioavailability in rat (dose 2 mg/kg i.v.),1,N,10125,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL874386,,BAO_0000218,,,,A,17796,10116.0,50597,Bioavailability in rat,1,N,10126,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623919,1969.0,BAO_0000218,,,,A,17796,10116.0,50597,Bioavailability in rat; Only traces detected in rat plasma,1,N,10127,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623920,,BAO_0000218,,,,A,5064,10116.0,50597,Bioavailability in rat,1,N,10128,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623148,,BAO_0000218,,,,A,5147,10116.0,50597,Bioavailability upon oral administration of compound,1,N,10129,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623149,,BAO_0000218,,,,A,1916,10116.0,50597,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),1,N,10130,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623150,,BAO_0000218,,,,A,6049,10116.0,50597,Bioavailability in rat,1,N,10131,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623151,,BAO_0000218,,,,A,1445,10116.0,50597,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",1,N,10132,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623152,,BAO_0000218,,,,A,1445,10116.0,50597,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",1,N,10133,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623153,,BAO_0000218,,,,F,2862,10116.0,50597,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,1,N,10134,,Rattus norvegicus,,1,,Expert
,,,CHEMBL623154,,BAO_0000218,,,,F,2862,10116.0,50597,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,1,N,10135,,Rattus norvegicus,,1,,Expert
,,,CHEMBL623155,,BAO_0000218,,,,A,4194,10116.0,50597,In vitro and metabolic stability was determined,1,N,10136,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623156,,BAO_0000218,,,,A,4194,10116.0,50597,In vitro metabolic stability in rat hepatocytes,1,N,10137,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623157,,BAO_0000218,,,,A,5486,10116.0,50597,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,1,N,10138,,Rattus norvegicus,,1,,Intermediate
,401.0,,CHEMBL623158,2107.0,BAO_0000218,,,Hepatocyte,A,17582,10116.0,50597,Metabolic rate for compound was observed in rat hepatocytes,1,N,10139,In vitro,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL623159,,BAO_0000218,,,,A,5600,10116.0,50597,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,1,N,10140,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL874390,,BAO_0000218,,,,A,14294,10116.0,50597,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),1,N,10141,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623160,,BAO_0000218,,,,A,14294,10116.0,50597,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),1,N,10142,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623161,,BAO_0000218,,,,A,14294,10116.0,50597,Metabolism of compound in rat S9 microsomes; Trace,1,N,10143,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623162,,BAO_0000218,,,,A,17847,10116.0,50597,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,1,N,10144,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623163,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,1,N,10145,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623164,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,1,N,10146,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623165,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,1,N,10147,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623166,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,1,N,10148,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624983,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,1,N,10149,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624984,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,1,N,10150,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624985,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,1,N,10151,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622970,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,1,N,10152,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622971,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,1,N,10153,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622972,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,1,N,10154,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622973,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,1,N,10155,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622974,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,1,N,10156,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622975,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,1,N,10157,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622976,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,1,N,10158,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622977,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,1,N,10159,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624351,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,1,N,10160,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624352,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,1,N,10161,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624353,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,1,N,10162,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622397,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,1,N,10163,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622398,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,1,N,10164,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622399,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,1,N,10165,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622400,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,1,N,10166,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628428,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,1,N,10167,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628590,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,1,N,10168,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628591,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,1,N,10169,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628592,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,1,N,10170,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628593,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,1,N,10171,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL875333,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,1,N,10172,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628594,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,1,N,10173,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628595,1969.0,BAO_0000218,,,,A,4969,10116.0,50597,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,1,N,10174,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL628596,1969.0,BAO_0000218,,,,A,6737,10116.0,50597,Stability in rat plasma was determined,1,N,10175,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL628597,1969.0,BAO_0000218,,,,A,6737,10116.0,50597,Stability in rat plasma was determined; ND= no data,1,N,10176,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL628598,1969.0,BAO_0000218,,,,A,5089,10116.0,50597,Tested for plasma half life period in rat (0-8 hr),1,N,10177,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL628599,1969.0,BAO_0000218,,,,A,5089,10116.0,50597,Tested for plasma half life period in rat (0-8 hr); Not determined,1,N,10178,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL628600,,BAO_0000218,,,,A,1466,10116.0,50597,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,1,N,10179,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628601,,BAO_0000218,,,,A,1466,10116.0,50597,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,1,N,10180,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628602,,BAO_0000218,,,,A,4950,10116.0,50597,Tested for the half life in rat,1,N,10181,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628603,,BAO_0000218,,,,A,2412,10116.0,50597,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,1,N,10182,In vitro,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628604,,BAO_0000218,,,,A,2412,10116.0,50597,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,1,N,10183,In vitro,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628605,,BAO_0000218,,,,A,2412,10116.0,50597,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,1,N,10184,In vitro,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628606,,BAO_0000218,,,,A,2412,10116.0,50597,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,1,N,10185,In vitro,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628607,,BAO_0000218,,,,A,2412,10116.0,50597,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,1,N,10186,In vitro,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628608,,BAO_0000218,,,,A,15022,10116.0,50597,The biological half life the compound was measured at the dose of 100 umol/kg,1,N,10187,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628609,,BAO_0000218,,,,A,15022,10116.0,50597,The biological half life the compound was measured at the dose of 30 umol/kg,1,N,10188,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628610,1969.0,BAO_0000218,,,,A,406,10116.0,50597,The compound was evaluated for plasma half life period in rat,1,N,10189,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL873819,,BAO_0000218,,,,A,15078,10116.0,50597,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",1,N,10190,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628611,,BAO_0000218,,,,A,15078,10116.0,50597,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",1,N,10191,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628612,,BAO_0000218,,,,A,5247,10116.0,50597,The pharmacokinetic parameter half-life period in vivo in rats,1,N,10192,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628613,,BAO_0000218,,,,A,5041,10116.0,50597,"The pharmacokinetic property, Half-life was determined",1,N,10193,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628614,,BAO_0000218,,,,A,5041,10116.0,50597,"The pharmacokinetic property, Half-life in rat in vivo",1,N,10194,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628615,,BAO_0000218,,,,A,5041,10116.0,50597,"The pharmacokinetic property, Half-life was determined; ND denotes no data",1,N,10195,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628616,,BAO_0000218,,,,A,5041,10116.0,50597,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",1,N,10196,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627924,1969.0,BAO_0000218,,,,A,3918,10116.0,50597,The plasma half life period in rats,1,N,10197,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL627925,2107.0,BAO_0000218,,,,A,2906,10116.0,50597,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,1,N,10198,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL627926,,BAO_0000218,,,,A,6467,10116.0,50597,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,1,N,10199,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627927,,BAO_0000218,,,,A,5510,10116.0,50597,t1/2 (apparent elimination)of the compound was determined,1,N,10200,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627928,,BAO_0000218,,,,A,3788,10116.0,50597,t1/2 value in rat,1,N,10201,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627539,,BAO_0000218,,,,A,17796,10116.0,50597,Half life in rat,1,N,10202,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL876790,1969.0,BAO_0000218,,,,A,12873,10116.0,50597,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",1,N,10203,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL858186,,BAO_0000218,,,,A,5983,10116.0,50597,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,1,N,10204,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627540,,BAO_0000218,,,,A,15765,10116.0,50597,Half-life period in fasted rats,1,N,10205,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627541,,BAO_0000218,,,,A,2661,10116.0,50597,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,1,N,10206,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627715,,BAO_0000218,,,,A,2661,10116.0,50597,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,1,N,10207,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627716,,BAO_0000218,,,,A,429,10116.0,50597,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,1,N,10208,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627717,,BAO_0000218,,,,A,17655,10116.0,50597,Maximum time required to achieve Cmax was determined in rat,1,N,10209,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627718,,BAO_0000218,,,,A,17717,10116.0,50597,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,1,N,10210,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627719,,BAO_0000218,,,,A,17717,10116.0,50597,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,1,N,10211,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627720,,BAO_0000218,,,,A,17717,10116.0,50597,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,1,N,10212,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627721,,BAO_0000218,,,,A,6570,10116.0,50597,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,1,N,10213,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627722,,BAO_0000218,,,,A,6570,10116.0,50597,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,1,N,10214,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627723,,BAO_0000218,,,,A,5978,10116.0,50597,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,1,N,10215,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626058,,BAO_0000218,,,,A,5978,10116.0,50597,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,1,N,10216,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626059,,BAO_0000218,,,,A,5978,10116.0,50597,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,1,N,10217,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626060,,BAO_0000218,,,,A,5978,10116.0,50597,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,1,N,10218,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626061,1969.0,BAO_0000218,,,,A,17720,10116.0,50597,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,1,N,10219,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL876791,,BAO_0000218,,,,A,4723,10116.0,50597,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,1,N,10220,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626062,,BAO_0000218,,,,A,4723,10116.0,50597,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,1,N,10221,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626063,,BAO_0000218,,,,A,4756,10116.0,50597,Tmax at the dose of 2 mg/Kg administered perorally in rats,1,N,10222,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626064,,BAO_0000218,,,,A,4756,10116.0,50597,Tmax at the dose of 5 mg/Kg administered perorally in rats,1,N,10223,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626065,1969.0,BAO_0000218,,,,A,17720,10116.0,50597,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,1,N,10224,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626066,1969.0,BAO_0000218,,,,A,17720,10116.0,50597,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,1,N,10225,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626067,,BAO_0000218,,,,A,1466,10116.0,50597,tmax upon peroral administration of 10.0 mg/Kg dose in rat,1,N,10226,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626068,,BAO_0000218,,,,F,7449,10116.0,50597,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,1,N,10227,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626069,,BAO_0000218,,,,F,7449,10116.0,50597,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,1,N,10228,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626070,,BAO_0000218,,,,F,7449,10116.0,50597,Percent total excretion of 3-methoxyacetaminophen glucuronide,1,N,10229,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626071,,BAO_0000218,,,,F,7449,10116.0,50597,Percent total excretion of N-methoxyacetaminophen glucuronide,1,N,10230,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626072,,BAO_0000218,,,,F,7449,10116.0,50597,Percent total excretion of N-methoxyacetaminophen sulfate,1,N,10231,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626073,,BAO_0000218,,,,F,7449,10116.0,50597,Percent total excretion of acetaminophen,1,N,10232,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626741,2046.0,BAO_0000218,,,,A,7768,10116.0,50597,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",1,N,10233,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL626742,,BAO_0000218,,,,A,17655,10116.0,50597,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",1,N,10234,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626743,,BAO_0000218,,,,A,17735,10116.0,50597,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,1,N,10235,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL876792,,BAO_0000218,,,,A,5960,10116.0,50597,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,1,N,10236,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626744,,BAO_0000218,,,,A,17735,10116.0,50597,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,1,N,10237,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626745,,BAO_0000218,,,,A,7116,10116.0,50597,Compound was tested for antidiuretic activity in rats,1,N,10238,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626746,1969.0,BAO_0000218,,,,A,4878,10116.0,50597,AUC in rat after 3mg/kg oral dose,1,N,10239,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626747,,BAO_0000218,,,,A,5939,10116.0,50597,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,1,N,10240,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626748,,BAO_0000218,,,,A,5939,10116.0,50597,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,1,N,10241,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626749,,BAO_0000218,,,,A,16367,10116.0,50597,Bioavailability administered orally at a dose of 10 mg/kg to rats,1,N,10242,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626750,,BAO_0000218,,,,A,16366,10116.0,50597,Oral Bioavailability was determined,1,N,10243,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626751,,BAO_0000218,,,,A,4426,10116.0,50597,Oral bioavailability in rat,1,N,10244,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626913,,BAO_0000218,,,,A,4426,10116.0,50597,Oral bioavailability in rat; Not performed.,1,N,10245,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626914,,BAO_0000218,,,,A,5041,10116.0,50597,Bioavailability,1,N,10246,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626915,,BAO_0000218,,,,A,5041,10116.0,50597,Bioavailability was determined; ND denotes no data,1,N,10247,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626916,,BAO_0000218,,,,A,1500,10116.0,50597,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,1,N,10248,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626917,,BAO_0000218,,,,A,1500,10116.0,50597,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,1,N,10249,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626918,,BAO_0000218,,,,A,17409,10116.0,50597,Binding towards rat plasma protein at 10 uM,1,N,10250,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626919,,BAO_0000218,,,,A,17409,10116.0,50597,Binding towards rat plasma protein at 100 uM,1,N,10251,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626920,,BAO_0000218,,,,A,2959,10116.0,50597,Bioavailability in rat (dose 20 mg/kg p.o.),1,N,10252,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621976,,BAO_0000218,,,,A,13501,10116.0,50597,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,1,N,10253,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL877599,,BAO_0000218,,,,A,6567,10116.0,50597,Bioavailability in rat after 5 mg/kg oral gavage,1,N,10254,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621977,,BAO_0000218,,,,A,6571,10116.0,50597,Bioavailability in rat,1,N,10255,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621978,,BAO_0000218,,,,A,6715,10116.0,50597,Bioavailability in rat (dose 1 mg/kg i.v.),1,N,10256,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621979,,BAO_0000218,,,,A,6715,10116.0,50597,Bioavailability in rat (dose 3 mg/kg p.o.),1,N,10257,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621980,,BAO_0000218,,,,A,2932,10116.0,50597,Oral bioavailability in rat,1,N,10258,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621981,,BAO_0000218,,,,A,4171,10116.0,50597,Bioavailability of the compound in rats after administration of 30 mg/kg,1,N,10259,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621982,,BAO_0000218,,,,A,17509,10116.0,50597,Bioavailability after administration of 10 mg/kg in rats,1,N,10260,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL882953,,BAO_0000218,,,,A,17509,10116.0,50597,Bioavailability after administration of 2 mg/kg in rats,1,N,10261,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621983,,BAO_0000218,,,,A,4527,10116.0,50597,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,1,N,10262,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621984,,BAO_0000218,,,,A,4026,10116.0,50597,Bioavailability in dogs was determined; high,1,N,10263,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621985,,BAO_0000218,,,,A,6659,10116.0,50597,Bioavailability in monkey after intravenous administration at 1 mpk,1,N,10264,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621986,,BAO_0000218,,,,A,6659,10116.0,50597,Bioavailability in monkey after peroral administration at 10 mpk,1,N,10265,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621987,,BAO_0000218,,,,A,6659,10116.0,50597,Bioavailability in rat after intravenous administration at 1 mpk,1,N,10266,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL877600,,BAO_0000218,,,,F,6659,10116.0,50597,Bioavailability in rat after intravenous administration at 2 mpk,1,N,10267,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621988,,BAO_0000218,,,,A,6659,10116.0,50597,Bioavailability in rat after peroral administration at 30 mpk,1,N,10268,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621989,,BAO_0000218,,,,F,6659,10116.0,50597,Bioavailability in rat after peroral administration at at 100 mpk,1,N,10269,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621990,,BAO_0000218,,,,A,6597,10116.0,50597,Bioavailability in rats was evaluated,1,N,10270,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621991,,BAO_0000218,,,,A,1202,10116.0,50597,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,1,N,10271,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621992,,BAO_0000218,,,,A,1202,10116.0,50597,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,1,N,10272,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621993,,BAO_0000218,,,,A,1202,10116.0,50597,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,1,N,10273,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621994,,BAO_0000218,,,,A,1202,10116.0,50597,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,1,N,10274,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621995,,BAO_0000218,,,,A,5207,10116.0,50597,Bioavailability in rat,1,N,10275,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621996,,BAO_0000218,,,,A,5970,10116.0,50597,Bioavailability in rat,1,N,10276,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621997,,BAO_0000218,,,,A,17538,10116.0,50597,Oral bioavailability in rat (dose 10 mg/kg),1,N,10277,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621998,,BAO_0000218,,,,A,17538,10116.0,50597,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,1,N,10278,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621999,,BAO_0000218,,,,A,1466,10116.0,50597,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,1,N,10279,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622000,,BAO_0000218,,,,A,2879,10116.0,50597,Oral bioavailability in rat,1,N,10280,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622001,,BAO_0000218,,,,A,2879,10116.0,50597,Bioavailability was measured in rat after oral administration; 2-4,1,N,10281,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622002,,BAO_0000218,,,,A,2879,10116.0,50597,Bioavailability was measured in rat after oral administration; 3-7,1,N,10282,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622003,,BAO_0000218,,,,A,3777,10116.0,50597,Bioavailability in rat (intraduodenal administration),1,N,10283,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL877601,,BAO_0000218,,,,A,3777,10116.0,50597,Bioavailability in rat (intraduodenal administration),1,N,10284,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624871,,BAO_0000218,,,,A,3777,10116.0,50597,Oral bioavailability in rat,1,N,10285,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622004,,BAO_0000218,,,,A,3777,10116.0,50597,Oral bioavailability in rat,1,N,10286,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL882954,,BAO_0000218,,,,A,5423,10116.0,50597,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),1,N,10287,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622005,,BAO_0000218,,,,A,16365,10116.0,50597,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,1,N,10288,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622006,,BAO_0000218,,,,A,16365,10116.0,50597,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,1,N,10289,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622007,,BAO_0000218,,,,A,4239,10116.0,50597,Bioavailability was measured in rat,1,N,10290,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622008,,BAO_0000218,,,,A,5438,10116.0,50597,Bioavailability was reported,1,N,10291,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622009,,BAO_0000218,,,,A,5334,10116.0,50597,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),1,N,10292,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622010,,BAO_0000218,,,,A,5334,10116.0,50597,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),1,N,10293,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622011,,BAO_0000218,,,,A,4199,10116.0,50597,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,1,N,10294,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622012,,BAO_0000218,,,,A,4199,10116.0,50597,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),1,N,10295,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622013,,BAO_0000218,,,,A,4199,10116.0,50597,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),1,N,10296,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622014,,BAO_0000218,,,,A,4890,10116.0,50597,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,1,N,10297,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624749,,BAO_0000218,,,,A,2792,10116.0,50597,Bioavailability was determined at 3 mg/kg po dose in rats,1,N,10298,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624750,,BAO_0000218,,,,A,5529,10116.0,50597,Oral bioavailability in rat (dose 2 mg/kg),1,N,10299,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624751,,BAO_0000218,,,,A,6685,10116.0,50597,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",1,N,10300,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624752,,BAO_0000218,,,,A,6685,10116.0,50597,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",1,N,10301,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624753,,BAO_0000218,,,,A,6685,10116.0,50597,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",1,N,10302,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624754,,BAO_0000218,,,,A,6005,10116.0,50597,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,1,N,10303,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624755,,BAO_0000218,,,,A,6410,10116.0,50597,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,1,N,10304,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624756,,BAO_0000218,,,,A,6410,10116.0,50597,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,1,N,10305,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624757,,BAO_0000218,,,,A,6103,10116.0,50597,Bioavailability in rat,1,N,10306,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624758,,BAO_0000218,,,,A,6410,10116.0,50597,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,1,N,10307,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622270,,BAO_0000218,,,,A,6410,10116.0,50597,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,1,N,10308,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622271,,BAO_0000218,,,,A,5353,10116.0,50597,Bioavailability in rat (Sprague-Dawley),1,N,10309,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622272,,BAO_0000218,,,,A,4727,10116.0,50597,Bioavailability in rat at the dose of 2 mg/kg,1,N,10310,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622273,,BAO_0000218,,,,A,17804,10116.0,50597,Oral bioavailability in rat,1,N,10311,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622274,,BAO_0000218,,,,A,5809,10116.0,50597,Bioavailability in rat (cannulated) (dose 2 mg/kg),1,N,10312,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622275,,BAO_0000218,,,,A,17804,10116.0,50597,Bioavailability value of compound in rats was determined after peroral administration,1,N,10313,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622276,,BAO_0000218,,,,A,3634,10116.0,50597,Oral bioavailability in rat (dose 20 mg/kg),1,N,10314,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622277,,BAO_0000218,,,,A,3341,10116.0,50597,Oral bioavailability in rat,1,N,10315,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622278,,BAO_0000218,,,,A,2690,10116.0,50597,Oral bioavailability in rat (dose 5 mg/kg),1,N,10316,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622279,,BAO_0000218,,,,A,3184,10116.0,50597,Oral bioavailability in rat,1,N,10317,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622280,,BAO_0000218,,,,A,740,10116.0,50597,Oral bioavailability in rat,1,N,10318,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624083,,BAO_0000218,,,,A,1806,10116.0,50597,Compound was evaluated for oral bioavailability in rats; 15-27 %,1,N,10319,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624084,,BAO_0000218,,,,A,4891,10116.0,50597,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,1,N,10320,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624085,,BAO_0000218,,,,A,3634,10116.0,50597,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),1,N,10321,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624086,,BAO_0000218,,,,A,64,10116.0,50597,Compound was tested for bioavailability in rats,1,N,10322,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624087,,BAO_0000218,,,,A,4839,10116.0,50597,Bioavailability in rat,1,N,10323,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624088,,BAO_0000218,,,,A,1094,10116.0,50597,Oral bioavailability in rat,1,N,10324,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624089,,BAO_0000218,,,,A,5005,9544.0,22224,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,1,U,10325,In vivo,Macaca mulatta,,0,,Intermediate
,,,CHEMBL624090,,BAO_0000218,,,,A,5005,10116.0,22224,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),1,U,10326,In vivo,Rattus norvegicus,,0,,Intermediate
,,,CHEMBL624091,,BAO_0000218,,,,A,4687,10116.0,50597,Evaluated for the bioavailability in rat (in vivo),1,N,10327,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624092,,BAO_0000218,,,,A,17804,10116.0,50597,F value of compound in rats was determined after peroral administration,1,N,10328,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624093,,BAO_0000218,,,,A,5974,10116.0,50597,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,1,N,10329,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624094,,BAO_0000218,,,,A,5974,10116.0,50597,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,1,N,10330,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624095,,BAO_0000218,,,,A,5974,10116.0,50597,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,1,N,10331,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624096,,BAO_0000218,,,,A,5974,10116.0,50597,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,1,N,10332,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624097,,BAO_0000218,,,,A,1088,10116.0,50597,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",1,N,10333,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624098,,BAO_0000218,,,,A,1742,10116.0,50597,Maximum fall in carotid flow in rat,1,N,10334,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL874392,,BAO_0000218,,,,A,4689,10116.0,50597,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,1,N,10335,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624099,,BAO_0000218,,,,A,2463,10116.0,50597,Oral bioavailability in rat (dose 5 mg/kg),1,N,10336,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624100,,BAO_0000218,,,,A,5654,10116.0,50597,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,1,N,10337,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624101,,BAO_0000218,,,,A,5654,10116.0,50597,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,1,N,10338,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624102,,BAO_0000218,,,,A,6874,10116.0,50597,Oral bioavailability in rat (male Wistar),1,N,10339,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624103,,BAO_0000218,,,,A,5633,10116.0,50597,Oral bioavailability after administration (30 mg/kg) in rat; good,1,N,10340,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624104,,BAO_0000218,,,,A,5496,10116.0,50597,Oral bioavailability at the dose of 2 mg/kg in rat,1,N,10341,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624105,,BAO_0000218,,,,A,2358,10116.0,50597,Oral bioavailability determined in rats,1,N,10342,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624106,,BAO_0000218,,,,A,16456,10116.0,50597,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),1,N,10343,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624107,,BAO_0000218,,,,A,5302,10116.0,50597,Oral bioavailability in rat (dose single 10 mg/kg),1,N,10344,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623943,,BAO_0000218,,,,A,5302,10116.0,50597,Oral bioavailability in rat (dose single 10 mg/kg),1,N,10345,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623944,,BAO_0000218,,,,A,5302,10116.0,50597,Oral bioavailability in rat (dose 5 mg/kg,1,N,10346,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623945,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,1,N,10347,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623946,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,1,N,10348,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623947,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,1,N,10349,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623948,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,1,N,10350,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623949,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,1,N,10351,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623950,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,1,N,10352,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL874398,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,1,N,10353,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623951,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,1,N,10354,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623952,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,1,N,10355,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623953,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,1,N,10356,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623954,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,1,N,10357,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623955,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,1,N,10358,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623956,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,1,N,10359,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627807,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,1,N,10360,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627808,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,1,N,10361,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627809,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,1,N,10362,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627810,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,1,N,10363,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627811,,BAO_0000218,,,,A,11020,10116.0,50597,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",1,N,10364,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627812,,BAO_0000218,,,,A,11020,10116.0,50597,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",1,N,10365,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627813,,BAO_0000218,,,,A,11020,10116.0,50597,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",1,N,10366,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627814,,BAO_0000218,,,,A,11020,10116.0,50597,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",1,N,10367,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL875336,,BAO_0000218,,,,A,11020,10116.0,50597,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",1,N,10368,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627815,,BAO_0000218,,,,A,11020,10116.0,50597,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",1,N,10369,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627816,,BAO_0000218,,,,A,11020,10116.0,50597,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",1,N,10370,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627817,,BAO_0000218,,,,A,11020,10116.0,50597,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",1,N,10371,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627818,,BAO_0000218,,,,A,11020,10116.0,50597,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",1,N,10372,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627819,,BAO_0000218,,,,A,11020,10116.0,50597,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",1,N,10373,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627820,,BAO_0000218,,,,A,11020,10116.0,50597,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",1,N,10374,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627821,,BAO_0000218,,,,A,11020,10116.0,50597,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",1,N,10375,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628464,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,1,N,10376,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626239,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,1,N,10377,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626240,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,1,N,10378,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626241,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,1,N,10379,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626242,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,1,N,10380,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626243,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,1,N,10381,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626244,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,1,N,10382,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626907,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,1,N,10383,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626908,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,1,N,10384,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626909,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,1,N,10385,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626910,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,1,N,10386,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL875342,,BAO_0000218,,,,F,7449,10116.0,50597,Percent total excretion of acetaminophen cysteine conjugate,1,N,10387,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626911,,BAO_0000218,,,,F,7449,10116.0,50597,Percent total excretion of acetaminophen glucuronide,1,N,10388,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626912,,BAO_0000218,,,,F,7449,10116.0,50597,Percent total excretion of acetaminophen sulfate,1,N,10389,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627065,,BAO_0000218,,,,F,7449,10116.0,50597,Percent total excretion of acetaminophen-mercapturic acid,1,N,10390,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627066,1088.0,BAO_0000218,,,,A,3172,10116.0,50597,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,1,N,10391,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL627067,,BAO_0000218,,,,A,16456,10116.0,50597,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,1,N,10392,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627068,2385.0,BAO_0000218,,,,A,10839,8656.0,22224,Biodistribution of compound in rat muscle after 5 min of administration,1,U,10393,In vivo,ratrat,Muscle tissue,0,,Autocuration
,,,CHEMBL627069,2385.0,BAO_0000218,,,,A,10839,8656.0,22224,Biodistribution of compound in rat muscle after 5 min of administration.,1,U,10394,In vivo,ratrat,Muscle tissue,0,,Autocuration
,,,CHEMBL627070,,BAO_0000218,,,,A,5334,9940.0,22224,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),1,U,10395,In vivo,Ovis aries,,0,,Autocuration
,,,CHEMBL627071,,BAO_0000218,,,,A,5334,9940.0,22224,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),1,U,10396,In vivo,Ovis aries,,0,,Autocuration
,,,CHEMBL627072,,BAO_0000218,,,,A,5334,9940.0,22224,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),1,U,10397,In vivo,Ovis aries,,0,,Autocuration
,,,CHEMBL627073,,BAO_0000218,,,,A,5334,9940.0,22224,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),1,U,10398,In vivo,Ovis aries,,0,,Autocuration
,,,CHEMBL625387,,BAO_0000218,,,,A,5334,9940.0,22224,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),1,U,10399,In vivo,Ovis aries,,0,,Autocuration
,,,CHEMBL625388,,BAO_0000218,,,,A,5334,9940.0,22224,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),1,U,10400,In vivo,Ovis aries,,0,,Autocuration
,,,CHEMBL625389,1969.0,BAO_0000218,,,,A,5334,9940.0,22224,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),1,U,10401,In vivo,Ovis aries,Plasma,0,,Autocuration
,,,CHEMBL875343,1969.0,BAO_0000218,,,,A,5334,9940.0,22224,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),1,U,10402,In vivo,Ovis aries,Plasma,0,,Autocuration
,,,CHEMBL876795,,BAO_0000218,,,,A,1735,8570.0,50497,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),1,N,10403,,Serpentes,,1,,Intermediate
,,,CHEMBL626552,,BAO_0000218,,,,A,1469,8570.0,50497,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,1,N,10404,,Serpentes,,1,,Intermediate
,,,CHEMBL626553,,BAO_0000218,,,,A,1336,8570.0,50497,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,1,N,10405,,Serpentes,,1,,Intermediate
,,,CHEMBL626554,1969.0,BAO_0000366,,,,A,12403,9606.0,22224,The human biological plasma half life of the compound,1,U,10406,,Homo sapiens,Plasma,0,,Autocuration
,,,CHEMBL626555,1088.0,BAO_0000218,,,,A,8151,10116.0,50597,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,1,N,10407,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL626556,,BAO_0000218,,,,A,8004,10116.0,50597,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,1,N,10408,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626557,,BAO_0000218,,,,A,8004,10116.0,50597,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,1,N,10409,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626558,,BAO_0000218,,,,A,8004,10116.0,50597,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,1,N,10410,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626559,,BAO_0000218,,,,A,8004,10116.0,50597,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,1,N,10411,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626560,,BAO_0000218,,,,A,8004,10116.0,50597,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,1,N,10412,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL876803,,BAO_0000218,,,,A,8004,10116.0,50597,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,1,N,10413,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627964,,BAO_0000218,,,,A,8004,10116.0,50597,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,1,N,10414,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627965,,BAO_0000218,,,,A,8004,10116.0,50597,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,1,N,10415,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627966,,BAO_0000218,,,,A,8004,10116.0,50597,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,1,N,10416,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627967,,BAO_0000218,,,,A,8004,10116.0,50597,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,1,N,10417,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627968,,BAO_0000218,,,,A,8004,10116.0,50597,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,1,N,10418,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627969,,BAO_0000218,,,,A,8004,10116.0,50597,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,1,N,10419,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627970,,BAO_0000218,,,,A,8004,10116.0,50597,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,1,N,10420,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627971,178.0,BAO_0000218,,,,A,8004,10116.0,50597,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,1,N,10421,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627972,178.0,BAO_0000218,,,,A,8004,10116.0,50597,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,1,N,10422,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL856029,,BAO_0000357,,,,B,15917,9606.0,180,Dissociation constant against binding to human cyclophilin A,1,D,10423,,Homo sapiens,,9,,Expert
,,,CHEMBL627973,,BAO_0000019,,,,B,12396,9913.0,11591,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,1,H,10424,,Bos taurus,,8,,Expert
,,,CHEMBL627974,,BAO_0000019,,,,A,7065,,22224,-Log C was determined by performing the electroshock minimum test,1,U,10425,,,,0,,Autocuration
,,,CHEMBL627975,,BAO_0000019,,,,A,7065,,22224,-Log C was determined by performing the foot shock test,1,U,10426,,,,0,,Autocuration
,,,CHEMBL627976,,BAO_0000019,,,,A,7065,,22224,-Log C was determined by performing the incl screen test,1,U,10427,,,,0,,Autocuration
,,,CHEMBL627977,,BAO_0000019,,,,A,7065,,22224,-Log C was determined by performing the maximum electroshock test,1,U,10428,,,,0,,Autocuration
,,,CHEMBL627978,,BAO_0000019,,,,A,7065,,22224,-Log C was determined by performing the pentylenetetrazole test,1,U,10429,,,,0,,Autocuration
,,,CHEMBL627979,,BAO_0000019,,,,A,12415,,22224,Tested for experimental arotinoid inhibitory dose,1,U,10430,,,,0,,Autocuration
,,,CHEMBL876804,,BAO_0000019,,,,A,10256,,22224,Negative log transformed activity,1,U,10431,,,,0,,Autocuration
,,,CHEMBL627980,,BAO_0000019,,,,A,7991,,22224,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",1,U,10432,,,,0,,Autocuration
,,,CHEMBL627981,,BAO_0000218,,,,A,14342,10141.0,50512,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,1,N,10433,,Cavia porcellus,,1,,Intermediate
,,,CHEMBL627982,,BAO_0000218,,,,A,14342,10141.0,50512,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,1,N,10434,,Cavia porcellus,,1,,Intermediate
,,,CHEMBL627983,,BAO_0000218,,,,A,14342,10141.0,50512,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,1,N,10435,,Cavia porcellus,,1,,Intermediate
,,,CHEMBL627984,2116.0,BAO_0000218,,,,A,14342,10141.0,50512,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,1,N,10436,,Cavia porcellus,Ileum,1,,Intermediate
,,,CHEMBL627985,,BAO_0000100,,,,P,6047,,22229,Solubility in water was determined; values expressed as -log,1,U,10437,,,,0,,Autocuration
,,,CHEMBL627986,,BAO_0000019,,,,A,17269,,22224,Ratio of Kcat to that of Km was determined,1,U,10438,,,,0,,Autocuration
,,,CHEMBL627987,,BAO_0000019,,,,A,10026,,22224,Observed first order rate constant,1,U,10439,,,,0,,Autocuration
,,,CHEMBL627988,,BAO_0000019,,,,A,14583,,22224,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,1,U,10440,,,,0,,Autocuration
,,,CHEMBL627989,,BAO_0000218,,,,A,2661,10116.0,50597,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,1,N,10441,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627990,,BAO_0000218,,,,A,2661,10116.0,50597,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,1,N,10442,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL876805,,BAO_0000218,,,,A,4029,10116.0,50597,Oral Bioavailability after administration of 10 mg/kg in male rat,1,N,10443,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627991,,BAO_0000218,,,,A,17735,10116.0,50597,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),1,N,10444,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627992,,BAO_0000218,,,,A,4576,10116.0,50597,Oral bioavailability in rat,1,N,10445,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627993,,BAO_0000218,,,,A,17582,10116.0,50597,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,1,N,10446,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622817,,BAO_0000218,,,,A,17651,10116.0,50597,Oral bioavailability at 1 mg/kg was determined in rat,1,N,10447,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622818,,BAO_0000218,,,,A,17651,10116.0,50597,Oral bioavailability at 10 mg/kg was determined in rat,1,N,10448,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622819,,BAO_0000218,,,,A,17670,10116.0,50597,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",1,N,10449,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL872267,,BAO_0000218,,,,A,5045,10116.0,50597,Oral bioavailability in rat,1,N,10450,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622820,,BAO_0000218,,,,A,1696,10116.0,50597,Oral bioavailability in rat,1,N,10451,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622821,,BAO_0000218,,,,A,17764,10116.0,50597,Oral bioavailability after intravenous administration in rats at 24 uM/kg,1,N,10452,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622822,,BAO_0000218,,,,A,6448,10116.0,50597,Oral bioavailability in rat,1,N,10453,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622823,,BAO_0000218,,,,A,6596,10116.0,50597,Oral bioavailability in rat,1,N,10454,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622824,,BAO_0000218,,,,A,17547,10116.0,50597,Oral bioavailability in rat,1,N,10455,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622825,,BAO_0000218,,,,A,17771,10116.0,50597,Oral bioavailability in rat at a dose of 3 mg/kg,1,N,10456,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622901,,BAO_0000218,,,,A,6495,10116.0,50597,Oral bioavailability in rat after oral administration at 10 mg/kg,1,N,10457,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622902,,BAO_0000218,,,,A,4558,10116.0,50597,Oral bioavailability in rat,1,N,10458,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621844,,BAO_0000218,,,,A,17596,10116.0,50597,Oral bioavailability in rat,1,N,10459,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621845,,BAO_0000218,,,,A,6827,10116.0,50597,Oral bioavailability in Dawley rats,1,N,10460,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621846,,BAO_0000218,,,,A,4026,10116.0,50597,Oral bioavailability,1,N,10461,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621847,,BAO_0000218,,,,A,10,10116.0,50597,Oral bioavailability in rat (dose 30 mg/kg),1,N,10462,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL877609,,BAO_0000218,,,,A,17717,10116.0,50597,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,1,N,10463,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621848,,BAO_0000218,,,,A,17717,10116.0,50597,Bioavailability in rat (dose 3 mg/kg i.v.),1,N,10464,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621849,,BAO_0000218,,,,A,17717,10116.0,50597,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,1,N,10465,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622030,,BAO_0000218,,,,A,17717,10116.0,50597,Oral bioavailability in rat (dose 60 mg/kg p.o.),1,N,10466,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622031,,BAO_0000218,,,,A,4796,10116.0,50597,Percent oral bioavailability determined in rats,1,N,10467,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622032,,BAO_0000218,,,,A,4883,10116.0,50597,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,1,N,10468,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622033,,BAO_0000218,,,,A,2137,10116.0,50597,The compound was evaluated for bioavailability in rats; 32-51,1,N,10469,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622034,,BAO_0000218,,,,A,2959,10116.0,50597,Bioavailability in rat (dose 20 mg/kg p.o.),1,N,10470,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622035,,BAO_0000218,,,,A,1361,10116.0,50597,Oral bioavailability in rat,1,N,10471,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL882966,,BAO_0000218,,,,A,4727,10116.0,50597,Bioavailability percent in rat at the dose of 2 mg/kg,1,N,10472,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622036,,BAO_0000218,,,,A,16423,10116.0,50597,Bioavailability was evaluated after 20 uM/kg of peroral administration,1,N,10473,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622037,,BAO_0000218,,,,A,5206,10116.0,50597,Oral bioavailability in rat,1,N,10474,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622038,,BAO_0000218,,,,A,6448,10116.0,50597,Oral bioavailability in rat,1,N,10475,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622039,,BAO_0000218,,,,A,17723,10116.0,50597,Bioavailability in rats,1,N,10476,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622040,178.0,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,1,N,10477,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL622041,178.0,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,1,N,10478,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL622042,178.0,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,1,N,10479,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL622043,178.0,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,1,N,10480,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL622044,178.0,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,1,N,10481,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL622045,10000001.0,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,1,N,10482,In vivo,Rattus norvegicus,Bone,1,,Intermediate
,,,CHEMBL622046,10000001.0,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,1,N,10483,In vivo,Rattus norvegicus,Bone,1,,Intermediate
,,,CHEMBL622047,10000001.0,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,1,N,10484,In vivo,Rattus norvegicus,Bone,1,,Intermediate
,,,CHEMBL877610,10000001.0,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,1,N,10485,In vivo,Rattus norvegicus,Bone,1,,Intermediate
,,,CHEMBL622048,955.0,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,1,N,10486,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL622049,955.0,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,1,N,10487,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL622050,955.0,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,1,N,10488,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL622051,955.0,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,1,N,10489,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL622052,,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,1,N,10490,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622053,,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,1,N,10491,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622054,,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,1,N,10492,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622055,,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,1,N,10493,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622056,,BAO_0000218,,,,A,5237,10116.0,50597,Oral bioavailability in rats was determined; High,1,N,10494,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622057,,BAO_0000218,,,,A,5503,10116.0,50597,Oral bioavailability in the rat was determined,1,N,10495,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628008,,BAO_0000218,,,,A,15765,10116.0,50597,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,1,N,10496,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622058,,BAO_0000218,,,,A,15660,10116.0,50597,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),1,N,10497,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622059,,BAO_0000218,,,,A,5978,10116.0,50597,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,1,N,10498,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622060,,BAO_0000218,,,,A,5978,10116.0,50597,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,1,N,10499,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622061,,BAO_0000218,,,,A,5978,10116.0,50597,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,1,N,10500,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622062,,BAO_0000218,,,,A,5978,10116.0,50597,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,1,N,10501,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622063,,BAO_0000218,,,,A,5656,10116.0,50597,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,1,N,10502,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL877611,,BAO_0000218,,,,A,3598,10116.0,50597,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,1,N,10503,In vivo,Rattus norvegicus,,1,,Expert
,,,CHEMBL622064,,BAO_0000218,,,,A,4216,10116.0,50597,Oral bioavailability of compound in Sprague Dawley rats,1,N,10504,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622065,,BAO_0000218,,,,A,17839,10116.0,50597,Oral bioavailability of compound in rat,1,N,10505,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622066,,BAO_0000218,,,,A,6570,10116.0,50597,Oral bioavailability in rat (dose 2 mg/kg),1,N,10506,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622067,,BAO_0000218,,,,A,5334,10116.0,50597,Oral bioavailability of compound in rat was determined,1,N,10507,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622068,,BAO_0000218,,,,A,6886,10116.0,50597,Oral bioavailability of compound in rats,1,N,10508,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622069,,BAO_0000218,,,,A,5210,10116.0,50597,Oral bioavailability of compound was determined in rats,1,N,10509,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624796,,BAO_0000218,,,,A,4170,10116.0,50597,Oral bioavailability at a dose of 30 mg/kg in rats,1,N,10510,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624797,,BAO_0000218,,,,A,6028,10116.0,50597,Oral bioavailability in rat (dose 10 mg/kg),1,N,10511,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623053,,BAO_0000218,,,,A,6028,10116.0,50597,Oral bioavailability in rat (dose 10 mg/kg),1,N,10512,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623054,,BAO_0000218,,,,A,6078,10116.0,50597,Oral bioavailability evaluated in rat,1,N,10513,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623055,,BAO_0000218,,,,A,6168,10116.0,50597,Oral bioavailability in fasted rat,1,N,10514,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623056,,BAO_0000218,,,,A,6168,10116.0,50597,Oral bioavailability in fed rat,1,N,10515,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623057,,BAO_0000218,,,,A,5160,10116.0,50597,Oral bioavailability in rat (mature male) (dose 30 mg/kg),1,N,10516,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623058,,BAO_0000218,,,,A,6057,10116.0,50597,Oral bioavailability in rat,1,N,10517,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623059,,BAO_0000218,,,,A,6535,10116.0,50597,Oral bioavailability in rat (dose 10 mg/kg p.o.),1,N,10518,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623060,,BAO_0000218,,,,A,6535,10116.0,50597,Oral bioavailability in rat after administration of 10 mg/kg po,1,N,10519,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623061,,BAO_0000218,,,,A,4194,10116.0,50597,Oral bioavailability in rat,1,N,10520,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623062,,BAO_0000218,,,,A,6230,10116.0,50597,Oral bioavailability in rat,1,N,10521,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623063,,BAO_0000218,,,,A,6619,10116.0,50597,Oral bioavailability in rat,1,N,10522,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623064,,BAO_0000218,,,,A,17607,10116.0,50597,Oral bioavailability in rat,1,N,10523,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623065,,BAO_0000218,,,,A,4942,10116.0,50597,Oral bioavailability in ratrs,1,N,10524,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623066,,BAO_0000218,,,,A,4942,10116.0,50597,Oral bioavailability in rat,1,N,10525,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623067,,BAO_0000218,,,,A,6646,10116.0,50597,Oral bioavailability in rat,1,N,10526,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623068,,BAO_0000218,,,,A,5237,10116.0,50597,Oral bioavailability in rats was determined; High,1,N,10527,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623069,,BAO_0000218,,,,A,6646,10116.0,50597,Oral bioavailability in rat,1,N,10528,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623070,,BAO_0000218,,,,A,4449,10116.0,50597,Oral bioavailability in rat,1,N,10529,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623071,,BAO_0000218,,,,A,6057,10116.0,50597,Oral bioavailability was calculated in rat,1,N,10530,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623072,,BAO_0000218,,,,A,2552,10116.0,50597,Oral bioavailability,1,N,10531,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623073,,BAO_0000218,,,,A,5496,10116.0,50597,Oral bioavailability,1,N,10532,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623074,,BAO_0000218,,,,A,6484,10116.0,50597,Oral bioavailability,1,N,10533,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623075,,BAO_0000218,,,,A,6485,10116.0,50597,Oral bioavailability,1,N,10534,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623076,,BAO_0000218,,,,A,6616,10116.0,50597,Oral bioavailability after i.v. administration,1,N,10535,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623077,,BAO_0000218,,,,A,4969,10116.0,50597,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),1,N,10536,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623078,,BAO_0000218,,,,A,5862,10116.0,50597,Oral bioavailability in rat (Sprague-Dawley),1,N,10537,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623079,,BAO_0000218,,,,A,4514,10116.0,50597,Oral bioavailability in Sprague-Dawley rats,1,N,10538,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623080,,BAO_0000218,,,,A,4514,10116.0,50597,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),1,N,10539,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623081,,BAO_0000218,,,,A,4514,10116.0,50597,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),1,N,10540,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623082,,BAO_0000218,,,,A,5546,10116.0,50597,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,1,N,10541,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL874400,,BAO_0000218,,,,A,6168,10116.0,50597,Oral bioavailability in fasted rat,1,N,10542,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623083,,BAO_0000218,,,,A,6168,10116.0,50597,Oral bioavailability in fed rat,1,N,10543,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623084,,BAO_0000218,,,,A,3624,10116.0,50597,Oral bioavailability in rat,1,N,10544,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623085,,BAO_0000218,,,,A,5213,10116.0,50597,Oral bioavailability in rat,1,N,10545,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623086,,BAO_0000218,,,,A,5496,10116.0,50597,Oral bioavailability in rat,1,N,10546,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623087,,BAO_0000218,,,,A,5553,10116.0,50597,Oral bioavailability in rat,1,N,10547,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623088,,BAO_0000218,,,,A,5833,10116.0,50597,Oral bioavailability in rat,1,N,10548,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623089,,BAO_0000218,,,,A,5836,10116.0,50597,Oral bioavailability in rat,1,N,10549,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623090,,BAO_0000218,,,,A,5865,10116.0,50597,Oral bioavailability in rat,1,N,10550,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623091,,BAO_0000218,,,,A,5960,10116.0,50597,Oral bioavailability in rat,1,N,10551,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623092,,BAO_0000218,,,,A,6249,10116.0,50597,Oral bioavailability in rat,1,N,10552,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623093,,BAO_0000218,,,,A,6448,10116.0,50597,Oral bioavailability in rat,1,N,10553,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL874401,,BAO_0000218,,,,A,6453,10116.0,50597,Oral bioavailability in rat,1,N,10554,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623094,,BAO_0000218,,,,A,6640,10116.0,50597,Oral bioavailability in rat,1,N,10555,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623095,,BAO_0000218,,,,A,17607,10116.0,50597,Oral bioavailability in rat,1,N,10556,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623096,,BAO_0000218,,,,A,5939,10116.0,50597,Oral bioavailability in rat after peroral administration at 10 mg/kg,1,N,10557,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624913,,BAO_0000218,,,,A,5939,10116.0,50597,Oral bioavailability in rat after peroral administration at 5 mg/kg,1,N,10558,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624914,,BAO_0000218,,,,A,6281,10116.0,50597,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),1,N,10559,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624915,,BAO_0000218,,,,A,5874,10116.0,50597,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,1,N,10560,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624916,,BAO_0000218,,,,A,5213,10116.0,50597,Oral bioavailability in rat; Not measured,1,N,10561,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624917,,BAO_0000218,,,,A,4964,10116.0,50597,Oral bioavailability in rat,1,N,10562,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625157,,BAO_0000218,,,,A,11020,10116.0,50597,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,1,N,10563,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625158,2107.0,BAO_0000218,,,,A,6251,10116.0,50597,In vitro metabolic potential in rat liver microsomes,1,N,10564,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625159,,BAO_0000218,,,,A,1568,10116.0,50597,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",1,N,10565,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625160,,BAO_0000218,,,,A,3032,10116.0,50597,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",1,N,10566,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625161,,BAO_0000218,,,,A,3748,10116.0,50597,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,1,N,10567,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625162,,BAO_0000218,,,,A,401,10116.0,50597,Oral bioavailability in rat,1,N,10568,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625163,,BAO_0000218,,,,A,6512,10116.0,50597,Oral bioavailability in rat,1,N,10569,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625164,,BAO_0000218,,,,A,17617,10116.0,50597,Oral bioavailability in rats at 10 mg/kg,1,N,10570,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625165,,BAO_0000218,,,,A,6679,10116.0,50597,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,1,N,10571,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625166,,BAO_0000218,,,,A,6742,10116.0,50597,Oral bioavailability in rat,1,N,10572,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625167,,BAO_0000218,,,,A,589,10116.0,50597,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,1,N,10573,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625168,,BAO_0000218,,,,A,589,10116.0,50597,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,1,N,10574,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625169,,BAO_0000218,,,,A,3185,10116.0,50597,Plasma clearance of the compound,1,N,10575,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626264,,BAO_0000218,,,,A,17596,10116.0,50597,Plasma clearance at 10 mg/kg in rat upon intravenous administration,1,N,10576,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626265,,BAO_0000218,,,,A,2713,10116.0,50597,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,1,N,10577,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626266,1969.0,BAO_0000218,,,,A,12500,10116.0,50597,The compound was tested for plasma clearance in rat,1,N,10578,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626267,1969.0,BAO_0000218,,,,A,12500,10116.0,50597,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,1,N,10579,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626268,,BAO_0000218,,,,A,2713,10116.0,50597,Plasma concentration upon oral administration of 1 mg/Kg in rats,1,N,10580,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626269,,BAO_0000218,,,,A,1446,10116.0,50597,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,1,N,10581,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626270,,BAO_0000218,,,,A,6227,10116.0,50597,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,1,N,10582,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626271,,BAO_0000218,,,,A,4709,10116.0,50597,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,1,N,10583,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626272,,BAO_0000218,,,,A,5510,10116.0,50597,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",1,N,10584,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626273,,BAO_0000218,,,,A,5510,10116.0,50597,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",1,N,10585,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL875346,,BAO_0000218,,,,A,5510,10116.0,50597,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",1,N,10586,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626274,,BAO_0000218,,,,A,5510,10116.0,50597,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",1,N,10587,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626275,,BAO_0000218,,,,A,4514,10116.0,50597,Compound was tested for protein binding in rat plasma,1,N,10588,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624646,,BAO_0000218,,,,A,2713,10116.0,50597,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,1,N,10589,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624647,,BAO_0000218,,,,A,2713,10116.0,50597,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,1,N,10590,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624648,2107.0,BAO_0000218,,,,A,5340,10116.0,50597,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,1,N,10591,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL624649,,BAO_0000218,,,,A,12058,10116.0,50597,Area under curve ratio was determined (po/iv) in rat,1,N,10592,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624650,,BAO_0000218,,,,A,11195,10116.0,50597,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,1,N,10593,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624651,,BAO_0000218,,,,A,11195,10116.0,50597,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,1,N,10594,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624652,,BAO_0000218,,,,A,11195,10116.0,50597,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,1,N,10595,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624653,,BAO_0000218,,,,A,6495,10116.0,50597,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,1,N,10596,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624654,,BAO_0000218,,,,A,6078,10116.0,50597,Ratio of AUCbrain to AUCplasma,1,N,10597,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624655,,BAO_0000218,,,,A,5656,10116.0,50597,Ratio of brain to plasma,1,N,10598,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624656,,BAO_0000218,,,,A,4910,10116.0,50597,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,1,N,10599,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624657,,BAO_0000218,,,,A,4910,10116.0,50597,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,1,N,10600,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624658,,BAO_0000218,,,,A,4910,10116.0,50597,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,1,N,10601,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624659,,BAO_0000218,,,,A,10130,10116.0,50597,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,1,N,10602,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624660,,BAO_0000218,,,,A,10130,10116.0,50597,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,1,N,10603,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624661,,BAO_0000218,,,,A,10130,10116.0,50597,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,1,N,10604,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624662,,BAO_0000218,,,,A,5213,10116.0,50597,Steady state brain :blood ratio was determined,1,N,10605,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625199,,BAO_0000218,,,,A,4910,10116.0,50597,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,1,N,10606,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625200,,BAO_0000218,,,,A,4910,10116.0,50597,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,1,N,10607,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625201,,BAO_0000218,,,,A,4910,10116.0,50597,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,1,N,10608,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625202,,BAO_0000218,,,,A,4910,10116.0,50597,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,1,N,10609,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625203,,BAO_0000218,,,,A,2083,10116.0,50597,Percentage recovery after 3h incubation with rat hapatocytes was determined,1,N,10610,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625204,,BAO_0000218,,,,A,2082,10116.0,50597,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,1,N,10611,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625205,,BAO_0000218,,,,A,2082,10116.0,50597,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,1,N,10612,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625206,,BAO_0000218,,,,A,6351,10116.0,50597,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,1,N,10613,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625207,,BAO_0000019,,,,A,14583,,22224,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",1,U,10614,,,,0,,Autocuration
,,,CHEMBL625208,,BAO_0000019,,,,A,14583,,22224,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,1,U,10615,,,,0,,Autocuration
,495.0,,CHEMBL625209,,BAO_0000218,,,Caco-2,A,4608,9606.0,50587,In vivo absorption in Caco-2 cell line monolayers was determined,1,N,10616,,Homo sapiens,,1,,Intermediate
,,,CHEMBL625210,,BAO_0000100,,,,P,13668,,22229,Calculated partition coefficient (clogP),1,U,10617,,,,0,,Autocuration
,,,CHEMBL625211,,BAO_0000218,,,,A,5669,10116.0,50597,Area under curve was determine after peroral administration at 10 mpk in Rat,1,N,10618,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625212,,BAO_0000218,,,,A,5669,9544.0,50797,Area under curve was determine after peroral administration at 10 mpk in Rhesus,1,N,10619,,Macaca mulatta,,1,,Intermediate
,,,CHEMBL625213,,BAO_0000218,,,,A,5669,10116.0,50597,Area under curve was determine after peroral administration at 160 mpk in Rat,1,N,10620,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625214,,BAO_0000218,,,,A,5669,10116.0,50597,Area under curve was determine after peroral administration at 20 mpk in Rat,1,N,10621,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL874542,,BAO_0000218,,,,A,5669,10116.0,50597,Area under curve was determine after peroral administration at 50 mpk in Rat,1,N,10622,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625215,,BAO_0000100,,,,P,6472,,22229,Calculated partition coefficient (clogP) (AlogP),1,U,10623,,,,0,,Autocuration
,,,CHEMBL625216,,BAO_0000019,,,,A,15106,,22224,Activated partial thromboplastin time measured,1,U,10624,,,,0,,Autocuration
,,,CHEMBL625217,,BAO_0000100,,,,P,15207,,22224,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),1,U,10625,,,,0,,Autocuration
,,,CHEMBL625218,,BAO_0000100,,,,P,15207,,22224,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),1,U,10626,,,,0,,Autocuration
,,,CHEMBL622864,1969.0,BAO_0000218,,,,A,13941,9615.0,50588,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,1,N,10627,,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL622865,1969.0,BAO_0000218,,,,A,13941,10116.0,50597,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,1,N,10628,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622866,1969.0,BAO_0000218,,,,A,13941,10116.0,50597,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,1,N,10629,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622867,1969.0,BAO_0000218,,,,A,13941,9615.0,50588,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,1,N,10630,,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL876808,1969.0,BAO_0000218,,,,A,15240,10141.0,50512,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,1,N,10631,,Cavia porcellus,Plasma,1,,Intermediate
,,,CHEMBL627725,955.0,BAO_0000019,,,,A,10655,,22224,AUC in brain,1,U,10632,,,Brain,0,,Autocuration
,,,CHEMBL627726,1977.0,BAO_0000019,,,,A,10655,,22224,AUC in serum,1,U,10633,,,Serum,0,,Autocuration
,,,CHEMBL627727,1969.0,BAO_0000019,,,,A,6504,,22224,AUC was determined,1,U,10634,,,Plasma,0,,Autocuration
,,,CHEMBL627728,1969.0,BAO_0000019,,,,A,10615,,22224,AUC of the compound.,1,U,10635,,,Plasma,0,,Autocuration
,,,CHEMBL627729,1969.0,BAO_0000019,,,,A,10353,,22224,AUC value (0-4 hr),1,U,10636,,,Plasma,0,,Autocuration
,,,CHEMBL627730,1969.0,BAO_0000019,,,,A,14907,,22224,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",1,U,10637,,,Plasma,0,,Autocuration
,,,CHEMBL627731,1969.0,BAO_0000019,,,,A,14907,,22224,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,1,U,10638,,,Plasma,0,,Autocuration
,,,CHEMBL627732,1969.0,BAO_0000019,,,,A,14907,,22224,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",1,U,10639,,,Plasma,0,,Autocuration
,,,CHEMBL627733,1969.0,BAO_0000019,,,,A,14907,,22224,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",1,U,10640,,,Plasma,0,,Autocuration
,,,CHEMBL627734,1969.0,BAO_0000218,,,,A,16359,10116.0,50597,AUC(area under curve) was determined after intravenous administration in rats,1,N,10641,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL627735,1969.0,BAO_0000218,,,,A,16359,10116.0,50597,AUC(area under curve) was determined after oral administration in rats,1,N,10642,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL627736,1969.0,BAO_0000218,,,,A,15240,10141.0,50512,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,1,N,10643,,Cavia porcellus,Plasma,1,,Intermediate
,,,CHEMBL876809,1969.0,BAO_0000218,,,,A,15240,10116.0,50597,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,1,N,10644,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL627737,,BAO_0000019,,,,A,15469,,22224,Area Under Curve after oral dosing of 100 uM/Kg,1,U,10645,,,,0,,Autocuration
,,,CHEMBL627738,,BAO_0000019,,,,A,15469,,22224,Area Under Curve after oral dosing of 30 uM/Kg,1,U,10646,,,,0,,Autocuration
,,,CHEMBL627739,,BAO_0000019,,,,A,13520,,22224,Area Under Curve was measured by ploting the graph between concentration verses time,1,U,10647,,,,0,,Autocuration
,,,CHEMBL626143,,BAO_0000218,,,,A,17025,9615.0,50588,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,1,N,10648,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626144,,BAO_0000218,,,,A,17025,314293.0,22224,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,1,U,10649,,Simiiformes,,0,,Autocuration
,,,CHEMBL626145,,BAO_0000218,,,,A,17025,9986.0,50592,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,1,N,10650,,Oryctolagus cuniculus,,1,,Intermediate
,,,CHEMBL626146,,BAO_0000218,,,,A,17025,10116.0,50597,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,1,N,10651,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626147,178.0,BAO_0000218,,,,A,12032,10116.0,50597,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,1,N,10652,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL626148,,BAO_0000019,,,,A,10291,,22224,Area under curve (AUC) was determined,1,U,10653,,,,0,,Autocuration
,,,CHEMBL626149,,BAO_0000218,,,,A,5767,,22224,Area under curve (AUC) following ip administration at 1 mg/kg,1,U,10654,,,,0,,Autocuration
,,,CHEMBL626150,,BAO_0000019,,,,A,1434,,22224,Area under curve (AUC) was determined; ND is Not determined,1,U,10655,,,,0,,Autocuration
,,,CHEMBL626151,,BAO_0000218,,,,A,14925,9615.0,50588,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,1,N,10656,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626152,,BAO_0000218,,,,A,14925,9615.0,50588,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,1,N,10657,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626153,,BAO_0000218,,,,A,14925,9615.0,50588,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,1,N,10658,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626154,,BAO_0000019,,,,A,1434,,22224,Area under curve (AUR) was determined,1,U,10659,,,,0,,Autocuration
,,,CHEMBL626155,,BAO_0000019,,,,A,11883,,22224,Area under curve at 1 uM/dg administered intravenously,1,U,10660,,,,0,,Autocuration
,,,CHEMBL626156,,BAO_0000019,,,,A,11883,,22224,Area under curve at 10 uM/dg administered perorally,1,U,10661,,,,0,,Autocuration
,,,CHEMBL626157,,BAO_0000019,,,,A,11883,,22224,Area under curve at 2 uM/dg administered intravenously,1,U,10662,,,,0,,Autocuration
,,,CHEMBL626158,,BAO_0000019,,,,A,11883,,22224,Area under curve at 20 uM/dg administered perorally,1,U,10663,,,,0,,Autocuration
,,,CHEMBL626159,,BAO_0000218,,,,A,15233,9615.0,50588,Area under curve at a peroral dose of 3 mg/kg in dog,1,N,10664,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626160,,BAO_0000218,,,,A,15233,10116.0,50597,Area under curve at a peroral dose of 3 mg/kg in rat,1,N,10665,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626161,,BAO_0000218,,,,A,15233,9615.0,50588,Area under curve at an iv dose of 1 mg/kg in dog,1,N,10666,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626162,,BAO_0000218,,,,A,15233,10116.0,50597,Area under curve at an iv dose of 1 mg/kg in rat,1,N,10667,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626163,,BAO_0000019,,,,A,12978,,22224,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,1,U,10668,,,,0,,Autocuration
,,,CHEMBL626164,,BAO_0000019,,,,A,12978,,22224,Area under curve gives the effective duration for the angiotensin II antagonist effect.,1,U,10669,,,,0,,Autocuration
,,,CHEMBL626165,,BAO_0000218,,,,A,11355,10090.0,50594,Area under curve measured as conc vs time after intravenous administration to mice.,1,N,10670,,Mus musculus,,1,,Intermediate
,,,CHEMBL626166,,BAO_0000218,,,,A,11355,10090.0,50594,Area under curve measured as conc vs time after peroral administration to mice.,1,N,10671,,Mus musculus,,1,,Intermediate
,,,CHEMBL626167,,BAO_0000218,,,,A,12923,9615.0,50588,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,1,N,10672,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626168,,BAO_0000218,,,,A,12923,9615.0,50588,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,1,N,10673,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL877463,,BAO_0000218,,,,A,12923,9615.0,50588,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,1,N,10674,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626169,,BAO_0000218,,,,A,12923,9615.0,50588,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,1,N,10675,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626170,948.0,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,1,N,10676,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL626171,948.0,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,1,N,10677,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL626172,948.0,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,1,N,10678,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL626173,948.0,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,1,N,10679,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL626174,2113.0,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,1,N,10680,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL626175,2113.0,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,1,N,10681,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL626176,2113.0,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,1,N,10682,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL626177,2113.0,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,1,N,10683,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL622499,2113.0,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,1,N,10684,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL622500,2107.0,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,1,N,10685,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622501,2107.0,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,1,N,10686,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622502,2107.0,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,1,N,10687,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622503,2107.0,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,1,N,10688,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL877614,2107.0,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,1,N,10689,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL624839,2048.0,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,1,N,10690,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL624840,2048.0,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,1,N,10691,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL624841,2048.0,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,1,N,10692,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL624842,2048.0,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,1,N,10693,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL624843,2385.0,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,1,N,10694,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL624844,2385.0,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,1,N,10695,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL624845,2385.0,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,1,N,10696,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL621904,2385.0,BAO_0000218,,,,A,17738,10116.0,50597,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,1,N,10697,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL621905,178.0,BAO_0000218,,,,A,11195,10116.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,1,N,10698,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL874382,178.0,BAO_0000218,,,,A,11195,10116.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,1,N,10699,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL621906,178.0,BAO_0000218,,,,A,11195,10116.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,1,N,10700,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL621907,955.0,BAO_0000218,,,,A,11195,10116.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,1,N,10701,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL622096,955.0,BAO_0000218,,,,A,11195,10116.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,1,N,10702,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL622097,955.0,BAO_0000218,,,,A,11195,10116.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,1,N,10703,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL622098,948.0,BAO_0000218,,,,A,11195,10116.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,1,N,10704,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL622099,948.0,BAO_0000218,,,,A,11195,10116.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,1,N,10705,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL622100,948.0,BAO_0000218,,,,A,11195,10116.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,1,N,10706,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL622101,2113.0,BAO_0000218,,,,A,11195,10116.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,1,N,10707,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL622102,2113.0,BAO_0000218,,,,A,11195,10116.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,1,N,10708,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL622103,2113.0,BAO_0000218,,,,A,11195,10116.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,1,N,10709,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL622104,2107.0,BAO_0000218,,,,A,11195,10116.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,1,N,10710,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622105,2107.0,BAO_0000218,,,,A,11195,10116.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,1,N,10711,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622106,2107.0,BAO_0000218,,,,A,11195,10116.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,1,N,10712,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622107,2048.0,BAO_0000218,,,,A,11195,10116.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,1,N,10713,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL622108,2048.0,BAO_0000218,,,,A,11195,10116.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,1,N,10714,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL622109,2048.0,BAO_0000218,,,,A,11195,10116.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,1,N,10715,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL622110,2385.0,BAO_0000218,,,,A,11195,10116.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,1,N,10716,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL622111,2385.0,BAO_0000218,,,,A,11195,10116.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,1,N,10717,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL874383,2385.0,BAO_0000218,,,,A,11195,10116.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,1,N,10718,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL622112,14.0,BAO_0000218,,,,A,11195,10116.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,1,N,10719,In vivo,Rattus norvegicus,Zone of skin,1,,Intermediate
,,,CHEMBL622113,14.0,BAO_0000218,,,,A,11195,10116.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,1,N,10720,In vivo,Rattus norvegicus,Zone of skin,1,,Intermediate
,,,CHEMBL622114,14.0,BAO_0000218,,,,A,11195,10116.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,1,N,10721,In vivo,Rattus norvegicus,Zone of skin,1,,Intermediate
,,,CHEMBL622115,2106.0,BAO_0000218,,,,A,11195,10116.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,1,N,10722,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL622116,2106.0,BAO_0000218,,,,A,11195,10116.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,1,N,10723,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL622117,,BAO_0000218,,,,A,6193,10116.0,50597,Oral bioavailability in rat,1,N,10724,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622118,,BAO_0000218,,,,A,6803,10116.0,50597,Oral bioavailability in rat,1,N,10725,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622119,,BAO_0000218,,,,A,6647,10116.0,50597,Oral bioavailability in rats at 6 mg/kg,1,N,10726,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622120,,BAO_0000218,,,,A,6647,10116.0,50597,Oral bioavailability in rat (dose 6 mg/kg),1,N,10727,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622121,,BAO_0000218,,,,A,6647,10116.0,50597,Oral bioavailability in rats at 6 mg/kg dose; Not tested,1,N,10728,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622122,,BAO_0000218,,,,A,6640,10116.0,50597,Oral bioavailability in rat,1,N,10729,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622123,,BAO_0000218,,,,A,6641,10116.0,50597,Oral bioavailability in rat,1,N,10730,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622124,,BAO_0000218,,,,A,6641,10116.0,50597,Oral bioavailability in rat,1,N,10731,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622125,,BAO_0000218,,,,A,6642,10116.0,50597,Bioavailability in rat,1,N,10732,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622126,,BAO_0000218,,,,A,5472,10116.0,50597,Oral bioavailability,1,N,10733,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620455,,BAO_0000218,,,,A,6141,10116.0,50597,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),1,N,10734,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620456,,BAO_0000218,,,,A,4390,10116.0,50597,Oral bioavailability in rat,1,N,10735,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620457,,BAO_0000218,,,,A,5472,10116.0,50597,Oral bioavailability in rat,1,N,10736,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620458,,BAO_0000218,,,,A,5472,10116.0,50597,Oral bioavailability was evaluated; Not tested,1,N,10737,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620459,,BAO_0000218,,,,A,5438,10116.0,50597,Oral bioavailability,1,N,10738,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620460,,BAO_0000218,,,,A,4883,10116.0,50597,Oral bioavailability in rat by oral dosing,1,N,10739,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620461,,BAO_0000218,,,,A,1908,10116.0,50597,Oral bioavailability in rat (dose 10 mg/kg p.o.),1,N,10740,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620462,,BAO_0000218,,,,A,4853,10116.0,50597,Oral bioavailability in rat (Sprague-Dawley),1,N,10741,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620463,,BAO_0000218,,,,A,4853,10116.0,50597,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),1,N,10742,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620464,,BAO_0000218,,,,A,4853,10116.0,50597,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),1,N,10743,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620465,,BAO_0000218,,,,A,4853,10116.0,50597,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),1,N,10744,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620466,,BAO_0000218,,,,A,4853,10116.0,50597,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),1,N,10745,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620467,,BAO_0000218,,,,A,4853,10116.0,50597,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,1,N,10746,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620468,,BAO_0000218,,,,A,4853,10116.0,50597,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,1,N,10747,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620469,,BAO_0000218,,,,A,12873,10116.0,50597,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,1,N,10748,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620470,,BAO_0000218,,,,A,12873,10116.0,50597,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,1,N,10749,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620471,,BAO_0000218,,,,A,3169,10116.0,50597,Oral bioavailability in rat,1,N,10750,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620472,,BAO_0000218,,,,A,6305,10116.0,50597,Oral bioavailability in rat,1,N,10751,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620473,,BAO_0000218,,,,A,4762,10116.0,50597,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,1,N,10752,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620474,,BAO_0000218,,,,A,17847,10116.0,50597,Oral bioavailability in rat,1,N,10753,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620475,,BAO_0000218,,,,A,6211,10116.0,50597,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),1,N,10754,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620476,,BAO_0000218,,,,A,6011,10116.0,50597,Oral bioavailability in rat,1,N,10755,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620477,,BAO_0000218,,,,A,6317,10116.0,50597,Oral bioavailability in rat,1,N,10756,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL620478,,BAO_0000218,,,,A,6644,10116.0,50597,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,1,N,10757,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618768,,BAO_0000218,,,,A,6644,10116.0,50597,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,1,N,10758,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618769,,BAO_0000218,,,,A,6644,10116.0,50597,Oral bioavailability in rat after oral administration at 13 mg/kg dose,1,N,10759,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618770,,BAO_0000218,,,,A,6644,10116.0,50597,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,1,N,10760,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618771,,BAO_0000218,,,,A,6113,10116.0,50597,Oral bioavailability (dose 20 mg/kg p.o.),1,N,10761,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618772,,BAO_0000218,,,,A,5937,10116.0,50597,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,1,N,10762,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618773,,BAO_0000218,,,,A,5711,10116.0,50597,Oral bioavailability in rat at 10 mg/kg of the compound,1,N,10763,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL875842,,BAO_0000218,,,,A,17717,10116.0,50597,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,1,N,10764,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618774,,BAO_0000218,,,,A,17717,10116.0,50597,Bioavailability in rat (dose 3 mg/kg i.v.),1,N,10765,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618775,,BAO_0000218,,,,A,17717,10116.0,50597,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,1,N,10766,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618776,,BAO_0000218,,,,A,17717,10116.0,50597,Oral bioavailability in rat (dose 60 mg/kg p.o.),1,N,10767,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618777,,BAO_0000218,,,,A,4722,10116.0,50597,Percent bioavailability (F) in rats after iv administration,1,N,10768,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618778,,BAO_0000218,,,,A,4722,10116.0,50597,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,1,N,10769,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618779,,BAO_0000218,,,,A,4353,10116.0,50597,Bioavailability in rat (dose 5 uM/kg p.o.),1,N,10770,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618780,,BAO_0000218,,,,A,15662,10116.0,50597,Oral bioavailability,1,N,10771,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618781,,BAO_0000218,,,,A,4756,10116.0,50597,Bioavailability in rat (dose 2 mg/kg p.o.),1,N,10772,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618782,,BAO_0000218,,,,A,4756,10116.0,50597,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,1,N,10773,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618783,,BAO_0000218,,,,A,3436,10116.0,50597,Oral bioavailability in rat (dose 20 mg/kg),1,N,10774,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618784,,BAO_0000218,,,,A,17800,10116.0,50597,Oral bioavailability in rat,1,N,10775,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618785,,BAO_0000218,,,,A,15762,10116.0,50597,Percent oral bioavailability evaluated in rat,1,N,10776,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618786,,BAO_0000218,,,,A,5089,10116.0,50597,Oral bioavailability in rat,1,N,10777,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618787,,BAO_0000218,,,,A,5089,10116.0,50597,Percent oral bioavailability in rat; Not determined,1,N,10778,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618788,,BAO_0000218,,,,A,3185,10116.0,50597,Oral bioavailability in rat,1,N,10779,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618789,,BAO_0000218,,,,A,5145,10116.0,50597,Bioavailability in rat,1,N,10780,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618790,,BAO_0000218,,,,A,3457,10116.0,50597,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),1,N,10781,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618791,,BAO_0000218,,,,A,3457,10116.0,50597,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),1,N,10782,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL875843,,BAO_0000218,,,,A,5983,10116.0,50597,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,1,N,10783,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL618792,,BAO_0000218,,,,A,5739,10116.0,50597,Oral bioavailability in rat (dose 20 mg/kg p.o.),1,N,10784,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623395,,BAO_0000218,,,,A,3579,10116.0,50597,Cmax at a dose of 30 mg/kg in rat,1,N,10785,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623396,,BAO_0000218,,,,A,17788,314293.0,22224,Cmax in monkeys at a dose of 1 mg/kg,1,U,10786,In vivo,Simiiformes,,0,,Autocuration
,,,CHEMBL623397,,BAO_0000218,,,,A,14956,10116.0,50597,Cmax in rat,1,N,10787,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623398,,BAO_0000218,,,,A,17788,10116.0,50597,Cmax in rats at a dose of 1 mg/kg,1,N,10788,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623399,,BAO_0000218,,,,A,9750,10090.0,50594,Cmax was measured in mice after an oral dose of 50 mg/kg.,1,N,10789,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL623400,,BAO_0000218,,,,A,12767,,22224,"Cmax value at a dose of 12.7 uM/kg, po",1,U,10790,In vivo,,,0,,Autocuration
,,,CHEMBL623401,,BAO_0000218,,,,A,12767,,22224,"Cmax value at a dose of 6.3 uM/kg, iv",1,U,10791,In vivo,,,0,,Autocuration
,,,CHEMBL623402,,BAO_0000218,,,,A,12767,,22224,"Cmax value at a dose of 7.1 uM/kg, iv",1,U,10792,In vivo,,,0,,Autocuration
,,,CHEMBL623403,,BAO_0000218,,,,A,12703,,22224,Cmax value of compound was determined after 1 hr,1,U,10793,In vivo,,,0,,Autocuration
,,,CHEMBL623404,,BAO_0000218,,,,A,15778,,22224,Cmax value of the compound,1,U,10794,In vivo,,,0,,Autocuration
,,,CHEMBL625997,,BAO_0000218,,,,A,12818,10116.0,50597,Cmax value administered intraintestinal in rats.,1,N,10795,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625998,,BAO_0000218,,,,A,14964,10116.0,50597,Cmax value administered perorally was determined in rat; Not determined,1,N,10796,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625999,,BAO_0000218,,,,A,15808,,22224,Cmax value at the dose of 2.3 mg/kg,1,U,10797,In vivo,,,0,,Autocuration
,,,CHEMBL626000,,BAO_0000218,,,,A,15808,,22224,Cmax value at the dose of 5 mg/kg,1,U,10798,In vivo,,,0,,Autocuration
,,,CHEMBL626001,,BAO_0000218,,,,A,15778,,22224,Cmax value in the period of 8 hr after dosing. ,1,U,10799,In vivo,,,0,,Autocuration
,,,CHEMBL626002,,BAO_0000218,,,,A,3715,,22224,Cmax value at a oral dose of 20 mg/kg; Not tested,1,U,10800,In vivo,,,0,,Autocuration
,,,CHEMBL626003,,BAO_0000218,,,,A,3715,,22224,Cmax value at a oral dose of 20 mg/kg,1,U,10801,In vivo,,,0,,Autocuration
,,,CHEMBL626004,,BAO_0000218,,,,A,1446,10116.0,50597,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,1,N,10802,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626005,,BAO_0000218,,,,A,15240,10141.0,50512,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,1,N,10803,In vivo,Cavia porcellus,,1,,Intermediate
,,,CHEMBL626006,,BAO_0000218,,,,A,15240,10116.0,50597,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,1,N,10804,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626007,1969.0,BAO_0000218,,,,A,14810,10116.0,50597,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,1,N,10805,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626008,1969.0,BAO_0000218,,,,A,14239,10090.0,50594,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,1,N,10806,In vivo,Mus musculus,Plasma,1,,Intermediate
,,,CHEMBL626009,2107.0,BAO_0000218,,,,A,12555,9615.0,50588,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,1,N,10807,In vivo,Canis lupus familiaris,Liver,1,,Intermediate
,,,CHEMBL626010,,BAO_0000218,,,,A,10754,9615.0,50588,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,1,N,10808,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626011,178.0,BAO_0000218,,,,A,10754,10090.0,50594,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,1,N,10809,In vivo,Mus musculus,Blood,1,,Intermediate
,,,CHEMBL626012,178.0,BAO_0000218,,,,A,10754,10090.0,50594,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,1,N,10810,In vivo,Mus musculus,Blood,1,,Intermediate
,,,CHEMBL626013,178.0,BAO_0000218,,,,A,10754,10090.0,50594,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,1,N,10811,In vivo,Mus musculus,Blood,1,,Intermediate
,,,CHEMBL626014,178.0,BAO_0000218,,,,A,10754,10090.0,50594,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,1,N,10812,In vivo,Mus musculus,Blood,1,,Intermediate
,,,CHEMBL877496,178.0,BAO_0000218,,,,A,10754,10090.0,50594,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,1,N,10813,In vivo,Mus musculus,Blood,1,,Intermediate
,,,CHEMBL626015,,BAO_0000218,,,,F,14600,9615.0,50588,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,1,N,10814,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626016,,BAO_0000218,,,,F,14600,9615.0,50588,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,1,N,10815,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626017,,BAO_0000218,,,,F,14600,9615.0,50588,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,1,N,10816,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626018,1969.0,BAO_0000218,,,,A,13543,9615.0,50588,Bioavailability as maximal plasma concentration in dogs,1,N,10817,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL626692,1969.0,BAO_0000218,,,,A,13543,9615.0,50588,Bioavailability as maximal plasma concentration in dogs,1,N,10818,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL626693,1969.0,BAO_0000218,,,,A,13543,10116.0,50597,Bioavailability as maximal plasma concentration in rats,1,N,10819,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626694,1969.0,BAO_0000218,,,,A,13543,10116.0,22224,Bioavailability as maximal plasma concentration in rats,1,U,10820,In vivo,Rattus norvegicus,Plasma,0,,Autocuration
,,,CHEMBL626695,178.0,BAO_0000218,,,,A,14600,9615.0,50588,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,1,N,10821,In vivo,Canis lupus familiaris,Blood,1,,Intermediate
,,,CHEMBL626696,178.0,BAO_0000218,,,,A,14600,9615.0,50588,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,1,N,10822,In vivo,Canis lupus familiaris,Blood,1,,Intermediate
,,,CHEMBL626697,178.0,BAO_0000218,,,,A,14600,9615.0,50588,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,1,N,10823,In vivo,Canis lupus familiaris,Blood,1,,Intermediate
,,,CHEMBL626859,178.0,BAO_0000218,,,,A,14600,9615.0,50588,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,1,N,10824,In vivo,Canis lupus familiaris,Blood,1,,Intermediate
,,,CHEMBL626860,178.0,BAO_0000218,,,,A,14600,9615.0,50588,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,1,N,10825,In vivo,Canis lupus familiaris,Blood,1,,Intermediate
,,,CHEMBL626861,178.0,BAO_0000218,,,,A,14600,9615.0,50588,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,1,N,10826,In vivo,Canis lupus familiaris,Blood,1,,Intermediate
,,,CHEMBL626296,,BAO_0000218,,,,A,14681,10116.0,50597,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,1,N,10827,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626297,,BAO_0000218,,,,A,15905,,22224,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,1,U,10828,In vivo,,,0,,Autocuration
,,,CHEMBL626298,1969.0,BAO_0000218,,,,A,15905,,22224,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,1,U,10829,In vivo,,Plasma,0,,Autocuration
,,,CHEMBL626299,1969.0,BAO_0000218,,,,A,13304,10116.0,50597,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",1,N,10830,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626300,1969.0,BAO_0000218,,,,A,15137,10116.0,50597,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,1,N,10831,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626301,1969.0,BAO_0000218,,,,A,15137,10116.0,50597,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,1,N,10832,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626962,1969.0,BAO_0000218,,,,A,15137,10116.0,50597,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,1,N,10833,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626963,1969.0,BAO_0000218,,,,A,15137,10116.0,50597,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,1,N,10834,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626964,1969.0,BAO_0000218,,,,A,15137,10116.0,50597,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,1,N,10835,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626965,1969.0,BAO_0000218,,,,A,14839,9541.0,100710,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,1,N,10836,In vivo,Macaca fascicularis,Plasma,1,,Intermediate
,,,CHEMBL626966,1969.0,BAO_0000218,,,,A,14839,10090.0,50594,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,1,N,10837,In vivo,Mus musculus,Plasma,1,,Intermediate
,,,CHEMBL626967,1969.0,BAO_0000218,,,,A,14839,10090.0,50594,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,1,N,10838,In vivo,Mus musculus,Plasma,1,,Intermediate
,,,CHEMBL626968,1969.0,BAO_0000218,,,,A,14839,9541.0,100710,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,1,N,10839,In vivo,Macaca fascicularis,Plasma,1,,Intermediate
,,,CHEMBL626969,948.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,1,N,10840,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL627126,948.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,1,N,10841,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL631276,948.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,1,N,10842,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL631277,948.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,1,N,10843,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL631278,948.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,1,N,10844,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL874457,948.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,1,N,10845,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL631279,948.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,1,N,10846,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL631280,948.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,1,N,10847,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL631281,948.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,1,N,10848,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL631968,948.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,1,N,10849,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL631969,948.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,1,N,10850,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL631970,948.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,1,N,10851,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL631971,948.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,1,N,10852,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL631972,948.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,1,N,10853,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL630435,948.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,1,N,10854,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL630436,948.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,1,N,10855,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL630437,948.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,1,N,10856,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL630438,948.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,1,N,10857,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL630439,948.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,1,N,10858,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL630440,2113.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,1,N,10859,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL630441,2113.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,1,N,10860,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL630442,2113.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,1,N,10861,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL625234,2113.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,1,N,10862,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL625235,2113.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,1,N,10863,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL625236,2113.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,1,N,10864,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL625237,2113.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,1,N,10865,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL626125,2113.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,1,N,10866,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL626126,2113.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,1,N,10867,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL626127,2113.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,1,N,10868,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL626128,2113.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,1,N,10869,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL626129,2113.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,1,N,10870,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL626130,2113.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,1,N,10871,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL626131,2113.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,1,N,10872,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL626132,2113.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,1,N,10873,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL626752,2113.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,1,N,10874,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL626753,2113.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,1,N,10875,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL626754,2113.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,1,N,10876,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL626755,2113.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,1,N,10877,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL626756,2107.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,1,N,10878,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL626757,2107.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,1,N,10879,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL626758,2107.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,1,N,10880,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL626759,2107.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,1,N,10881,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL626760,2107.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,1,N,10882,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL626394,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),1,N,10883,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626395,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,1,N,10884,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626396,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),1,N,10885,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626397,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),1,N,10886,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626398,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),1,N,10887,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626399,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),1,N,10888,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL874653,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,1,N,10889,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626400,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),1,N,10890,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626401,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),1,N,10891,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626402,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),1,N,10892,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626403,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),1,N,10893,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626404,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),1,N,10894,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626405,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,1,N,10895,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625529,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),1,N,10896,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625530,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),1,N,10897,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625531,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),1,N,10898,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625532,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),1,N,10899,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625533,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),1,N,10900,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL875474,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,1,N,10901,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625534,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),1,N,10902,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625535,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),1,N,10903,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625536,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),1,N,10904,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625537,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),1,N,10905,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625538,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),1,N,10906,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625539,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,1,N,10907,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625540,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),1,N,10908,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625541,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),1,N,10909,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625542,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),1,N,10910,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625543,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),1,N,10911,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625544,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),1,N,10912,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625545,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,1,N,10913,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625546,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),1,N,10914,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625547,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,1,N,10915,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625548,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),1,N,10916,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625549,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),1,N,10917,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625550,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),1,N,10918,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625551,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),1,N,10919,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL875475,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),1,N,10920,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625552,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),1,N,10921,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625553,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),1,N,10922,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625554,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),1,N,10923,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625555,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),1,N,10924,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625556,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),1,N,10925,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624986,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,1,N,10926,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624987,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),1,N,10927,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624988,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),1,N,10928,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624989,1637.0,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,1,N,10929,In vivo,Canis lupus familiaris,Artery,1,,Intermediate
,,,CHEMBL624990,1637.0,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,1,N,10930,In vivo,Canis lupus familiaris,Artery,1,,Intermediate
,,,CHEMBL874391,1637.0,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,1,N,10931,In vivo,Canis lupus familiaris,Artery,1,,Intermediate
,,,CHEMBL624991,1637.0,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,1,N,10932,In vivo,Canis lupus familiaris,Artery,1,,Intermediate
,,,CHEMBL624992,1637.0,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,1,N,10933,In vivo,Canis lupus familiaris,Artery,1,,Intermediate
,,,CHEMBL624993,1637.0,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,1,N,10934,In vivo,Canis lupus familiaris,Artery,1,,Intermediate
,,,CHEMBL624994,1637.0,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,1,N,10935,In vivo,Canis lupus familiaris,Artery,1,,Intermediate
,,,CHEMBL624995,1637.0,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,1,N,10936,In vivo,Canis lupus familiaris,Artery,1,,Intermediate
,,,CHEMBL624996,1637.0,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,1,N,10937,In vivo,Canis lupus familiaris,Artery,1,,Intermediate
,,,CHEMBL624997,1637.0,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,1,N,10938,In vivo,Canis lupus familiaris,Artery,1,,Intermediate
,,,CHEMBL624998,1637.0,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,1,N,10939,In vivo,Canis lupus familiaris,Artery,1,,Intermediate
,,,CHEMBL624999,1637.0,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,1,N,10940,In vivo,Canis lupus familiaris,Artery,1,,Intermediate
,,,CHEMBL882955,1637.0,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,1,N,10941,In vivo,Canis lupus familiaris,Artery,1,,Intermediate
,,,CHEMBL625000,1637.0,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,1,N,10942,In vivo,Canis lupus familiaris,Artery,1,,Intermediate
,,,CHEMBL625001,1637.0,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,1,N,10943,In vivo,Canis lupus familiaris,Artery,1,,Intermediate
,,,CHEMBL625089,1637.0,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,1,N,10944,In vivo,Canis lupus familiaris,Artery,1,,Intermediate
,,,CHEMBL625090,1637.0,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,1,N,10945,In vivo,Canis lupus familiaris,Artery,1,,Intermediate
,,,CHEMBL625091,1637.0,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,1,N,10946,In vivo,Canis lupus familiaris,Artery,1,,Intermediate
,,,CHEMBL625092,1637.0,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,1,N,10947,In vivo,Canis lupus familiaris,Artery,1,,Intermediate
,,,CHEMBL625093,1637.0,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,1,N,10948,In vivo,Canis lupus familiaris,Artery,1,,Intermediate
,,,CHEMBL625094,1637.0,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,1,N,10949,In vivo,Canis lupus familiaris,Artery,1,,Intermediate
,,,CHEMBL625095,1637.0,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,1,N,10950,In vivo,Canis lupus familiaris,Artery,1,,Intermediate
,,,CHEMBL625096,,BAO_0000218,,,,A,2249,9615.0,50588,Compound was evaluated for its bioavailability in the dogs,1,N,10951,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625097,,BAO_0000218,,,,A,2249,10116.0,50597,Compound was evaluated for its bioavailability in the rats,1,N,10952,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL882956,,BAO_0000218,,,,A,17515,,22224,Compound was evaluated for oral bioavailability,1,U,10953,In vivo,,,0,,Autocuration
,,,CHEMBL625098,,BAO_0000218,,,,A,14541,10116.0,50597,Compound was evaluated for percentage of Oral bioavailability in rats,1,N,10954,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625099,,BAO_0000218,,,,A,12797,10141.0,22224,Bioavailability in guinea pig,1,U,10955,In vivo,Cavia porcellus,,0,,Autocuration
,,,CHEMBL625100,,BAO_0000218,,,,A,12797,10116.0,50597,Compound was evaluated for the oral bioavailability in rat,1,N,10956,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625101,,BAO_0000218,,,,A,12797,9615.0,50588,Compound was evaluated for the oral bioavailability in dog,1,N,10957,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL874396,,BAO_0000218,,,,A,12797,10116.0,50597,Compound was evaluated for the oral bioavailability in rat,1,N,10958,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625102,,BAO_0000218,,,,F,11727,9615.0,22224,Bioavailability in dog (dosed i.v.),1,U,10959,In vivo,Canis lupus familiaris,,0,,Autocuration
,,,CHEMBL625103,,BAO_0000218,,,,A,13249,9615.0,50588,Compound was tested for in vivo bioavailability in dog,1,N,10960,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625104,,BAO_0000218,,,,A,13249,10026.0,100712,Compound was tested for in vivo bioavailability in hamsters,1,N,10961,In vivo,Cricetinae,,1,,Intermediate
,,,CHEMBL625105,,BAO_0000218,,,,A,13249,314293.0,22224,Compound was tested for in vivo bioavailability in monkey,1,U,10962,In vivo,Simiiformes,,0,,Autocuration
,,,CHEMBL625106,,BAO_0000218,,,,A,13249,10116.0,50597,Compound was tested for in vivo bioavailability in rat,1,N,10963,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625107,,BAO_0000218,,,,A,9552,10090.0,22224,Oral bioavailability in mouse,1,U,10964,In vivo,Mus musculus,,0,,Autocuration
,,,CHEMBL625108,,BAO_0000218,,,,A,9552,10090.0,50594,Compound was tested for percent of oral bioavailability in mice; 56-74,1,N,10965,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL625109,,BAO_0000218,,,,A,14839,10090.0,22224,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),1,U,10966,In vivo,Mus musculus,,0,,Autocuration
,,,CHEMBL625110,,BAO_0000218,,,,A,14839,9541.0,22224,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),1,U,10967,In vivo,Macaca fascicularis,,0,,Autocuration
,,,CHEMBL625111,,BAO_0000218,,,,A,14839,9541.0,22224,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),1,U,10968,In vivo,Macaca fascicularis,,0,,Autocuration
,,,CHEMBL625112,,BAO_0000218,,,,A,14839,10090.0,50594,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),1,N,10969,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL875334,,BAO_0000218,,,,A,14839,10090.0,50594,Oral bioavailability in nude mice,1,N,10970,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL628617,,BAO_0000218,,,,A,11219,9443.0,22224,Bioavailability in monkey (i.d. dosing),1,U,10971,In vivo,Primates,,0,,Autocuration
,,,CHEMBL628618,,BAO_0000218,,,,A,9552,10116.0,22224,Bioavailability in rat,1,U,10972,In vivo,Rattus norvegicus,,0,,Autocuration
,,,CHEMBL628619,,BAO_0000218,,,,A,11732,,22224,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,1,U,10973,In vivo,,,0,,Autocuration
,,,CHEMBL628620,,BAO_0000218,,,,A,11732,,22224,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,1,U,10974,In vivo,,,0,,Autocuration
,,,CHEMBL628621,,BAO_0000218,,,,A,14839,9541.0,100710,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",1,N,10975,In vivo,Macaca fascicularis,,1,,Intermediate
,,,CHEMBL628622,,BAO_0000218,,,,A,14839,9541.0,100710,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",1,N,10976,In vivo,Macaca fascicularis,,1,,Intermediate
,,,CHEMBL628623,,BAO_0000218,,,,A,14839,9541.0,100710,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",1,N,10977,In vivo,Macaca fascicularis,,1,,Intermediate
,,,CHEMBL628624,1969.0,BAO_0000218,,,,A,14839,9541.0,100710,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,1,N,10978,In vivo,Macaca fascicularis,Plasma,1,,Intermediate
,,,CHEMBL628625,1969.0,BAO_0000218,,,,A,14839,10090.0,50594,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,1,N,10979,In vivo,Mus musculus,Plasma,1,,Intermediate
,,,CHEMBL628626,1969.0,BAO_0000218,,,,A,14839,9541.0,100710,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,1,N,10980,In vivo,Macaca fascicularis,Plasma,1,,Intermediate
,,,CHEMBL627041,1969.0,BAO_0000218,,,,A,14839,10090.0,50594,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,1,N,10981,In vivo,Mus musculus,Plasma,1,,Intermediate
,,,CHEMBL627042,1969.0,BAO_0000218,,,,A,14839,10090.0,50594,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,1,N,10982,In vivo,Mus musculus,Plasma,1,,Intermediate
,,,CHEMBL627043,1969.0,BAO_0000218,,,,A,14839,10090.0,50594,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,1,N,10983,In vivo,Mus musculus,Plasma,1,,Intermediate
,,,CHEMBL627044,1969.0,BAO_0000218,,,,A,13932,,22224,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,1,U,10984,In vivo,,Plasma,0,,Autocuration
,,,CHEMBL627045,1969.0,BAO_0000218,,,,A,11637,10090.0,50594,Cmax in mouse plasma,1,N,10985,In vivo,Mus musculus,Plasma,1,,Intermediate
,,,CHEMBL627046,1969.0,BAO_0000218,,,,A,11637,,22224,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,1,U,10986,In vivo,,Plasma,0,,Autocuration
,,,CHEMBL627047,1969.0,BAO_0000218,,,,A,13960,10116.0,50597,Maximal plasma concentration in rat,1,N,10987,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL627048,1969.0,BAO_0000218,,,,A,15905,10116.0,50597,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,1,N,10988,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL627049,,BAO_0000218,,,,A,14062,10116.0,50597,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,1,N,10989,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627050,,BAO_0000218,,,,A,14062,10116.0,50597,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,1,N,10990,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627051,,BAO_0000218,,,,A,14062,10116.0,50597,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,1,N,10991,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627052,,BAO_0000218,,,,A,14062,10116.0,50597,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,1,N,10992,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627053,,BAO_0000218,,,,A,14062,10116.0,50597,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,1,N,10993,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627054,,BAO_0000218,,,,A,14062,10116.0,50597,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,1,N,10994,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627055,,BAO_0000218,,,,A,15011,10090.0,50594,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,1,N,10995,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL627056,,BAO_0000218,,,,A,15011,10090.0,50594,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,1,N,10996,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL627057,,BAO_0000218,,,,A,15011,10090.0,50594,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),1,N,10997,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL627058,,BAO_0000218,,,,A,15011,10090.0,50594,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,1,N,10998,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL626211,,BAO_0000218,,,,A,15011,10090.0,50594,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,1,N,10999,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL626212,,BAO_0000218,,,,A,10291,,22224,Maximum Concentration of the compound.,1,U,11000,In vivo,,,0,,Autocuration
,,,CHEMBL626213,,BAO_0000218,,,,A,14599,9615.0,50588,Maximum Concentration was measured after iv administration into Beagle dog,1,N,11001,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626214,,BAO_0000218,,,,A,14599,9615.0,50588,Maximum Concentration was measured after iv administration into Beagle dog.,1,N,11002,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626215,,BAO_0000218,,,,A,14599,9615.0,50588,Maximum Concentration was measured after po administration into Beagle dog,1,N,11003,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626216,,BAO_0000218,,,,A,14599,9615.0,50588,Maximum Concentration was measured after po administration into Beagle dog.,1,N,11004,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626217,178.0,BAO_0000218,,,,A,12767,,22224,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,1,U,11005,In vivo,,Blood,0,,Autocuration
,,,CHEMBL626218,178.0,BAO_0000218,,,,A,12767,,22224,Maximum blood level reached after an iv dose of 12.2 uM/kg,1,U,11006,In vivo,,Blood,0,,Autocuration
,,,CHEMBL626219,178.0,BAO_0000218,,,,A,12767,,22224,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,1,U,11007,In vivo,,Blood,0,,Autocuration
,,,CHEMBL626220,178.0,BAO_0000218,,,,A,12767,,22224,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,1,U,11008,In vivo,,Blood,0,,Autocuration
,,,CHEMBL626221,178.0,BAO_0000218,,,,A,12767,,22224,Maximum blood level reached after an oral dose of 5.0 mg/kg,1,U,11009,In vivo,,Blood,0,,Autocuration
,,,CHEMBL626222,178.0,BAO_0000218,,,,A,12767,,22224,Maximum blood level reached at dose of 10.6 uM/kg orally,1,U,11010,In vivo,,Blood,0,,Autocuration
,,,CHEMBL626223,,BAO_0000218,,,,A,14706,10141.0,50512,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,1,N,11011,In vivo,Cavia porcellus,,1,,Intermediate
,,,CHEMBL626224,,BAO_0000218,,,,A,14706,10141.0,50512,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,1,N,11012,In vivo,Cavia porcellus,,1,,Intermediate
,,,CHEMBL626225,955.0,BAO_0000218,,,,A,14793,10116.0,50597,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,1,N,11013,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL626226,955.0,BAO_0000218,,,,A,14793,10116.0,50597,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,1,N,11014,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL626227,955.0,BAO_0000218,,,,A,14793,10116.0,50597,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,1,N,11015,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL626228,955.0,BAO_0000218,,,,A,14793,10116.0,50597,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,1,N,11016,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL626229,,BAO_0000218,,,,A,14793,10116.0,50597,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,1,N,11017,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626921,,BAO_0000218,,,,A,14793,10116.0,50597,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,1,N,11018,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL876793,,BAO_0000218,,,,A,14793,10116.0,50597,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,1,N,11019,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625309,,BAO_0000218,,,,A,14793,10116.0,50597,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,1,N,11020,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625310,,BAO_0000218,,,,A,10524,1423.0,50278,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),1,N,11021,In vivo,Bacillus subtilis,,1,,Intermediate
,,,CHEMBL625311,,BAO_0000218,,,,A,11871,314293.0,22224,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,1,U,11022,In vivo,Simiiformes,,0,,Autocuration
,,,CHEMBL625312,,BAO_0000218,,,,A,11871,10116.0,50597,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,1,N,11023,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625313,,BAO_0000218,,,,A,3437,,22224,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,1,U,11024,In vivo,,,0,,Autocuration
,,,CHEMBL625314,,BAO_0000218,,,,A,12038,10090.0,50594,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,1,N,11025,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL625315,,BAO_0000218,,,,A,12038,10116.0,50597,Maximum concentration in male rats after iv administration of 20 mg/kg,1,N,11026,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625316,2107.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,1,N,11027,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625317,2107.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,1,N,11028,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625318,2107.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,1,N,11029,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625319,2107.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,1,N,11030,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625320,2107.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,1,N,11031,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625321,2107.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,1,N,11032,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625322,2107.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,1,N,11033,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL876801,2107.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,1,N,11034,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625323,2107.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,1,N,11035,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625324,2107.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,1,N,11036,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625325,2107.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,1,N,11037,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625326,2107.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,1,N,11038,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625327,2107.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,1,N,11039,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625328,2107.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,1,N,11040,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625329,2048.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,1,N,11041,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL625330,2048.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,1,N,11042,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627774,2048.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,1,N,11043,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627775,2048.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,1,N,11044,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627949,2048.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,1,N,11045,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627950,2048.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,1,N,11046,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627951,2048.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,1,N,11047,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627952,2048.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,1,N,11048,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627953,2048.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,1,N,11049,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627954,2048.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,1,N,11050,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627955,2048.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,1,N,11051,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627956,2048.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,1,N,11052,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL876802,2048.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,1,N,11053,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627957,2048.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,1,N,11054,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627958,2048.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,1,N,11055,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627959,2048.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,1,N,11056,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627960,2048.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,1,N,11057,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627961,2048.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,1,N,11058,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627962,2048.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,1,N,11059,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627963,,BAO_0000218,,,,A,9796,10116.0,50597,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,1,N,11060,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624759,,BAO_0000218,,,,A,9796,10116.0,50597,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,1,N,11061,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624760,,BAO_0000218,,,,A,9796,10116.0,50597,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,1,N,11062,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624761,,BAO_0000218,,,,A,9796,10116.0,50597,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,1,N,11063,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL877607,,BAO_0000218,,,,A,9796,10116.0,50597,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,1,N,11064,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624762,2107.0,BAO_0000218,,,,A,9796,10116.0,50597,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,1,N,11065,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL624763,2107.0,BAO_0000218,,,,A,9796,10116.0,50597,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,1,N,11066,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL624764,2107.0,BAO_0000218,,,,A,9796,10116.0,50597,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,1,N,11067,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL624765,2107.0,BAO_0000218,,,,A,9796,10116.0,50597,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,1,N,11068,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL624766,2107.0,BAO_0000218,,,,A,9796,10116.0,50597,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,1,N,11069,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL624767,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),1,N,11070,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624768,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,1,N,11071,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624769,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),1,N,11072,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624770,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),1,N,11073,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624771,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),1,N,11074,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624772,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),1,N,11075,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624773,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,1,N,11076,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624774,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),1,N,11077,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624775,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),1,N,11078,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624776,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),1,N,11079,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624777,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),1,N,11080,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624778,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),1,N,11081,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624779,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,1,N,11082,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624780,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),1,N,11083,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624781,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),1,N,11084,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL877608,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),1,N,11085,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624782,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),1,N,11086,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624783,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),1,N,11087,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624784,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,1,N,11088,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624785,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),1,N,11089,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624786,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),1,N,11090,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624787,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),1,N,11091,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628676,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),1,N,11092,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621842,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,1,N,11093,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621843,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),1,N,11094,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623873,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),1,N,11095,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623874,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),1,N,11096,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623875,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),1,N,11097,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623876,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),1,N,11098,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623877,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,1,N,11099,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL623878,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),1,N,11100,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL623879,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,1,N,11101,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL623880,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),1,N,11102,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL623881,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),1,N,11103,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL623957,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),1,N,11104,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL623958,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),1,N,11105,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL623959,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),1,N,11106,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL623960,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),1,N,11107,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL623961,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),1,N,11108,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL623962,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),1,N,11109,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624676,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),1,N,11110,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624677,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),1,N,11111,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624678,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,1,N,11112,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624679,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),1,N,11113,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624680,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),1,N,11114,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624849,,BAO_0000218,,,,A,11732,,22224,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,1,U,11115,In vivo,,,0,,Autocuration
,,,CHEMBL624850,,BAO_0000218,,,,A,11732,,22224,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,1,U,11116,In vivo,,,0,,Autocuration
,,,CHEMBL874399,,BAO_0000218,,,,A,11732,,22224,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,1,U,11117,In vivo,,,0,,Autocuration
,,,CHEMBL624851,,BAO_0000218,,,,A,11732,,22224,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,1,U,11118,In vivo,,,0,,Autocuration
,,,CHEMBL624852,,BAO_0000218,,,,A,11732,,22224,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,1,U,11119,In vivo,,,0,,Autocuration
,,,CHEMBL624853,,BAO_0000218,,,,A,13359,10116.0,22224,Oral bioavailability in rat (dose 10 mg/kg),1,U,11120,In vivo,Rattus norvegicus,,0,,Autocuration
,,,CHEMBL624854,,BAO_0000218,,,,A,16618,10116.0,22224,Oral bioavailability in rat (Sprague-Dawley),1,U,11121,In vivo,Rattus norvegicus,,0,,Autocuration
,,,CHEMBL624855,,BAO_0000218,,,,A,13960,10116.0,22224,Oral bioavailability in rat,1,U,11122,In vivo,Rattus norvegicus,,0,,Autocuration
,,,CHEMBL624856,,BAO_0000218,,,,A,13917,10116.0,22224,Oral bioavailability in rats was determined in vivo,1,U,11123,In vivo,Rattus norvegicus,,0,,Autocuration
,,,CHEMBL882957,,BAO_0000218,,,,A,14266,9615.0,22224,Oral bioavailability in dog,1,U,11124,In vivo,Canis lupus familiaris,,0,,Autocuration
,,,CHEMBL624857,,BAO_0000218,,,,A,12359,314293.0,22224,Oral bioavailability of compound in monkey,1,U,11125,In vivo,Simiiformes,,0,,Autocuration
,,,CHEMBL622202,,BAO_0000218,,,,A,12359,10116.0,50597,Oral bioavailability of compound in rat,1,N,11126,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622203,,BAO_0000218,,,,A,12359,10116.0,22224,Bioavailability in rat of PMEA prodrug,1,U,11127,In vivo,Rattus norvegicus,,0,,Autocuration
,,,CHEMBL625522,,BAO_0000218,,,,A,12359,10116.0,50597,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,1,N,11128,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622868,,BAO_0000218,,,,A,10791,9544.0,22224,Serum conc at 3 hours following 25 mg/kg dose,1,U,11129,In vivo,Macaca mulatta,,0,,Autocuration
,,,CHEMBL622869,1088.0,BAO_0000218,,,,A,10791,9544.0,22224,Urine conc 0-5 hours following 25 mg/kg dose,1,U,11130,In vivo,Macaca mulatta,Urine,0,,Autocuration
,,,CHEMBL622870,1088.0,BAO_0000218,,,,A,10791,9544.0,22224,Urine conc 0-24 hours following 25 mg/kg dose,1,U,11131,In vivo,Macaca mulatta,Urine,0,,Autocuration
,,,CHEMBL622871,,BAO_0000218,,,,A,138,9534.0,22224,Oral bioavailability in African green monkeys; 20-25,1,U,11132,In vivo,Chlorocebus aethiops,,0,,Autocuration
,,,CHEMBL620560,,BAO_0000218,,,,A,14521,9541.0,100710,Oral bioavailability in cynomolgus monkey.,1,N,11133,In vivo,Macaca fascicularis,,1,,Intermediate
,,,CHEMBL620561,,BAO_0000218,,,,A,13953,9615.0,22224,Oral bioavailability in dog,1,U,11134,In vivo,Canis lupus familiaris,,0,,Autocuration
,,,CHEMBL620562,,BAO_0000218,,,,A,12836,9615.0,50588,Oral bioavailability in dog at 10 mg/kg oral dose,1,N,11135,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL620563,,BAO_0000218,,,,A,12836,10026.0,100712,Oral bioavailability in hamster at 10 mg/kg oral dose,1,N,11136,In vivo,Cricetinae,,1,,Intermediate
,,,CHEMBL620564,,BAO_0000218,,,,A,12836,10116.0,50597,Oral bioavailability in rat at 10 mg/kg oral dose,1,N,11137,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL872265,,BAO_0000218,,,,A,14521,10116.0,22224,Oral bioavailability in rat,1,U,11138,In vivo,Rattus norvegicus,,0,,Autocuration
,,,CHEMBL620565,,BAO_0000218,,,,A,13953,10116.0,22224,Oral bioavailability in rat,1,U,11139,In vivo,Rattus norvegicus,,0,,Autocuration
,,,CHEMBL620566,,BAO_0000218,,,,A,6799,9347.0,22224,Oral bioavailability,1,U,11140,In vivo,Eutheria,,0,,Autocuration
,,,CHEMBL620567,,BAO_0000218,,,,A,11311,,22224,Oral bioavailability was determined; range 49-102%,1,U,11141,In vivo,,,0,,Autocuration
,,,CHEMBL620568,,BAO_0000218,,,,A,4013,9615.0,50588,Oral bioavailability was determined in dogs,1,N,11142,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL620569,,BAO_0000218,,,,A,4013,10116.0,22224,Oral bioavailability in rat,1,U,11143,In vivo,Rattus norvegicus,,0,,Autocuration
,,,CHEMBL620570,,BAO_0000218,,,,A,17591,9347.0,22224,Oral bioavailability,1,U,11144,In vivo,Eutheria,,0,,Autocuration
,,,CHEMBL620571,,BAO_0000218,,,,A,17591,,22224,Oral bioavailability was determined; Not orally available,1,U,11145,In vivo,,,0,,Autocuration
,,,CHEMBL620572,,BAO_0000218,,,,A,15011,10090.0,50594,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),1,N,11146,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL620573,,BAO_0000218,,,,A,15011,10090.0,22224,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),1,U,11147,In vivo,Mus musculus,,0,,Autocuration
,,,CHEMBL620574,,BAO_0000218,,,,A,15011,10090.0,22224,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,1,U,11148,In vivo,Mus musculus,,0,,Autocuration
,,,CHEMBL620575,,BAO_0000218,,,,A,9552,9544.0,22224,Oral bioavailability in Rhesus monkey,1,U,11149,In vivo,Macaca mulatta,,0,,Autocuration
,,,CHEMBL620576,,BAO_0000218,,,,A,9552,9615.0,22224,Oral bioavailability in dog (female mongrel),1,U,11150,In vivo,Canis lupus familiaris,,0,,Autocuration
,,,CHEMBL875846,,BAO_0000218,,,,A,3639,,22224,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,1,U,11151,In vivo,,,0,,Autocuration
,,,CHEMBL620577,,BAO_0000218,,,,A,13397,9615.0,22224,Oral bioavailability in dog,1,U,11152,In vivo,Canis lupus familiaris,,0,,Autocuration
,,,CHEMBL620578,,BAO_0000218,,,,A,3031,,22224,Percentage Bioavailability was evaluated.,1,U,11153,In vivo,,,0,,Autocuration
,,,CHEMBL620579,,BAO_0000218,,,,A,12818,10116.0,22224,Bioavailability in rat administered i.d.,1,U,11154,In vivo,Rattus norvegicus,,0,,Autocuration
,,,CHEMBL621248,,BAO_0000218,,,,A,4847,9347.0,22224,Bioavailability,1,U,11155,In vivo,Eutheria,,0,,Autocuration
,,,CHEMBL625390,,BAO_0000218,,,,A,12421,9615.0,22224,Bioavailability in dog (male Beagle) i.v. administration,1,U,11156,In vivo,Canis lupus familiaris,,0,,Autocuration
,,,CHEMBL625391,,BAO_0000218,,,,A,11966,10116.0,22224,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",1,U,11157,In vivo,Rattus norvegicus,,0,,Autocuration
,,,CHEMBL872266,,BAO_0000218,,,,A,11218,9443.0,22224,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),1,U,11158,In vivo,Primates,,0,,Autocuration
,,,CHEMBL625392,,BAO_0000218,,,,A,13129,10116.0,22224,Oral bioavailability in rat (Sprague-Dawley) (male),1,U,11159,In vivo,Rattus norvegicus,,0,,Autocuration
,,,CHEMBL625393,,BAO_0000218,,,,A,12350,10116.0,50597,The oral bioavailability was measured on rats after oral administration,1,N,11160,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625394,,BAO_0000218,,,,A,2231,10116.0,50597,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,1,N,11161,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625395,,BAO_0000218,,,,A,2231,9544.0,50797,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,1,N,11162,In vivo,Macaca mulatta,,1,,Intermediate
,,,CHEMBL625396,,BAO_0000218,,,,A,12187,10116.0,22224,Bioavailability in rat (dose 10 mg/kg i.d.),1,U,11163,In vivo,Rattus norvegicus,,0,,Autocuration
,,,CHEMBL625397,,BAO_0000218,,,,A,12421,9615.0,22224,Bioavailability in dog (male Beagle) i.v. administration,1,U,11164,In vivo,Canis lupus familiaris,,0,,Autocuration
,,,CHEMBL625398,,BAO_0000218,,,,A,13256,10090.0,50594,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),1,N,11165,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL625399,178.0,BAO_0000218,,,,A,13256,10090.0,50594,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),1,N,11166,In vivo,Mus musculus,Blood,1,,Intermediate
,,,CHEMBL626074,2037.0,BAO_0000218,,,,A,13256,10090.0,50594,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),1,N,11167,In vivo,Mus musculus,Cerebellum,1,,Intermediate
,,,CHEMBL626075,,BAO_0000218,,,,A,13256,10090.0,50594,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),1,N,11168,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL626076,1969.0,BAO_0000218,,,,A,2231,10116.0,50597,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,1,N,11169,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626077,1969.0,BAO_0000218,,,,A,2231,9544.0,50797,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,1,N,11170,In vivo,Macaca mulatta,Plasma,1,,Intermediate
,,,CHEMBL626078,178.0,BAO_0000218,,,,A,12178,10116.0,50597,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),1,N,11171,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL625846,178.0,BAO_0000218,,,,A,12178,,22224,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),1,U,11172,In vivo,,Blood,0,,Autocuration
,,,CHEMBL625847,178.0,BAO_0000218,,,,A,12178,,22224,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),1,U,11173,In vivo,,Blood,0,,Autocuration
,,,CHEMBL625848,,BAO_0000218,,,,A,15633,10116.0,50597,Maximum concentration observed in rats at an oral dose of 50 mg/kg,1,N,11174,In vivo,Rattus norvegicus,,1,,Expert
,,,CHEMBL625849,1969.0,BAO_0000218,,,,A,14258,10116.0,50597,Maximum concentration of compound in plasma administered orally to rats,1,N,11175,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626023,1969.0,BAO_0000218,,,,A,14224,9615.0,50588,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",1,N,11176,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL626024,1969.0,BAO_0000218,,,,A,14224,9615.0,50588,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",1,N,11177,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL626025,1969.0,BAO_0000218,,,,A,14224,9615.0,50588,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",1,N,11178,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL626026,,BAO_0000218,,,,A,5566,,22224,Maximum concentration after 10 mg/kg by oral administration,1,U,11179,In vivo,,,0,,Autocuration
,,,CHEMBL626027,,BAO_0000218,,,,A,16935,,22224,Maximum concentration at a dose of 1.5 mg/kg,1,U,11180,In vivo,,,0,,Autocuration
,,,CHEMBL626028,,BAO_0000218,,,,A,16935,,22224,Maximum concentration at a dose of 2.0 mg/kg,1,U,11181,In vivo,,,0,,Autocuration
,,,CHEMBL626029,1969.0,BAO_0000218,,,,A,14224,9615.0,50588,Maximum concentration in dog plasma,1,N,11182,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL626030,1969.0,BAO_0000218,,,,A,12536,,22224,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,1,U,11183,In vivo,,Plasma,0,,Autocuration
,,,CHEMBL626031,1969.0,BAO_0000218,,,,A,12536,,22224,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,1,U,11184,In vivo,,Plasma,0,,Autocuration
,,,CHEMBL626032,1969.0,BAO_0000218,,,,A,12536,,22224,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,1,U,11185,In vivo,,Plasma,0,,Autocuration
,,,CHEMBL626033,1969.0,BAO_0000218,,,,A,12536,,22224,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,1,U,11186,In vivo,,Plasma,0,,Autocuration
,,,CHEMBL626034,1969.0,BAO_0000218,,,,A,12536,,22224,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,1,U,11187,In vivo,,Plasma,0,,Autocuration
,,,CHEMBL626035,1969.0,BAO_0000218,,,,A,9994,9615.0,50588,Maximum concentration in plasma after oral administration in dog (25 mg/kg),1,N,11188,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL626036,1969.0,BAO_0000218,,,,A,1434,,22224,Maximum concentration in plasma at Tmax,1,U,11189,In vivo,,Plasma,0,,Autocuration
,,,CHEMBL626037,1969.0,BAO_0000218,,,,A,12836,9615.0,50588,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,1,N,11190,In vivo,Canis lupus familiaris,Plasma,1,,Expert
,,,CHEMBL626038,1969.0,BAO_0000218,,,,A,12836,10026.0,100712,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,1,N,11191,In vivo,Cricetinae,Plasma,1,,Intermediate
,,,CHEMBL626039,1969.0,BAO_0000218,,,,A,12836,10116.0,50597,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,1,N,11192,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626040,1969.0,BAO_0000218,,,,A,12545,10116.0,50597,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,1,N,11193,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626041,1969.0,BAO_0000218,,,,A,13856,9986.0,50592,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,1,N,11194,In vivo,Oryctolagus cuniculus,Plasma,1,,Intermediate
,,,CHEMBL626042,,BAO_0000218,,,,A,3550,,22224,Maximum concentration was calculated,1,U,11195,In vivo,,,0,,Autocuration
,,,CHEMBL626043,,BAO_0000218,,,,A,2632,,22224,Maximum concentration was calculated.,1,U,11196,In vivo,,,0,,Autocuration
,,,CHEMBL626044,,BAO_0000218,,,,A,5566,,22224,Maximum concentration at a peroral dose of 10 mg/kg,1,U,11197,In vivo,,,0,,Autocuration
,,,CHEMBL626045,,BAO_0000218,,,,A,11883,,22224,Maximum concentration of the drug at 10 uM/dg administered perorally,1,U,11198,In vivo,,,0,,Autocuration
,,,CHEMBL626046,,BAO_0000218,,,,A,11883,,22224,Maximum concentration of the drug at 2 uM/dg administered intravenously,1,U,11199,In vivo,,,0,,Autocuration
,,,CHEMBL626047,1969.0,BAO_0000218,,,,A,14122,9615.0,50588,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",1,N,11200,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL626048,1969.0,BAO_0000218,,,,A,14122,10026.0,100712,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",1,N,11201,In vivo,Cricetinae,Plasma,1,,Intermediate
,,,CHEMBL626049,1969.0,BAO_0000218,,,,A,14122,10116.0,50597,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",1,N,11202,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626050,1969.0,BAO_0000218,,,,A,12542,10116.0,50597,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,1,N,11203,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL874541,1969.0,BAO_0000218,,,,A,12542,9615.0,50588,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,1,N,11204,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL622826,1969.0,BAO_0000218,,,,A,12542,10026.0,100712,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,1,N,11205,In vivo,Cricetinae,Plasma,1,,Intermediate
,,,CHEMBL622827,1969.0,BAO_0000218,,,,A,12542,10026.0,100712,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,1,N,11206,In vivo,Cricetinae,Plasma,1,,Intermediate
,,,CHEMBL622828,1969.0,BAO_0000218,,,,A,12542,10116.0,50597,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,1,N,11207,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622829,1969.0,BAO_0000218,,,,A,14080,10116.0,50597,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,1,N,11208,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL876806,,BAO_0000218,,,,A,11911,10116.0,50597,Maximum concentration reached following intravenous administration in male rat,1,N,11209,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622830,,BAO_0000218,,,,A,13204,9615.0,50588,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,1,N,11210,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL622831,,BAO_0000218,,,,A,13204,10116.0,50597,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,1,N,11211,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626794,,BAO_0000218,,,,A,14346,9615.0,50588,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,1,N,11212,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626795,,BAO_0000218,,,,A,14346,10116.0,50597,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,1,N,11213,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626796,,BAO_0000218,,,,A,14346,10116.0,50597,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,1,N,11214,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626797,,BAO_0000218,,,,A,14346,10116.0,50597,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,1,N,11215,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626798,,BAO_0000218,,,,A,14127,10116.0,50597,Maximum drug concentration is determined after oral dosing in rats.,1,N,11216,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626799,,BAO_0000218,,,,A,14339,9615.0,50588,Maximum observed concentration in oral (5 mg/kg) fasted dogs,1,N,11217,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626800,,BAO_0000218,,,,A,14339,9615.0,50588,Maximum observed concentration in oral (5 mg/kg) fed dogs,1,N,11218,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626801,1969.0,BAO_0000218,,,,A,13494,,22224,Maximum plasma concentration,1,U,11219,In vivo,,Plasma,0,,Autocuration
,,,CHEMBL876816,1969.0,BAO_0000218,,,,A,14925,10116.0,50597,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,1,N,11220,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626802,1969.0,BAO_0000218,,,,A,14474,10116.0,50597,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,1,N,11221,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626803,1969.0,BAO_0000218,,,,A,14474,9615.0,50588,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,1,N,11222,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL626804,1969.0,BAO_0000218,,,,A,13917,,22224,Maximum plasma concentration following oral administration of 30 umol/kg,1,U,11223,In vivo,,Plasma,0,,Autocuration
,,,CHEMBL626805,1969.0,BAO_0000218,,,,A,9796,10116.0,50597,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,1,N,11224,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626309,1969.0,BAO_0000218,,,,A,9796,10116.0,50597,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,1,N,11225,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626310,1969.0,BAO_0000218,,,,A,9796,10116.0,50597,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,1,N,11226,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626311,1969.0,BAO_0000218,,,,A,9796,10116.0,50597,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,1,N,11227,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626312,1969.0,BAO_0000218,,,,A,9796,10116.0,50597,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,1,N,11228,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626313,995.0,BAO_0000218,,,,A,9796,10116.0,50597,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,1,N,11229,,Rattus norvegicus,Uterus,1,,Intermediate
,,,CHEMBL626314,995.0,BAO_0000218,,,,A,9796,10116.0,50597,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,1,N,11230,,Rattus norvegicus,Uterus,1,,Intermediate
,,,CHEMBL626315,995.0,BAO_0000218,,,,A,9796,10116.0,50597,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,1,N,11231,,Rattus norvegicus,Uterus,1,,Intermediate
,,,CHEMBL626316,995.0,BAO_0000218,,,,A,9796,10116.0,50597,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,1,N,11232,,Rattus norvegicus,Uterus,1,,Intermediate
,,,CHEMBL626317,995.0,BAO_0000218,,,,A,9796,10116.0,50597,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,1,N,11233,,Rattus norvegicus,Uterus,1,,Intermediate
,,,CHEMBL626318,,BAO_0000218,,,,A,8363,10116.0,50597,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),1,N,11234,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626319,,BAO_0000218,,,,A,8363,10116.0,50597,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),1,N,11235,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626320,,BAO_0000218,,,,A,8363,10116.0,50597,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),1,N,11236,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL875053,,BAO_0000218,,,,A,8363,10116.0,50597,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),1,N,11237,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626321,,BAO_0000218,,,,A,8363,10116.0,50597,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),1,N,11238,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626322,,BAO_0000218,,,,A,8363,10116.0,50597,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),1,N,11239,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626323,,BAO_0000218,,,,A,8363,10116.0,50597,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),1,N,11240,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626324,,BAO_0000218,,,,A,8363,10116.0,50597,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),1,N,11241,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626325,,BAO_0000218,,,,A,8363,10116.0,50597,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),1,N,11242,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626326,,BAO_0000218,,,,A,8363,10116.0,50597,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),1,N,11243,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626327,,BAO_0000218,,,,A,8363,10116.0,50597,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),1,N,11244,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626328,,BAO_0000218,,,,A,8363,10116.0,50597,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),1,N,11245,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626329,178.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",1,N,11246,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL626330,178.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",1,N,11247,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL626331,178.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",1,N,11248,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL626332,178.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",1,N,11249,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL626333,178.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",1,N,11250,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL626334,178.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",1,N,11251,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL626335,178.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",1,N,11252,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL624798,178.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",1,N,11253,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL624799,955.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",1,N,11254,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL624800,955.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",1,N,11255,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL624801,955.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",1,N,11256,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL624802,955.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",1,N,11257,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL624803,955.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",1,N,11258,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL624804,955.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",1,N,11259,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL624805,955.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",1,N,11260,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL624806,955.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",1,N,11261,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL624807,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",1,N,11262,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624808,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",1,N,11263,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624809,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",1,N,11264,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624810,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",1,N,11265,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL877618,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",1,N,11266,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624811,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",1,N,11267,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624812,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",1,N,11268,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624813,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",1,N,11269,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624814,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",1,N,11270,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624815,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",1,N,11271,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624816,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",1,N,11272,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624817,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",1,N,11273,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624818,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),1,N,11274,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624819,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,1,N,11275,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624820,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),1,N,11276,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624821,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),1,N,11277,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624822,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),1,N,11278,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624823,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),1,N,11279,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624824,,BAO_0000218,,,,A,15599,562.0,50212,Observed diffusion coefficient in organic solvent for Escherichia coli,1,N,11280,,Escherichia coli,,1,,Intermediate
,,,CHEMBL624825,178.0,BAO_0000218,,,,A,9614,10116.0,50597,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",1,N,11281,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL624826,178.0,BAO_0000218,,,,A,9614,10116.0,50597,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",1,N,11282,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL876817,2081.0,BAO_0000218,,,,A,9614,10116.0,50597,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",1,N,11283,,Rattus norvegicus,Cardiac atrium,1,,Intermediate
,,,CHEMBL624827,2081.0,BAO_0000218,,,,A,9614,10116.0,50597,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",1,N,11284,,Rattus norvegicus,Cardiac atrium,1,,Intermediate
,,,CHEMBL624828,,BAO_0000218,,,,A,9614,10116.0,50597,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",1,N,11285,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624829,,BAO_0000218,,,,A,9614,10116.0,50597,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",1,N,11286,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624830,2107.0,BAO_0000218,,,,A,9614,10116.0,50597,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",1,N,11287,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL624831,2107.0,BAO_0000218,,,,A,9614,10116.0,50597,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",1,N,11288,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL624832,2081.0,BAO_0000218,,,,A,9614,10116.0,50597,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",1,N,11289,,Rattus norvegicus,Cardiac atrium,1,,Intermediate
,,,CHEMBL624833,2081.0,BAO_0000218,,,,A,9614,10116.0,50597,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",1,N,11290,,Rattus norvegicus,Cardiac atrium,1,,Intermediate
,,,CHEMBL624834,,BAO_0000218,,,,A,9614,10116.0,50597,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",1,N,11291,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624835,,BAO_0000218,,,,A,9614,10116.0,50597,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",1,N,11292,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624836,2106.0,BAO_0000218,,,,A,9614,10116.0,50597,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",1,N,11293,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL624837,2106.0,BAO_0000218,,,,A,9614,10116.0,50597,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",1,N,11294,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL624838,178.0,BAO_0000218,,,,A,9071,10116.0,50597,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,1,N,11295,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL622188,178.0,BAO_0000218,,,,A,9071,10116.0,50597,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,1,N,11296,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL622189,948.0,BAO_0000218,,,,A,9071,10116.0,50597,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,1,N,11297,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL622190,948.0,BAO_0000218,,,,A,9071,10116.0,50597,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,1,N,11298,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL625170,948.0,BAO_0000218,,,,A,9071,10116.0,50597,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,1,N,11299,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL625171,2113.0,BAO_0000218,,,,A,9071,10116.0,50597,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,1,N,11300,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL625172,2113.0,BAO_0000218,,,,A,9071,10116.0,50597,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,1,N,11301,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL625173,2113.0,BAO_0000218,,,,A,9071,10116.0,50597,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,1,N,11302,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL625174,2107.0,BAO_0000218,,,,A,9071,10116.0,50597,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,1,N,11303,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625175,2107.0,BAO_0000218,,,,A,9071,10116.0,50597,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,1,N,11304,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625176,2107.0,BAO_0000218,,,,A,9071,10116.0,50597,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,1,N,11305,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625177,2048.0,BAO_0000218,,,,A,9071,10116.0,50597,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,1,N,11306,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL625178,2048.0,BAO_0000218,,,,A,9071,10116.0,50597,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,1,N,11307,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL625179,2048.0,BAO_0000218,,,,A,9071,10116.0,50597,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,1,N,11308,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL625180,2048.0,BAO_0000218,,,,A,9071,10116.0,50597,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,1,N,11309,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL625181,,BAO_0000218,,,,A,10677,,22224,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",1,U,11310,,,,0,,Autocuration
,,,CHEMBL625182,1088.0,BAO_0000218,,,,A,9750,10090.0,50594,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,1,N,11311,,Mus musculus,Urine,1,,Intermediate
,,,CHEMBL625183,,BAO_0000218,,,,A,8319,10116.0,50597,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,1,N,11312,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL875848,,BAO_0000218,,,,A,8319,10116.0,50597,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,1,N,11313,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622260,,BAO_0000218,,,,A,8319,10116.0,50597,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,1,N,11314,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622261,,BAO_0000218,,,,A,8319,10116.0,50597,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,1,N,11315,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622262,,BAO_0000218,,,,A,8319,10116.0,50597,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,1,N,11316,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622263,2113.0,BAO_0000218,,,,A,8319,10116.0,50597,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,1,N,11317,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL622418,2113.0,BAO_0000218,,,,A,8319,10116.0,50597,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,1,N,11318,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL622419,2107.0,BAO_0000218,,,,A,8319,10116.0,50597,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,1,N,11319,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL623388,,BAO_0000218,,,,A,13256,10090.0,50594,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),1,N,11320,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL623389,2107.0,BAO_0000218,,,,A,13256,10090.0,50594,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),1,N,11321,In vivo,Mus musculus,Liver,1,,Intermediate
,,,CHEMBL623390,,BAO_0000218,,,,A,13256,10090.0,50594,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),1,N,11322,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL623391,,BAO_0000218,,,,A,13256,10090.0,50594,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),1,N,11323,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL623392,178.0,BAO_0000218,,,,A,13256,10090.0,50594,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),1,N,11324,In vivo,Mus musculus,Blood,1,,Intermediate
,,,CHEMBL623393,2037.0,BAO_0000218,,,,A,13256,10090.0,50594,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),1,N,11325,In vivo,Mus musculus,Cerebellum,1,,Intermediate
,,,CHEMBL623394,,BAO_0000218,,,,A,13256,10090.0,50594,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),1,N,11326,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL618885,,BAO_0000218,,,,A,13256,10090.0,50594,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),1,N,11327,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL618886,2107.0,BAO_0000218,,,,A,13256,10090.0,50594,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),1,N,11328,In vivo,Mus musculus,Liver,1,,Intermediate
,,,CHEMBL618887,,BAO_0000218,,,,A,13256,10090.0,50594,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),1,N,11329,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL619535,,BAO_0000218,,,,A,13256,10090.0,50594,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),1,N,11330,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL619536,178.0,BAO_0000218,,,,A,13256,10090.0,50594,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),1,N,11331,In vivo,Mus musculus,Blood,1,,Intermediate
,,,CHEMBL619537,2037.0,BAO_0000218,,,,A,13256,10090.0,50594,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),1,N,11332,In vivo,Mus musculus,Cerebellum,1,,Intermediate
,,,CHEMBL619705,,BAO_0000218,,,,A,13256,10090.0,50594,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),1,N,11333,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL619706,,BAO_0000218,,,,A,13256,10090.0,50594,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),1,N,11334,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL619707,2107.0,BAO_0000218,,,,A,13256,10090.0,50594,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),1,N,11335,In vivo,Mus musculus,Liver,1,,Intermediate
,,,CHEMBL619708,,BAO_0000218,,,,A,13256,10090.0,50594,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),1,N,11336,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL625219,,BAO_0000218,,,,A,13256,10090.0,50594,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),1,N,11337,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL625220,178.0,BAO_0000218,,,,A,13256,10090.0,50594,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),1,N,11338,In vivo,Mus musculus,Blood,1,,Intermediate
,,,CHEMBL625221,2037.0,BAO_0000218,,,,A,13256,10090.0,50594,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),1,N,11339,In vivo,Mus musculus,Cerebellum,1,,Intermediate
,,,CHEMBL625222,,BAO_0000218,,,,A,13256,10090.0,50594,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),1,N,11340,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL625223,,BAO_0000218,,,,A,13256,10090.0,50594,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),1,N,11341,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL625224,2107.0,BAO_0000218,,,,A,13256,10090.0,50594,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),1,N,11342,In vivo,Mus musculus,Liver,1,,Intermediate
,,,CHEMBL625225,,BAO_0000218,,,,A,13256,10090.0,50594,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),1,N,11343,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL625226,178.0,BAO_0000218,,,,A,8829,10116.0,50597,Biodistribution in Rat blood after 24 hours of iv administration,1,N,11344,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL625227,178.0,BAO_0000218,,,,A,8829,10116.0,50597,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,1,N,11345,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL625228,178.0,BAO_0000218,,,,A,8829,10116.0,50597,Biodistribution in Rat blood after 30 minutes of iv administration,1,N,11346,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL875354,178.0,BAO_0000218,,,,A,8829,10116.0,50597,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,1,N,11347,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL625229,178.0,BAO_0000218,,,,A,8829,10116.0,50597,Biodistribution in Rat blood after 5 minutes of iv administration,1,N,11348,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL625230,178.0,BAO_0000218,,,,A,8829,10116.0,50597,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,1,N,11349,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL625231,948.0,BAO_0000218,,,,A,8829,10116.0,50597,Biodistribution in Rat heart after 24 hours of iv administration,1,N,11350,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL625900,948.0,BAO_0000218,,,,A,8829,10116.0,50597,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,1,N,11351,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL625901,948.0,BAO_0000218,,,,A,8829,10116.0,50597,Biodistribution in Rat heart after 30 minutes of iv administration,1,N,11352,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL625902,948.0,BAO_0000218,,,,A,8829,10116.0,50597,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,1,N,11353,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL625903,948.0,BAO_0000218,,,,A,8829,10116.0,50597,Biodistribution in Rat heart after 5 minutes of iv administration,1,N,11354,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL625904,948.0,BAO_0000218,,,,A,8829,10116.0,50597,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,1,N,11355,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL625905,2107.0,BAO_0000218,,,,A,8829,10116.0,50597,Biodistribution in Rat liver after 24 hours of iv administration,1,N,11356,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL627861,2107.0,BAO_0000218,,,,A,8829,10116.0,50597,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,1,N,11357,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL627862,2107.0,BAO_0000218,,,,A,8829,10116.0,50597,Biodistribution in Rat liver after 30 minutes of iv administration,1,N,11358,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL627863,2107.0,BAO_0000218,,,,A,8829,10116.0,50597,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,1,N,11359,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL627769,2107.0,BAO_0000218,,,,A,8829,10116.0,50597,Biodistribution in Rat liver after 30 minutes of iv administration,1,N,11360,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL627770,1969.0,BAO_0000218,,,,A,13249,9615.0,50588,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,1,N,11361,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL627771,,BAO_0000218,,,,A,13622,9541.0,100710,Cmax in cynomolgus monkey (PO dose),1,N,11362,In vivo,Macaca fascicularis,,1,,Intermediate
,,,CHEMBL627772,,BAO_0000218,,,,A,13622,10116.0,50597,Cmax in rat (PO dose),1,N,11363,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627773,,BAO_0000218,,,,A,13622,10116.0,50597,Cmax in rat (PO dose),1,N,11364,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL621922,1969.0,BAO_0000218,,,,A,13494,10116.0,50597,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,1,N,11365,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL621923,1969.0,BAO_0000218,,,,A,12170,10116.0,50597,Cmax in rat plasma after oral dose (10 mg/kg),1,N,11366,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL621924,1969.0,BAO_0000218,,,,A,12170,,22224,Cmax in plasma after oral dose (10 mg/kg),1,U,11367,In vivo,,Plasma,0,,Autocuration
,,,CHEMBL621925,1969.0,BAO_0000218,,,,A,17025,9615.0,50588,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,1,N,11368,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL621926,1969.0,BAO_0000218,,,,A,17025,314293.0,22224,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,1,U,11369,In vivo,Simiiformes,Plasma,0,,Autocuration
,,,CHEMBL621927,1969.0,BAO_0000218,,,,A,17025,9986.0,50592,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,1,N,11370,In vivo,Oryctolagus cuniculus,Plasma,1,,Intermediate
,,,CHEMBL621928,1969.0,BAO_0000218,,,,A,17025,10116.0,50597,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,1,N,11371,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL621929,1969.0,BAO_0000218,,,,A,14187,10116.0,50597,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,1,N,11372,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL621930,1969.0,BAO_0000218,,,,A,14816,10090.0,50594,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,1,N,11373,In vivo,Mus musculus,Plasma,1,,Intermediate
,,,CHEMBL621931,1969.0,BAO_0000218,,,,A,17820,10116.0,50597,Maximum plasma concentration after oral dosing in rat,1,N,11374,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL621932,1969.0,BAO_0000218,,,,A,14380,,22224,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,1,U,11375,In vivo,,Plasma,0,,Autocuration
,,,CHEMBL621933,1969.0,BAO_0000218,,,,A,14380,,22224,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,1,U,11376,In vivo,,Plasma,0,,Autocuration
,,,CHEMBL621934,1969.0,BAO_0000218,,,,A,14691,9615.0,50588,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,1,N,11377,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL621935,1969.0,BAO_0000218,,,,A,14691,9615.0,50588,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,1,N,11378,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL621936,1969.0,BAO_0000218,,,,A,13375,10116.0,50597,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,1,N,11379,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL621937,1969.0,BAO_0000218,,,,A,6236,,22224,Maximum plasma concentration was determined,1,U,11380,In vivo,,Plasma,0,,Autocuration
,,,CHEMBL621938,1969.0,BAO_0000218,,,,A,14380,,22224,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,1,U,11381,In vivo,,Plasma,0,,Autocuration
,,,CHEMBL621939,1969.0,BAO_0000218,,,,A,14380,,22224,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,1,U,11382,In vivo,,Plasma,0,,Autocuration
,,,CHEMBL621940,1969.0,BAO_0000218,,,,A,14380,,22224,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,1,U,11383,In vivo,,Plasma,0,,Autocuration
,,,CHEMBL621941,1969.0,BAO_0000218,,,,A,14380,,22224,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,1,U,11384,In vivo,,Plasma,0,,Autocuration
,,,CHEMBL621942,1969.0,BAO_0000218,,,,A,14380,,22224,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,1,U,11385,In vivo,,Plasma,0,,Autocuration
,,,CHEMBL626178,1969.0,BAO_0000218,,,,A,14380,,22224,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,1,U,11386,In vivo,,Plasma,0,,Autocuration
,,,CHEMBL626179,1969.0,BAO_0000218,,,,A,14380,,22224,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,1,U,11387,In vivo,,Plasma,0,,Autocuration
,,,CHEMBL626180,1969.0,BAO_0000218,,,,A,14380,,22224,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,1,U,11388,In vivo,,Plasma,0,,Autocuration
,,,CHEMBL626181,1969.0,BAO_0000218,,,,A,13622,10116.0,50597,Plasma Cmax in rat (PO dose),1,N,11389,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626182,,BAO_0000218,,,,A,15372,10116.0,50597,Maximum serum concentration after po dose of 5.22 mg/kg in rats,1,N,11390,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626183,,BAO_0000218,,,,A,15372,10116.0,50597,Maximum serum concentration after po dose of 5.46 mg/kg in rats,1,N,11391,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626184,,BAO_0000218,,,,A,15372,10116.0,50597,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,1,N,11392,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626185,,BAO_0000218,,,,A,15372,10116.0,50597,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,1,N,11393,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626186,1969.0,BAO_0000218,,,,A,14925,9615.0,50588,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,1,N,11394,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL877589,1969.0,BAO_0000218,,,,A,14925,9615.0,50588,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,1,N,11395,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL626187,,BAO_0000218,,,,A,11883,,22224,Maximum concentration of the drug at 1 uM/dg administered intravenously,1,U,11396,In vivo,,,0,,Autocuration
,,,CHEMBL626188,,BAO_0000218,,,,A,11883,,22224,Maximum concentration of the drug at 20 uM/dg administered perorally,1,U,11397,In vivo,,,0,,Autocuration
,,,CHEMBL626189,,BAO_0000218,,,,A,13391,,22224,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,1,U,11398,In vivo,,,0,,Autocuration
,,,CHEMBL626855,178.0,BAO_0000218,,,,A,13391,,22224,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,1,U,11399,In vivo,,Blood,0,,Autocuration
,,,CHEMBL623781,178.0,BAO_0000218,,,,A,13391,,22224,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,1,U,11400,In vivo,,Blood,0,,Autocuration
,,,CHEMBL623782,178.0,BAO_0000218,,,,A,13391,,22224,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,1,U,11401,In vivo,,Blood,0,,Autocuration
,,,CHEMBL623783,1969.0,BAO_0000218,,,,A,16360,10116.0,50597,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,1,N,11402,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623784,1969.0,BAO_0000218,,,,A,3673,9615.0,50588,Cmax in dog plasma after 1mg/kg oral dose,1,N,11403,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL623785,1969.0,BAO_0000218,,,,A,14431,9615.0,50588,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,1,N,11404,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL623786,1969.0,BAO_0000218,,,,A,14431,10116.0,50597,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,1,N,11405,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623787,,BAO_0000218,,,,A,14964,10116.0,50597,Oral maximum concentration in rat,1,N,11406,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623788,,BAO_0000218,,,,A,14964,10116.0,50597,Oral maximum concentration in rat,1,N,11407,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623789,1969.0,BAO_0000218,,,,A,14209,10090.0,50594,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,1,N,11408,In vivo,Mus musculus,Plasma,1,,Intermediate
,,,CHEMBL623790,178.0,BAO_0000218,,,,A,11355,10090.0,50594,Peak concentration in blood after intravenous administration to mice,1,N,11409,In vivo,Mus musculus,Blood,1,,Intermediate
,,,CHEMBL623791,178.0,BAO_0000218,,,,A,11355,10090.0,50594,Peak concentration in blood after peroral administration to mice,1,N,11410,In vivo,Mus musculus,Blood,1,,Intermediate
,,,CHEMBL623792,1969.0,BAO_0000218,,,,A,11966,10116.0,50597,Peak concentration in rat plasma was determined,1,N,11411,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623793,1969.0,BAO_0000218,,,,A,8918,314293.0,22224,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,1,U,11412,In vivo,Simiiformes,Plasma,0,,Autocuration
,,,CHEMBL623794,1969.0,BAO_0000218,,,,A,8918,10090.0,50594,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,1,N,11413,In vivo,Mus musculus,Plasma,1,,Intermediate
,,,CHEMBL623795,1969.0,BAO_0000218,,,,A,8918,10116.0,50597,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,1,N,11414,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623796,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",1,N,11415,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623797,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",1,N,11416,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623798,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",1,N,11417,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623799,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",1,N,11418,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624490,160.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",1,N,11419,,Rattus norvegicus,Intestine,1,,Intermediate
,,,CHEMBL624491,160.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",1,N,11420,,Rattus norvegicus,Intestine,1,,Intermediate
,,,CHEMBL624492,160.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",1,N,11421,,Rattus norvegicus,Intestine,1,,Intermediate
,,,CHEMBL624493,160.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",1,N,11422,,Rattus norvegicus,Intestine,1,,Intermediate
,,,CHEMBL877595,160.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",1,N,11423,,Rattus norvegicus,Intestine,1,,Intermediate
,,,CHEMBL624494,160.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",1,N,11424,,Rattus norvegicus,Intestine,1,,Intermediate
,,,CHEMBL624495,160.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",1,N,11425,,Rattus norvegicus,Intestine,1,,Intermediate
,,,CHEMBL624681,160.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",1,N,11426,,Rattus norvegicus,Intestine,1,,Intermediate
,,,CHEMBL624682,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",1,N,11427,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624683,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",1,N,11428,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624684,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",1,N,11429,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624685,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",1,N,11430,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624686,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",1,N,11431,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624687,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",1,N,11432,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624688,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",1,N,11433,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627161,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",1,N,11434,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622127,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",1,N,11435,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622128,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",1,N,11436,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL874384,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",1,N,11437,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624898,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",1,N,11438,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624899,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",1,N,11439,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624900,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",1,N,11440,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624901,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",1,N,11441,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624902,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",1,N,11442,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624903,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",1,N,11443,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624904,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",1,N,11444,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624905,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",1,N,11445,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624906,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",1,N,11446,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624907,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",1,N,11447,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624908,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",1,N,11448,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624909,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",1,N,11449,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624910,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",1,N,11450,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624911,2385.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",1,N,11451,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL874388,2385.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",1,N,11452,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL624912,2385.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",1,N,11453,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL622930,2385.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",1,N,11454,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL623121,2385.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",1,N,11455,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL623122,2385.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",1,N,11456,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL623123,2385.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",1,N,11457,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL623124,2385.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",1,N,11458,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL623125,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",1,N,11459,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623126,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",1,N,11460,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623127,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",1,N,11461,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623128,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",1,N,11462,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623129,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",1,N,11463,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623130,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",1,N,11464,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623131,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",1,N,11465,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623132,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",1,N,11466,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623133,2107.0,BAO_0000218,,,,A,8319,10116.0,50597,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,1,N,11467,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL623134,,BAO_0000218,,,,A,8319,10116.0,50597,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,1,N,11468,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL874389,,BAO_0000218,,,,A,8319,10116.0,50597,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,1,N,11469,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623135,,BAO_0000218,,,,A,8319,10116.0,50597,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,1,N,11470,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623136,,BAO_0000218,,,,A,8319,10116.0,50597,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,1,N,11471,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623137,,BAO_0000218,,,,A,8319,10116.0,50597,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,1,N,11472,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623138,,BAO_0000218,,,,A,8319,10116.0,50597,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,1,N,11473,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623139,2113.0,BAO_0000218,,,,A,8319,10116.0,50597,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,1,N,11474,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL623140,2113.0,BAO_0000218,,,,A,8319,10116.0,50597,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,1,N,11475,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL623141,2107.0,BAO_0000218,,,,A,8319,10116.0,50597,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,1,N,11476,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL623142,2107.0,BAO_0000218,,,,A,8319,10116.0,50597,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,1,N,11477,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL623143,,BAO_0000218,,,,A,8319,10116.0,50597,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,1,N,11478,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623144,1088.0,BAO_0000218,,,,A,14571,10090.0,50594,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,1,N,11479,,Mus musculus,Urine,1,,Intermediate
,,,CHEMBL623405,1088.0,BAO_0000218,,,,A,14571,10116.0,50597,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,1,N,11480,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL624074,,BAO_0000218,,,,A,8319,10116.0,50597,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,1,N,11481,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624075,,BAO_0000218,,,,A,8319,10116.0,50597,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,1,N,11482,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624076,,BAO_0000218,,,,A,8319,10116.0,50597,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,1,N,11483,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624077,,BAO_0000218,,,,A,8319,10116.0,50597,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,1,N,11484,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624078,,BAO_0000218,,,,A,8319,10116.0,50597,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,1,N,11485,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624079,2113.0,BAO_0000218,,,,A,8319,10116.0,50597,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,1,N,11486,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL624261,2113.0,BAO_0000218,,,,A,8319,10116.0,50597,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,1,N,11487,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL624262,,BAO_0000218,,,,A,8319,10116.0,50597,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,1,N,11488,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624263,,BAO_0000218,,,,A,8319,10116.0,50597,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,1,N,11489,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624264,,BAO_0000218,,,,A,8319,10116.0,50597,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,1,N,11490,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624265,,BAO_0000218,,,,A,8319,10116.0,50597,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,1,N,11491,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624266,,BAO_0000218,,,,A,8319,10116.0,50597,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,1,N,11492,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624267,,BAO_0000218,,,,A,8319,10116.0,50597,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,1,N,11493,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624268,,BAO_0000218,,,,A,8319,10116.0,50597,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,1,N,11494,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL875227,,BAO_0000218,,,,A,8319,10116.0,50597,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,1,N,11495,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624269,2113.0,BAO_0000218,,,,A,8319,10116.0,50597,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,1,N,11496,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL624270,2113.0,BAO_0000218,,,,A,8319,10116.0,50597,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,1,N,11497,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL624271,,BAO_0000218,,,,A,8319,10116.0,50597,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,1,N,11498,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624272,,BAO_0000218,,,,A,8319,10116.0,50597,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,1,N,11499,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624273,,BAO_0000218,,,,A,8319,10116.0,50597,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,1,N,11500,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624274,1088.0,BAO_0000218,,,,A,12064,10116.0,50597,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,1,N,11501,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL624275,1088.0,BAO_0000218,,,,A,12064,10116.0,50597,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,1,N,11502,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL624276,1088.0,BAO_0000218,,,,A,12064,10116.0,50597,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,1,N,11503,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL624277,1088.0,BAO_0000218,,,,A,12038,10116.0,50597,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,1,N,11504,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL624278,,BAO_0000019,,,,A,14314,,22224,% dose converted to 2-amino-5-chlorophenyl sulfate,1,U,11505,,,,0,,Autocuration
,,,CHEMBL624279,,BAO_0000019,,,,A,14314,,22224,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),1,U,11506,,,,0,,Autocuration
,,,CHEMBL624280,1988.0,BAO_0000218,,,,A,11488,10116.0,50597,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",1,N,11507,,Rattus norvegicus,Feces,1,,Intermediate
,,,CHEMBL624281,1988.0,BAO_0000218,,,,A,11488,10116.0,50597,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",1,N,11508,,Rattus norvegicus,Feces,1,,Intermediate
,,,CHEMBL622933,1988.0,BAO_0000218,,,,A,11488,10116.0,50597,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",1,N,11509,,Rattus norvegicus,Feces,1,,Intermediate
,,,CHEMBL622934,1988.0,BAO_0000218,,,,A,11488,10116.0,50597,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",1,N,11510,,Rattus norvegicus,Feces,1,,Intermediate
,,,CHEMBL622935,2107.0,BAO_0000218,,,,A,8829,10116.0,50597,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,1,N,11511,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622936,2107.0,BAO_0000218,,,,A,8829,10116.0,50597,Biodistribution in Rat liver after 5 minutes of iv administration,1,N,11512,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL875228,2107.0,BAO_0000218,,,,A,8829,10116.0,50597,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,1,N,11513,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622937,2048.0,BAO_0000218,,,,A,8829,10116.0,50597,Biodistribution in Rat lung after 24 hours of iv administration,1,N,11514,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL622938,2048.0,BAO_0000218,,,,A,8829,10116.0,50597,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,1,N,11515,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL619736,2048.0,BAO_0000218,,,,A,8829,10116.0,50597,Biodistribution in Rat lung after 30 minutes of iv administration,1,N,11516,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL625117,2048.0,BAO_0000218,,,,A,8829,10116.0,50597,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,1,N,11517,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL625118,2048.0,BAO_0000218,,,,A,8829,10116.0,50597,Biodistribution in Rat lung after 5 minutes of iv administration,1,N,11518,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL625119,2048.0,BAO_0000218,,,,A,8829,10116.0,50597,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,1,N,11519,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL625120,2037.0,BAO_0000218,,,,A,14972,10116.0,50597,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",1,N,11520,In vivo,Rattus norvegicus,Cerebellum,1,,Intermediate
,,,CHEMBL625121,,BAO_0000218,,,,A,14972,10116.0,50597,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",1,N,11521,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625122,10000006.0,BAO_0000218,,,,A,14972,10116.0,50597,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",1,N,11522,In vivo,Rattus norvegicus,Thalamus,1,,Intermediate
,,,CHEMBL622204,178.0,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,N,11523,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL877503,178.0,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,N,11524,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627127,178.0,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,N,11525,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627128,10000000.0,BAO_0000218,,,,A,14608,,22224,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,U,11526,In vivo,,Hippocampus,0,,Autocuration
,,,CHEMBL627129,10000000.0,BAO_0000218,,,,A,14608,,22224,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,U,11527,In vivo,,Hippocampus,0,,Autocuration
,,,CHEMBL627130,10000000.0,BAO_0000218,,,,A,14608,,22224,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,U,11528,In vivo,,Hippocampus,0,,Autocuration
,,,CHEMBL627131,955.0,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,N,11529,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL627132,955.0,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,N,11530,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL627133,955.0,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,N,11531,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL627134,2037.0,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,N,11532,In vivo,Rattus norvegicus,Cerebellum,1,,Intermediate
,,,CHEMBL627135,2037.0,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,N,11533,In vivo,Rattus norvegicus,Cerebellum,1,,Intermediate
,,,CHEMBL627136,2037.0,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,N,11534,In vivo,Rattus norvegicus,Cerebellum,1,,Intermediate
,,,CHEMBL628435,,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,N,11535,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628436,,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,N,11536,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628437,,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,N,11537,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628438,948.0,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,N,11538,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL628439,948.0,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,N,11539,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL628440,948.0,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,N,11540,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL628441,10000000.0,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,N,11541,In vivo,Rattus norvegicus,Hippocampus,1,,Intermediate
,,,CHEMBL628442,10000000.0,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,N,11542,In vivo,Rattus norvegicus,Hippocampus,1,,Intermediate
,,,CHEMBL628443,10000000.0,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,N,11543,In vivo,Rattus norvegicus,Hippocampus,1,,Intermediate
,,,CHEMBL628444,2113.0,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,N,11544,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL628445,2113.0,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,N,11545,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL877504,2113.0,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,N,11546,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL628446,2107.0,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,N,11547,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL626874,2107.0,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,N,11548,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL626875,2107.0,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,N,11549,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL626876,2048.0,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,N,11550,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL626877,2048.0,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,N,11551,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL626878,2048.0,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,N,11552,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL626879,2385.0,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,N,11553,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL626880,1969.0,BAO_0000218,,,,A,8918,314293.0,22224,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,1,U,11554,In vivo,Simiiformes,Plasma,0,,Autocuration
,,,CHEMBL626881,1969.0,BAO_0000218,,,,A,8918,10090.0,50594,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,1,N,11555,In vivo,Mus musculus,Plasma,1,,Intermediate
,,,CHEMBL626882,1969.0,BAO_0000218,,,,A,8918,10116.0,50597,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,1,N,11556,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626883,1969.0,BAO_0000218,,,,A,14470,9615.0,50588,Peak plasma concentration was measured in dogs,1,N,11557,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL626884,,BAO_0000218,,,,A,14393,10116.0,50597,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,1,N,11558,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626885,,BAO_0000218,,,,A,14886,10116.0,50597,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,1,N,11559,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626886,,BAO_0000218,,,,A,14886,10116.0,50597,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,1,N,11560,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626887,,BAO_0000218,,,,A,14886,10116.0,50597,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,1,N,11561,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626888,,BAO_0000218,,,,A,14393,10116.0,50597,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,1,N,11562,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626889,,BAO_0000218,,,,A,13465,9615.0,50588,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,1,N,11563,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626761,,BAO_0000218,,,,A,13465,314293.0,22224,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,1,U,11564,In vivo,Simiiformes,,0,,Autocuration
,,,CHEMBL626762,,BAO_0000218,,,,A,13465,9615.0,50588,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,1,N,11565,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626763,,BAO_0000218,,,,A,13465,9615.0,50588,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,1,N,11566,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626764,,BAO_0000218,,,,A,13465,10116.0,50597,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,1,N,11567,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626765,,BAO_0000218,,,,A,13465,10116.0,50597,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,1,N,11568,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626766,,BAO_0000218,,,,A,13465,9615.0,50588,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,1,N,11569,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626767,,BAO_0000218,,,,A,13465,10116.0,50597,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,1,N,11570,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626768,,BAO_0000218,,,,A,13465,10116.0,50597,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,1,N,11571,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626769,,BAO_0000218,,,,A,13465,9615.0,50588,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,1,N,11572,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL874463,,BAO_0000218,,,,A,13465,9615.0,50588,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,1,N,11573,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626770,,BAO_0000218,,,,A,13465,314293.0,22224,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,1,U,11574,In vivo,Simiiformes,,0,,Autocuration
,,,CHEMBL626771,,BAO_0000218,,,,A,13465,314293.0,22224,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,1,U,11575,In vivo,Simiiformes,,0,,Autocuration
,,,CHEMBL626772,,BAO_0000218,,,,A,13465,10116.0,50597,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,1,N,11576,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626773,,BAO_0000218,,,,A,14731,9541.0,100710,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,1,N,11577,In vivo,Macaca fascicularis,,1,,Intermediate
,,,CHEMBL626774,,BAO_0000218,,,,A,14731,10090.0,50594,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,1,N,11578,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL626775,,BAO_0000218,,,,A,13376,9615.0,50588,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,1,N,11579,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626776,,BAO_0000218,,,,A,13376,9615.0,50588,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,1,N,11580,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626777,,BAO_0000218,,,,A,14443,10116.0,50597,Maximum concentration (Cmax) in rat when administered orally,1,N,11581,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626778,1969.0,BAO_0000218,,,,A,13465,314293.0,22224,Maximal concentration in monkey plasma after 25 mg/kg oral dose,1,U,11582,In vivo,Simiiformes,Plasma,0,,Autocuration
,,,CHEMBL626779,,BAO_0000218,,,,A,16359,10116.0,22224,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",1,U,11583,In vivo,Rattus norvegicus,,0,,Autocuration
,,,CHEMBL626780,,BAO_0000218,,,,A,16359,10116.0,22224,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",1,U,11584,In vivo,Rattus norvegicus,,0,,Autocuration
,,,CHEMBL626781,1969.0,BAO_0000218,,,,A,15618,,22224,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,1,U,11585,In vivo,,Plasma,0,,Autocuration
,,,CHEMBL632164,,BAO_0000218,,,,A,14554,10116.0,50597,Pharmacokinetic profile Cmax was evaluated in rats,1,N,11586,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL632165,,BAO_0000218,,,,A,11537,9615.0,50588,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),1,N,11587,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL632166,,BAO_0000218,,,,A,11537,10090.0,50594,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),1,N,11588,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL632167,,BAO_0000218,,,,A,11537,9615.0,50588,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),1,N,11589,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL632168,,BAO_0000218,,,,A,11537,10090.0,50594,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),1,N,11590,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL632169,1969.0,BAO_0000218,,,,A,2021,10116.0,22224,Cmax in rat plasma,1,U,11591,In vivo,Rattus norvegicus,Plasma,0,,Autocuration
,,,CHEMBL632170,1969.0,BAO_0000218,,,,A,5932,9615.0,50588,Cmax in dog plasma after 30mg/kg oral dose,1,N,11592,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL632171,1969.0,BAO_0000218,,,,A,5932,10116.0,50597,Cmax in rat plasma after 30mg/kg oral dose,1,N,11593,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL632172,1969.0,BAO_0000218,,,,A,17320,10116.0,50597,Plasma level in rats at 30 mg/kg,1,N,11594,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL632173,1969.0,BAO_0000218,,,,A,15831,10090.0,50594,Tested for maximum plasma concentration in mice,1,N,11595,In vivo,Mus musculus,Plasma,1,,Intermediate
,,,CHEMBL632174,,BAO_0000218,,,,A,15078,10116.0,50597,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",1,N,11596,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL632175,,BAO_0000218,,,,A,14941,10116.0,50597,The Cmax values in female wistar rats.,1,N,11597,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL632176,1969.0,BAO_0000218,,,,A,15343,9615.0,50588,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,1,N,11598,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL632177,1969.0,BAO_0000218,,,,A,15343,10116.0,50597,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,1,N,11599,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL632178,1969.0,BAO_0000218,,,,A,14856,10116.0,50597,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,1,N,11600,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL632179,,BAO_0000218,,,,A,13129,10116.0,50597,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,1,N,11601,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL632180,178.0,BAO_0000218,,,,A,13098,10116.0,50597,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,1,N,11602,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL632181,178.0,BAO_0000218,,,,A,13098,10116.0,50597,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,1,N,11603,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL632182,178.0,BAO_0000218,,,,A,13098,10116.0,50597,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,1,N,11604,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL632183,178.0,BAO_0000218,,,,A,15478,10090.0,22224,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,1,U,11605,In vivo,Mus musculus,Blood,0,,Autocuration
,,,CHEMBL632184,,BAO_0000218,,,,A,15341,9615.0,50588,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,1,N,11606,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL874470,,BAO_0000218,,,,A,15341,10116.0,50597,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,1,N,11607,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631302,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",1,N,11608,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631303,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",1,N,11609,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631304,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",1,N,11610,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631305,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",1,N,11611,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631306,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",1,N,11612,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631307,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",1,N,11613,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631308,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",1,N,11614,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625557,,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",1,N,11615,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625558,2106.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",1,N,11616,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL625559,2106.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",1,N,11617,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL625560,2106.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",1,N,11618,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL625561,2106.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",1,N,11619,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL625562,2106.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",1,N,11620,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL875320,2106.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",1,N,11621,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL625563,2106.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",1,N,11622,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL625564,2106.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",1,N,11623,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL625565,995.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",1,N,11624,,Rattus norvegicus,Uterus,1,,Intermediate
,,,CHEMBL625566,995.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",1,N,11625,,Rattus norvegicus,Uterus,1,,Intermediate
,,,CHEMBL625567,995.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",1,N,11626,,Rattus norvegicus,Uterus,1,,Intermediate
,,,CHEMBL625568,995.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",1,N,11627,,Rattus norvegicus,Uterus,1,,Intermediate
,,,CHEMBL628217,995.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",1,N,11628,,Rattus norvegicus,Uterus,1,,Intermediate
,,,CHEMBL628218,995.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",1,N,11629,,Rattus norvegicus,Uterus,1,,Intermediate
,,,CHEMBL628219,995.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",1,N,11630,,Rattus norvegicus,Uterus,1,,Intermediate
,,,CHEMBL628220,995.0,BAO_0000218,,,,A,8684,10116.0,50597,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",1,N,11631,,Rattus norvegicus,Uterus,1,,Intermediate
,,,CHEMBL628221,,BAO_0000019,,,,A,8926,,22224,Distribution in the blood after 120 min of intravenous administration,1,U,11632,,,,0,,Autocuration
,,,CHEMBL628222,,BAO_0000019,,,,A,8926,,22224,Distribution in the blood after 15 min of intravenous administration,1,U,11633,,,,0,,Autocuration
,,,CHEMBL628223,,BAO_0000019,,,,A,8926,,22224,Distribution in the blood after 30 min of intravenous administration,1,U,11634,,,,0,,Autocuration
,,,CHEMBL628224,,BAO_0000019,,,,A,8926,,22224,Distribution in the blood after 5 min of intravenous administration,1,U,11635,,,,0,,Autocuration
,,,CHEMBL628225,,BAO_0000019,,,,A,8926,,22224,Distribution in the blood after 60 min of intravenous administration,1,U,11636,,,,0,,Autocuration
,,,CHEMBL628226,,BAO_0000019,,,,A,8926,,22224,Distribution in the blood after 90 min of intravenous administration,1,U,11637,,,,0,,Autocuration
,,,CHEMBL628227,,BAO_0000019,,,,A,8926,,22224,Distribution in the bone after 120 min of intravenous administration,1,U,11638,,,,0,,Autocuration
,,,CHEMBL875481,,BAO_0000019,,,,A,8926,,22224,Distribution in the bone after 15 min of intravenous administration,1,U,11639,,,,0,,Autocuration
,,,CHEMBL628228,,BAO_0000019,,,,A,8926,,22224,Distribution in the bone after 30 min of intravenous administration,1,U,11640,,,,0,,Autocuration
,,,CHEMBL628229,,BAO_0000019,,,,A,8926,,22224,Distribution in the bone after 5 min of intravenous administration,1,U,11641,,,,0,,Autocuration
,,,CHEMBL628230,,BAO_0000019,,,,A,8926,,22224,Distribution in the bone after 60 min of intravenous administration,1,U,11642,,,,0,,Autocuration
,,,CHEMBL628231,,BAO_0000019,,,,A,8926,,22224,Distribution in the bone after 90 min of intravenous administration,1,U,11643,,,,0,,Autocuration
,,,CHEMBL628232,,BAO_0000019,,,,A,8926,,22224,Distribution in the heart after 120 min of intravenous administration,1,U,11644,,,,0,,Autocuration
,,,CHEMBL628233,,BAO_0000019,,,,A,8926,,22224,Distribution in the heart after 15 min of intravenous administration,1,U,11645,,,,0,,Autocuration
,,,CHEMBL628234,,BAO_0000019,,,,A,8926,,22224,Distribution in the heart after 30 min of intravenous administration,1,U,11646,,,,0,,Autocuration
,,,CHEMBL628235,,BAO_0000019,,,,A,8926,,22224,Distribution in the heart after 5 min of intravenous administration,1,U,11647,,,,0,,Autocuration
,,,CHEMBL628236,,BAO_0000019,,,,A,8926,,22224,Distribution in the heart after 60 min of intravenous administration,1,U,11648,,,,0,,Autocuration
,,,CHEMBL628237,,BAO_0000019,,,,A,8926,,22224,Distribution in the heart after 90 min of intravenous administration,1,U,11649,,,,0,,Autocuration
,,,CHEMBL628238,,BAO_0000019,,,,A,8926,,22224,Distribution in the kidneys after 120 min of intravenous administration,1,U,11650,,,,0,,Autocuration
,,,CHEMBL628239,,BAO_0000019,,,,A,8926,,22224,Distribution in the kidneys after 15 min of intravenous administration,1,U,11651,,,,0,,Autocuration
,,,CHEMBL628240,,BAO_0000019,,,,A,8926,,22224,Distribution in the kidneys after 30 min of intravenous administration,1,U,11652,,,,0,,Autocuration
,,,CHEMBL628241,,BAO_0000019,,,,A,8926,,22224,Distribution in the kidneys after 5 min of intravenous administration,1,U,11653,,,,0,,Autocuration
,,,CHEMBL628242,,BAO_0000019,,,,A,8926,,22224,Distribution in the kidneys after 60 min of intravenous administration,1,U,11654,,,,0,,Autocuration
,,,CHEMBL875482,,BAO_0000019,,,,A,8926,,22224,Distribution in the kidneys after 90 min of intravenous administration,1,U,11655,,,,0,,Autocuration
,,,CHEMBL628243,,BAO_0000019,,,,A,8926,,22224,Distribution in the liver after 120 min of intravenous administration,1,U,11656,,,,0,,Autocuration
,,,CHEMBL628244,,BAO_0000019,,,,A,8926,,22224,Distribution in the liver after 15 min of intravenous administration,1,U,11657,,,,0,,Autocuration
,,,CHEMBL628245,,BAO_0000019,,,,A,8926,,22224,Distribution in the liver after 30 min of intravenous administration,1,U,11658,,,,0,,Autocuration
,,,CHEMBL628246,,BAO_0000019,,,,A,8926,,22224,Distribution in the liver after 5 min of intravenous administration,1,U,11659,,,,0,,Autocuration
,,,CHEMBL628247,,BAO_0000019,,,,A,8926,,22224,Distribution in the liver after 60 min of intravenous administration,1,U,11660,,,,0,,Autocuration
,,,CHEMBL628248,,BAO_0000019,,,,A,8926,,22224,Distribution in the liver after 90 min of intravenous administration,1,U,11661,,,,0,,Autocuration
,,,CHEMBL628249,,BAO_0000019,,,,A,8926,,22224,Distribution in the lung after 120 min of intravenous administration,1,U,11662,,,,0,,Autocuration
,,,CHEMBL625452,,BAO_0000218,,,,A,14839,10090.0,50594,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",1,N,11663,,Mus musculus,,1,,Intermediate
,,,CHEMBL625453,,BAO_0000218,,,,A,14839,10090.0,50594,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",1,N,11664,,Mus musculus,,1,,Intermediate
,,,CHEMBL625454,,BAO_0000218,,,,A,14839,10090.0,50594,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",1,N,11665,,Mus musculus,,1,,Intermediate
,,,CHEMBL623844,,BAO_0000218,,,,A,14839,10090.0,50594,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",1,N,11666,,Mus musculus,,1,,Intermediate
,,,CHEMBL623845,,BAO_0000218,,,,A,12178,10116.0,50597,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,1,N,11667,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623846,,BAO_0000218,,,,A,12178,10116.0,50597,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,1,N,11668,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623847,,BAO_0000218,,,,A,12178,,22224,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,1,U,11669,,,,0,,Autocuration
,,,CHEMBL623848,,BAO_0000218,,,,A,12186,9541.0,100710,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,1,N,11670,,Macaca fascicularis,,1,,Intermediate
,,,CHEMBL623849,,BAO_0000218,,,,A,12186,9541.0,100710,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,1,N,11671,,Macaca fascicularis,,1,,Intermediate
,,,CHEMBL623850,,BAO_0000218,,,,A,12186,9541.0,100710,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,1,N,11672,,Macaca fascicularis,,1,,Intermediate
,,,CHEMBL623851,,BAO_0000218,,,,A,12186,9541.0,100710,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,1,N,11673,,Macaca fascicularis,,1,,Intermediate
,,,CHEMBL623852,,BAO_0000218,,,,A,12187,314293.0,22224,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,1,U,11674,,Simiiformes,,0,,Autocuration
,,,CHEMBL624551,,BAO_0000218,,,,A,12187,9669.0,50506,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,1,N,11675,,Mustela putorius furo,,1,,Intermediate
,,,CHEMBL624552,,BAO_0000218,,,,A,12187,9669.0,50506,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",1,N,11676,,Mustela putorius furo,,1,,Intermediate
,,,CHEMBL624553,,BAO_0000218,,,,A,12187,314293.0,22224,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,1,U,11677,,Simiiformes,,0,,Autocuration
,,,CHEMBL624554,,BAO_0000218,,,,A,12187,314293.0,22224,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,1,U,11678,,Simiiformes,,0,,Autocuration
,,,CHEMBL624555,,BAO_0000218,,,,A,12187,10116.0,50597,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,1,N,11679,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624741,,BAO_0000218,,,,A,12187,10116.0,50597,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",1,N,11680,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624742,,BAO_0000218,,,,A,14122,9615.0,50588,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",1,N,11681,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624743,,BAO_0000218,,,,A,14122,10026.0,100712,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",1,N,11682,,Cricetinae,,1,,Intermediate
,,,CHEMBL877606,,BAO_0000218,,,,A,14122,10116.0,50597,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",1,N,11683,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624744,,BAO_0000218,,,,A,13391,,22224,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,1,U,11684,,,,0,,Autocuration
,,,CHEMBL624745,178.0,BAO_0000218,,,,A,13391,,22224,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,1,U,11685,,,Blood,0,,Autocuration
,,,CHEMBL624746,178.0,BAO_0000218,,,,A,13391,,22224,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,1,U,11686,,,Blood,0,,Autocuration
,,,CHEMBL624747,178.0,BAO_0000218,,,,A,13391,,22224,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,1,U,11687,,,Blood,0,,Autocuration
,,,CHEMBL624748,,BAO_0000019,,,,A,16360,,22224,Oral absorption expressed as Area under curve was determined,1,U,11688,,,,0,,Autocuration
,,,CHEMBL622504,,BAO_0000218,,,,A,3673,9615.0,50588,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,1,N,11689,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL622505,,BAO_0000218,,,,A,14122,9615.0,50588,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",1,N,11690,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL622506,,BAO_0000218,,,,A,14122,10026.0,100712,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",1,N,11691,,Cricetinae,,1,,Intermediate
,,,CHEMBL622507,,BAO_0000218,,,,A,14122,10026.0,100712,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",1,N,11692,,Cricetinae,,1,,Intermediate
,,,CHEMBL622508,,BAO_0000218,,,,A,14122,10116.0,50597,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",1,N,11693,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622509,,BAO_0000019,,,,A,13889,,22224,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,1,U,11694,,,,0,,Autocuration
,,,CHEMBL622510,,BAO_0000218,,,,A,14393,10116.0,50597,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,1,N,11695,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622511,,BAO_0000218,,,,A,17279,10116.0,50597,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),1,N,11696,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622512,,BAO_0000218,,,,A,14548,9541.0,100710,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,1,N,11697,,Macaca fascicularis,,1,,Intermediate
,,,CHEMBL622513,,BAO_0000218,,,,A,14548,9541.0,100710,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,1,N,11698,,Macaca fascicularis,,1,,Intermediate
,,,CHEMBL622514,,BAO_0000218,,,,A,14548,9541.0,100710,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,1,N,11699,,Macaca fascicularis,,1,,Intermediate
,,,CHEMBL622515,,BAO_0000218,,,,A,14548,9615.0,50588,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,1,N,11700,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL622516,,BAO_0000218,,,,A,14548,9615.0,50588,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,1,N,11701,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL622517,,BAO_0000218,,,,A,14548,10116.0,50597,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,1,N,11702,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622518,,BAO_0000218,,,,A,14548,10116.0,50597,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,1,N,11703,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622519,,BAO_0000218,,,,A,14548,10116.0,50597,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,1,N,11704,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622520,2385.0,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,N,11705,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL622521,2385.0,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,N,11706,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL625113,14.0,BAO_0000218,,,,A,14608,10090.0,50594,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,N,11707,In vivo,Mus musculus,Zone of skin,1,,Intermediate
,,,CHEMBL625114,14.0,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,N,11708,In vivo,Rattus norvegicus,Zone of skin,1,,Intermediate
,,,CHEMBL874397,14.0,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,N,11709,In vivo,Rattus norvegicus,Zone of skin,1,,Intermediate
,,,CHEMBL625115,2106.0,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,N,11710,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL625116,2106.0,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,N,11711,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL623932,2106.0,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,N,11712,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL623933,2435.0,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,N,11713,In vivo,Rattus norvegicus,Striatum,1,,Intermediate
,,,CHEMBL623934,2435.0,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,N,11714,In vivo,Rattus norvegicus,Striatum,1,,Intermediate
,,,CHEMBL623935,2435.0,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,N,11715,In vivo,Rattus norvegicus,Striatum,1,,Intermediate
,,,CHEMBL623936,2046.0,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,N,11716,In vivo,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL623937,2046.0,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,N,11717,In vivo,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL623938,2046.0,BAO_0000218,,,,A,14608,10116.0,50597,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,N,11718,In vivo,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL623939,,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,1,N,11719,,Mus musculus,,1,,Intermediate
,,,CHEMBL623940,,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,1,N,11720,,Mus musculus,,1,,Intermediate
,,,CHEMBL623941,,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,1,N,11721,,Mus musculus,,1,,Intermediate
,,,CHEMBL627216,,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,N,11722,,Mus musculus,,1,,Intermediate
,,,CHEMBL623942,,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,N,11723,,Mus musculus,,1,,Intermediate
,,,CHEMBL618793,955.0,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,1,N,11724,,Mus musculus,Brain,1,,Intermediate
,,,CHEMBL618794,955.0,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,N,11725,,Mus musculus,Brain,1,,Intermediate
,,,CHEMBL618795,955.0,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,N,11726,,Mus musculus,Brain,1,,Intermediate
,,,CHEMBL618796,,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,N,11727,,Mus musculus,,1,,Intermediate
,,,CHEMBL618797,,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,N,11728,,Mus musculus,,1,,Intermediate
,,,CHEMBL618798,2113.0,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,1,N,11729,,Mus musculus,Kidney,1,,Intermediate
,,,CHEMBL618799,2113.0,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,1,N,11730,,Mus musculus,Kidney,1,,Intermediate
,,,CHEMBL618800,2113.0,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,1,N,11731,,Mus musculus,Kidney,1,,Intermediate
,,,CHEMBL618801,2113.0,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,1,N,11732,,Mus musculus,Kidney,1,,Intermediate
,,,CHEMBL618802,2113.0,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,N,11733,,Mus musculus,Kidney,1,,Intermediate
,,,CHEMBL618803,2113.0,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,N,11734,,Mus musculus,Kidney,1,,Intermediate
,,,CHEMBL618804,2107.0,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,1,N,11735,,Mus musculus,Liver,1,,Intermediate
,,,CHEMBL618805,2107.0,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,1,N,11736,,Mus musculus,Liver,1,,Intermediate
,,,CHEMBL618806,2107.0,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,1,N,11737,,Mus musculus,Liver,1,,Intermediate
,,,CHEMBL618807,2107.0,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,1,N,11738,,Mus musculus,Liver,1,,Intermediate
,,,CHEMBL618808,2107.0,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,N,11739,,Mus musculus,Liver,1,,Intermediate
,,,CHEMBL618809,2107.0,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,N,11740,,Mus musculus,Liver,1,,Intermediate
,,,CHEMBL618810,2385.0,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,1,N,11741,,Mus musculus,Muscle tissue,1,,Intermediate
,,,CHEMBL618811,2385.0,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,1,N,11742,,Mus musculus,Muscle tissue,1,,Intermediate
,,,CHEMBL875844,2385.0,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,1,N,11743,,Mus musculus,Muscle tissue,1,,Intermediate
,,,CHEMBL618812,2385.0,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,N,11744,,Mus musculus,Muscle tissue,1,,Intermediate
,,,CHEMBL618813,2385.0,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,N,11745,,Mus musculus,Muscle tissue,1,,Intermediate
,,,CHEMBL618814,,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,1,N,11746,,Mus musculus,,1,,Intermediate
,,,CHEMBL618815,,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,N,11747,,Mus musculus,,1,,Intermediate
,,,CHEMBL618816,,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,N,11748,,Mus musculus,,1,,Intermediate
,,,CHEMBL618817,,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,N,11749,,Mus musculus,,1,,Intermediate
,,,CHEMBL620544,,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,N,11750,,Mus musculus,,1,,Intermediate
,,,CHEMBL626230,,BAO_0000218,,,,A,15341,10116.0,50597,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,1,N,11751,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626231,,BAO_0000218,,,,A,15341,10116.0,50597,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,1,N,11752,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626232,,BAO_0000218,,,,A,15341,10116.0,50597,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,1,N,11753,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626233,1969.0,BAO_0000218,,,,A,14906,9615.0,50588,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,1,N,11754,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL626234,1969.0,BAO_0000218,,,,A,14906,10116.0,50597,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,1,N,11755,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL875341,1969.0,BAO_0000218,,,,A,14906,10116.0,50597,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,1,N,11756,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626235,1969.0,BAO_0000218,,,,A,14215,9606.0,50587,The maximum plasma concentration (100 mg/kg) administered orally in human,1,N,11757,In vivo,Homo sapiens,Plasma,1,,Intermediate
,,,CHEMBL626236,1969.0,BAO_0000218,,,,A,14215,9481.0,22224,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,1,U,11758,In vivo,Callithrix,Plasma,0,,Autocuration
,,,CHEMBL626237,1969.0,BAO_0000218,,,,A,14215,314293.0,22224,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,1,U,11759,In vivo,Simiiformes,Plasma,0,,Autocuration
,,,CHEMBL626238,1969.0,BAO_0000218,,,,A,14215,9615.0,50588,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,1,N,11760,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL622412,1969.0,BAO_0000218,,,,A,14215,9606.0,50587,The maximum plasma concentration (200 mg/kg) administered orally in human,1,N,11761,In vivo,Homo sapiens,Plasma,1,,Intermediate
,,,CHEMBL623114,1969.0,BAO_0000218,,,,A,14215,10116.0,50597,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,1,N,11762,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623115,1969.0,BAO_0000218,,,,A,14215,9481.0,22224,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,1,U,11763,In vivo,Callithrix,Plasma,0,,Autocuration
,,,CHEMBL623116,1969.0,BAO_0000218,,,,A,14215,314293.0,22224,The maximum plasma concentration (25 mg/kg) administered orally in monkey,1,U,11764,In vivo,Simiiformes,Plasma,0,,Autocuration
,,,CHEMBL623117,1969.0,BAO_0000218,,,,A,14215,9615.0,22224,The maximum plasma concentration (30 mg/kg) administered orally in dog,1,U,11765,In vivo,Canis lupus familiaris,Plasma,0,,Autocuration
,,,CHEMBL623118,1969.0,BAO_0000218,,,,A,14215,9606.0,50587,The maximum plasma concentration (400 mg/kg) administered orally in human,1,N,11766,In vivo,Homo sapiens,Plasma,1,,Intermediate
,,,CHEMBL623119,1969.0,BAO_0000218,,,,A,14215,10116.0,50597,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,1,N,11767,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623120,1969.0,BAO_0000218,,,,A,14215,10116.0,50597,The maximum plasma concentration (50 mg/kg) administered orally in rat,1,N,11768,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623286,1969.0,BAO_0000218,,,,A,14215,9606.0,50587,The maximum plasma concentration (800 mg/kg) administered orally in human,1,N,11769,In vivo,Homo sapiens,Plasma,1,,Intermediate
,,,CHEMBL623287,1969.0,BAO_0000218,,,,A,14067,10116.0,50597,The maximum plasma concentration was measured on rats,1,N,11770,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623288,1969.0,BAO_0000218,,,,A,12350,10116.0,50597,The maximum plasma concentration was measured on rats after oral administration,1,N,11771,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623289,1969.0,BAO_0000218,,,,A,14813,10116.0,50597,Plasma drug Cmax in rat (PO dose),1,N,11772,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623290,,BAO_0000218,,,,A,12536,,22224,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,1,U,11773,In vivo,,,0,,Autocuration
,,,CHEMBL623291,1969.0,BAO_0000218,,,,A,14169,9615.0,50588,maximum Plasma concentration in Dog was determined after Peroral administration,1,N,11774,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL623292,1969.0,BAO_0000218,,,,A,14169,10116.0,50597,maximum Plasma concentration in Rats was determined after Peroral administration,1,N,11775,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623293,1969.0,BAO_0000218,,,,A,15604,9615.0,50588,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,1,N,11776,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL623294,1969.0,BAO_0000218,,,,A,15604,314293.0,22224,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,1,U,11777,In vivo,Simiiformes,Plasma,0,,Autocuration
,,,CHEMBL623295,1969.0,BAO_0000218,,,,A,15604,10116.0,50597,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,1,N,11778,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623296,,BAO_0000218,,,,A,14387,10090.0,50594,maximum concentration was measured when administered through oral route in mice,1,N,11779,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL875349,,BAO_0000218,,,,A,15115,10090.0,50594,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,1,N,11780,,Mus musculus,,1,,Intermediate
,,,CHEMBL623297,,BAO_0000019,,,,A,15115,314293.0,22224,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,1,U,11781,,Simiiformes,,0,,Autocuration
,,,CHEMBL623298,,BAO_0000019,,,,A,15115,314293.0,22224,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,1,U,11782,,Simiiformes,,0,,Autocuration
,,,CHEMBL623299,,BAO_0000019,,,,A,15115,314293.0,22224,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,1,U,11783,,Simiiformes,,0,,Autocuration
,,,CHEMBL623300,,BAO_0000218,,,,A,16359,10116.0,50597,Pharmacokinetic parameter was evaluated in rats,1,N,11784,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623301,,BAO_0000218,,,,A,12829,10090.0,50594,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,1,N,11785,,Mus musculus,,1,,Intermediate
,,,CHEMBL623302,,BAO_0000218,,,,A,12829,10090.0,50594,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,1,N,11786,,Mus musculus,,1,,Intermediate
,,,CHEMBL623303,,BAO_0000218,,,,A,12829,10090.0,50594,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,1,N,11787,,Mus musculus,,1,,Intermediate
,,,CHEMBL623304,,BAO_0000218,,,,A,12829,10090.0,50594,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,1,N,11788,,Mus musculus,,1,,Intermediate
,,,CHEMBL623305,,BAO_0000218,,,,A,12829,10090.0,50594,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,1,N,11789,,Mus musculus,,1,,Intermediate
,,,CHEMBL623306,1969.0,BAO_0000218,,,,A,15137,10116.0,50597,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,1,N,11790,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623307,1969.0,BAO_0000218,,,,A,15137,10116.0,50597,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,1,N,11791,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623308,1969.0,BAO_0000218,,,,A,15137,10116.0,50597,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,1,N,11792,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623309,1969.0,BAO_0000218,,,,A,15137,10090.0,50594,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,1,N,11793,,Mus musculus,Plasma,1,,Intermediate
,,,CHEMBL623310,,BAO_0000218,,,,A,13509,10090.0,50594,Plasma Concentration after 120 min of oral administration to mice,1,N,11794,,Mus musculus,,1,,Intermediate
,,,CHEMBL623311,,BAO_0000218,,,,A,13509,10090.0,50594,Plasma Concentration after 30 min of oral administration to mice,1,N,11795,,Mus musculus,,1,,Intermediate
,,,CHEMBL623312,,BAO_0000218,,,,A,13509,9541.0,100710,Plasma Concentration after 60 min of oral administration to mice,1,N,11796,,Macaca fascicularis,,1,,Intermediate
,,,CHEMBL875350,,BAO_0000218,,,,A,13509,10090.0,50594,Plasma Concentration after 60 min of oral administration to mice; Not determined,1,N,11797,,Mus musculus,,1,,Intermediate
,,,CHEMBL628635,,BAO_0000218,,,,A,13509,10090.0,50594,Plasma Concentration after 90 min of oral administration to mice,1,N,11798,,Mus musculus,,1,,Intermediate
,,,CHEMBL628636,,BAO_0000218,,,,A,12064,10116.0,50597,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,1,N,11799,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628637,,BAO_0000218,,,,A,12064,10116.0,50597,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,1,N,11800,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628058,,BAO_0000218,,,,A,12064,10116.0,50597,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,1,N,11801,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628059,,BAO_0000218,,,,A,10677,10116.0,50597,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,1,N,11802,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628060,,BAO_0000218,,,,A,10677,10116.0,50597,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,1,N,11803,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628061,,BAO_0000019,,,,A,8926,,22224,Distribution in the lung after 15 min of intravenous administration,1,U,11804,,,,0,,Autocuration
,,,CHEMBL628062,,BAO_0000019,,,,A,8926,,22224,Distribution in the lung after 30 min of intravenous administration,1,U,11805,,,,0,,Autocuration
,,,CHEMBL628063,,BAO_0000019,,,,A,8926,,22224,Distribution in the lung after 5 min of intravenous administration,1,U,11806,,,,0,,Autocuration
,,,CHEMBL628064,,BAO_0000019,,,,A,8926,,22224,Distribution in the lung after 60 min of intravenous administration,1,U,11807,,,,0,,Autocuration
,,,CHEMBL628065,,BAO_0000019,,,,A,8926,,22224,Distribution in the lung after 90 min of intravenous administration,1,U,11808,,,,0,,Autocuration
,,,CHEMBL628066,2385.0,BAO_0000019,,,,A,8926,,22224,Distribution in the muscle after 120 min of intravenous administration,1,U,11809,,,Muscle tissue,0,,Autocuration
,,,CHEMBL628067,2385.0,BAO_0000019,,,,A,8926,,22224,Distribution in the muscle after 15 min of intravenous administration,1,U,11810,,,Muscle tissue,0,,Autocuration
,,,CHEMBL874646,2385.0,BAO_0000218,,,,A,8926,10090.0,50594,Distribution in the muscle after 30 min of intravenous administration,1,N,11811,,Mus musculus,Muscle tissue,1,,Intermediate
,,,CHEMBL628068,2385.0,BAO_0000019,,,,A,8926,,22224,Distribution in the muscle after 5 min of intravenous administration,1,U,11812,,,Muscle tissue,0,,Autocuration
,,,CHEMBL628069,2385.0,BAO_0000019,,,,A,8926,,22224,Distribution in the muscle after 60 min of intravenous administration,1,U,11813,,,Muscle tissue,0,,Autocuration
,,,CHEMBL628070,2385.0,BAO_0000019,,,,A,8926,,22224,Distribution in the muscle after 90 min of intravenous administration,1,U,11814,,,Muscle tissue,0,,Autocuration
,,,CHEMBL628071,2106.0,BAO_0000019,,,,A,8926,,22224,Distribution in the spleen after 120 min of intravenous administration,1,U,11815,,,Spleen,0,,Autocuration
,,,CHEMBL628072,2106.0,BAO_0000019,,,,A,8926,,22224,Distribution in the spleen after 15 min of intravenous administration,1,U,11816,,,Spleen,0,,Autocuration
,,,CHEMBL628073,2106.0,BAO_0000019,,,,A,8926,,22224,Distribution in the spleen after 30 min of intravenous administration,1,U,11817,,,Spleen,0,,Autocuration
,,,CHEMBL628074,2106.0,BAO_0000019,,,,A,8926,,22224,Distribution in the spleen after 5 min of intravenous administration,1,U,11818,,,Spleen,0,,Autocuration
,,,CHEMBL628075,2106.0,BAO_0000019,,,,A,8926,,22224,Distribution in the spleen after 60 min of intravenous administration,1,U,11819,,,Spleen,0,,Autocuration
,,,CHEMBL628076,2106.0,BAO_0000019,,,,A,8926,,22224,Distribution in the spleen after 90 min of intravenous administration,1,U,11820,,,Spleen,0,,Autocuration
,,,CHEMBL628077,1235.0,BAO_0000218,,,,A,7570,10116.0,50597,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,1,N,11821,,Rattus norvegicus,Adrenal cortex,1,,Intermediate
,,,CHEMBL628078,178.0,BAO_0000218,,,,A,7570,10116.0,50597,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,1,N,11822,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL628079,2107.0,BAO_0000218,,,,A,7570,10116.0,50597,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,1,N,11823,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL628080,992.0,BAO_0000218,,,,A,7570,10116.0,50597,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,1,N,11824,,Rattus norvegicus,Female gonad,1,,Intermediate
,,,CHEMBL628081,2046.0,BAO_0000218,,,,A,7570,10116.0,50597,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,1,N,11825,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL628082,1235.0,BAO_0000218,,,,A,7570,10116.0,50597,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,1,N,11826,,Rattus norvegicus,Adrenal cortex,1,,Intermediate
,,,CHEMBL874647,178.0,BAO_0000218,,,,A,7570,10116.0,50597,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,1,N,11827,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL626406,2107.0,BAO_0000218,,,,A,7570,10116.0,50597,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,1,N,11828,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL626407,992.0,BAO_0000218,,,,A,7570,10116.0,50597,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,1,N,11829,,Rattus norvegicus,Female gonad,1,,Intermediate
,,,CHEMBL626408,2046.0,BAO_0000218,,,,A,7570,10116.0,50597,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,1,N,11830,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL626409,178.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",1,N,11831,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL626410,178.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",1,N,11832,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL626411,178.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",1,N,11833,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL626412,178.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",1,N,11834,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL626413,178.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",1,N,11835,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL626414,178.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",1,N,11836,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL626415,178.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",1,N,11837,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL626416,178.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",1,N,11838,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627062,178.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",1,N,11839,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627063,178.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",1,N,11840,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627064,178.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",1,N,11841,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627227,178.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",1,N,11842,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627228,178.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",1,N,11843,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627229,178.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",1,N,11844,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL625792,178.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",1,N,11845,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL625793,178.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",1,N,11846,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL625794,178.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",1,N,11847,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL625795,178.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",1,N,11848,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL625796,,BAO_0000218,,,,A,13792,10090.0,50594,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,1,N,11849,,Mus musculus,,1,,Intermediate
,,,CHEMBL625797,,BAO_0000218,,,,A,13376,9615.0,50588,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,1,N,11850,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625798,,BAO_0000218,,,,A,13376,9615.0,50588,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,1,N,11851,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL875613,,BAO_0000218,,,,A,14380,,22224,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,1,U,11852,,,,0,,Autocuration
,,,CHEMBL625799,,BAO_0000218,,,,A,14380,,22224,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,1,U,11853,,,,0,,Autocuration
,,,CHEMBL625800,,BAO_0000218,,,,A,14380,,22224,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,1,U,11854,,,,0,,Autocuration
,,,CHEMBL625801,,BAO_0000218,,,,A,14380,,22224,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,1,U,11855,,,,0,,Autocuration
,,,CHEMBL625802,,BAO_0000218,,,,A,14380,,22224,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,1,U,11856,,,,0,,Autocuration
,,,CHEMBL625803,,BAO_0000218,,,,A,14380,,22224,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,1,U,11857,,,,0,,Autocuration
,,,CHEMBL625804,,BAO_0000019,,,,A,14380,,22224,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,1,U,11858,,,,0,,Autocuration
,,,CHEMBL622530,,BAO_0000218,,,,A,14380,,22224,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,1,U,11859,,,,0,,Autocuration
,,,CHEMBL622531,,BAO_0000218,,,,A,13701,10090.0,50594,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,1,N,11860,,Mus musculus,,1,,Intermediate
,,,CHEMBL622532,,BAO_0000218,,,,A,13701,10090.0,50594,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),1,N,11861,,Mus musculus,,1,,Intermediate
,,,CHEMBL623176,,BAO_0000218,,,,A,13701,10090.0,50594,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),1,N,11862,,Mus musculus,,1,,Intermediate
,,,CHEMBL623177,,BAO_0000218,,,,A,13701,10090.0,50594,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),1,N,11863,,Mus musculus,,1,,Intermediate
,,,CHEMBL623178,,BAO_0000218,,,,A,13701,10090.0,50594,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),1,N,11864,,Mus musculus,,1,,Intermediate
,,,CHEMBL623179,,BAO_0000218,,,,A,13701,10090.0,50594,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,1,N,11865,,Mus musculus,,1,,Intermediate
,,,CHEMBL623180,,BAO_0000218,,,,A,13701,10090.0,50594,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),1,N,11866,,Mus musculus,,1,,Intermediate
,,,CHEMBL623181,,BAO_0000218,,,,A,13701,10090.0,50594,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),1,N,11867,,Mus musculus,,1,,Intermediate
,,,CHEMBL624131,,BAO_0000218,,,,A,13701,10090.0,50594,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),1,N,11868,,Mus musculus,,1,,Intermediate
,,,CHEMBL624132,,BAO_0000218,,,,A,13701,10090.0,50594,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),1,N,11869,,Mus musculus,,1,,Intermediate
,,,CHEMBL624133,,BAO_0000218,,,,A,13701,10090.0,50594,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),1,N,11870,,Mus musculus,,1,,Intermediate
,,,CHEMBL624846,,BAO_0000218,,,,A,13701,10090.0,50594,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,1,N,11871,,Mus musculus,,1,,Intermediate
,,,CHEMBL624847,,BAO_0000218,,,,A,13701,10090.0,50594,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),1,N,11872,,Mus musculus,,1,,Intermediate
,,,CHEMBL624848,,BAO_0000218,,,,A,13701,10090.0,50594,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),1,N,11873,,Mus musculus,,1,,Intermediate
,,,CHEMBL625012,,BAO_0000218,,,,A,13701,10090.0,50594,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),1,N,11874,,Mus musculus,,1,,Intermediate
,,,CHEMBL625013,,BAO_0000218,,,,A,13701,10090.0,50594,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),1,N,11875,,Mus musculus,,1,,Intermediate
,,,CHEMBL625014,,BAO_0000218,,,,A,13701,10090.0,50594,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,1,N,11876,,Mus musculus,,1,,Intermediate
,,,CHEMBL625015,,BAO_0000218,,,,A,13701,10090.0,50594,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),1,N,11877,,Mus musculus,,1,,Intermediate
,,,CHEMBL625016,,BAO_0000218,,,,A,13701,10090.0,50594,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),1,N,11878,,Mus musculus,,1,,Intermediate
,,,CHEMBL625017,,BAO_0000218,,,,A,13701,10090.0,50594,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,1,N,11879,,Mus musculus,,1,,Intermediate
,,,CHEMBL625018,,BAO_0000218,,,,A,13701,10090.0,50594,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),1,N,11880,,Mus musculus,,1,,Intermediate
,,,CHEMBL625019,,BAO_0000218,,,,A,13701,10090.0,50594,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),1,N,11881,,Mus musculus,,1,,Intermediate
,,,CHEMBL625020,,BAO_0000218,,,,A,13701,10090.0,50594,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),1,N,11882,,Mus musculus,,1,,Intermediate
,,,CHEMBL625021,,BAO_0000218,,,,A,13701,10090.0,50594,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,1,N,11883,,Mus musculus,,1,,Intermediate
,,,CHEMBL625022,,BAO_0000218,,,,A,14393,10116.0,50597,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,1,N,11884,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625023,,BAO_0000218,,,,A,14731,10090.0,50594,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,1,N,11885,,Mus musculus,,1,,Intermediate
,,,CHEMBL625024,,BAO_0000218,,,,A,14731,9541.0,100710,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,1,N,11886,,Macaca fascicularis,,1,,Intermediate
,,,CHEMBL627626,,BAO_0000218,,,,A,14731,9541.0,100710,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,1,N,11887,,Macaca fascicularis,,1,,Intermediate
,,,CHEMBL627627,955.0,BAO_0000218,,,,A,13758,,22224,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,1,U,11888,,,Brain,0,,Autocuration
,,,CHEMBL627628,1977.0,BAO_0000218,,,,A,13758,,22224,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,1,U,11889,,,Serum,0,,Autocuration
,,,CHEMBL627629,955.0,BAO_0000218,,,,A,13758,,22224,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,1,U,11890,,,Brain,0,,Autocuration
,,,CHEMBL627630,1977.0,BAO_0000218,,,,A,13758,,22224,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,1,U,11891,,,Serum,0,,Autocuration
,,,CHEMBL627631,,BAO_0000019,,,,A,16359,,22224,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),1,U,11892,,,,0,,Autocuration
,,,CHEMBL629515,,BAO_0000218,,,,A,16359,,22224,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),1,U,11893,,,,0,,Autocuration
,,,CHEMBL629516,2106.0,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,1,N,11894,,Mus musculus,Spleen,1,,Intermediate
,,,CHEMBL629517,2106.0,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,N,11895,,Mus musculus,Spleen,1,,Intermediate
,,,CHEMBL629518,2106.0,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,N,11896,,Mus musculus,Spleen,1,,Intermediate
,,,CHEMBL877499,,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,1,N,11897,,Mus musculus,,1,,Intermediate
,,,CHEMBL629519,,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,1,N,11898,,Mus musculus,,1,,Intermediate
,,,CHEMBL629520,,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,N,11899,,Mus musculus,,1,,Intermediate
,,,CHEMBL629521,,BAO_0000218,,,,A,15383,10090.0,50594,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,N,11900,,Mus musculus,,1,,Intermediate
,,,CHEMBL629522,,BAO_0000218,,,,A,14439,10090.0,50594,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),1,N,11901,,Mus musculus,,1,,Intermediate
,,,CHEMBL629523,,BAO_0000218,,,,A,14439,10090.0,50594,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),1,N,11902,,Mus musculus,,1,,Intermediate
,,,CHEMBL629524,,BAO_0000218,,,,A,14439,10090.0,50594,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),1,N,11903,,Mus musculus,,1,,Intermediate
,,,CHEMBL629525,,BAO_0000218,,,,A,14439,10090.0,50594,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),1,N,11904,,Mus musculus,,1,,Intermediate
,,,CHEMBL629526,,BAO_0000218,,,,A,14439,10090.0,50594,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),1,N,11905,,Mus musculus,,1,,Intermediate
,,,CHEMBL629527,,BAO_0000218,,,,A,14439,10090.0,50594,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),1,N,11906,,Mus musculus,,1,,Intermediate
,,,CHEMBL629528,,BAO_0000218,,,,A,14439,10090.0,50594,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),1,N,11907,,Mus musculus,,1,,Intermediate
,,,CHEMBL629529,,BAO_0000218,,,,A,14439,10090.0,50594,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),1,N,11908,,Mus musculus,,1,,Intermediate
,,,CHEMBL629530,,BAO_0000218,,,,A,14439,10090.0,50594,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),1,N,11909,,Mus musculus,,1,,Intermediate
,,,CHEMBL629531,,BAO_0000218,,,,A,14439,10090.0,50594,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),1,N,11910,,Mus musculus,,1,,Intermediate
,,,CHEMBL628656,,BAO_0000218,,,,A,14439,10090.0,50594,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),1,N,11911,,Mus musculus,,1,,Intermediate
,,,CHEMBL628657,,BAO_0000218,,,,A,14439,10090.0,50594,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),1,N,11912,,Mus musculus,,1,,Intermediate
,,,CHEMBL628658,,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",1,N,11913,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628659,,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,N,11914,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL877500,,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",1,N,11915,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628660,,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,N,11916,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628661,,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,N,11917,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628662,,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,N,11918,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628663,,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",1,N,11919,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628664,,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",1,N,11920,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628665,178.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,N,11921,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL628666,178.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",1,N,11922,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL628667,178.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,N,11923,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL628668,178.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,N,11924,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL628669,178.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,N,11925,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL628670,178.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",1,N,11926,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL628671,178.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",1,N,11927,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL628672,10000001.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,N,11928,In vivo,Rattus norvegicus,Bone,1,,Intermediate
,,,CHEMBL630300,10000001.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,N,11929,In vivo,Rattus norvegicus,Bone,1,,Intermediate
,,,CHEMBL629787,10000001.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,N,11930,In vivo,Rattus norvegicus,Bone,1,,Intermediate
,,,CHEMBL629788,10000001.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,N,11931,In vivo,Rattus norvegicus,Bone,1,,Intermediate
,,,CHEMBL629789,955.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,N,11932,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL629790,955.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",1,N,11933,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL629791,955.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,N,11934,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL629792,955.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,N,11935,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL629793,955.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,N,11936,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL629794,955.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",1,N,11937,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL874459,,BAO_0000218,,,,A,10677,10116.0,50597,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,1,N,11938,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629795,,BAO_0000218,,,,A,10677,10116.0,50597,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,1,N,11939,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629796,,BAO_0000218,,,,A,10677,10116.0,50597,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,1,N,11940,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629797,,BAO_0000218,,,,A,10677,10116.0,50597,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,1,N,11941,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629798,,BAO_0000218,,,,A,10677,10116.0,50597,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,1,N,11942,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629799,2369.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,N,11943,In vivo,Rattus norvegicus,Adrenal gland,1,,Intermediate
,,,CHEMBL629800,2369.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,N,11944,In vivo,Rattus norvegicus,Adrenal gland,1,,Intermediate
,,,CHEMBL629801,2369.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,N,11945,In vivo,Rattus norvegicus,Adrenal gland,1,,Intermediate
,,,CHEMBL629802,2369.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,1,N,11946,In vivo,Rattus norvegicus,Adrenal gland,1,,Intermediate
,,,CHEMBL629803,2369.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,N,11947,In vivo,Rattus norvegicus,Adrenal gland,1,,Intermediate
,,,CHEMBL629804,178.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,N,11948,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL629805,178.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,N,11949,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL629806,178.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,1,N,11950,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL629807,178.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,N,11951,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL629808,178.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,N,11952,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL629809,955.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,N,11953,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL629810,955.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,N,11954,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL629811,955.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,1,N,11955,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL629812,955.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,N,11956,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL629813,955.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,1,N,11957,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL874460,955.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,N,11958,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL629814,,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,N,11959,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629815,,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,N,11960,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629816,,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,N,11961,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629817,,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,N,11962,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626643,2113.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,N,11963,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL626644,2113.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,N,11964,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL626806,2113.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,N,11965,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL626807,2113.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,N,11966,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL627261,2107.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,N,11967,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL627262,2107.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,N,11968,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL627263,2107.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,N,11969,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL627264,2107.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,N,11970,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL627265,2048.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,N,11971,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627266,2048.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,N,11972,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627267,2048.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,N,11973,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627268,2048.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,N,11974,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627269,2385.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,N,11975,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL627270,2385.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,N,11976,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL627271,,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",1,N,11977,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627946,,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",1,N,11978,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL875472,,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",1,N,11979,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627947,,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",1,N,11980,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627948,,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",1,N,11981,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628113,,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",1,N,11982,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628114,,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",1,N,11983,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628115,,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",1,N,11984,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628116,,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",1,N,11985,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628117,,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",1,N,11986,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628118,,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",1,N,11987,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628119,,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",1,N,11988,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628120,,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",1,N,11989,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628121,,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",1,N,11990,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628122,,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",1,N,11991,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627297,,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",1,N,11992,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627298,,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",1,N,11993,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627299,,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",1,N,11994,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627300,,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",1,N,11995,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627301,,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",1,N,11996,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627302,,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",1,N,11997,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627303,,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",1,N,11998,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627304,,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",1,N,11999,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627305,,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",1,N,12000,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627306,,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",1,N,12001,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623982,,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",1,N,12002,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623983,,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",1,N,12003,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623984,,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",1,N,12004,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623985,,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",1,N,12005,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623986,,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",1,N,12006,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623987,,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",1,N,12007,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623988,,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",1,N,12008,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623989,,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",1,N,12009,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622215,,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",1,N,12010,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622216,,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",1,N,12011,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL877481,,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",1,N,12012,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622217,,BAO_0000218,,,,A,16359,,22224,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),1,U,12013,,,,0,,Autocuration
,,,CHEMBL622218,,BAO_0000218,,,,A,13701,10090.0,50594,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),1,N,12014,,Mus musculus,,1,,Intermediate
,,,CHEMBL622219,,BAO_0000218,,,,A,14554,10116.0,50597,Pharmacokinetic profile AUC was evaluated in rats,1,N,12015,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622220,,BAO_0000019,,,,A,6241,,22224,Pharmacokinetic property (Area under curve),1,U,12016,,,,0,,Autocuration
,,,CHEMBL622221,,BAO_0000218,,,,A,11537,9615.0,50588,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",1,N,12017,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL622222,,BAO_0000218,,,,A,11537,10090.0,50594,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",1,N,12018,,Mus musculus,,1,,Intermediate
,,,CHEMBL622223,,BAO_0000218,,,,A,11537,9615.0,50588,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",1,N,12019,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL622224,,BAO_0000218,,,,A,11537,10090.0,50594,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",1,N,12020,,Mus musculus,,1,,Intermediate
,,,CHEMBL622225,,BAO_0000019,,,,A,13118,,22224,Plasma concentration (AUC) was determined,1,U,12021,,,,0,,Autocuration
,,,CHEMBL622226,,BAO_0000019,,,,A,13118,,22224,Plasma concentration (AUC) was determined; Not detectable,1,U,12022,,,,0,,Autocuration
,,,CHEMBL624154,,BAO_0000218,,,,A,9562,10141.0,50512,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),1,N,12023,,Cavia porcellus,,1,,Intermediate
,,,CHEMBL624155,,BAO_0000218,,,,A,10363,10116.0,50597,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,1,N,12024,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624156,,BAO_0000218,,,,A,10363,10116.0,50597,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,1,N,12025,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624157,,BAO_0000218,,,,A,10363,10116.0,50597,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,1,N,12026,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624158,,BAO_0000218,,,,A,10363,10116.0,50597,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,1,N,12027,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624159,,BAO_0000218,,,,A,12504,10116.0,50597,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,1,N,12028,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624160,,BAO_0000218,,,,A,12504,10116.0,50597,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,1,N,12029,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624161,,BAO_0000218,,,,A,12504,10116.0,50597,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,1,N,12030,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624162,,BAO_0000218,,,,A,12504,10116.0,50597,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,1,N,12031,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624163,,BAO_0000218,,,,A,13317,9615.0,50588,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,1,N,12032,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624164,,BAO_0000218,,,,A,15078,10116.0,50597,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",1,N,12033,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624165,,BAO_0000218,,,,A,14941,10116.0,50597,The AUC(0-infinity) values in female wistar rats.,1,N,12034,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624166,,BAO_0000218,,,,A,15078,10116.0,50597,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",1,N,12035,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624167,,BAO_0000218,,,,A,15078,10116.0,50597,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",1,N,12036,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624168,,BAO_0000218,,,,A,14941,10116.0,50597,The AUC(0-t)values in female wistar rats.,1,N,12037,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624169,,BAO_0000218,,,,A,14067,10116.0,50597,The Area under the concentration time curve of compound was measured on rats,1,N,12038,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624170,,BAO_0000218,,,,A,14215,9606.0,50587,The area under curve (100 mg/kg) administered orally in humans,1,N,12039,,Homo sapiens,,1,,Intermediate
,,,CHEMBL624171,,BAO_0000218,,,,A,14215,9481.0,22224,The area under curve (12.5 mg/kg) administered intravenously in marmoset,1,U,12040,,Callithrix,,0,,Autocuration
,,,CHEMBL624172,,BAO_0000218,,,,A,14215,314293.0,22224,The area under curve (12.5 mg/kg) administered intravenously in monkey,1,U,12041,,Simiiformes,,0,,Autocuration
,,,CHEMBL624173,,BAO_0000218,,,,A,14215,9615.0,50588,The area under curve (15 mg/kg) administered intravenously in dog,1,N,12042,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL877488,,BAO_0000218,,,,A,14215,9606.0,50587,The area under curve (200 mg/kg) administered orally in humans,1,N,12043,,Homo sapiens,,1,,Intermediate
,,,CHEMBL624174,,BAO_0000218,,,,A,14215,10116.0,50597,The area under curve (25 mg/kg) administered intravenously in rat,1,N,12044,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624175,,BAO_0000218,,,,A,14215,9481.0,22224,The area under curve (25 mg/kg) administered orally in marmoset,1,U,12045,,Callithrix,,0,,Autocuration
,,,CHEMBL624176,,BAO_0000218,,,,A,14215,314293.0,22224,The area under curve (25 mg/kg) administered orally in monkey,1,U,12046,,Simiiformes,,0,,Autocuration
,,,CHEMBL624177,,BAO_0000218,,,,A,14215,9615.0,50588,The area under curve (30 mg/kg) administered orally in dog,1,N,12047,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624178,,BAO_0000218,,,,A,14215,9606.0,50587,The area under curve (400 mg/kg) administered orally in humans,1,N,12048,,Homo sapiens,,1,,Intermediate
,,,CHEMBL624179,,BAO_0000218,,,,A,14215,10116.0,50597,The area under curve (50 mg/kg) administered orally in fasted rat,1,N,12049,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627689,,BAO_0000218,,,,A,14215,10116.0,50597,The area under curve (50 mg/kg) administered orally in rat,1,N,12050,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627690,,BAO_0000218,,,,A,14215,9606.0,50587,The area under curve (800 mg/kg) administered orally in humans,1,N,12051,,Homo sapiens,,1,,Intermediate
,,,CHEMBL627691,,BAO_0000019,,,,A,11324,,22224,The compound was evaluated for area under the curve,1,U,12052,,,,0,,Autocuration
,,,CHEMBL627692,,BAO_0000019,,,,A,11324,9481.0,22224,The compound was evaluated for area under the curve in marmosets,1,U,12053,,Callithrix,,0,,Autocuration
,,,CHEMBL627693,,BAO_0000019,,,,A,11324,9481.0,22224,The compound was evaluated for area under the curve in marmosets,1,U,12054,,Callithrix,,0,,Autocuration
,,,CHEMBL627694,,BAO_0000218,,,,A,13875,10116.0,50597,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,1,N,12055,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627695,,BAO_0000218,,,,A,13875,10116.0,50597,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,1,N,12056,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627696,,BAO_0000218,,,,A,13875,,22224,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),1,U,12057,,,,0,,Autocuration
,,,CHEMBL627697,,BAO_0000218,,,,A,13875,10116.0,50597,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,1,N,12058,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627698,,BAO_0000218,,,,A,13875,10116.0,50597,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,1,N,12059,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627699,,BAO_0000218,,,,A,13875,10116.0,50597,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,1,N,12060,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627700,,BAO_0000218,,,,A,13807,10116.0,50597,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,1,N,12061,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627701,,BAO_0000218,,,,A,14127,10116.0,50597,Total drug exposure is determined after oral dosing in rats.,1,N,12062,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627702,,BAO_0000218,,,,A,15116,,22224,Total drug exposure (5 mg/kg) when administered intravenously,1,U,12063,,,,0,,Autocuration
,,,CHEMBL627703,,BAO_0000218,,,,A,15116,,22224,Total drug exposure (5 mg/kg) when administered orally,1,U,12064,,,,0,,Autocuration
,,,CHEMBL626873,,BAO_0000218,,,,A,15604,314293.0,22224,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,1,U,12065,,Simiiformes,,0,,Autocuration
,,,CHEMBL629583,,BAO_0000218,,,,A,15604,10116.0,50597,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,1,N,12066,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629584,,BAO_0000218,,,,A,15604,9615.0,50588,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,1,N,12067,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL629585,,BAO_0000218,,,,A,15604,9615.0,50588,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,1,N,12068,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL629586,955.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",1,N,12069,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL629587,955.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,N,12070,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL629588,,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,N,12071,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629589,,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",1,N,12072,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629590,,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,N,12073,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629591,,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,N,12074,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629592,,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,N,12075,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629593,,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",1,N,12076,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629594,,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",1,N,12077,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629595,948.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,N,12078,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL630290,948.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",1,N,12079,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL627137,948.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,N,12080,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL627138,948.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,N,12081,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL627139,948.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,N,12082,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL627140,948.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",1,N,12083,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL627141,948.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",1,N,12084,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL627142,2113.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,N,12085,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL627143,2113.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",1,N,12086,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL874449,2113.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,N,12087,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL627144,2113.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,N,12088,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL627145,2113.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,N,12089,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL627146,2113.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",1,N,12090,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL627147,2113.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",1,N,12091,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL627148,2107.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,N,12092,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL627149,2048.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,N,12093,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL632160,2048.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",1,N,12094,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL632161,2048.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,N,12095,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL632162,2048.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,N,12096,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL632163,2048.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,N,12097,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL874469,2048.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",1,N,12098,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627182,2048.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",1,N,12099,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627183,2385.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,N,12100,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL627184,2385.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",1,N,12101,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL627185,2385.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,N,12102,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL627186,2385.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,N,12103,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL627187,2385.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,N,12104,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL627188,2385.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",1,N,12105,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL627189,2385.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",1,N,12106,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL627190,,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,N,12107,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627191,2107.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",1,N,12108,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL627192,2107.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,N,12109,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL627193,2107.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",1,N,12110,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL874590,2385.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,1,N,12111,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL627194,2385.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,N,12112,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL627195,2385.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,N,12113,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL627196,992.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,N,12114,In vivo,Rattus norvegicus,Female gonad,1,,Intermediate
,,,CHEMBL627197,992.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,N,12115,In vivo,Rattus norvegicus,Female gonad,1,,Intermediate
,,,CHEMBL627198,992.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,N,12116,In vivo,Rattus norvegicus,Female gonad,1,,Intermediate
,,,CHEMBL627199,992.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,1,N,12117,In vivo,Rattus norvegicus,Female gonad,1,,Intermediate
,,,CHEMBL627200,992.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,N,12118,In vivo,Rattus norvegicus,Female gonad,1,,Intermediate
,,,CHEMBL627201,1969.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,N,12119,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL627202,1969.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,N,12120,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL627203,1969.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,N,12121,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL627204,1969.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,N,12122,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL627205,2106.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,N,12123,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL627206,2106.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,N,12124,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL627207,2106.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,N,12125,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL627208,2106.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,N,12126,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL627209,2046.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,N,12127,In vivo,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL627210,2046.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,N,12128,In vivo,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL627211,2046.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,N,12129,In vivo,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL627212,2046.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,N,12130,In vivo,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL627213,995.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,N,12131,In vivo,Rattus norvegicus,Uterus,1,,Intermediate
,,,CHEMBL626599,995.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,N,12132,In vivo,Rattus norvegicus,Uterus,1,,Intermediate
,,,CHEMBL626600,995.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,N,12133,In vivo,Rattus norvegicus,Uterus,1,,Intermediate
,,,CHEMBL626601,995.0,BAO_0000218,,,,A,10911,10116.0,50597,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,N,12134,In vivo,Rattus norvegicus,Uterus,1,,Intermediate
,,,CHEMBL627484,,BAO_0000019,,,,A,8081,,22224,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,1,U,12135,,,,0,,Autocuration
,,,CHEMBL627485,1969.0,BAO_0000218,,,,A,17248,9541.0,100710,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),1,N,12136,,Macaca fascicularis,Plasma,1,,Intermediate
,,,CHEMBL628147,1969.0,BAO_0000218,,,,A,17248,9541.0,100710,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,1,N,12137,,Macaca fascicularis,Plasma,1,,Intermediate
,,,CHEMBL628148,1969.0,BAO_0000218,,,,A,17248,9541.0,100710,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,1,N,12138,,Macaca fascicularis,Plasma,1,,Intermediate
,,,CHEMBL628149,1969.0,BAO_0000218,,,,A,17248,9615.0,50588,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),1,N,12139,,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL628150,1969.0,BAO_0000218,,,,A,17248,9615.0,50588,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,1,N,12140,,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL628318,1969.0,BAO_0000218,,,,A,17248,9615.0,50588,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,1,N,12141,,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL628319,1969.0,BAO_0000218,,,,A,17248,9615.0,50588,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,1,N,12142,,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL875609,,BAO_0000218,,,,A,15592,9615.0,50588,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",1,N,12143,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628320,,BAO_0000019,,,,A,7040,,22224,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,1,U,12144,,,,0,,Autocuration
,,,CHEMBL628321,,BAO_0000019,,,,A,7040,,22224,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,1,U,12145,,,,0,,Autocuration
,,,CHEMBL628322,,BAO_0000019,,,,A,7040,,22224,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,1,U,12146,,,,0,,Autocuration
,,,CHEMBL628323,,BAO_0000019,,,,A,7040,,22224,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,1,U,12147,,,,0,,Autocuration
,,,CHEMBL628324,,BAO_0000019,,,,A,7040,,22224,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,1,U,12148,,,,0,,Autocuration
,,,CHEMBL628325,,BAO_0000019,,,,A,7040,,22224,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,1,U,12149,,,,0,,Autocuration
,,,CHEMBL628326,,BAO_0000019,,,,A,7040,,22224,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,1,U,12150,,,,0,,Autocuration
,,,CHEMBL628327,1236.0,BAO_0000218,,,,A,9614,9615.0,50588,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",1,N,12151,,Canis lupus familiaris,Adrenal medulla,1,,Intermediate
,,,CHEMBL628328,1236.0,BAO_0000218,,,,A,9614,9615.0,50588,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",1,N,12152,,Canis lupus familiaris,Adrenal medulla,1,,Intermediate
,,,CHEMBL628329,178.0,BAO_0000218,,,,A,9614,9615.0,50588,"Concentration of compound in blood of dog 1, after administering intravenously",1,N,12153,,Canis lupus familiaris,Blood,1,,Intermediate
,,,CHEMBL628330,2107.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",1,N,12154,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL628331,2107.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",1,N,12155,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL628332,2107.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",1,N,12156,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL628333,2107.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",1,N,12157,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL628334,2107.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",1,N,12158,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL628335,2107.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",1,N,12159,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL628336,2107.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",1,N,12160,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL628337,2107.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",1,N,12161,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL628338,2107.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",1,N,12162,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL875610,2107.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",1,N,12163,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL628339,2107.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",1,N,12164,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL628340,2107.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",1,N,12165,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL628341,2107.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",1,N,12166,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622214,2107.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",1,N,12167,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL623167,2107.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",1,N,12168,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL623168,2107.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",1,N,12169,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL623169,2107.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",1,N,12170,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL623170,2107.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",1,N,12171,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL627224,2048.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",1,N,12172,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL875634,2048.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",1,N,12173,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627225,2048.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",1,N,12174,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627226,2048.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",1,N,12175,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL626083,2048.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",1,N,12176,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL626084,2048.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",1,N,12177,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL626085,2048.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",1,N,12178,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL626086,2048.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",1,N,12179,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL626087,2048.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",1,N,12180,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL626088,2048.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",1,N,12181,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL626089,2048.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",1,N,12182,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL626090,2048.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",1,N,12183,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL626091,2048.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",1,N,12184,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL626092,2048.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",1,N,12185,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL626093,2048.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",1,N,12186,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL626094,2048.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",1,N,12187,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL626095,2048.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",1,N,12188,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL626096,2048.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",1,N,12189,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL626097,,BAO_0000218,,,,A,15604,314293.0,22224,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,1,U,12190,,Simiiformes,,0,,Autocuration
,,,CHEMBL626098,,BAO_0000218,,,,A,15604,10116.0,50597,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,1,N,12191,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626099,1969.0,BAO_0000218,,,,A,1806,,22224,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,1,U,12192,,,Plasma,0,,Autocuration
,,,CHEMBL626100,1969.0,BAO_0000218,,,,A,1806,,22224,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,1,U,12193,,,Plasma,0,,Autocuration
,,,CHEMBL626101,1969.0,BAO_0000218,,,,A,17237,9615.0,50588,AUC 0-inf in dog,1,N,12194,,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL626102,1969.0,BAO_0000218,,,,A,17237,10141.0,50512,AUC 0-inf in guinea pig,1,N,12195,,Cavia porcellus,Plasma,1,,Intermediate
,,,CHEMBL626103,1969.0,BAO_0000218,,,,A,17237,9615.0,50588,AUC 0-t in dog,1,N,12196,,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL628391,1969.0,BAO_0000218,,,,A,17237,10141.0,50512,AUC 0-t in guinea pig,1,N,12197,,Cavia porcellus,Plasma,1,,Intermediate
,,,CHEMBL628392,,BAO_0000218,,,,A,15194,10116.0,50597,The compound was tested for brain to plasma partition in rat,1,N,12198,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628393,,BAO_0000218,,,,A,15194,10116.0,50597,The compound was tested for brain to plasma partition in rat.,1,N,12199,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628394,178.0,BAO_0000019,,,,A,8787,,22224,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,1,U,12200,,,Blood,0,,Autocuration
,,,CHEMBL628395,,BAO_0000218,,,,A,17025,9615.0,50588,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,1,N,12201,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628396,,BAO_0000218,,,,A,17025,314293.0,22224,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,1,U,12202,,Simiiformes,,0,,Autocuration
,,,CHEMBL628397,,BAO_0000218,,,,A,17025,9986.0,50592,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,1,N,12203,,Oryctolagus cuniculus,,1,,Intermediate
,,,CHEMBL628398,,BAO_0000218,,,,A,17025,10116.0,50597,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,1,N,12204,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628399,,BAO_0000218,,,,A,4236,9544.0,50797,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,1,N,12205,,Macaca mulatta,,1,,Intermediate
,,,CHEMBL628400,,BAO_0000218,,,,A,15343,9615.0,50588,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,1,N,12206,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL874907,,BAO_0000218,,,,A,15343,10116.0,50597,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,1,N,12207,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628401,,BAO_0000019,,,,A,17720,,22224,Area under curve of the compound was determined,1,U,12208,,,,0,,Autocuration
,,,CHEMBL628402,1969.0,BAO_0000218,,,,A,17788,314293.0,22224,AUC in monkeys at a dose of 1 mg/kg,1,U,12209,,Simiiformes,Plasma,0,,Autocuration
,,,CHEMBL628403,1969.0,BAO_0000218,,,,A,17788,10116.0,50597,AUC in rats at a dose of 1 mg/kg,1,N,12210,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL628404,,BAO_0000019,,,,A,8778,,22224,Compound was evaluated for the overall absorbance loss at pH of 2,1,U,12211,,,,0,,Autocuration
,,,CHEMBL628405,,BAO_0000019,,,,A,8778,,22224,Compound was evaluated for the overall absorbance loss at pH of 4,1,U,12212,,,,0,,Autocuration
,,,CHEMBL628406,,BAO_0000019,,,,A,8778,,22224,Compound was evaluated for the overall absorbance loss at pH of 7,1,U,12213,,,,0,,Autocuration
,,,CHEMBL628407,,BAO_0000218,,,,A,2249,10116.0,50597,Compound was evaluated for its absorption in the rats,1,N,12214,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628408,1088.0,BAO_0000218,,,,A,8881,10116.0,50597,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,1,N,12215,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL629171,1088.0,BAO_0000218,,,,A,8881,10116.0,50597,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,1,N,12216,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL629172,1088.0,BAO_0000218,,,,A,8881,10116.0,50597,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,1,N,12217,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL629173,1088.0,BAO_0000218,,,,A,8881,10116.0,50597,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,1,N,12218,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL629174,,BAO_0000218,,,,A,15286,10116.0,50597,In vitro percent permeability into rat ileum,1,N,12219,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629175,,BAO_0000218,,,,A,15286,10116.0,50597,In vitro percent permeability into rat ileum; Range is 10-17,1,N,12220,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629176,,BAO_0000218,,,,A,15286,10116.0,50597,In vitro percent permeability into rat ileum; Range is 10-18,1,N,12221,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629177,,BAO_0000218,,,,A,15286,10116.0,50597,In vitro percent permeability into rat ileum; Range is 10-19,1,N,12222,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629178,,BAO_0000218,,,,A,15286,10116.0,50597,In vitro percent permeability into rat ileum; Range is 12-15,1,N,12223,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631869,,BAO_0000218,,,,A,15286,10116.0,50597,In vitro percent permeability into rat ileum; Range is 13-19,1,N,12224,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631870,,BAO_0000218,,,,A,15286,10116.0,50597,In vitro percent permeability into rat ileum; Range is 14-17,1,N,12225,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631871,,BAO_0000218,,,,A,15286,10116.0,50597,In vitro percent permeability into rat ileum; Range is 15-18,1,N,12226,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631872,,BAO_0000218,,,,A,15286,10116.0,50597,In vitro percent permeability into rat ileum; Range is 2-5,1,N,12227,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL875775,2116.0,BAO_0000221,,,,A,15286,,22224,In vitro percent permeability into rat ileum; Range is 23-42,1,U,12228,,,Ileum,0,,Autocuration
,,,CHEMBL631873,,BAO_0000218,,,,A,15286,10116.0,50597,In vitro percent permeability into rat ileum; Range is 28-36,1,N,12229,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631874,,BAO_0000218,,,,A,15286,10116.0,50597,In vitro percent permeability into rat ileum; Range is 29-35,1,N,12230,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631875,,BAO_0000218,,,,A,15286,10116.0,50597,In vitro percent permeability into rat ileum; Range is 46-66,1,N,12231,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631876,,BAO_0000218,,,,A,15286,10116.0,50597,In vitro percent permeability into rat ileum; Range is 50-68,1,N,12232,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631877,,BAO_0000218,,,,A,15286,10116.0,50597,In vitro percent permeability into rat ileum; Range is 78-81,1,N,12233,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631878,,BAO_0000218,,,,A,15286,10116.0,50597,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,1,N,12234,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631879,,BAO_0000218,,,,A,15286,10116.0,50597,In vitro percent permeability into rat ileum; nd indicates not detected,1,N,12235,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631880,,BAO_0000218,,,,A,15286,10116.0,50597,In vitro percent permeability into rat ileum; nt indicates not detected,1,N,12236,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631881,,BAO_0000218,,,,A,15286,10116.0,50597,In vitro percent permeability into rat ileum; nt indicates not tested,1,N,12237,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631882,,BAO_0000218,,,,A,13770,10116.0,50597,Compound was tested for oral absorption in bile-duct cannulated rats,1,N,12238,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630749,,BAO_0000218,,,,A,13770,10116.0,50597,Compound was tested for oral absorption in bile-duct cannulated rats.,1,N,12239,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630750,,BAO_0000218,,,,A,5202,9606.0,50587,Oral absorption using Caco-2 cell monolayers.,1,N,12240,,Homo sapiens,,1,,Intermediate
,,,CHEMBL630253,,BAO_0000218,,,,A,14920,9606.0,50587,Percent of the drug absorbed after administration to humans was determined,1,N,12241,,Homo sapiens,,1,,Intermediate
,,,CHEMBL630254,1969.0,BAO_0000218,,,,A,14103,10116.0,50597,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,1,N,12242,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL630255,1969.0,BAO_0000218,,,,A,14103,10116.0,50597,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,1,N,12243,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL630256,1969.0,BAO_0000218,,,,A,14103,10116.0,50597,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,1,N,12244,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL875781,2107.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,N,12245,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL630257,2107.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,N,12246,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL630258,2107.0,BAO_0000218,,,,A,13751,10116.0,50597,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",1,N,12247,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL630259,,BAO_0000218,,,,A,15807,10116.0,50597,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",1,N,12248,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630260,2435.0,BAO_0000218,,,,A,15807,10116.0,50597,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",1,N,12249,,Rattus norvegicus,Striatum,1,,Intermediate
,,,CHEMBL630261,2435.0,BAO_0000218,,,,A,15807,10116.0,50597,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",1,N,12250,,Rattus norvegicus,Striatum,1,,Intermediate
,,,CHEMBL630262,,BAO_0000218,,,,A,14950,10116.0,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,1,N,12251,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630263,,BAO_0000218,,,,A,14950,10116.0,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,1,N,12252,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630264,,BAO_0000218,,,,A,14950,10116.0,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,1,N,12253,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630265,,BAO_0000218,,,,A,14950,10116.0,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,1,N,12254,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630266,,BAO_0000218,,,,A,14950,10116.0,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,1,N,12255,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630267,2113.0,BAO_0000218,,,,A,14950,10116.0,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,1,N,12256,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL630268,2113.0,BAO_0000218,,,,A,14950,10116.0,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,1,N,12257,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL630269,,BAO_0000218,,,,A,14950,10116.0,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,1,N,12258,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630270,,BAO_0000218,,,,A,14950,10116.0,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,1,N,12259,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630141,2048.0,BAO_0000218,,,,A,14950,10116.0,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,1,N,12260,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL630142,2048.0,BAO_0000218,,,,A,14950,10116.0,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,1,N,12261,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL630143,2385.0,BAO_0000218,,,,A,14950,10116.0,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,1,N,12262,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL630144,2385.0,BAO_0000218,,,,A,14950,10116.0,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,1,N,12263,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL630145,2367.0,BAO_0000218,,,,A,14950,10116.0,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,1,N,12264,,Rattus norvegicus,Prostate gland,1,,Intermediate
,,,CHEMBL630146,2367.0,BAO_0000218,,,,A,14950,10116.0,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,1,N,12265,,Rattus norvegicus,Prostate gland,1,,Intermediate
,,,CHEMBL630147,,BAO_0000218,,,,A,14950,10116.0,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,1,N,12266,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630148,,BAO_0000218,,,,A,14950,10116.0,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,1,N,12267,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630149,,BAO_0000218,,,,A,14950,10116.0,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,1,N,12268,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630150,2106.0,BAO_0000218,,,,A,14950,10116.0,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,1,N,12269,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL630151,2106.0,BAO_0000218,,,,A,14950,10116.0,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,1,N,12270,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL632031,2046.0,BAO_0000218,,,,A,14950,10116.0,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,1,N,12271,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL632032,2046.0,BAO_0000218,,,,A,14950,10116.0,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,1,N,12272,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL632033,,BAO_0000218,,,,A,14950,10116.0,50597,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,1,N,12273,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL632034,,BAO_0000218,,,,A,14950,10116.0,50597,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,1,N,12274,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL632035,2385.0,BAO_0000218,,,,A,14950,10116.0,50597,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,1,N,12275,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL632036,,BAO_0000218,,,,A,14950,10116.0,50597,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,1,N,12276,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL632037,2046.0,BAO_0000218,,,,A,14950,10116.0,50597,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,1,N,12277,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL632038,178.0,BAO_0000218,,,,A,8631,10116.0,50597,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,1,N,12278,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL632039,178.0,BAO_0000218,,,,A,8631,10116.0,50597,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,1,N,12279,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL632040,178.0,BAO_0000218,,,,A,8631,10116.0,50597,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,1,N,12280,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL632041,178.0,BAO_0000218,,,,A,8631,10116.0,50597,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,1,N,12281,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL632042,178.0,BAO_0000218,,,,A,9614,9615.0,50588,"Concentration of compound in blood of dog 2, after administering intravenously",1,N,12282,,Canis lupus familiaris,Blood,1,,Intermediate
,,,CHEMBL632043,,BAO_0000218,,,,A,9614,9615.0,50588,"Concentration of compound in left ventricle of dog 1, after administering intravenously",1,N,12283,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL632044,,BAO_0000218,,,,A,9614,9615.0,50588,"Concentration of compound in left ventricle of dog 2, after administering intravenously",1,N,12284,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL632045,2107.0,BAO_0000218,,,,A,9614,9615.0,50588,"Concentration of compound in liver of dog 1, after administering intravenously",1,N,12285,,Canis lupus familiaris,Liver,1,,Intermediate
,,,CHEMBL632046,2107.0,BAO_0000218,,,,A,9614,9615.0,50588,"Concentration of compound in liver of dog 2, after administering intravenously",1,N,12286,,Canis lupus familiaris,Liver,1,,Intermediate
,,,CHEMBL632047,2048.0,BAO_0000218,,,,A,9614,9615.0,50588,"Concentration of compound in lung of dog 1, after administering intravenously",1,N,12287,,Canis lupus familiaris,Lung,1,,Intermediate
,,,CHEMBL632048,2048.0,BAO_0000218,,,,A,9614,9615.0,50588,"Concentration of compound in lung of dog 2, after administering intravenously",1,N,12288,,Canis lupus familiaris,Lung,1,,Intermediate
,,,CHEMBL632049,2385.0,BAO_0000218,,,,A,9614,9615.0,50588,"Concentration of compound in muscle of dog 1, after administering intravenously",1,N,12289,,Canis lupus familiaris,Muscle tissue,1,,Intermediate
,,,CHEMBL876418,2385.0,BAO_0000218,,,,A,9614,9615.0,50588,"Concentration of compound in muscle of dog 2, after administering intravenously",1,N,12290,,Canis lupus familiaris,Muscle tissue,1,,Intermediate
,,,CHEMBL632050,2106.0,BAO_0000218,,,,A,9614,9615.0,50588,"Concentration of compound in spleen of dog 1,after administering intravenously",1,N,12291,,Canis lupus familiaris,Spleen,1,,Intermediate
,,,CHEMBL632051,2106.0,BAO_0000218,,,,A,9614,9615.0,50588,"Concentration of compound in spleen of dog 2, after administering intravenously",1,N,12292,,Canis lupus familiaris,Spleen,1,,Intermediate
,,,CHEMBL632052,,BAO_0000218,,,,F,10353,,22224,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,1,U,12293,,,,0,,Autocuration
,,,CHEMBL632053,,BAO_0000218,,,,F,10353,,22224,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,1,U,12294,,,,0,,Autocuration
,,,CHEMBL632054,,BAO_0000218,,,,A,10353,,22224,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,1,U,12295,,,,0,,Autocuration
,,,CHEMBL632055,,BAO_0000218,,,,F,10353,,22224,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,1,U,12296,,,,0,,Autocuration
,,,CHEMBL631181,,BAO_0000218,,,,F,10353,,22224,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,1,U,12297,,,,0,,Autocuration
,,,CHEMBL631182,,BAO_0000218,,,,A,9196,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,1,U,12298,,,,0,,Autocuration
,,,CHEMBL631183,,BAO_0000218,,,,A,9196,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,1,U,12299,,,,0,,Autocuration
,,,CHEMBL631184,,BAO_0000218,,,,A,9196,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,1,U,12300,,,,0,,Autocuration
,,,CHEMBL629774,,BAO_0000218,,,,A,9196,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,1,U,12301,,,,0,,Autocuration
,,,CHEMBL629775,,BAO_0000218,,,,A,9196,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,1,U,12302,,,,0,,Autocuration
,,,CHEMBL876549,,BAO_0000218,,,,A,9196,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,1,U,12303,,,,0,,Autocuration
,,,CHEMBL628172,,BAO_0000218,,,,A,9196,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,1,U,12304,,,,0,,Autocuration
,,,CHEMBL628173,,BAO_0000218,,,,A,9196,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,1,U,12305,,,,0,,Autocuration
,,,CHEMBL628174,,BAO_0000218,,,,A,9196,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,1,U,12306,,,,0,,Autocuration
,,,CHEMBL628175,,BAO_0000218,,,,A,9196,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,1,U,12307,,,,0,,Autocuration
,,,CHEMBL628176,,BAO_0000218,,,,A,9196,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,1,U,12308,,,,0,,Autocuration
,,,CHEMBL628177,,BAO_0000218,,,,A,9196,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,1,U,12309,,,,0,,Autocuration
,,,CHEMBL628178,,BAO_0000218,,,,A,9196,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,1,U,12310,,,,0,,Autocuration
,,,CHEMBL628179,,BAO_0000218,,,,A,9196,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,1,U,12311,,,,0,,Autocuration
,,,CHEMBL628180,,BAO_0000218,,,,A,9196,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,1,U,12312,,,,0,,Autocuration
,,,CHEMBL628181,,BAO_0000218,,,,A,9196,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,1,U,12313,,,,0,,Autocuration
,,,CHEMBL628182,,BAO_0000218,,,,A,9196,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,1,U,12314,,,,0,,Autocuration
,,,CHEMBL628183,,BAO_0000218,,,,A,9196,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,1,U,12315,,,,0,,Autocuration
,,,CHEMBL628184,,BAO_0000218,,,,A,9196,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,1,U,12316,,,,0,,Autocuration
,,,CHEMBL628185,,BAO_0000218,,,,A,9196,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,1,U,12317,,,,0,,Autocuration
,,,CHEMBL875617,,BAO_0000218,,,,A,9196,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,1,U,12318,,,,0,,Autocuration
,,,CHEMBL628186,,BAO_0000218,,,,A,9196,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,1,U,12319,,,,0,,Autocuration
,,,CHEMBL628187,,BAO_0000218,,,,A,9196,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,1,U,12320,,,,0,,Autocuration
,,,CHEMBL628188,,BAO_0000218,,,,A,9196,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,1,U,12321,,,,0,,Autocuration
,,,CHEMBL628189,,BAO_0000218,,,,A,9196,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,1,U,12322,,,,0,,Autocuration
,,,CHEMBL628190,,BAO_0000218,,,,A,9196,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,1,U,12323,,,,0,,Autocuration
,,,CHEMBL628191,,BAO_0000218,,,,A,9196,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,1,U,12324,,,,0,,Autocuration
,,,CHEMBL626513,,BAO_0000218,,,,A,9196,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,1,U,12325,,,,0,,Autocuration
,,,CHEMBL626514,2046.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",1,N,12326,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL626515,2046.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",1,N,12327,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL626516,2046.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",1,N,12328,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL626517,2046.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",1,N,12329,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL626518,2046.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",1,N,12330,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL626519,2046.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",1,N,12331,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL626520,2046.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",1,N,12332,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL626521,2046.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",1,N,12333,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL626522,2046.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",1,N,12334,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL626523,2046.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",1,N,12335,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL626524,2046.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",1,N,12336,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL626688,2046.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",1,N,12337,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL626689,2046.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",1,N,12338,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL626690,2046.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",1,N,12339,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL626691,2046.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",1,N,12340,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL627319,2046.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",1,N,12341,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL624052,2046.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",1,N,12342,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL624053,2046.0,BAO_0000218,,,,A,8608,10116.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",1,N,12343,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL624054,,BAO_0000218,,,,A,8085,10116.0,50597,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,N,12344,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624055,,BAO_0000218,,,,A,8085,10116.0,50597,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,N,12345,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624056,,BAO_0000218,,,,A,8085,10116.0,50597,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,N,12346,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624057,995.0,BAO_0000218,,,,A,8085,10116.0,50597,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,N,12347,,Rattus norvegicus,Uterus,1,,Intermediate
,,,CHEMBL622281,995.0,BAO_0000218,,,,A,8085,10116.0,50597,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,N,12348,,Rattus norvegicus,Uterus,1,,Intermediate
,,,CHEMBL622282,995.0,BAO_0000218,,,,A,8085,10116.0,50597,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,N,12349,,Rattus norvegicus,Uterus,1,,Intermediate
,,,CHEMBL622283,995.0,BAO_0000218,,,,A,8085,10116.0,50597,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,N,12350,,Rattus norvegicus,Uterus,1,,Intermediate
,,,CHEMBL622284,995.0,BAO_0000218,,,,A,8085,10116.0,50597,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,N,12351,,Rattus norvegicus,Uterus,1,,Intermediate
,,,CHEMBL622285,995.0,BAO_0000218,,,,A,8085,10116.0,50597,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,N,12352,,Rattus norvegicus,Uterus,1,,Intermediate
,,,CHEMBL622286,995.0,BAO_0000218,,,,A,8085,10116.0,50597,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,N,12353,,Rattus norvegicus,Uterus,1,,Intermediate
,,,CHEMBL622287,,BAO_0000100,,,,P,7657,,22224,Distribution coefficient (D %) between octanol and buffer of pH 7.4,1,U,12354,,,,0,,Autocuration
,,,CHEMBL622288,,BAO_0000218,,,,A,8935,10090.0,50594,Partition coefficient (logD7.4),1,N,12355,,Mus musculus,,1,,Intermediate
,,,CHEMBL622289,,BAO_0000218,,,,A,13792,10090.0,50594,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",1,N,12356,,Mus musculus,,1,,Intermediate
,,,CHEMBL622290,955.0,BAO_0000218,,,,A,13792,10090.0,50594,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",1,N,12357,,Mus musculus,Brain,1,,Intermediate
,,,CHEMBL622291,,BAO_0000218,,,,A,13792,10090.0,50594,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,1,N,12358,,Mus musculus,,1,,Intermediate
,,,CHEMBL622292,955.0,BAO_0000218,,,,A,13792,10090.0,50594,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,1,N,12359,,Mus musculus,Brain,1,,Intermediate
,,,CHEMBL622293,,BAO_0000218,,,,A,13792,10090.0,50594,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",1,N,12360,,Mus musculus,,1,,Intermediate
,,,CHEMBL622294,955.0,BAO_0000218,,,,A,13792,10090.0,50594,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",1,N,12361,,Mus musculus,Brain,1,,Intermediate
,,,CHEMBL622295,,BAO_0000218,,,,A,13792,10090.0,50594,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,1,N,12362,,Mus musculus,,1,,Intermediate
,,,CHEMBL622296,955.0,BAO_0000218,,,,A,13792,10116.0,50597,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,1,N,12363,,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL874409,1969.0,BAO_0000218,,,,A,14103,10116.0,50597,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,1,N,12364,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622297,1969.0,BAO_0000218,,,,A,14103,10116.0,50597,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,1,N,12365,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622298,1969.0,BAO_0000218,,,,A,14103,10116.0,50597,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,1,N,12366,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622299,1969.0,BAO_0000218,,,,A,14103,10116.0,50597,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,1,N,12367,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622300,1969.0,BAO_0000218,,,,A,14103,10116.0,50597,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,1,N,12368,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622301,1969.0,BAO_0000218,,,,A,14103,10116.0,50597,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,1,N,12369,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622302,1969.0,BAO_0000218,,,,A,14103,10116.0,50597,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,1,N,12370,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622303,1969.0,BAO_0000218,,,,A,14103,10116.0,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,1,N,12371,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622304,1969.0,BAO_0000218,,,,A,14103,10116.0,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,1,N,12372,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622305,1969.0,BAO_0000218,,,,A,14103,10116.0,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,1,N,12373,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622306,1969.0,BAO_0000218,,,,A,14103,10116.0,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,1,N,12374,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626864,1969.0,BAO_0000218,,,,A,14103,10116.0,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,1,N,12375,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626865,1969.0,BAO_0000218,,,,A,14103,10116.0,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,1,N,12376,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626866,1969.0,BAO_0000218,,,,A,14103,10116.0,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,1,N,12377,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626867,1969.0,BAO_0000218,,,,A,14103,10116.0,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,1,N,12378,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626868,1969.0,BAO_0000218,,,,A,14103,10116.0,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,1,N,12379,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626869,1969.0,BAO_0000218,,,,A,14103,10116.0,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,1,N,12380,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626870,1969.0,BAO_0000218,,,,A,14103,10116.0,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,1,N,12381,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626871,1969.0,BAO_0000218,,,,A,14103,10116.0,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,1,N,12382,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626872,1969.0,BAO_0000218,,,,A,14103,10116.0,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,1,N,12383,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL632185,1969.0,BAO_0000218,,,,A,14103,10116.0,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,1,N,12384,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL632186,1969.0,BAO_0000218,,,,A,14103,10116.0,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,1,N,12385,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL629310,,BAO_0000019,,,,A,12904,,22224,Amount of acetic acid produced by the compound,1,U,12386,,,,0,,Autocuration
,,,CHEMBL629311,,BAO_0000019,,,,A,12904,,22224,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,1,U,12387,,,,0,,Autocuration
,,,CHEMBL629312,,BAO_0000218,,,,A,9663,10116.0,50597,Log of (Cbrain/Cblood) in rats,1,N,12388,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629313,,BAO_0000221,,,,A,7652,,22224,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),1,U,12389,,,,0,,Autocuration
,,,CHEMBL629314,,BAO_0000221,,,,A,7652,,22224,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),1,U,12390,,,,0,,Autocuration
,,,CHEMBL629315,,BAO_0000221,,,,A,7652,,22224,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),1,U,12391,,,,0,,Autocuration
,,,CHEMBL629316,,BAO_0000219,,,,B,7652,,22224,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),1,U,12392,,,,0,,Autocuration
,,,CHEMBL629317,,BAO_0000221,,,,A,7652,,22224,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),1,U,12393,,,,0,,Autocuration
,,,CHEMBL629318,,BAO_0000019,,,,A,7652,,22224,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),1,U,12394,,,,0,,Autocuration
,,,CHEMBL877497,,BAO_0000019,,,,A,7652,,22224,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),1,U,12395,,,,0,,Autocuration
,,,CHEMBL629319,,BAO_0000019,,,,A,7652,,22224,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),1,U,12396,,,,0,,Autocuration
,,,CHEMBL629320,,BAO_0000019,,,,A,7652,,22224,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),1,U,12397,,,,0,,Autocuration
,,,CHEMBL629496,,BAO_0000019,,,,A,7652,,22224,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),1,U,12398,,,,0,,Autocuration
,,,CHEMBL629497,,BAO_0000019,,,,A,7652,,22224,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),1,U,12399,,,,0,,Autocuration
,,,CHEMBL629498,,BAO_0000019,,,,A,7652,,22224,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),1,U,12400,,,,0,,Autocuration
,,,CHEMBL629499,,BAO_0000019,,,,A,7652,,22224,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),1,U,12401,,,,0,,Autocuration
,,,CHEMBL629500,,BAO_0000019,,,,A,7652,,22224,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),1,U,12402,,,,0,,Autocuration
,,,CHEMBL629501,,BAO_0000019,,,,A,7652,,22224,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),1,U,12403,,,,0,,Autocuration
,,,CHEMBL629502,,BAO_0000019,,,,A,7652,,22224,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),1,U,12404,,,,0,,Autocuration
,,,CHEMBL629503,,BAO_0000218,,,,F,8267,,22224,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,1,U,12405,In vivo,,,0,,Autocuration
,,,CHEMBL629504,,BAO_0000218,,,,A,8267,9615.0,50588,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,1,N,12406,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL629505,,BAO_0000019,,,,A,14479,,22224,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,1,U,12407,,,,0,,Autocuration
,,,CHEMBL629506,,BAO_0000019,,,,A,17515,,22224,Compound was evaluated for total body clearance,1,U,12408,,,,0,,Autocuration
,,,CHEMBL629507,,BAO_0000019,,,,A,17515,,22224,Compound was evaluated for volume of distribution at steady state,1,U,12409,,,,0,,Autocuration
,,,CHEMBL877498,,BAO_0000019,,,,A,8142,,22224,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,1,U,12410,,,,0,,Autocuration
,,,CHEMBL629508,,BAO_0000019,,,,A,14849,,22224,Percentage of the diamine which is monoprotonated at pH 7.4,1,U,12411,,,,0,,Autocuration
,,,CHEMBL629509,,BAO_0000019,,,,A,7653,,22224,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,1,U,12412,,,,0,,Autocuration
,,,CHEMBL629510,178.0,BAO_0000218,,,,A,8631,10116.0,50597,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,1,N,12413,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL629511,178.0,BAO_0000218,,,,A,8631,10116.0,50597,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,1,N,12414,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL629512,178.0,BAO_0000218,,,,A,8631,10116.0,50597,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,1,N,12415,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL629513,178.0,BAO_0000218,,,,A,8631,10116.0,50597,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,1,N,12416,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL629514,178.0,BAO_0000218,,,,A,8631,10116.0,50597,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,1,N,12417,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL628447,178.0,BAO_0000218,,,,A,8631,10116.0,50597,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,1,N,12418,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL628448,178.0,BAO_0000218,,,,A,8631,10116.0,50597,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,1,N,12419,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL628449,178.0,BAO_0000218,,,,A,8631,10116.0,50597,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,1,N,12420,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631119,178.0,BAO_0000218,,,,A,8631,10116.0,50597,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,1,N,12421,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631120,178.0,BAO_0000218,,,,A,8631,10116.0,50597,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,1,N,12422,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631121,178.0,BAO_0000218,,,,A,8631,10116.0,50597,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,1,N,12423,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL874458,178.0,BAO_0000218,,,,A,8631,10116.0,50597,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,1,N,12424,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631122,178.0,BAO_0000218,,,,A,8631,10116.0,50597,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,1,N,12425,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631123,178.0,BAO_0000218,,,,A,8631,10116.0,50597,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,1,N,12426,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631124,178.0,BAO_0000218,,,,A,8631,10116.0,50597,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,1,N,12427,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631125,178.0,BAO_0000218,,,,A,8631,10116.0,50597,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,1,N,12428,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631290,178.0,BAO_0000218,,,,A,8631,10116.0,50597,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,1,N,12429,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631291,178.0,BAO_0000218,,,,A,8631,10116.0,50597,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,1,N,12430,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631292,178.0,BAO_0000218,,,,A,8631,10116.0,50597,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,1,N,12431,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631293,178.0,BAO_0000218,,,,A,8631,10116.0,50597,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,1,N,12432,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631294,178.0,BAO_0000218,,,,A,8631,10116.0,50597,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,1,N,12433,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631295,178.0,BAO_0000218,,,,A,8631,10116.0,50597,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,1,N,12434,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631296,178.0,BAO_0000218,,,,A,8631,10116.0,50597,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,1,N,12435,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631297,178.0,BAO_0000218,,,,A,8631,10116.0,50597,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,1,N,12436,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631298,,BAO_0000218,,,,A,10263,,22224,Maximum biodistribution (Bmax) was determined.,1,U,12437,,,,0,,Autocuration
,,,CHEMBL631299,,BAO_0000218,,,,A,12364,10090.0,50594,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,1,N,12438,,Mus musculus,,1,,Intermediate
,,,CHEMBL631300,,BAO_0000218,,,,A,12364,10090.0,50594,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,1,N,12439,,Mus musculus,,1,,Intermediate
,,,CHEMBL631301,,BAO_0000218,,,,A,12364,10090.0,50594,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,1,N,12440,,Mus musculus,,1,,Intermediate
,,,CHEMBL630291,,BAO_0000218,,,,A,12364,10090.0,50594,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,1,N,12441,,Mus musculus,,1,,Intermediate
,,,CHEMBL630292,,BAO_0000218,,,,A,14793,,22224,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,1,U,12442,,,,0,,Autocuration
,,,CHEMBL630293,,BAO_0000218,,,,A,14793,,22224,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,1,U,12443,,,,0,,Autocuration
,,,CHEMBL630294,,BAO_0000218,,,,A,14793,,22224,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,1,U,12444,,,,0,,Autocuration
,,,CHEMBL630295,,BAO_0000218,,,,A,14793,,22224,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,1,U,12445,,,,0,,Autocuration
,,,CHEMBL630296,,BAO_0000218,,,,A,14793,,22224,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,1,U,12446,,,,0,,Autocuration
,,,CHEMBL626782,,BAO_0000218,,,,A,14793,,22224,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,1,U,12447,,,,0,,Autocuration
,,,CHEMBL626783,,BAO_0000218,,,,A,14793,,22224,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,1,U,12448,,,,0,,Autocuration
,,,CHEMBL626784,,BAO_0000218,,,,A,14793,,22224,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,1,U,12449,,,,0,,Autocuration
,,,CHEMBL626785,,BAO_0000218,,,,A,14793,,22224,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,1,U,12450,,,,0,,Autocuration
,,,CHEMBL626786,,BAO_0000218,,,,A,14793,,22224,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,1,U,12451,,,,0,,Autocuration
,,,CHEMBL626787,,BAO_0000218,,,,A,9196,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,1,U,12452,,,,0,,Autocuration
,,,CHEMBL626788,,BAO_0000218,,,,A,9196,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,1,U,12453,,,,0,,Autocuration
,,,CHEMBL625927,,BAO_0000218,,,,A,9196,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,1,U,12454,,,,0,,Autocuration
,,,CHEMBL625928,178.0,BAO_0000218,,,,A,8374,10116.0,50597,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,N,12455,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL625929,178.0,BAO_0000218,,,,A,8374,10116.0,50597,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,1,N,12456,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL625930,178.0,BAO_0000218,,,,A,8374,10116.0,50597,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,1,N,12457,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL625931,178.0,BAO_0000218,,,,A,8374,10116.0,50597,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",1,N,12458,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627230,178.0,BAO_0000218,,,,A,8374,10116.0,50597,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,1,N,12459,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627231,178.0,BAO_0000218,,,,A,8374,10116.0,50597,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,N,12460,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627232,178.0,BAO_0000218,,,,A,8374,10116.0,50597,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,1,N,12461,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627233,178.0,BAO_0000218,,,,A,8374,10116.0,50597,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,1,N,12462,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL875470,178.0,BAO_0000218,,,,A,8374,10116.0,50597,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,N,12463,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627234,178.0,BAO_0000218,,,,A,8374,10116.0,50597,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,N,12464,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627235,178.0,BAO_0000218,,,,A,8374,10116.0,50597,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,N,12465,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627236,178.0,BAO_0000218,,,,A,8374,10116.0,50597,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,N,12466,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627237,178.0,BAO_0000218,,,,A,8374,10116.0,50597,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,N,12467,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627238,178.0,BAO_0000218,,,,A,8374,10116.0,50597,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,N,12468,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627239,178.0,BAO_0000218,,,,A,8374,10116.0,50597,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,N,12469,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627240,178.0,BAO_0000218,,,,A,8374,10116.0,50597,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,N,12470,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627241,178.0,BAO_0000218,,,,A,8374,10116.0,50597,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,N,12471,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627242,178.0,BAO_0000218,,,,A,8374,10116.0,50597,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,N,12472,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627243,178.0,BAO_0000218,,,,A,8374,10116.0,50597,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,1,N,12473,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627244,178.0,BAO_0000218,,,,A,8374,10116.0,50597,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,1,N,12474,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627245,178.0,BAO_0000218,,,,A,8374,10116.0,50597,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,N,12475,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627246,178.0,BAO_0000218,,,,A,8374,10116.0,50597,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,N,12476,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627247,178.0,BAO_0000218,,,,A,8374,10116.0,50597,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,N,12477,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627248,178.0,BAO_0000218,,,,A,8374,10116.0,50597,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,N,12478,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627249,178.0,BAO_0000218,,,,A,8374,10116.0,50597,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,N,12479,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL625569,178.0,BAO_0000218,,,,A,8374,10116.0,50597,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,N,12480,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL625570,178.0,BAO_0000218,,,,A,8374,10116.0,50597,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,N,12481,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL625571,178.0,BAO_0000218,,,,A,8374,10116.0,50597,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,N,12482,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL625572,178.0,BAO_0000218,,,,A,8374,10116.0,50597,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,1,N,12483,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL625573,178.0,BAO_0000218,,,,A,8374,10116.0,50597,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,1,N,12484,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL625574,178.0,BAO_0000218,,,,A,8374,10116.0,50597,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,1,N,12485,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL626245,178.0,BAO_0000218,,,,A,8374,10116.0,50597,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,1,N,12486,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL626246,178.0,BAO_0000218,,,,A,8374,10116.0,50597,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,N,12487,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL626247,,BAO_0000218,,,,A,9196,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,1,U,12488,,,,0,,Autocuration
,,,CHEMBL626248,,BAO_0000218,,,,A,9196,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,1,U,12489,,,,0,,Autocuration
,,,CHEMBL626249,,BAO_0000218,,,,A,9196,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,1,U,12490,,,,0,,Autocuration
,,,CHEMBL626420,,BAO_0000218,,,,A,9196,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,1,U,12491,,,,0,,Autocuration
,,,CHEMBL626421,,BAO_0000218,,,,A,9196,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,1,U,12492,,,,0,,Autocuration
,,,CHEMBL626422,,BAO_0000218,,,,A,9196,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,1,U,12493,,,,0,,Autocuration
,,,CHEMBL626423,,BAO_0000218,,,,A,9196,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,1,U,12494,,,,0,,Autocuration
,,,CHEMBL626424,,BAO_0000218,,,,A,9196,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,1,U,12495,,,,0,,Autocuration
,,,CHEMBL626425,,BAO_0000218,,,,A,12023,9615.0,50588,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,1,N,12496,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL875476,,BAO_0000218,,,,A,12023,10116.0,50597,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,1,N,12497,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626426,,BAO_0000218,,,,A,12023,9541.0,100710,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,1,N,12498,,Macaca fascicularis,,1,,Intermediate
,,,CHEMBL626427,,BAO_0000100,,,,P,10580,,22224,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,1,U,12499,,,,0,,Autocuration
,,,CHEMBL626428,,BAO_0000100,,,,P,10580,,22224,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,1,U,12500,,,,0,,Autocuration
,,,CHEMBL626429,,BAO_0000019,,,,A,16032,,22224,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,1,U,12501,,,,0,,Autocuration
,,,CHEMBL625025,1088.0,BAO_0000019,,,,A,16032,,22224,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,1,U,12502,,,Urine,0,,Autocuration
,,,CHEMBL625026,178.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,1,N,12503,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL625027,178.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,1,N,12504,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL874410,178.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,1,N,12505,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL625028,178.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,1,N,12506,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL625029,178.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,1,N,12507,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL625030,178.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,1,N,12508,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL625031,178.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,1,N,12509,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL625032,178.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,1,N,12510,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL625033,178.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,1,N,12511,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL625034,178.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,1,N,12512,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL624872,948.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,1,N,12513,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL624873,948.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,1,N,12514,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL624874,948.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,1,N,12515,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL624875,948.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,1,N,12516,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL624876,948.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,1,N,12517,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL624877,948.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,1,N,12518,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL624878,948.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,1,N,12519,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL624879,948.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,1,N,12520,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL624880,948.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,1,N,12521,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL624881,948.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,1,N,12522,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL624882,948.0,BAO_0000218,,,,A,8594,10116.0,50597,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",1,N,12523,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL624883,2113.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,1,N,12524,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL624884,2113.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,1,N,12525,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL624885,2113.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,1,N,12526,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL624886,2113.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,1,N,12527,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL624887,2113.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,1,N,12528,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL624888,2113.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,1,N,12529,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL624889,2113.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,1,N,12530,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL624890,2113.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,1,N,12531,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL621964,2113.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,1,N,12532,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL621965,2113.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,1,N,12533,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL621966,2107.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,1,N,12534,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL621967,2107.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,1,N,12535,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL622164,2107.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,1,N,12536,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL623097,,BAO_0000019,,,,A,7653,,22224,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),1,U,12537,,,,0,,Autocuration
,,,CHEMBL623098,,BAO_0000019,,,,A,7653,,22224,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),1,U,12538,,,,0,,Autocuration
,,,CHEMBL623099,,BAO_0000019,,,,A,7653,,22224,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,1,U,12539,,,,0,,Autocuration
,,,CHEMBL623100,,BAO_0000019,,,,A,7653,,22224,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,1,U,12540,,,,0,,Autocuration
,,,CHEMBL628673,,BAO_0000218,,,,A,9104,10116.0,50597,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",1,N,12541,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628674,,BAO_0000218,,,,A,9104,10116.0,50597,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",1,N,12542,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628675,,BAO_0000218,,,,A,9104,10116.0,50597,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",1,N,12543,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627644,,BAO_0000218,,,,A,9104,10116.0,50597,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",1,N,12544,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627645,,BAO_0000218,,,,A,9104,10116.0,50597,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",1,N,12545,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627646,,BAO_0000218,,,,A,9104,10116.0,50597,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",1,N,12546,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627647,,BAO_0000218,,,,A,9104,10116.0,50597,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",1,N,12547,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627648,,BAO_0000218,,,,A,9104,10116.0,50597,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",1,N,12548,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627649,,BAO_0000218,,,,A,12902,10116.0,50597,Free level in rat plasma,1,N,12549,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628313,,BAO_0000019,,,,A,6614,,22224,Level reaching in blood plasma of rat or human was determined,1,U,12550,,,,0,,Autocuration
,,,CHEMBL628314,,BAO_0000218,,,,A,9663,10116.0,50597,Log (Cbrain/Cblood) in rats,1,N,12551,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628315,,BAO_0000019,,,,A,17658,,22224,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,1,U,12552,,,,0,,Autocuration
,,,CHEMBL628316,,BAO_0000019,,,,A,17658,,22224,Mean percentage of compound transport through membrane; expressed as membrane transport,1,U,12553,,,,0,,Autocuration
,,,CHEMBL628317,,BAO_0000218,,,,A,14314,,22224,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,1,U,12554,,,,0,,Autocuration
,,,CHEMBL628473,,BAO_0000019,,,,A,7385,,22224,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,1,U,12555,,,,0,,Autocuration
,,,CHEMBL628474,,BAO_0000019,,,,A,7385,,22224,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",1,U,12556,,,,0,,Autocuration
,,,CHEMBL628475,,BAO_0000019,,,,A,7385,,22224,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,1,U,12557,,,,0,,Autocuration
,,,CHEMBL628476,,BAO_0000019,,,,A,1329,,22224,Net water uptake by a carrier mediated transport (%cm) mechanism,1,U,12558,,,,0,,Autocuration
,,,CHEMBL628477,,BAO_0000218,,,,A,12187,314293.0,22224,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,1,U,12559,,Simiiformes,,0,,Autocuration
,,,CHEMBL628478,,BAO_0000218,,,,A,12187,9669.0,50506,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,1,N,12560,,Mustela putorius furo,,1,,Intermediate
,,,CHEMBL628479,,BAO_0000218,,,,A,12187,9669.0,50506,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",1,N,12561,,Mustela putorius furo,,1,,Intermediate
,,,CHEMBL628480,,BAO_0000218,,,,A,12187,314293.0,22224,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,1,U,12562,,Simiiformes,,0,,Autocuration
,,,CHEMBL628481,,BAO_0000218,,,,A,12187,314293.0,22224,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",1,U,12563,,Simiiformes,,0,,Autocuration
,,,CHEMBL628482,,BAO_0000218,,,,A,12187,10116.0,50597,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,1,N,12564,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628483,,BAO_0000218,,,,A,12187,10116.0,50597,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",1,N,12565,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628484,1969.0,BAO_0000218,,,,A,9278,10116.0,50597,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",1,N,12566,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL628485,1969.0,BAO_0000218,,,,A,9278,10116.0,50597,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",1,N,12567,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL628486,1969.0,BAO_0000218,,,,A,9278,9541.0,100710,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",1,N,12568,,Macaca fascicularis,Plasma,1,,Intermediate
,,,CHEMBL628487,1969.0,BAO_0000218,,,,A,9278,9606.0,50587,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",1,N,12569,,Homo sapiens,Plasma,1,,Intermediate
,,,CHEMBL628488,1969.0,BAO_0000218,,,,A,9278,10116.0,50597,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",1,N,12570,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL628489,1969.0,BAO_0000218,,,,A,9278,10116.0,50597,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",1,N,12571,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL628490,1969.0,BAO_0000218,,,,A,9278,10116.0,50597,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",1,N,12572,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL628491,,BAO_0000218,,,,A,12186,9541.0,100710,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,1,N,12573,,Macaca fascicularis,,1,,Intermediate
,,,CHEMBL877507,,BAO_0000218,,,,A,12186,9541.0,100710,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,1,N,12574,,Macaca fascicularis,,1,,Intermediate
,,,CHEMBL628492,,BAO_0000218,,,,A,12186,,22224,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,1,U,12575,,,,0,,Autocuration
,,,CHEMBL628493,,BAO_0000019,,,,A,12041,314293.0,22224,% metabolized in monkey S-9 after 2 hours (10 ug/mL),1,U,12576,,Simiiformes,,0,,Autocuration
,,,CHEMBL628494,,BAO_0000019,,,,A,12041,314293.0,22224,% metabolized in monkey S-9 after 2 hours (1 ug/ml),1,U,12577,,Simiiformes,,0,,Autocuration
,,,CHEMBL628495,,BAO_0000019,,,,A,12041,314293.0,22224,% metabolized in monkey S-9 after 2 hours (10 ug/ml),1,U,12578,,Simiiformes,,0,,Autocuration
,,,CHEMBL628496,,BAO_0000218,,,,A,6737,9606.0,50587,Permeability in Caco-2 assay at 10E-6,1,N,12579,,Homo sapiens,,1,,Intermediate
,,,CHEMBL628497,955.0,BAO_0000218,,,,A,13758,,22224,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,1,U,12580,,,Brain,0,,Autocuration
,,,CHEMBL628498,955.0,BAO_0000218,,,,A,13758,,22224,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,1,U,12581,,,Brain,0,,Autocuration
,,,CHEMBL628499,,BAO_0000019,,,,A,5676,,22224,Plasma protein binding was determined,1,U,12582,,,,0,,Autocuration
,,,CHEMBL627656,,BAO_0000218,,,,A,14793,,22224,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,1,U,12583,,,,0,,Autocuration
,,,CHEMBL627657,,BAO_0000218,,,,A,14793,,22224,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,1,U,12584,,,,0,,Autocuration
,,,CHEMBL626808,,BAO_0000218,,,,A,14793,,22224,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,1,U,12585,,,,0,,Autocuration
,,,CHEMBL626809,,BAO_0000218,,,,A,14793,,22224,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,1,U,12586,,,,0,,Autocuration
,,,CHEMBL626810,,BAO_0000218,,,,A,14793,,22224,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,1,U,12587,,,,0,,Autocuration
,,,CHEMBL626811,,BAO_0000218,,,,A,14793,,22224,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,1,U,12588,,,,0,,Autocuration
,,,CHEMBL874465,,BAO_0000218,,,,A,14793,,22224,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,1,U,12589,,,,0,,Autocuration
,,,CHEMBL626812,,BAO_0000218,,,,A,14793,,22224,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,1,U,12590,,,,0,,Autocuration
,,,CHEMBL626813,,BAO_0000218,,,,A,14793,,22224,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,1,U,12591,,,,0,,Autocuration
,,,CHEMBL626814,,BAO_0000218,,,,A,14793,,22224,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,1,U,12592,,,,0,,Autocuration
,,,CHEMBL626815,,BAO_0000019,,,,A,14000,,22224,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,1,U,12593,,,,0,,Autocuration
,,,CHEMBL628566,,BAO_0000019,,,,A,5948,,22224,Partition coefficient (logP),1,U,12594,,,,0,,Autocuration
,,,CHEMBL628567,,BAO_0000100,,,,P,13824,,22229,Calculated partition coefficient (clogP) (CLOGP3 V3.4),1,U,12595,,,,0,,Autocuration
,,,CHEMBL628568,,BAO_0000100,,,,P,10778,,22229,Calculated partition coefficient (clogP),1,U,12596,,,,0,,Autocuration
,,,CHEMBL628569,,BAO_0000218,,,,A,17237,9615.0,50588,C max in dog,1,N,12597,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628570,,BAO_0000218,,,,A,17237,10141.0,50512,C max in guinea pig,1,N,12598,In vivo,Cavia porcellus,,1,,Intermediate
,,,CHEMBL628571,,BAO_0000218,,,,A,2809,,22224,C max value was evaluated,1,U,12599,In vivo,,,0,,Autocuration
,,,CHEMBL628572,,BAO_0000218,,,,A,11954,,22224,Cmax value after oral dose of 0.1 mg//kg,1,U,12600,In vivo,,,0,,Autocuration
,,,CHEMBL628573,,BAO_0000218,,,,A,11954,,22224,Cmax value after oral dose of 0.3 mg/kg,1,U,12601,In vivo,,,0,,Autocuration
,,,CHEMBL628574,,BAO_0000218,,,,A,11954,,22224,Cmax value after oral dose of 1 mg/kg,1,U,12602,In vivo,,,0,,Autocuration
,,,CHEMBL628575,,BAO_0000218,,,,A,11954,,22224,Cmax value after oral dose of 10 mg/kg,1,U,12603,In vivo,,,0,,Autocuration
,,,CHEMBL628576,,BAO_0000218,,,,A,11954,,22224,Cmax value after oral dose of 23.4 mg/kg,1,U,12604,In vivo,,,0,,Autocuration
,,,CHEMBL628577,,BAO_0000218,,,,A,11954,,22224,Cmax value after oral dose of 3 mg/kg,1,U,12605,In vivo,,,0,,Autocuration
,,,CHEMBL628578,,BAO_0000218,,,,A,11954,,22224,Cmax value after oral dose of 3.87 mg/kg,1,U,12606,In vivo,,,0,,Autocuration
,,,CHEMBL874466,,BAO_0000218,,,,A,12768,9615.0,50588,Cmax value in female Beagle dogs,1,N,12607,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628579,,BAO_0000218,,,,A,12768,10116.0,50597,Cmax value in male rats,1,N,12608,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628580,1969.0,BAO_0000218,,,,A,12780,10116.0,50597,Cmax value in rat plasma when administered 20 mg/kg perorally,1,N,12609,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL628581,1969.0,BAO_0000218,,,,A,15592,9615.0,50588,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,1,N,12610,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL628582,1969.0,BAO_0000218,,,,A,15592,9615.0,50588,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,1,N,12611,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL628583,,BAO_0000218,,,,A,17025,9615.0,50588,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,1,N,12612,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625782,,BAO_0000218,,,,A,17025,314293.0,22224,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,1,U,12613,,Simiiformes,,0,,Autocuration
,,,CHEMBL625783,,BAO_0000218,,,,A,17025,9986.0,50592,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,1,N,12614,,Oryctolagus cuniculus,,1,,Intermediate
,,,CHEMBL625784,,BAO_0000218,,,,A,17025,10116.0,50597,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,1,N,12615,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625785,1969.0,BAO_0000218,,,,A,4236,9544.0,50797,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,1,N,12616,,Macaca mulatta,Plasma,1,,Intermediate
,,,CHEMBL625786,,BAO_0000218,,,,A,15791,10116.0,50597,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,1,N,12617,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL874467,,BAO_0000019,,,,A,11149,,22224,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,1,U,12618,,,,0,,Autocuration
,,,CHEMBL625787,,BAO_0000218,,,,A,15592,9615.0,50588,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",1,N,12619,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625964,,BAO_0000218,,,,A,15778,12721.0,50677,cytotoxicity against HIV protease enzyme.,1,N,12620,,Human immunodeficiency virus,,1,,Intermediate
,,,CHEMBL625965,,BAO_0000218,,,,A,12745,10090.0,50594,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,1,N,12621,,Mus musculus,,1,,Intermediate
,,,CHEMBL625966,,BAO_0000218,,,,A,12745,10090.0,50594,Apparent clearance in mice after oral administration of 100 mg/kg of dose,1,N,12622,,Mus musculus,,1,,Intermediate
,,,CHEMBL625967,1969.0,BAO_0000218,,,,A,13941,9615.0,50588,The plasma clearance in dog.,1,N,12623,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL625968,1969.0,BAO_0000218,,,,A,13941,10116.0,50597,The plasma clearance in rat.,1,N,12624,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL625969,1969.0,BAO_0000218,,,,A,16449,10116.0,50597,Clearance from plasma in male Sprague-Dawley rats,1,N,12625,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL625970,1969.0,BAO_0000218,,,,A,16449,9541.0,100710,Clearance from plasma in male cynomolgus monkeys,1,N,12626,In vivo,Macaca fascicularis,Plasma,1,,Intermediate
,,,CHEMBL625971,1969.0,BAO_0000218,,,,A,14224,9615.0,50588,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",1,N,12627,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL625972,1969.0,BAO_0000218,,,,A,14224,9615.0,50588,Clearance of compound in dog plasma,1,N,12628,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL625973,1969.0,BAO_0000218,,,,A,14224,9606.0,50587,Clearance of compound in human plasma,1,N,12629,In vivo,Homo sapiens,Plasma,1,,Intermediate
,,,CHEMBL625974,,BAO_0000218,,,,A,14317,9615.0,50588,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,1,N,12630,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625975,,BAO_0000218,,,,A,14317,9615.0,50588,Clearance of compound when administered intravenously as an individual dose to a single dog.,1,N,12631,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625976,1969.0,BAO_0000218,,,,A,14224,9615.0,50588,"Clearance (10 mg/kg, intravenously) in dog plasma",1,N,12632,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL625977,,BAO_0000218,,,,A,17237,9615.0,50588,Clearance value in dog,1,N,12633,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625978,,BAO_0000218,,,,A,17237,10141.0,50512,Clearance value in guinea pig,1,N,12634,In vivo,Cavia porcellus,,1,,Intermediate
,,,CHEMBL874468,,BAO_0000218,,,,A,14187,10116.0,50597,Clearance values in rats after iv administration.,1,N,12635,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625421,1969.0,BAO_0000218,,,,A,4806,,22224,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,1,U,12636,In vivo,,Plasma,0,,Autocuration
,,,CHEMBL625422,,BAO_0000218,,,,A,15025,9986.0,50592,In vivo clearance (5 mg/kg) was determined in rabbits,1,N,12637,In vivo,Oryctolagus cuniculus,,1,,Intermediate
,,,CHEMBL625423,,BAO_0000218,,,,A,13197,10116.0,50597,Plasma Clearance rate was determined for the compound in rats,1,N,12638,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625424,,BAO_0000218,,,,A,13197,9520.0,22224,Plasma Clearance rate was determined for the compound in squirrel monkeys,1,U,12639,In vivo,Saimiri,,0,,Autocuration
,,,CHEMBL625425,,BAO_0000218,,,,A,13960,10116.0,50597,Plasma clearance in rat,1,N,12640,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625426,,BAO_0000218,,,,A,17820,,22224,Plasma clearance of the compound,1,U,12641,In vivo,,,0,,Autocuration
,,,CHEMBL625427,,BAO_0000218,,,,A,14706,10141.0,50512,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,1,N,12642,In vivo,Cavia porcellus,,1,,Intermediate
,,,CHEMBL625428,,BAO_0000218,,,,A,14706,10141.0,50512,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,1,N,12643,In vivo,Cavia porcellus,,1,,Intermediate
,,,CHEMBL625429,,BAO_0000218,,,,A,6504,,22224,Plasma clearance was determined,1,U,12644,In vivo,,,0,,Autocuration
,,,CHEMBL625430,,BAO_0000218,,,,A,14925,9615.0,50588,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,1,N,12645,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625431,,BAO_0000218,,,,A,13197,10116.0,50597,Plasma clearance rate was determined for the compound in rats,1,N,12646,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627307,,BAO_0000218,,,,A,13197,9520.0,22224,Plasma clearance rate was determined for the compound in squirrel monkeys,1,U,12647,In vivo,Saimiri,,0,,Autocuration
,,,CHEMBL627308,,BAO_0000218,,,,A,3437,,22224,Slow clearance (CL) was determined,1,U,12648,In vivo,,,0,,Autocuration
,,,CHEMBL627309,,BAO_0000218,,,,A,9196,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,1,U,12649,,,,0,,Autocuration
,,,CHEMBL627310,,BAO_0000218,,,,A,9196,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,1,U,12650,,,,0,,Autocuration
,,,CHEMBL627311,,BAO_0000218,,,,A,9196,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,1,U,12651,,,,0,,Autocuration
,,,CHEMBL627312,,BAO_0000218,,,,A,9196,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,1,U,12652,,,,0,,Autocuration
,,,CHEMBL627313,,BAO_0000218,,,,A,9196,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,1,U,12653,,,,0,,Autocuration
,,,CHEMBL627314,,BAO_0000218,,,,A,9196,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,1,U,12654,,,,0,,Autocuration
,,,CHEMBL627315,,BAO_0000218,,,,A,9196,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,1,U,12655,,,,0,,Autocuration
,,,CHEMBL627316,,BAO_0000218,,,,A,9196,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,1,U,12656,,,,0,,Autocuration
,,,CHEMBL627317,,BAO_0000218,,,,A,9196,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,1,U,12657,,,,0,,Autocuration
,,,CHEMBL627318,,BAO_0000218,,,,A,9196,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,1,U,12658,,,,0,,Autocuration
,,,CHEMBL627999,,BAO_0000218,,,,A,9196,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,1,U,12659,,,,0,,Autocuration
,,,CHEMBL628000,,BAO_0000218,,,,A,9196,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,1,U,12660,,,,0,,Autocuration
,,,CHEMBL628001,,BAO_0000218,,,,A,9196,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,1,U,12661,,,,0,,Autocuration
,,,CHEMBL628002,,BAO_0000218,,,,A,9196,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,1,U,12662,,,,0,,Autocuration
,,,CHEMBL625610,,BAO_0000218,,,,A,9196,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,1,U,12663,,,,0,,Autocuration
,,,CHEMBL625611,,BAO_0000218,,,,A,9196,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,1,U,12664,,,,0,,Autocuration
,,,CHEMBL625612,,BAO_0000218,,,,A,9196,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,1,U,12665,,,,0,,Autocuration
,,,CHEMBL625613,,BAO_0000218,,,,A,9196,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,1,U,12666,,,,0,,Autocuration
,,,CHEMBL875479,,BAO_0000218,,,,A,9196,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,1,U,12667,,,,0,,Autocuration
,,,CHEMBL625614,,BAO_0000218,,,,A,9196,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,1,U,12668,,,,0,,Autocuration
,,,CHEMBL625615,,BAO_0000218,,,,A,9196,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,1,U,12669,,,,0,,Autocuration
,,,CHEMBL626302,,BAO_0000218,,,,A,9196,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,1,U,12670,,,,0,,Autocuration
,,,CHEMBL626303,178.0,BAO_0000218,,,,A,8374,10116.0,50597,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,N,12671,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627420,178.0,BAO_0000218,,,,A,8374,10116.0,50597,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,N,12672,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627421,,BAO_0000218,,,,A,13477,10116.0,50597,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,1,N,12673,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625695,,BAO_0000218,,,,A,13477,10116.0,50597,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,1,N,12674,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625696,,BAO_0000218,,,,A,13477,10116.0,50597,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,1,N,12675,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL875606,955.0,BAO_0000218,,,,A,10009,10090.0,50594,Distribution of compound in mice brain was measured after 1 hr,1,N,12676,,Mus musculus,Brain,1,,Intermediate
,,,CHEMBL625697,955.0,BAO_0000218,,,,A,10009,10090.0,50594,Distribution of compound in mice brain was measured after 24 hr r,1,N,12677,,Mus musculus,Brain,1,,Intermediate
,,,CHEMBL625698,955.0,BAO_0000218,,,,A,10009,10090.0,50594,Distribution of compound in mice brain was measured after 2 hr,1,N,12678,,Mus musculus,Brain,1,,Intermediate
,,,CHEMBL625699,955.0,BAO_0000218,,,,A,10009,10090.0,50594,Distribution of compound in mice brain was measured after 3 hr,1,N,12679,,Mus musculus,Brain,1,,Intermediate
,,,CHEMBL625700,955.0,BAO_0000218,,,,A,10009,10090.0,50594,Distribution of compound in mice brain was measured after 6 hr,1,N,12680,,Mus musculus,Brain,1,,Intermediate
,,,CHEMBL625701,,BAO_0000218,,,,A,10009,10090.0,50594,Distribution of compound in mice liver was measured after 1 hr,1,N,12681,,Mus musculus,,1,,Intermediate
,,,CHEMBL625702,,BAO_0000218,,,,A,10009,10090.0,50594,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,1,N,12682,,Mus musculus,,1,,Intermediate
,,,CHEMBL625703,,BAO_0000218,,,,A,10009,10090.0,50594,Distribution of compound in mice liver was measured after 2 hr,1,N,12683,,Mus musculus,,1,,Intermediate
,,,CHEMBL625704,,BAO_0000218,,,,A,10009,10090.0,50594,Distribution of compound in mice liver was measured after 3 hr,1,N,12684,,Mus musculus,,1,,Intermediate
,,,CHEMBL625705,,BAO_0000218,,,,A,10009,10090.0,50594,Distribution of compound in mice liver was measured after 6 hr,1,N,12685,,Mus musculus,,1,,Intermediate
,,,CHEMBL625706,1236.0,BAO_0000218,,,,A,8170,9615.0,50588,Distribution in dog adrenal medulla 30 min after administration.,1,N,12686,,Canis lupus familiaris,Adrenal medulla,1,,Intermediate
,,,CHEMBL625707,1236.0,BAO_0000218,,,,A,8170,9615.0,50588,Distribution in dog adrenal medulla 72 hours after administration.,1,N,12687,,Canis lupus familiaris,Adrenal medulla,1,,Intermediate
,,,CHEMBL625708,,BAO_0000218,,,,A,8170,9615.0,50588,Distribution in female dog Ovary 24 hours after administration.,1,N,12688,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625709,,BAO_0000218,,,,A,8170,9615.0,50588,Distribution in female dog Ovary 72 hours after administration.,1,N,12689,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624180,,BAO_0000218,,,,A,8170,9615.0,50588,Distribution in female dog adipose 24 hours after administration.,1,N,12690,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624181,,BAO_0000218,,,,A,8170,9615.0,50588,Distribution in female dog adipose 72 hours after administration.,1,N,12691,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624182,1235.0,BAO_0000218,,,,A,8170,9615.0,50588,Distribution in female dog adrenal cortex 72 hours after administration.,1,N,12692,,Canis lupus familiaris,Adrenal cortex,1,,Intermediate
,,,CHEMBL624183,1235.0,BAO_0000218,,,,A,8170,9615.0,50588,Distribution in female dog adrenal cortex 72 hours after administration.,1,N,12693,,Canis lupus familiaris,Adrenal cortex,1,,Intermediate
,,,CHEMBL624184,2107.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,1,N,12694,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL877489,2107.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,1,N,12695,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL624185,2107.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,1,N,12696,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL624186,2107.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,1,N,12697,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL624187,2107.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,1,N,12698,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL624188,2107.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,1,N,12699,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL624189,2048.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,1,N,12700,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL624190,2048.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,1,N,12701,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL624191,2048.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,1,N,12702,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL624192,2048.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,1,N,12703,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL624193,2048.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,1,N,12704,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL624194,2048.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,1,N,12705,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL624891,2048.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,1,N,12706,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL624892,2048.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,1,N,12707,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL624893,2048.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,1,N,12708,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627632,2048.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,1,N,12709,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627633,,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,1,N,12710,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627634,,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,1,N,12711,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627635,,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,1,N,12712,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627636,,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,1,N,12713,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626816,,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,1,N,12714,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626817,,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,1,N,12715,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626818,,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,1,N,12716,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626819,,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,1,N,12717,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626820,,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,1,N,12718,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626821,,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,1,N,12719,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626822,2046.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,1,N,12720,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL626823,2046.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,1,N,12721,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL626824,2046.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,1,N,12722,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL626825,2046.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,1,N,12723,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL626826,2046.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,1,N,12724,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL626827,2046.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,1,N,12725,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL626828,2046.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,1,N,12726,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL626829,2046.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,1,N,12727,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL626830,2046.0,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,1,N,12728,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL627150,,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,1,N,12729,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627151,,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,1,N,12730,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627152,,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,1,N,12731,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627153,,BAO_0000218,,,,A,8594,10116.0,50597,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,1,N,12732,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627154,,BAO_0000019,,,,A,12904,,22224,Rate of acetate production by the compound was determined,1,U,12733,,,,0,,Autocuration
,,,CHEMBL627155,,BAO_0000019,,,,A,12904,,22224,Rate of acetate production by the compound was determined; Not determined,1,U,12734,,,,0,,Autocuration
,,,CHEMBL627156,,BAO_0000019,,,,A,3730,,22224,Rate of hydrolysis of nitrocefin by compound was evaluated in water,1,U,12735,,,,0,,Autocuration
,,,CHEMBL627157,,BAO_0000019,,,,A,3627,,22224,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,1,U,12736,,,,0,,Autocuration
,,,CHEMBL627158,,BAO_0000218,,,,A,13799,9986.0,50592,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,1,N,12737,,Oryctolagus cuniculus,,1,,Intermediate
,,,CHEMBL627159,1969.0,BAO_0000218,,,,A,13799,9986.0,50592,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,1,N,12738,,Oryctolagus cuniculus,Plasma,1,,Intermediate
,,,CHEMBL627160,,BAO_0000218,,,,A,13799,10090.0,50594,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,1,N,12739,,Mus musculus,,1,,Intermediate
,,,CHEMBL628540,,BAO_0000218,,,,A,13799,10116.0,50597,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,1,N,12740,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628541,1969.0,BAO_0000218,,,,A,13799,10116.0,50597,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,1,N,12741,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL628542,1969.0,BAO_0000218,,,,A,13799,10116.0,50597,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,1,N,12742,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL628543,,BAO_0000100,,,,P,6629,,22229,Solubility after at a pH 1.2,1,U,12743,,,,0,,Autocuration
,,,CHEMBL628544,,BAO_0000100,,,,P,6629,,22229,Solubility after at pH 1.2,1,U,12744,,,,0,,Autocuration
,,,CHEMBL628545,,BAO_0000100,,,,P,6629,,22229,Solubility after injection of water,1,U,12745,,,,0,,Autocuration
,,,CHEMBL628546,,BAO_0000019,,,,A,14000,,22224,Statistical significance of IC 50 values; Expressed as R value,1,U,12746,,,,0,,Autocuration
,,,CHEMBL874455,,BAO_0000019,,,,A,8267,,22224,Systemic availability with respect to methyldopa was determined,1,U,12747,,,,0,,Autocuration
,,,CHEMBL628547,,BAO_0000218,,,,A,13799,10116.0,50597,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,1,N,12748,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628548,1969.0,BAO_0000218,,,,A,13799,10116.0,50597,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,1,N,12749,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL628549,1988.0,BAO_0000218,,,,A,7132,9986.0,50592,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",1,N,12750,,Oryctolagus cuniculus,Feces,1,,Intermediate
,,,CHEMBL628550,1988.0,BAO_0000218,,,,A,7132,9986.0,50592,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",1,N,12751,,Oryctolagus cuniculus,Feces,1,,Intermediate
,,,CHEMBL628551,1988.0,BAO_0000218,,,,A,7132,9986.0,50592,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",1,N,12752,,Oryctolagus cuniculus,Feces,1,,Intermediate
,,,CHEMBL628552,1088.0,BAO_0000218,,,,A,7132,9986.0,50592,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",1,N,12753,,Oryctolagus cuniculus,Urine,1,,Intermediate
,,,CHEMBL628553,1088.0,BAO_0000218,,,,A,7132,9986.0,50592,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",1,N,12754,,Oryctolagus cuniculus,Urine,1,,Intermediate
,,,CHEMBL628554,1088.0,BAO_0000218,,,,A,7132,9986.0,50592,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",1,N,12755,,Oryctolagus cuniculus,Urine,1,,Intermediate
,,,CHEMBL628555,1088.0,BAO_0000218,,,,A,7132,9986.0,50592,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",1,N,12756,,Oryctolagus cuniculus,Urine,1,,Intermediate
,,,CHEMBL628556,1088.0,BAO_0000218,,,,A,7132,9986.0,50592,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",1,N,12757,,Oryctolagus cuniculus,Urine,1,,Intermediate
,,,CHEMBL628557,2113.0,BAO_0000218,,,,A,7132,9986.0,50592,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",1,N,12758,,Oryctolagus cuniculus,Kidney,1,,Intermediate
,,,CHEMBL628558,1988.0,BAO_0000218,,,,A,7132,9986.0,50592,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",1,N,12759,,Oryctolagus cuniculus,Feces,1,,Intermediate
,,,CHEMBL628559,1988.0,BAO_0000218,,,,A,7132,9986.0,50592,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",1,N,12760,,Oryctolagus cuniculus,Feces,1,,Intermediate
,,,CHEMBL628560,1988.0,BAO_0000218,,,,A,7132,9986.0,50592,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",1,N,12761,,Oryctolagus cuniculus,Feces,1,,Intermediate
,,,CHEMBL874456,1088.0,BAO_0000218,,,,A,7132,9986.0,50592,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",1,N,12762,,Oryctolagus cuniculus,Urine,1,,Intermediate
,,,CHEMBL628561,1988.0,BAO_0000218,,,,A,7132,9986.0,50592,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",1,N,12763,,Oryctolagus cuniculus,Feces,1,,Intermediate
,,,CHEMBL628562,1988.0,BAO_0000218,,,,A,7132,9986.0,50592,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",1,N,12764,,Oryctolagus cuniculus,Feces,1,,Intermediate
,,,CHEMBL628563,1088.0,BAO_0000218,,,,A,7132,9986.0,50592,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",1,N,12765,,Oryctolagus cuniculus,Urine,1,,Intermediate
,,,CHEMBL628564,1088.0,BAO_0000218,,,,A,7132,9986.0,50592,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",1,N,12766,,Oryctolagus cuniculus,Urine,1,,Intermediate
,,,CHEMBL628565,1088.0,BAO_0000218,,,,A,7132,9986.0,50592,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",1,N,12767,,Oryctolagus cuniculus,Urine,1,,Intermediate
,,,CHEMBL631248,1088.0,BAO_0000218,,,,A,7132,9986.0,50592,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",1,N,12768,,Oryctolagus cuniculus,Urine,1,,Intermediate
,,,CHEMBL631249,1088.0,BAO_0000218,,,,A,7132,9986.0,50592,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",1,N,12769,,Oryctolagus cuniculus,Urine,1,,Intermediate
,,,CHEMBL627214,2113.0,BAO_0000218,,,,A,7132,9986.0,50592,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",1,N,12770,,Oryctolagus cuniculus,Kidney,1,,Intermediate
,,,CHEMBL874591,1988.0,BAO_0000218,,,,A,7132,9986.0,50592,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",1,N,12771,,Oryctolagus cuniculus,Feces,1,,Intermediate
,,,CHEMBL627215,1988.0,BAO_0000218,,,,A,7132,9986.0,50592,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",1,N,12772,,Oryctolagus cuniculus,Feces,1,,Intermediate
,,,CHEMBL625471,1988.0,BAO_0000218,,,,A,7132,9986.0,50592,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,1,N,12773,,Oryctolagus cuniculus,Feces,1,,Intermediate
,,,CHEMBL625472,,BAO_0000218,,,,A,7132,9986.0,50592,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,1,N,12774,,Oryctolagus cuniculus,,1,,Intermediate
,,,CHEMBL625473,,BAO_0000218,,,,A,7132,9986.0,50592,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,1,N,12775,,Oryctolagus cuniculus,,1,,Intermediate
,,,CHEMBL625474,,BAO_0000218,,,,A,13317,9615.0,50588,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,1,N,12776,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625475,,BAO_0000218,,,,A,15341,9615.0,50588,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,1,N,12777,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625476,,BAO_0000218,,,,A,15341,10116.0,50597,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,1,N,12778,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625477,,BAO_0000218,,,,A,15341,10116.0,50597,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,1,N,12779,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625478,,BAO_0000218,,,,A,15341,10116.0,50597,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,1,N,12780,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625479,,BAO_0000218,,,,A,12801,10116.0,50597,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,1,N,12781,In vitro,Rattus norvegicus,esophageal tunica muscularis mucosae,1,,Intermediate
,,,CHEMBL625480,,BAO_0000218,,,,A,12801,10116.0,50597,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,1,N,12782,In vitro,Rattus norvegicus,esophageal tunica muscularis mucosae,1,,Intermediate
,,,CHEMBL625481,1969.0,BAO_0000218,,,,A,14856,10116.0,50597,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,1,N,12783,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL625482,,BAO_0000218,,,,A,14062,10116.0,50597,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,1,N,12784,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625483,,BAO_0000218,,,,A,14062,10116.0,50597,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,1,N,12785,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625484,,BAO_0000218,,,,A,14062,10116.0,50597,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,1,N,12786,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625485,,BAO_0000218,,,,A,14062,10116.0,50597,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,1,N,12787,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625486,1969.0,BAO_0000218,,,,A,14346,9615.0,50588,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,1,N,12788,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL625487,1969.0,BAO_0000218,,,,A,14346,10116.0,50597,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,1,N,12789,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL625488,1969.0,BAO_0000218,,,,A,14346,10116.0,50597,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,1,N,12790,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL625489,1969.0,BAO_0000218,,,,A,14346,10116.0,50597,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,1,N,12791,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL625490,1969.0,BAO_0000218,,,,A,14346,10116.0,50597,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,1,N,12792,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL625491,1969.0,BAO_0000218,,,,A,14346,9615.0,50588,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,1,N,12793,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL625492,1969.0,BAO_0000218,,,,A,14346,10116.0,50597,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,1,N,12794,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL625493,1969.0,BAO_0000218,,,,A,15711,9606.0,50587,plasma clearance in human,1,N,12795,In vivo,Homo sapiens,Plasma,1,,Intermediate
,,,CHEMBL625494,,BAO_0000218,,,,A,14886,10116.0,50597,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,1,N,12796,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625495,,BAO_0000218,,,,A,14886,10116.0,50597,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,1,N,12797,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625496,,BAO_0000218,,,,A,14886,10116.0,50597,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,1,N,12798,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625497,,BAO_0000100,,,,P,4115,,22229,1-Octanol/water partition coefficient measured at 7.4,1,U,12799,,,,0,,Autocuration
,,,CHEMBL625498,,BAO_0000100,,,,P,13733,,22229,Calculated partition coefficient (clogP),1,U,12800,,,,0,,Autocuration
,,,CHEMBL625499,,BAO_0000019,,,,A,12102,,22224,Partition coefficient (logP),1,U,12801,,,,0,,Autocuration
,,,CHEMBL625500,,BAO_0000100,,,,P,12676,,22229,Calculated partition coefficient (clogP),1,U,12802,,,,0,,Autocuration
,,,CHEMBL625501,,BAO_0000100,,,,P,13733,,22229,Calculated partition coefficient (clogP),1,U,12803,,,,0,,Autocuration
,,,CHEMBL625502,,BAO_0000100,,,,P,13740,,22229,Calculated partition coefficient (clogP),1,U,12804,,,,0,,Autocuration
,,,CHEMBL625503,,BAO_0000100,,,,P,12766,,22229,Calculated partition coefficient (clogP) (relative to BAY K 8644),1,U,12805,,,,0,,Autocuration
,,,CHEMBL625504,,BAO_0000100,,,,P,2764,,22229,Calculated partition coefficient (clogP),1,U,12806,,,,0,,Autocuration
,,,CHEMBL625505,,BAO_0000100,,,,P,12355,,22229,Calculated partition coefficient (clogP),1,U,12807,,,,0,,Autocuration
,,,CHEMBL625506,,BAO_0000100,,,,P,11314,,22229,Calculated partition coefficient of the compound,1,U,12808,,,,0,,Autocuration
,,,CHEMBL625507,,BAO_0000019,,,,A,12706,,22224,Partition coefficient (logP),1,U,12809,,,,0,,Autocuration
,,,CHEMBL625508,,BAO_0000100,,,,P,12645,,22229,Calculated partition coefficient (clogP),1,U,12810,,,,0,,Autocuration
,,,CHEMBL625509,,BAO_0000100,,,,P,13668,,22229,Calculated partition coefficient (clogP),1,U,12811,,,,0,,Autocuration
,,,CHEMBL625510,,BAO_0000100,,,,P,12819,,22229,Calculated partition coefficient (clogP),1,U,12812,,,,0,,Autocuration
,,,CHEMBL883125,,BAO_0000100,,,,P,13668,,22229,Calculated partition coefficient (clogP),1,U,12813,,,,0,,Autocuration
,,,CHEMBL625511,,BAO_0000100,,,,P,13017,,22229,Calculated partition coefficient (clogP),1,U,12814,,,,0,,Autocuration
,,,CHEMBL874650,,BAO_0000019,,,,A,2448,,22224,Partition coefficient of the compound,1,U,12815,,,,0,,Autocuration
,,,CHEMBL625512,,BAO_0000019,,,,A,11526,,22224,Partition coefficient of the compound,1,U,12816,,,,0,,Autocuration
,,,CHEMBL625513,,BAO_0000019,,,,A,12426,,22224,Partition coefficient of compound was determined,1,U,12817,,,,0,,Autocuration
,,,CHEMBL625514,,BAO_0000019,,,,A,2448,,22224,Partition coefficient was determined,1,U,12818,,,,0,,Autocuration
,,,CHEMBL625515,,BAO_0000100,,,,P,12001,,22229,Calculated partition coefficient (clogP),1,U,12819,,,,0,,Autocuration
,,,CHEMBL625516,,BAO_0000100,,,,P,12426,,22229,partition coefficient of compound was determined,1,U,12820,,,,0,,Autocuration
,,,CHEMBL625517,,BAO_0000218,,,,A,13204,9615.0,50588,The total body administered intravenously in dog,1,N,12821,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625518,,BAO_0000218,,,,A,13204,10116.0,50597,The total body administered intravenously in rats,1,N,12822,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625519,,BAO_0000218,,,,A,13889,10090.0,50594,Time taken for the administration to female NIH mice weighing 25-30 g.,1,N,12823,,Mus musculus,,1,,Intermediate
,,,CHEMBL625520,,BAO_0000019,,,,A,13889,,22224,Time taken for the administration,1,U,12824,,,,0,,Autocuration
,,,CHEMBL874651,,BAO_0000218,,,,A,17025,9615.0,50588,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,1,N,12825,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625521,,BAO_0000218,,,,A,17025,314293.0,22224,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,1,U,12826,In vivo,Simiiformes,,0,,Autocuration
,,,CHEMBL623171,,BAO_0000218,,,,A,17025,9986.0,50592,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,1,N,12827,In vivo,Oryctolagus cuniculus,,1,,Intermediate
,,,CHEMBL623853,,BAO_0000218,,,,A,17025,10116.0,50597,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,1,N,12828,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623854,,BAO_0000019,,,,A,15067,,22224,Plasma clearance for the compound was determined.,1,U,12829,,,,0,,Autocuration
,,,CHEMBL874405,,BAO_0000100,,,,P,3091,,22224,CLog P value of the compound,1,U,12830,,,,0,,Autocuration
,,,CHEMBL623855,,BAO_0000100,,,,P,15592,,22229,Calculated partition coefficient (clogP),1,U,12831,,,,0,,Autocuration
,,,CHEMBL623856,,BAO_0000100,,,,P,14738,,22229,Calculated partition coefficient (clogP),1,U,12832,,,,0,,Autocuration
,,,CHEMBL623857,,BAO_0000100,,,,P,14738,,22224,ClogP value of the compound; nd ='no data',1,U,12833,,,,0,,Autocuration
,,,CHEMBL623858,,BAO_0000100,,,,P,14738,,22224,ClogP value of the compound; nd ='not determined',1,U,12834,,,,0,,Autocuration
,,,CHEMBL623859,,BAO_0000100,,,,P,6076,,22224,CLog P was determined,1,U,12835,,,,0,,Autocuration
,,,CHEMBL839829,,BAO_0000100,,,,P,17840,,22229,Calculated partition coefficient (clogP),1,U,12836,,,,0,,Autocuration
,,,CHEMBL623860,,BAO_0000019,,,,A,13589,,22224,CLogP was calculated,1,U,12837,,,,0,,Autocuration
,,,CHEMBL623861,,BAO_0000019,,,,A,17655,,22224,CLogP value was determined,1,U,12838,,,,0,,Autocuration
,,,CHEMBL623862,,BAO_0000019,,,,A,5867,,22224,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,1,U,12839,,,,0,,Autocuration
,,,CHEMBL874406,,BAO_0000100,,,,P,5867,,22229,Calculated partition coefficient (clogP),1,U,12840,,,,0,,Autocuration
,,,CHEMBL623863,,BAO_0000100,,,,P,10783,,22229,Calculated partition coefficient (clogP),1,U,12841,,,,0,,Autocuration
,,,CHEMBL624021,,BAO_0000100,,,,P,14849,,22229,Calculated partition coefficient (clogP),1,U,12842,,,,0,,Autocuration
,,,CHEMBL624022,1236.0,BAO_0000218,,,,A,8170,9615.0,50588,Distribution in female dog adrenal medulla 24 hours after administration.,1,N,12843,,Canis lupus familiaris,Adrenal medulla,1,,Intermediate
,,,CHEMBL624023,1236.0,BAO_0000218,,,,A,8170,9615.0,50588,Distribution in female dog adrenal medulla 72 hours after administration.,1,N,12844,,Canis lupus familiaris,Adrenal medulla,1,,Intermediate
,,,CHEMBL624024,,BAO_0000218,,,,A,8170,9615.0,50588,Distribution in female dog bile 24 hours after administration.,1,N,12845,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624025,,BAO_0000218,,,,A,8170,9615.0,50588,Distribution in female dog bile 72 hr after administration.,1,N,12846,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624026,,BAO_0000218,,,,A,8170,9615.0,50588,Distribution in female dog blood 24 hours after administration.,1,N,12847,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624027,,BAO_0000218,,,,A,8170,9615.0,50588,Distribution in female dog blood 72 hours after administration.,1,N,12848,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624028,,BAO_0000218,,,,A,8170,9615.0,50588,Distribution in female dog heart 24 hours after administration.,1,N,12849,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624029,,BAO_0000218,,,,A,8170,9615.0,50588,Distribution in female dog heart 72 hours after administration.,1,N,12850,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624030,,BAO_0000218,,,,A,8170,9615.0,50588,Distribution in female dog kidney 24 hours after administration.,1,N,12851,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624031,,BAO_0000218,,,,A,8170,9615.0,50588,Distribution in female dog kidney 72 hours after administration.,1,N,12852,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624032,160.0,BAO_0000218,,,,A,8170,9615.0,50588,Distribution in female dog large intestine 24 hours after administration.,1,N,12853,,Canis lupus familiaris,Intestine,1,,Intermediate
,,,CHEMBL874407,160.0,BAO_0000218,,,,A,8170,9615.0,50588,Distribution in female dog large intestine 72 hours after administration.,1,N,12854,,Canis lupus familiaris,Intestine,1,,Intermediate
,,,CHEMBL624033,,BAO_0000218,,,,A,8170,9615.0,50588,Distribution in female dog liver 24 hours after administration.,1,N,12855,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624034,,BAO_0000218,,,,A,8170,9615.0,50588,Distribution in female dog liver 72 hours after administration.,1,N,12856,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624035,,BAO_0000218,,,,A,8170,9615.0,50588,Distribution in female dog lung 24 hours after administration.,1,N,12857,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624036,,BAO_0000218,,,,A,8170,9615.0,50588,Distribution in female dog lung 72 hours after administration.,1,N,12858,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624037,2385.0,BAO_0000218,,,,A,8170,9615.0,50588,Distribution in female dog muscle 24 hours after administration.,1,N,12859,,Canis lupus familiaris,Muscle tissue,1,,Intermediate
,,,CHEMBL624038,2385.0,BAO_0000218,,,,A,8170,9615.0,50588,Distribution in female dog muscle 72 hours after administration.,1,N,12860,,Canis lupus familiaris,Muscle tissue,1,,Intermediate
,,,CHEMBL624039,,BAO_0000218,,,,A,8170,9615.0,50588,Distribution in female dog pancreas 24 hours after administration.,1,N,12861,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624040,,BAO_0000218,,,,A,8170,9615.0,50588,Distribution in female dog pancreas 72 hours after administration.,1,N,12862,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624041,160.0,BAO_0000218,,,,A,8170,9615.0,50588,Distribution in female dog small intestine 24 hours after administration.,1,N,12863,,Canis lupus familiaris,Intestine,1,,Intermediate
,,,CHEMBL624042,160.0,BAO_0000218,,,,A,8170,9615.0,50588,Distribution in female dog small intestine 72 hours after administration.,1,N,12864,,Canis lupus familiaris,Intestine,1,,Intermediate
,,,CHEMBL624043,2106.0,BAO_0000218,,,,A,8170,9615.0,50588,Distribution in female dog spleen 24 hours after administration.,1,N,12865,,Canis lupus familiaris,Spleen,1,,Intermediate
,,,CHEMBL624044,2106.0,BAO_0000218,,,,A,8170,9615.0,50588,Distribution in female dog spleen 72 hours after administration.,1,N,12866,,Canis lupus familiaris,Spleen,1,,Intermediate
,,,CHEMBL624045,945.0,BAO_0000218,,,,A,8170,9615.0,50588,Distribution in female dog stomach 24 hours after administration.,1,N,12867,,Canis lupus familiaris,Stomach,1,,Intermediate
,,,CHEMBL624046,945.0,BAO_0000218,,,,A,8170,9615.0,50588,Distribution in female dog stomach 72 hours after administration.,1,N,12868,,Canis lupus familiaris,Stomach,1,,Intermediate
,,,CHEMBL624047,2046.0,BAO_0000218,,,,A,8170,9615.0,50588,Distribution in female dog thyroid 24 hours after administration.,1,N,12869,,Canis lupus familiaris,Thyroid gland,1,,Intermediate
,,,CHEMBL624048,2046.0,BAO_0000218,,,,A,8170,9615.0,50588,Distribution in female dog thyroid 72 hours after administration.,1,N,12870,,Canis lupus familiaris,Thyroid gland,1,,Intermediate
,,,CHEMBL874408,1088.0,BAO_0000218,,,,A,8170,9615.0,50588,Distribution in female dog urine 24 hours after administration.,1,N,12871,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL624049,1088.0,BAO_0000218,,,,A,8170,9615.0,50588,Distribution in female dog urine 72 hr after administration.,1,N,12872,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL624050,1969.0,BAO_0000218,,,,A,14283,,22224,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,1,U,12873,,,Plasma,0,,Autocuration
,,,CHEMBL624051,,BAO_0000019,,,,A,5623,,22224,Plasma concentration at 7 hr after intravenous dosing,1,U,12874,,,,0,,Autocuration
,,,CHEMBL623278,,BAO_0000218,,,,A,13477,10116.0,50597,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,1,N,12875,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623279,,BAO_0000218,,,,A,13477,10116.0,50597,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,1,N,12876,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623280,,BAO_0000218,,,,A,13477,10116.0,50597,Plasma concentration of 3 mg/kg iv after 1 hr in rats,1,N,12877,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623963,,BAO_0000218,,,,A,13477,10116.0,50597,Plasma concentration of 3 mg/kg iv after 2 hr in rats,1,N,12878,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623964,,BAO_0000218,,,,A,13477,10116.0,50597,Plasma concentration of 3 mg/kg iv after 4 hr in rats,1,N,12879,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623965,,BAO_0000218,,,,A,13477,10116.0,50597,Plasma concentration of 3 mg/kg iv after 6 hr in rats,1,N,12880,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623966,,BAO_0000218,,,,A,13477,10116.0,50597,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,1,N,12881,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL874415,,BAO_0000218,,,,A,13477,10116.0,50597,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,1,N,12882,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623967,,BAO_0000218,,,,A,13477,10116.0,50597,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,1,N,12883,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623968,,BAO_0000218,,,,A,13477,10116.0,50597,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,1,N,12884,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623969,,BAO_0000218,,,,A,13477,10116.0,50597,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,1,N,12885,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628409,,BAO_0000218,,,,A,13477,10116.0,50597,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,1,N,12886,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628410,,BAO_0000218,,,,A,13477,10116.0,50597,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,1,N,12887,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628411,,BAO_0000218,,,,A,13477,10116.0,50597,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,1,N,12888,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628412,,BAO_0000218,,,,A,13477,10116.0,50597,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,1,N,12889,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628413,,BAO_0000019,,,,A,12553,,22224,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,1,U,12890,,,,0,,Autocuration
,,,CHEMBL628414,1969.0,BAO_0000019,,,,A,14548,,22224,The concentration in plasmat; Not determined,1,U,12891,,,Plasma,0,,Autocuration
,,,CHEMBL628415,,BAO_0000218,,,,A,14393,10116.0,50597,Tissue level at 10 mg/kg/po in wistar rats in blood,1,N,12892,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628416,,BAO_0000218,,,,A,14393,10116.0,50597,Tissue level at 10 mg/kg/po in wistar rats in brown fat,1,N,12893,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628417,,BAO_0000218,,,,A,14393,10116.0,50597,Tissue level at 10 mg/kg/po in wistar rats in heart,1,N,12894,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL874908,2107.0,BAO_0000218,,,,A,14393,10116.0,50597,Tissue level at 10 mg/kg/po in wistar rats in liver,1,N,12895,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL628418,,BAO_0000218,,,,A,14393,10116.0,50597,Tissue level at 10 mg/kg/po in wistar rats in plasma,1,N,12896,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628419,2385.0,BAO_0000218,,,,A,14393,10116.0,50597,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,1,N,12897,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL628420,,BAO_0000218,,,,A,14393,10116.0,50597,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,1,N,12898,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628421,,BAO_0000019,,,,A,1629,,22224,Water solubility at 37 degree C.,1,U,12899,,,,0,,Autocuration
,,,CHEMBL626726,,BAO_0000100,,,,P,8194,,22229,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,1,U,12900,,,,0,,Autocuration
,,,CHEMBL626727,,BAO_0000100,,,,P,8194,,22229,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,1,U,12901,,,,0,,Autocuration
,,,CHEMBL626728,178.0,BAO_0000218,,,,A,8594,10116.0,50597,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,1,N,12902,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL626729,178.0,BAO_0000218,,,,A,8594,10116.0,50597,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,1,N,12903,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL626730,178.0,BAO_0000218,,,,A,8594,10116.0,50597,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,1,N,12904,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL626731,178.0,BAO_0000218,,,,A,8594,10116.0,50597,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,1,N,12905,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL626732,178.0,BAO_0000218,,,,A,8594,10116.0,50597,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,1,N,12906,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL626733,948.0,BAO_0000218,,,,A,8594,10116.0,50597,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,1,N,12907,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL626734,948.0,BAO_0000218,,,,A,8594,10116.0,50597,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,1,N,12908,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL626735,948.0,BAO_0000218,,,,A,8594,10116.0,50597,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,1,N,12909,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL874909,948.0,BAO_0000218,,,,A,8594,10116.0,50597,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,1,N,12910,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL626736,948.0,BAO_0000218,,,,A,8594,10116.0,50597,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,1,N,12911,,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL626737,2113.0,BAO_0000218,,,,A,8594,10116.0,50597,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,1,N,12912,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL630999,2113.0,BAO_0000218,,,,A,8594,10116.0,50597,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,1,N,12913,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL631000,2113.0,BAO_0000218,,,,A,8594,10116.0,50597,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,1,N,12914,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL631001,2113.0,BAO_0000218,,,,A,8594,10116.0,50597,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,1,N,12915,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL631002,2113.0,BAO_0000218,,,,A,8594,10116.0,50597,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,1,N,12916,,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL631003,2107.0,BAO_0000218,,,,A,8594,10116.0,50597,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,1,N,12917,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL631004,2107.0,BAO_0000218,,,,A,8594,10116.0,50597,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,1,N,12918,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL631005,2107.0,BAO_0000218,,,,A,8594,10116.0,50597,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,1,N,12919,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL631006,2107.0,BAO_0000218,,,,A,8594,10116.0,50597,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,1,N,12920,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL631007,2107.0,BAO_0000218,,,,A,8594,10116.0,50597,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,1,N,12921,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL631008,2048.0,BAO_0000218,,,,A,8594,10116.0,50597,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,1,N,12922,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL631009,2048.0,BAO_0000218,,,,A,8594,10116.0,50597,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,1,N,12923,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL631010,2048.0,BAO_0000218,,,,A,8594,10116.0,50597,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,1,N,12924,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL631011,2048.0,BAO_0000218,,,,A,8594,10116.0,50597,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,1,N,12925,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL631012,2048.0,BAO_0000218,,,,A,8594,10116.0,50597,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,1,N,12926,,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL630271,2046.0,BAO_0000218,,,,A,8594,10116.0,50597,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,1,N,12927,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL630272,2046.0,BAO_0000218,,,,A,8594,10116.0,50597,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,1,N,12928,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL630273,2046.0,BAO_0000218,,,,A,8594,10116.0,50597,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,1,N,12929,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL630274,2046.0,BAO_0000218,,,,A,8594,10116.0,50597,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,1,N,12930,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL630275,2046.0,BAO_0000218,,,,A,8594,10116.0,50597,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,1,N,12931,,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL875782,,BAO_0000218,,,,A,8594,10116.0,50597,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,1,N,12932,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630276,,BAO_0000218,,,,A,8594,10116.0,50597,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,1,N,12933,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630277,,BAO_0000218,,,,A,8594,10116.0,50597,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,1,N,12934,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630278,,BAO_0000218,,,,A,8594,10116.0,50597,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,1,N,12935,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630279,,BAO_0000218,,,,A,8594,10116.0,50597,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,1,N,12936,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630280,,BAO_0000019,,,,A,8151,,22224,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,1,U,12937,,,,0,,Autocuration
,,,CHEMBL630281,,BAO_0000019,,,,A,8151,,22224,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,1,U,12938,,,,0,,Autocuration
,,,CHEMBL630282,,BAO_0000218,,,,A,7132,9986.0,50592,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,1,N,12939,,Oryctolagus cuniculus,,1,,Intermediate
,,,CHEMBL630283,,BAO_0000218,,,,A,7132,9986.0,50592,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,1,N,12940,,Oryctolagus cuniculus,,1,,Intermediate
,,,CHEMBL630284,,BAO_0000019,,,,A,5797,,22224,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),1,U,12941,,,,0,,Autocuration
,,,CHEMBL630285,,BAO_0000019,,,,A,7849,,22224,Alkylating activity was determined,1,U,12942,,,,0,,Autocuration
,,,CHEMBL630286,,BAO_0000251,,,,A,14220,,22224,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),1,U,12943,,,,0,Microsomes,Autocuration
,,,CHEMBL630069,,BAO_0000218,,,,A,8650,9986.0,50592,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",1,N,12944,,Oryctolagus cuniculus,,1,,Intermediate
,,,CHEMBL630070,,BAO_0000218,,,,A,8650,9986.0,50592,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",1,N,12945,,Oryctolagus cuniculus,,1,,Intermediate
,,,CHEMBL630071,,BAO_0000218,,,,A,8650,9986.0,50592,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",1,N,12946,,Oryctolagus cuniculus,,1,,Intermediate
,,,CHEMBL630072,,BAO_0000218,,,,A,8650,9986.0,50592,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",1,N,12947,,Oryctolagus cuniculus,,1,,Intermediate
,,,CHEMBL875110,,BAO_0000218,,,,A,8650,9986.0,50592,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",1,N,12948,,Oryctolagus cuniculus,,1,,Intermediate
,,,CHEMBL630073,,BAO_0000218,,,,A,7116,10116.0,50597,Compound was tested for antidiuretic activity in rats,1,N,12949,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630074,,BAO_0000019,,,,A,14131,,22224,Compound was tested for inactivation kinetic values,1,U,12950,,,,0,,Autocuration
,,,CHEMBL630075,,BAO_0000218,,,,A,7415,,22224,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,1,U,12951,In vivo,,,0,,Autocuration
,,,CHEMBL630076,,BAO_0000019,,,,A,13178,,22224,Dissociation rate calculated from the first-order equation using the t1/2 value,1,U,12952,,,,0,,Autocuration
,,,CHEMBL630077,,BAO_0000100,,,,P,8815,,22229,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,1,U,12953,,,,0,,Autocuration
,,,CHEMBL630078,,BAO_0000100,,,,P,1450,,22229,Aqueous solubility was measured,1,U,12954,,,,0,,Autocuration
,,,CHEMBL630079,,BAO_0000100,,,,P,1450,,22229,Aqueous solubility was measured at a pH 4,1,U,12955,,,,0,,Autocuration
,,,CHEMBL630080,,BAO_0000100,,,,P,1450,,22229,Aqueous solubility (pH 7),1,U,12956,,,,0,,Autocuration
,,,CHEMBL630081,,BAO_0000100,,,,P,1450,,22229,Aqueous solubility was measured at a pH 9,1,U,12957,,,,0,,Autocuration
,,,CHEMBL630082,,BAO_0000019,,,,A,12711,,22224,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",1,U,12958,,,,0,,Autocuration
,,,CHEMBL630083,,BAO_0000019,,,,A,12711,,22224,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",1,U,12959,,,,0,,Autocuration
,,,CHEMBL630084,,BAO_0000019,,,,A,12711,,22224,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",1,U,12960,,,,0,,Autocuration
,,,CHEMBL629198,,BAO_0000100,,,,P,15032,,22229,Aqueous solubility of the compound,1,U,12961,,,,0,,Autocuration
,,,CHEMBL629199,,BAO_0000100,,,,P,9964,,22229,Aqueous solubility at 37 degree Celsius at pH 7.38,1,U,12962,,,,0,,Autocuration
,,,CHEMBL629200,,BAO_0000100,,,,P,14962,,22229,Aqueous solubility in pH 7.4 phosphate buffer,1,U,12963,,,,0,,Autocuration
,,,CHEMBL629201,,BAO_0000218,,,,A,12487,9615.0,50588,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,1,N,12964,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL629202,,BAO_0000218,,,,A,12487,9615.0,50588,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,1,N,12965,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL875111,,BAO_0000218,,,,A,10026,9606.0,50587,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,1,N,12966,,Homo sapiens,,1,,Intermediate
,,,CHEMBL629203,,BAO_0000218,,,,A,10026,9606.0,50587,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,1,N,12967,,Homo sapiens,,1,,Intermediate
,,,CHEMBL629204,,BAO_0000218,,,,A,10026,9606.0,50587,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,1,N,12968,,Homo sapiens,,1,,Intermediate
,,,CHEMBL629205,,BAO_0000218,,,,A,10026,9606.0,50587,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,1,N,12969,,Homo sapiens,,1,,Intermediate
,,,CHEMBL629206,,BAO_0000218,,,,A,10026,9606.0,50587,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,1,N,12970,,Homo sapiens,,1,,Intermediate
,,,CHEMBL631185,,BAO_0000019,,,,A,10026,,22224,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,1,U,12971,,,,0,,Autocuration
,,,CHEMBL631186,,BAO_0000218,,,,A,7415,10116.0,50597,Compound was evaluated for the average bile flow rat in rats,1,N,12972,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631187,,BAO_0000218,,,,A,17025,9986.0,50592,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",1,N,12973,,Oryctolagus cuniculus,,1,,Intermediate
,,,CHEMBL631188,,BAO_0000218,,,,A,17025,9986.0,50592,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",1,N,12974,,Oryctolagus cuniculus,,1,,Intermediate
,,,CHEMBL876419,,BAO_0000019,,,,A,10184,,22224,Average half life period was determined,1,U,12975,,,,0,,Autocuration
,,,CHEMBL631189,,BAO_0000019,,,,A,10184,,22224,Average half life period was determined,1,U,12976,,,,0,,Autocuration
,,,CHEMBL631190,,BAO_0000218,,,,A,8613,10298.0,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,1,N,12977,,Human herpesvirus 1,,1,,Intermediate
,,,CHEMBL631191,,BAO_0000218,,,,A,8613,10298.0,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,1,N,12978,,Human herpesvirus 1,,1,,Intermediate
,,,CHEMBL631192,,BAO_0000218,,,,A,8613,10298.0,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,1,N,12979,,Human herpesvirus 1,,1,,Intermediate
,,,CHEMBL632400,,BAO_0000218,,,,A,8613,10298.0,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,1,N,12980,,Human herpesvirus 1,,1,,Intermediate
,,,CHEMBL630564,,BAO_0000218,,,,A,8613,10298.0,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,1,N,12981,,Human herpesvirus 1,,1,,Intermediate
,,,CHEMBL630565,,BAO_0000218,,,,A,8613,10298.0,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,1,N,12982,,Human herpesvirus 1,,1,,Intermediate
,,,CHEMBL630566,,BAO_0000218,,,,A,8613,10298.0,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,1,N,12983,,Human herpesvirus 1,,1,,Intermediate
,,,CHEMBL631229,,BAO_0000218,,,,A,8613,10298.0,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,1,N,12984,,Human herpesvirus 1,,1,,Intermediate
,,,CHEMBL631230,,BAO_0000218,,,,A,8613,10298.0,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,1,N,12985,,Human herpesvirus 1,,1,,Intermediate
,,,CHEMBL876428,,BAO_0000100,,,,P,6030,,22229,Calculated partition coefficient (clogP),1,U,12986,,,,0,,Autocuration
,,,CHEMBL631231,,BAO_0000100,,,,P,6147,,22229,Calculated partition coefficient (clogP),1,U,12987,,,,0,,Autocuration
,,,CHEMBL631232,,BAO_0000100,,,,P,14556,,22229,Calculated partition coefficient (clogP) (MacLogP),1,U,12988,,,,0,,Autocuration
,,,CHEMBL631233,,BAO_0000019,,,,A,768,,22224,Hydrophilicity was determined,1,U,12989,,,,0,,Autocuration
,,,CHEMBL631234,,BAO_0000100,,,,P,14452,,22229,Calculated partition coefficient (clogP),1,U,12990,,,,0,,Autocuration
,,,CHEMBL883126,,BAO_0000019,,,,A,5237,,22224,Increased absorption was determined,1,U,12991,,,,0,,Autocuration
,,,CHEMBL631235,,BAO_0000100,,,,P,14378,,22224,Lipophilicity value was evaluated,1,U,12992,,,,0,,Autocuration
,,,CHEMBL631236,,BAO_0000100,,,,P,14418,,22224,Log P value of the compound.,1,U,12993,,,,0,,Autocuration
,,,CHEMBL631237,,BAO_0000019,,,,A,5249,,22224,Partition coefficient of compound was determined,1,U,12994,,,,0,,Autocuration
,,,CHEMBL631238,,BAO_0000100,,,,P,14621,,22229,Calculated partition coefficient (clogP),1,U,12995,,,,0,,Autocuration
,,,CHEMBL876429,,BAO_0000100,,,,P,12542,,22229,Calculated partition coefficient (clogP),1,U,12996,,,,0,,Autocuration
,,,CHEMBL631414,,BAO_0000019,,,,A,12542,,22224,Partition coefficient was measured by medchem software; Not calculated,1,U,12997,,,,0,,Autocuration
,,,CHEMBL631415,,BAO_0000100,,,,P,12542,,22224,Partition coefficient was measured by octanol-water using standard shake-flask method,1,U,12998,,,,0,,Autocuration
,,,CHEMBL631416,,BAO_0000100,,,,P,15462,,22229,Calculated partition coefficient (clogP),1,U,12999,,,,0,,Autocuration
,,,CHEMBL631417,,BAO_0000019,,,,A,14884,,22224,Partition coefficient (logP),1,U,13000,,,,0,,Autocuration
,,,CHEMBL631418,,BAO_0000100,,,,P,16526,,22229,Calculated partition coefficient (clogP),1,U,13001,,,,0,,Autocuration
,,,CHEMBL631419,,BAO_0000100,,,,P,13693,,22229,The Octanol/Water partition coefficient CLogP,1,U,13002,,,,0,,Autocuration
,,,CHEMBL631420,,BAO_0000019,,,,A,13693,,22224,The pharmacokinetic parameter C Log p was reported,1,U,13003,,,,0,,Autocuration
,,,CHEMBL631421,,BAO_0000100,,,,P,13779,,22229,Calculated partition coefficient (clogP),1,U,13004,,,,0,,Autocuration
,,,CHEMBL631422,,BAO_0000100,,,,P,14772,,22229,Calculated partition coefficient (clogP),1,U,13005,,,,0,,Autocuration
,,,CHEMBL631423,,BAO_0000100,,,,P,14393,,22229,Calculated partition coefficient (clogP),1,U,13006,,,,0,,Autocuration
,,,CHEMBL876430,1969.0,BAO_0000218,,,,A,14793,10116.0,50597,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,1,N,13007,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL631424,1969.0,BAO_0000218,,,,A,14793,10116.0,50597,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,1,N,13008,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL631425,1969.0,BAO_0000218,,,,A,13744,9615.0,50588,Compound was administered intravenously in dog to evaluate plasma clearance values,1,N,13009,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL631426,1969.0,BAO_0000218,,,,A,13744,314293.0,22224,Compound was administered intravenously in monkey to evaluate plasma clearance values,1,U,13010,In vivo,Simiiformes,Plasma,0,,Autocuration
,,,CHEMBL631427,1969.0,BAO_0000218,,,,A,13744,10090.0,50594,Compound was administered intravenously in mouse to evaluate plasma clearance values,1,N,13011,In vivo,Mus musculus,Plasma,1,,Intermediate
,,,CHEMBL631428,1969.0,BAO_0000218,,,,A,13207,9615.0,50588,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,1,N,13012,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL631429,2107.0,BAO_0000218,,,,A,5669,9544.0,50797,Intrinsic clearance in Rhesus liver microsome,1,N,13013,In vitro,Macaca mulatta,Liver,1,Microsomes,Intermediate
,,,CHEMBL631430,2107.0,BAO_0000218,,,,A,5669,9615.0,50588,Intrinsic clearance in dog liver microsome,1,N,13014,In vitro,Canis lupus familiaris,Liver,1,Microsomes,Intermediate
,,,CHEMBL631431,2107.0,BAO_0000218,,,,A,5669,10116.0,50597,Intrinsic clearance in rat liver microsome,1,N,13015,In vitro,Rattus norvegicus,Liver,1,Microsomes,Intermediate
,,,CHEMBL631432,1969.0,BAO_0000218,,,,A,4853,9544.0,50797,Low plasma clearance was calculated in rhesus monkey,1,N,13016,In vivo,Macaca mulatta,Plasma,1,,Intermediate
,,,CHEMBL631433,,BAO_0000218,,,,A,16452,9615.0,50588,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,1,N,13017,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL631434,,BAO_0000218,,,,A,11954,,22224,Plasma clearance after intravenous dose of 0.3 mg/kg,1,U,13018,In vivo,,,0,,Autocuration
,,,CHEMBL631435,,BAO_0000218,,,,A,11954,,22224,Plasma clearance after intravenous dose of 1 mg/kg,1,U,13019,In vivo,,,0,,Autocuration
,,,CHEMBL631436,,BAO_0000218,,,,A,11954,,22224,Plasma clearance after intravenous dose of 3 mg/kg,1,U,13020,In vivo,,,0,,Autocuration
,,,CHEMBL631437,,BAO_0000218,,,,A,11954,,22224,Plasma clearance after intravenous dose of 3.87 mg/kg,1,U,13021,In vivo,,,0,,Autocuration
,,,CHEMBL631438,,BAO_0000218,,,,A,5669,10116.0,50597,Plasma clearance after peroral administration at 10 mpk in Rat,1,N,13022,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL876431,,BAO_0000218,,,,A,5669,9544.0,50797,Plasma clearance after peroral administration at 10 mpk in Rhesus,1,N,13023,In vivo,Macaca mulatta,,1,,Intermediate
,,,CHEMBL631439,,BAO_0000218,,,,A,5669,9615.0,50588,Plasma clearance after peroral administration at 10 mpk in dog,1,N,13024,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL631440,,BAO_0000218,,,,A,13662,10116.0,50597,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,1,N,13025,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631441,,BAO_0000019,,,,A,8272,,22224,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),1,U,13026,,,,0,,Autocuration
,,,CHEMBL631442,,BAO_0000019,,,,A,13410,,22224,Critical Micellar concentration was determined,1,U,13027,,,,0,,Autocuration
,,,CHEMBL626525,,BAO_0000019,,,,A,13410,,22224,Critical Micellar concentration of the compound. was determined,1,U,13028,,,,0,,Autocuration
,,,CHEMBL627168,,BAO_0000019,,,,A,12628,,22224,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,1,U,13029,,,,0,,Autocuration
,,,CHEMBL875618,,BAO_0000019,,,,A,9675,,22224,Critical micellar concentration was measured in water by the dye solubilization method,1,U,13030,,,,0,,Autocuration
,,,CHEMBL626612,,BAO_0000019,,,,B,12628,,22224,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,1,U,13031,,,,0,,Autocuration
,,,CHEMBL626613,,BAO_0000019,,,,A,12766,,22224,CMR value (relative to BAY K 8644),1,U,13032,,,,0,,Autocuration
,,,CHEMBL626614,,BAO_0000019,,,,A,7849,,22224,Carbamoylating activity was determined,1,U,13033,,,,0,,Autocuration
,,,CHEMBL626615,,BAO_0000218,,,,A,12187,314293.0,22224,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,1,U,13034,,Simiiformes,,0,,Autocuration
,,,CHEMBL626616,,BAO_0000019,,,,A,2040,,22224,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,1,U,13035,,,,0,,Autocuration
,,,CHEMBL626617,,BAO_0000019,,,,A,2040,,22224,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,1,U,13036,,,,0,,Autocuration
,,,CHEMBL626618,1969.0,BAO_0000218,,,,A,14180,9615.0,50588,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,1,N,13037,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL626619,1969.0,BAO_0000218,,,,A,14180,10116.0,50597,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,1,N,13038,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626620,,BAO_0000218,,,,A,14474,9615.0,50588,"Clearance rate at 0.46 mg/kg, iv, in dogs",1,N,13039,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626621,,BAO_0000218,,,,A,14474,10116.0,50597,"Clearance rate at 5.5 mg/kg, iv, in rat",1,N,13040,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626622,,BAO_0000218,,,,A,14548,9541.0,100710,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,1,N,13041,In vivo,Macaca fascicularis,,1,,Intermediate
,,,CHEMBL626623,,BAO_0000218,,,,A,14548,9541.0,100710,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,1,N,13042,In vivo,Macaca fascicularis,,1,,Intermediate
,,,CHEMBL626624,,BAO_0000218,,,,A,14548,9615.0,50588,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,1,N,13043,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626625,,BAO_0000218,,,,A,14548,10116.0,50597,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,1,N,13044,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626626,2107.0,BAO_0000218,,,,A,6125,10116.0,50597,Clearance rate constant using isolated perfused rat liver (IPRL) assay,1,N,13045,Ex vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL626627,,BAO_0000218,,,,A,6874,,22224,Tested for the total clearance of the compound,1,U,13046,In vivo,,,0,,Autocuration
,,,CHEMBL626628,,BAO_0000218,,,,A,15343,9615.0,50588,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,1,N,13047,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626629,,BAO_0000218,,,,A,6236,,22224,Total body clearance was determined,1,U,13048,In vivo,,,0,,Autocuration
,,,CHEMBL626630,,BAO_0000218,,,,A,11510,10116.0,50597,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,1,N,13049,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626631,,BAO_0000218,,,,A,11510,10116.0,50597,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,1,N,13050,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626632,,BAO_0000100,,,,P,8194,,22229,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,1,U,13051,,,,0,,Autocuration
,,,CHEMBL626633,,BAO_0000100,,,,P,8194,,22229,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,1,U,13052,,,,0,,Autocuration
,,,CHEMBL626634,,BAO_0000100,,,,P,8194,,22229,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,1,U,13053,,,,0,,Autocuration
,,,CHEMBL626635,,BAO_0000100,,,,P,8194,,22229,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,1,U,13054,,,,0,,Autocuration
,,,CHEMBL626636,,BAO_0000100,,,,P,8194,,22229,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,1,U,13055,,,,0,,Autocuration
,,,CHEMBL626637,,BAO_0000100,,,,P,8194,,22229,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,1,U,13056,,,,0,,Autocuration
,,,CHEMBL626638,,BAO_0000218,,,,A,13273,4754.0,50339,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),1,N,13057,,Pneumocystis carinii,,1,,Intermediate
,,,CHEMBL626639,,BAO_0000218,,,,A,13273,4754.0,50339,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,1,N,13058,,Pneumocystis carinii,,1,,Intermediate
,,,CHEMBL626640,,BAO_0000218,,,,A,13273,4754.0,50339,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,1,N,13059,,Pneumocystis carinii,,1,,Intermediate
,,,CHEMBL626641,,BAO_0000218,,,,A,13273,4754.0,50339,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,1,N,13060,,Pneumocystis carinii,,1,,Intermediate
,,,CHEMBL627272,,BAO_0000218,,,,A,13273,4754.0,50339,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,1,N,13061,,Pneumocystis carinii,,1,,Intermediate
,,,CHEMBL627273,,BAO_0000218,,,,A,13273,4754.0,50339,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,1,N,13062,,Pneumocystis carinii,,1,,Intermediate
,,,CHEMBL627441,,BAO_0000218,,,,A,13273,4754.0,50339,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),1,N,13063,,Pneumocystis carinii,,1,,Intermediate
,,,CHEMBL628355,,BAO_0000218,,,,A,13273,4754.0,50339,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),1,N,13064,,Pneumocystis carinii,,1,,Intermediate
,,,CHEMBL628356,,BAO_0000218,,,,A,13273,4754.0,50339,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),1,N,13065,,Pneumocystis carinii,,1,,Intermediate
,,,CHEMBL628357,,BAO_0000218,,,,A,13273,4754.0,50339,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),1,N,13066,,Pneumocystis carinii,,1,,Intermediate
,,,CHEMBL628358,,BAO_0000218,,,,A,13273,4754.0,50339,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),1,N,13067,,Pneumocystis carinii,,1,,Intermediate
,,,CHEMBL622307,,BAO_0000218,,,,A,13273,4754.0,50339,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),1,N,13068,,Pneumocystis carinii,,1,,Intermediate
,,,CHEMBL622527,,BAO_0000019,,,,A,13118,,22224,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,1,U,13069,,,,0,,Autocuration
,,,CHEMBL622528,,BAO_0000019,,,,A,13118,,22224,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,1,U,13070,,,,0,,Autocuration
,,,CHEMBL622529,,BAO_0000019,,,,A,13118,,22224,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,1,U,13071,,,,0,,Autocuration
,,,CHEMBL622992,,BAO_0000019,,,,A,13118,,22224,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,1,U,13072,,,,0,,Autocuration
,,,CHEMBL622993,,BAO_0000019,,,,A,13118,,22224,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,1,U,13073,,,,0,,Autocuration
,,,CHEMBL622994,,BAO_0000019,,,,A,13118,,22224,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,1,U,13074,,,,0,,Autocuration
,,,CHEMBL622995,,BAO_0000218,,,,A,10633,10116.0,50597,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",1,N,13075,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622996,,BAO_0000218,,,,A,10633,10116.0,50597,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",1,N,13076,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622997,,BAO_0000218,,,,A,10633,10116.0,50597,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",1,N,13077,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622998,,BAO_0000218,,,,A,10633,10116.0,50597,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",1,N,13078,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622999,,BAO_0000218,,,,A,5767,,22224,Cp max following ip administration at 1 mg/kg,1,U,13079,,,,0,,Autocuration
,,,CHEMBL623000,1969.0,BAO_0000218,,,,A,3302,,22224,Maximum concentration in plasma was reported at 0.5 hour,1,U,13080,In vivo,,Plasma,0,,Autocuration
,,,CHEMBL623001,1969.0,BAO_0000218,,,,A,3302,,22224,Maximum concentration in plasma was reported at 2 hour,1,U,13081,In vivo,,Plasma,0,,Autocuration
,,,CHEMBL623002,,BAO_0000218,,,,A,12467,10090.0,50594,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,1,N,13082,,Mus musculus,,1,,Intermediate
,,,CHEMBL623003,,BAO_0000100,,,,P,11778,,22229,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),1,U,13083,,,,0,,Autocuration
,,,CHEMBL623004,,BAO_0000019,,,,A,4321,,22224,Steady state concentration was evaluated,1,U,13084,,,,0,,Autocuration
,,,CHEMBL623005,,BAO_0000019,,,,A,14884,,22224,Partition coefficient (logP),1,U,13085,,,,0,,Autocuration
,,,CHEMBL623006,,BAO_0000019,,,,A,15234,,22224,Partition coefficient (logD7.4),1,U,13086,,,,0,,Autocuration
,,,CHEMBL623007,2107.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,1,N,13087,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL623008,10000001.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,1,N,13088,In vivo,Rattus norvegicus,Bone,1,,Intermediate
,,,CHEMBL876654,2037.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,1,N,13089,In vivo,Rattus norvegicus,Cerebellum,1,,Intermediate
,,,CHEMBL623009,,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,1,N,13090,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623010,,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,1,N,13091,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623011,948.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,1,N,13092,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL623012,160.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,1,N,13093,In vivo,Rattus norvegicus,Intestine,1,,Intermediate
,,,CHEMBL623013,,BAO_0000019,,,,A,8151,,22224,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,1,U,13094,,,,0,,Autocuration
,,,CHEMBL623014,,BAO_0000019,,,,A,8151,,22224,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,1,U,13095,,,,0,,Autocuration
,,,CHEMBL623015,1088.0,BAO_0000019,,,,A,8151,,22224,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,1,U,13096,,,Urine,0,,Autocuration
,,,CHEMBL623016,1088.0,BAO_0000019,,,,A,8151,,22224,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,1,U,13097,,,Urine,0,,Autocuration
,,,CHEMBL624858,1088.0,BAO_0000019,,,,A,8151,,22224,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,1,U,13098,,,Urine,0,,Autocuration
,,,CHEMBL624859,,BAO_0000218,,,,A,8151,10116.0,50597,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,1,N,13099,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624860,,BAO_0000218,,,,A,8151,10116.0,50597,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,1,N,13100,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624861,,BAO_0000218,,,,A,8151,10116.0,50597,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,1,N,13101,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624862,,BAO_0000218,,,,A,8151,10116.0,50597,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,1,N,13102,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624863,,BAO_0000218,,,,A,8151,10116.0,50597,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,1,N,13103,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL876655,,BAO_0000218,,,,A,8151,10116.0,50597,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,1,N,13104,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624864,,BAO_0000218,,,,A,6996,9615.0,50588,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,1,N,13105,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624865,,BAO_0000218,,,,A,6996,9615.0,50588,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,1,N,13106,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624866,,BAO_0000218,,,,A,6996,9615.0,50588,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,1,N,13107,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL624867,,BAO_0000218,,,,F,6996,9615.0,50588,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,1,N,13108,,Canis lupus familiaris,,1,,Expert
,,,CHEMBL624868,,BAO_0000218,,,,A,6996,9615.0,50588,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,1,N,13109,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628450,,BAO_0000218,,,,A,6996,9615.0,50588,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,1,N,13110,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628451,,BAO_0000218,,,,A,6996,9615.0,50588,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,1,N,13111,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628452,,BAO_0000218,,,,A,6996,9615.0,50588,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,1,N,13112,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628453,,BAO_0000218,,,,A,6996,9615.0,50588,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,1,N,13113,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628454,,BAO_0000218,,,,A,6996,9615.0,50588,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,1,N,13114,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628455,,BAO_0000218,,,,A,6996,9615.0,50588,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,1,N,13115,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628456,,BAO_0000218,,,,A,6996,9615.0,50588,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,1,N,13116,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628457,,BAO_0000218,,,,A,6996,9615.0,50588,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,1,N,13117,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL877505,,BAO_0000218,,,,A,6996,9615.0,50588,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,1,N,13118,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628458,,BAO_0000218,,,,A,6996,9615.0,50588,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,1,N,13119,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628459,,BAO_0000218,,,,A,6996,9615.0,50588,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,1,N,13120,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628460,,BAO_0000218,,,,A,6996,9615.0,50588,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,1,N,13121,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628461,,BAO_0000218,,,,A,6996,9615.0,50588,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,1,N,13122,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628462,,BAO_0000218,,,,B,6996,,22224,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",1,U,13123,,,,0,,Autocuration
,,,CHEMBL628463,,BAO_0000218,,,,A,6996,9615.0,50588,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,1,N,13124,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625666,,BAO_0000218,,,,F,6996,10116.0,50597,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",1,N,13125,,Rattus norvegicus,,1,,Expert
,,,CHEMBL625667,,BAO_0000218,,,,B,6996,,22224,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,1,U,13126,,,,0,,Autocuration
,,,CHEMBL625668,,BAO_0000218,,,,A,6996,10116.0,50597,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,1,N,13127,,Rattus norvegicus,,1,,Expert
,,,CHEMBL625669,,BAO_0000218,,,,A,6996,10116.0,50597,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,1,N,13128,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625670,,BAO_0000019,,,,A,7114,,22224,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,1,U,13129,,,,0,,Autocuration
,,,CHEMBL625671,,BAO_0000218,,,,A,7114,10116.0,50597,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,1,N,13130,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625672,,BAO_0000218,,,,A,8613,10298.0,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,1,N,13131,,Human herpesvirus 1,,1,,Intermediate
,,,CHEMBL625673,,BAO_0000218,,,,A,8613,10298.0,50602,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,1,N,13132,,Human herpesvirus 1,,1,,Intermediate
,,,CHEMBL625674,,BAO_0000218,,,,A,8613,10298.0,50602,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,1,N,13133,,Human herpesvirus 1,,1,,Intermediate
,,,CHEMBL625675,,BAO_0000218,,,,A,8613,10298.0,50602,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,1,N,13134,,Human herpesvirus 1,,1,,Intermediate
,,,CHEMBL627637,,BAO_0000218,,,,A,8613,10298.0,50602,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,1,N,13135,,Human herpesvirus 1,,1,,Intermediate
,,,CHEMBL627638,,BAO_0000218,,,,A,8613,10298.0,50602,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,1,N,13136,,Human herpesvirus 1,,1,,Intermediate
,,,CHEMBL627639,,BAO_0000218,,,,A,8613,10298.0,50602,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,1,N,13137,,Human herpesvirus 1,,1,,Intermediate
,,,CHEMBL627640,,BAO_0000218,,,,A,8613,10298.0,50602,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,1,N,13138,,Human herpesvirus 1,,1,,Intermediate
,,,CHEMBL627641,,BAO_0000218,,,,A,8613,10298.0,50602,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,1,N,13139,,Human herpesvirus 1,,1,,Intermediate
,,,CHEMBL627642,,BAO_0000218,,,,A,8613,10298.0,50602,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,1,N,13140,,Human herpesvirus 1,,1,,Intermediate
,,,CHEMBL877506,,BAO_0000218,,,,A,8613,10298.0,50602,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,1,N,13141,,Human herpesvirus 1,,1,,Intermediate
,,,CHEMBL627275,,BAO_0000218,,,,A,8613,10090.0,50594,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,1,N,13142,,Mus musculus,,1,,Intermediate
,,,CHEMBL627643,,BAO_0000218,,,,A,11219,9669.0,50506,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",1,N,13143,,Mustela putorius furo,,1,,Intermediate
,,,CHEMBL631246,,BAO_0000218,,,,A,11219,9669.0,50506,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",1,N,13144,,Mustela putorius furo,,1,,Intermediate
,,,CHEMBL631247,,BAO_0000218,,,,A,11219,9669.0,50506,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",1,N,13145,,Mustela putorius furo,,1,,Intermediate
,,,CHEMBL629532,,BAO_0000218,,,,A,11219,9669.0,50506,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,1,N,13146,,Mustela putorius furo,,1,,Intermediate
,,,CHEMBL629533,,BAO_0000218,,,,A,11219,9669.0,50506,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,1,N,13147,,Mustela putorius furo,,1,,Intermediate
,,,CHEMBL629534,,BAO_0000218,,,,A,11219,9669.0,50506,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,1,N,13148,,Mustela putorius furo,,1,,Intermediate
,,,CHEMBL629535,,BAO_0000218,,,,A,11219,9669.0,50506,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,1,N,13149,,Mustela putorius furo,,1,,Intermediate
,,,CHEMBL625932,,BAO_0000019,,,,A,14837,,22224,Pharmacokinetic parameter :drug bound to plasma was reported,1,U,13150,,,,0,,Autocuration
,,,CHEMBL625933,,BAO_0000019,,,,A,14837,,22224,compound was evaluated for drug bound in plasma,1,U,13151,,,,0,,Autocuration
,,,CHEMBL625934,,BAO_0000218,,,,A,15343,10116.0,50597,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,1,N,13152,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625935,,BAO_0000218,,,,A,13761,9347.0,22224,Bioavailability,1,U,13153,,Eutheria,,0,,Autocuration
,,,CHEMBL625936,,BAO_0000218,,,,A,14810,10116.0,50597,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,1,N,13154,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625937,,BAO_0000218,,,,A,14810,10116.0,50597,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,1,N,13155,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625938,,BAO_0000218,,,,A,13249,9615.0,50588,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,1,N,13156,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625939,1970.0,BAO_0000218,,,,A,9267,10116.0,50597,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,1,N,13157,,Rattus norvegicus,Bile,1,,Intermediate
,,,CHEMBL625940,1970.0,BAO_0000218,,,,A,9267,10116.0,50597,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,1,N,13158,,Rattus norvegicus,Bile,1,,Intermediate
,,,CHEMBL874464,1970.0,BAO_0000218,,,,A,9267,10116.0,50597,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,1,N,13159,,Rattus norvegicus,Bile,1,,Intermediate
,,,CHEMBL625941,1970.0,BAO_0000218,,,,A,9267,10116.0,50597,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,1,N,13160,,Rattus norvegicus,Bile,1,,Intermediate
,,,CHEMBL625942,1970.0,BAO_0000218,,,,A,9267,10116.0,50597,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,1,N,13161,,Rattus norvegicus,Bile,1,,Intermediate
,,,CHEMBL625943,1970.0,BAO_0000218,,,,A,9267,10116.0,50597,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,1,N,13162,,Rattus norvegicus,Bile,1,,Intermediate
,,,CHEMBL625944,1977.0,BAO_0000218,,,,A,15549,9606.0,50587,In vitro protein binding in human serum at 5 ug/ml,1,N,13163,,Homo sapiens,Serum,1,,Intermediate
,,,CHEMBL625945,,BAO_0000019,,,,A,10929,,22224,Serum protein binding ability was measured,1,U,13164,,,,0,,Autocuration
,,,CHEMBL625946,,BAO_0000019,,,,A,15444,,22224,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),1,U,13165,,,,0,,Autocuration
,,,CHEMBL625947,,BAO_0000218,,,,A,12860,9615.0,22224,Oral bioavailability in dog,1,U,13166,In vivo,Canis lupus familiaris,,0,,Autocuration
,,,CHEMBL625948,,BAO_0000218,,,,A,12170,10116.0,50597,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,1,N,13167,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625949,,BAO_0000218,,,,A,15173,,22224,Absolute oral bioavailability at an iv dose of 14 mg/kg,1,U,13168,In vivo,,,0,,Autocuration
,,,CHEMBL625950,,BAO_0000218,,,,A,15173,,22224,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,1,U,13169,In vivo,,,0,,Autocuration
,,,CHEMBL625951,,BAO_0000218,,,,A,15173,9347.0,22224,Oral bioavailability (dose 15 mg/kg i.v.),1,U,13170,In vivo,Eutheria,,0,,Autocuration
,,,CHEMBL625952,,BAO_0000218,,,,A,15173,,22224,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,1,U,13171,In vivo,,,0,,Autocuration
,,,CHEMBL625953,,BAO_0000218,,,,A,15173,,22224,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,1,U,13172,In vivo,,,0,,Autocuration
,,,CHEMBL625954,,BAO_0000218,,,,A,15173,,22224,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,1,U,13173,In vivo,,,0,,Autocuration
,,,CHEMBL882959,,BAO_0000218,,,,A,15173,,22224,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,1,U,13174,In vivo,,,0,,Autocuration
,,,CHEMBL625955,,BAO_0000218,,,,A,11767,9615.0,50588,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,1,N,13175,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625956,,BAO_0000218,,,,A,11219,9669.0,22224,Bioavailability in ferret,1,U,13176,In vivo,Mustela putorius furo,,0,,Autocuration
,,,CHEMBL625957,,BAO_0000218,,,,A,12186,9541.0,100710,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,1,N,13177,In vivo,Macaca fascicularis,,1,,Intermediate
,,,CHEMBL625958,,BAO_0000218,,,,A,11510,10116.0,50597,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,1,N,13178,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625959,,BAO_0000218,,,,A,11510,10116.0,50597,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,1,N,13179,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626642,,BAO_0000218,,,,A,11510,10116.0,50597,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,1,N,13180,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631330,,BAO_0000218,,,,A,11510,10116.0,50597,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,1,N,13181,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631331,,BAO_0000218,,,,A,11510,10116.0,50597,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,1,N,13182,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631332,,BAO_0000218,,,,A,11510,10116.0,50597,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,1,N,13183,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631333,,BAO_0000218,,,,A,11510,10116.0,50597,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,1,N,13184,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL632018,,BAO_0000218,,,,A,11510,10116.0,50597,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,1,N,13185,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL632019,,BAO_0000218,,,,A,11510,10116.0,50597,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,1,N,13186,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL632020,,BAO_0000218,,,,A,11510,10116.0,50597,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,1,N,13187,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL632021,,BAO_0000218,,,,A,11510,10116.0,50597,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,1,N,13188,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL632022,,BAO_0000218,,,,A,11510,10116.0,50597,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,1,N,13189,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL632023,,BAO_0000218,,,,A,11510,10116.0,50597,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,1,N,13190,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL632024,,BAO_0000218,,,,A,11510,10116.0,50597,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,1,N,13191,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL874472,,BAO_0000218,,,,A,11510,10116.0,50597,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,1,N,13192,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL632025,,BAO_0000218,,,,A,11510,10116.0,50597,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,1,N,13193,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL632026,,BAO_0000218,,,,A,11510,10116.0,50597,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,1,N,13194,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL632027,,BAO_0000218,,,,A,11510,10116.0,50597,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,1,N,13195,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL632028,,BAO_0000218,,,,A,11510,10116.0,50597,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,1,N,13196,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626430,,BAO_0000218,,,,A,11510,10116.0,50597,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,1,N,13197,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626431,,BAO_0000218,,,,A,11510,10116.0,50597,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,1,N,13198,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626432,,BAO_0000218,,,,A,11510,10116.0,50597,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,1,N,13199,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626433,,BAO_0000218,,,,A,11510,10116.0,50597,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,1,N,13200,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626434,,BAO_0000218,,,,A,11510,10116.0,50597,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,1,N,13201,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627280,,BAO_0000218,,,,A,11510,10116.0,50597,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,1,N,13202,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627281,,BAO_0000218,,,,A,11510,10116.0,50597,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,1,N,13203,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627282,,BAO_0000218,,,,A,11510,10116.0,50597,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,1,N,13204,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627283,,BAO_0000019,,,,A,7199,,22224,Total body clearance was measured at given dose,1,U,13205,,,,0,,Autocuration
,,,CHEMBL627284,,BAO_0000218,,,,A,7199,,22224,Total body clearance was measured at given dose.,1,U,13206,,,,0,,Autocuration
,,,CHEMBL627285,,BAO_0000218,,,,A,7095,10116.0,50597,Metabolic clearance from the body in rat,1,N,13207,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627286,,BAO_0000218,,,,A,7095,,22224,Renal clearance from the body,1,U,13208,In vivo,,,0,,Autocuration
,,,CHEMBL875477,,BAO_0000218,,,,A,7095,10116.0,50597,Renal clearance from the body in rat,1,N,13209,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627287,,BAO_0000218,,,,A,12528,10116.0,50597,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,1,N,13210,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627288,,BAO_0000218,,,,A,12528,9615.0,50588,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,1,N,13211,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL627289,,BAO_0000218,,,,A,7095,10116.0,50597,Total clearance from the body in rat,1,N,13212,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627290,1969.0,BAO_0000218,,,,A,14223,10116.0,50597,Clearance into cortex from rat plasma or PBS,1,N,13213,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL627291,,BAO_0000218,,,,A,13569,,22224,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,1,U,13214,In vivo,,,0,,Autocuration
,,,CHEMBL627292,,BAO_0000218,,,,A,13569,,22224,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,1,U,13215,In vivo,,,0,,Autocuration
,,,CHEMBL627293,,BAO_0000218,,,,A,13569,,22224,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,1,U,13216,In vivo,,,0,,Autocuration
,,,CHEMBL627294,,BAO_0000218,,,,A,13569,,22224,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,1,U,13217,In vivo,,,0,,Autocuration
,,,CHEMBL875478,,BAO_0000218,,,,A,13569,,22224,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,1,U,13218,In vivo,,,0,,Autocuration
,,,CHEMBL627295,,BAO_0000218,,,,A,13979,,22224,Clearance was determined,1,U,13219,In vivo,,,0,,Autocuration
,,,CHEMBL627296,,BAO_0000218,,,,A,14315,10090.0,50594,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,1,N,13220,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL626119,,BAO_0000218,,,,A,14315,9986.0,50592,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,1,N,13221,In vivo,Oryctolagus cuniculus,,1,,Intermediate
,,,CHEMBL626120,,BAO_0000218,,,,A,14315,10116.0,50597,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,1,N,13222,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626121,,BAO_0000218,,,,A,12174,10116.0,50597,Clearance in rat after iv dose (100 ug/kg),1,N,13223,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626122,,BAO_0000218,,,,A,12797,10141.0,22224,Clearance in guinea pig,1,U,13224,In vivo,Cavia porcellus,,0,,Autocuration
,,,CHEMBL626123,,BAO_0000218,,,,A,12797,10116.0,50597,Compound was evaluated for clearance in rat,1,N,13225,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623456,,BAO_0000218,,,,A,12797,9615.0,50588,Compound was evaluated for the clearance in dog,1,N,13226,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL623457,,BAO_0000218,,,,A,12797,10116.0,50597,Compound was evaluated for the clearance in rat,1,N,13227,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623458,,BAO_0000218,,,,A,11500,10116.0,50597,Compound was tested in vivo for clearance after iv administration in the rat,1,N,13228,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623459,,BAO_0000218,,,,A,15173,,22224,IV clearance determined at an iv dose of 14 mg/kg,1,U,13229,In vivo,,,0,,Autocuration
,,,CHEMBL875484,,BAO_0000218,,,,A,15173,,22224,IV clearance determined at an iv dose of 15.2 mg/kg,1,U,13230,In vivo,,,0,,Autocuration
,,,CHEMBL623460,,BAO_0000218,,,,A,15173,,22224,IV clearance determined at an iv dose of 15 mg/kg,1,U,13231,In vivo,,,0,,Autocuration
,,,CHEMBL623461,,BAO_0000218,,,,A,15173,,22224,IV clearance determined at an peroral dose of 30 mg/kg.,1,U,13232,In vivo,,,0,,Autocuration
,,,CHEMBL623462,,BAO_0000218,,,,A,15173,,22224,IV clearance determined at an peroral dose of 30.2 mg/kg.,1,U,13233,In vivo,,,0,,Autocuration
,,,CHEMBL627386,,BAO_0000218,,,,A,15173,,22224,IV clearance determined at an peroral dose of 30.3 mg/kg.,1,U,13234,In vivo,,,0,,Autocuration
,,,CHEMBL627387,2113.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,1,N,13235,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL627388,2107.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,1,N,13236,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL627389,2048.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,1,N,13237,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627390,2385.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,1,N,13238,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL627391,1969.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,1,N,13239,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL627392,,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,1,N,13240,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627393,2106.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,1,N,13241,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL627394,3126.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,1,N,13242,In vivo,Rattus norvegicus,Trachea,1,,Intermediate
,,,CHEMBL627395,10000001.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,1,N,13243,In vivo,Rattus norvegicus,Bone,1,,Intermediate
,,,CHEMBL875485,2037.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,1,N,13244,In vivo,Rattus norvegicus,Cerebellum,1,,Intermediate
,,,CHEMBL627396,,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,1,N,13245,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627397,,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,1,N,13246,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627398,948.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,1,N,13247,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL627399,10000001.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,1,N,13248,In vivo,Rattus norvegicus,Bone,1,,Intermediate
,,,CHEMBL627400,2113.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,1,N,13249,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL627401,2107.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,1,N,13250,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL627402,2048.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,1,N,13251,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627403,2385.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,1,N,13252,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL627404,1969.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,1,N,13253,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL623101,,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,1,N,13254,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL877480,2106.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,1,N,13255,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL623102,3126.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,1,N,13256,In vivo,Rattus norvegicus,Trachea,1,,Intermediate
,,,CHEMBL623103,10000001.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,1,N,13257,In vivo,Rattus norvegicus,Bone,1,,Intermediate
,,,CHEMBL623104,2037.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,1,N,13258,In vivo,Rattus norvegicus,Cerebellum,1,,Intermediate
,,,CHEMBL623105,,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,1,N,13259,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623106,,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,1,N,13260,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623107,948.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,1,N,13261,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL623108,160.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,1,N,13262,In vivo,Rattus norvegicus,Intestine,1,,Intermediate
,,,CHEMBL623109,2113.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,1,N,13263,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL623110,2107.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,1,N,13264,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL623111,2048.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,1,N,13265,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL625060,2385.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,1,N,13266,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL625061,1969.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,1,N,13267,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL625062,,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,1,N,13268,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625063,2106.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,1,N,13269,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL625064,3126.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,1,N,13270,In vivo,Rattus norvegicus,Trachea,1,,Intermediate
,,,CHEMBL625065,10000001.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,1,N,13271,In vivo,Rattus norvegicus,Bone,1,,Intermediate
,,,CHEMBL625066,2037.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,1,N,13272,In vivo,Rattus norvegicus,Cerebellum,1,,Intermediate
,,,CHEMBL625067,,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,1,N,13273,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625068,,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,1,N,13274,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622159,948.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,1,N,13275,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL622160,160.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,1,N,13276,In vivo,Rattus norvegicus,Intestine,1,,Intermediate
,,,CHEMBL622161,2113.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,1,N,13277,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL622162,2048.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,1,N,13278,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL622163,2385.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,1,N,13279,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL622313,1969.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,1,N,13280,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622314,,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,1,N,13281,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622315,2106.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,1,N,13282,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL622316,3126.0,BAO_0000218,,,,A,14198,10116.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,1,N,13283,In vivo,Rattus norvegicus,Trachea,1,,Intermediate
,,,CHEMBL877486,,BAO_0000218,,,,A,15599,562.0,50212,Normal diffusion coefficient in water for Escherichia coli,1,N,13284,,Escherichia coli,,1,,Intermediate
,,,CHEMBL622317,,BAO_0000019,,,,A,8204,,22224,Average max percent decrease in RVR (renal vascular resistance) was determined,1,U,13285,,,,0,,Autocuration
,,,CHEMBL622318,,BAO_0000019,,,,A,8204,,22224,Average max percent decrease in RVR (renal vascular resistance) was determined.,1,U,13286,,,,0,,Autocuration
,,,CHEMBL622319,,BAO_0000019,,,,A,6154,,22224,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,1,U,13287,,,,0,,Autocuration
,,,CHEMBL622320,,BAO_0000019,,,,A,6154,,22224,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,1,U,13288,,,,0,,Autocuration
,,,CHEMBL622321,,BAO_0000019,,,,A,6154,,22224,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,1,U,13289,,,,0,,Autocuration
,,,CHEMBL622322,,BAO_0000019,,,,A,6154,,22224,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,1,U,13290,,,,0,,Autocuration
,,,CHEMBL622323,,BAO_0000019,,,,A,7114,,22224,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,1,U,13291,,,,0,,Autocuration
,,,CHEMBL622324,,BAO_0000218,,,,A,7114,10116.0,50597,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,1,N,13292,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622325,1088.0,BAO_0000218,,,,A,8133,9615.0,50588,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",1,N,13293,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL622326,1088.0,BAO_0000218,,,,A,8133,9615.0,50588,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",1,N,13294,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL877487,1088.0,BAO_0000218,,,,A,8133,9615.0,50588,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",1,N,13295,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL622327,1088.0,BAO_0000218,,,,A,8133,9615.0,50588,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",1,N,13296,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL622328,1088.0,BAO_0000218,,,,A,8133,9615.0,50588,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",1,N,13297,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL622329,1088.0,BAO_0000218,,,,A,8133,9615.0,50588,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",1,N,13298,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL622330,1088.0,BAO_0000218,,,,A,8133,9615.0,50588,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",1,N,13299,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL622331,1088.0,BAO_0000218,,,,A,8133,9615.0,50588,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",1,N,13300,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL622332,1088.0,BAO_0000218,,,,A,8133,9615.0,50588,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",1,N,13301,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL622333,1088.0,BAO_0000218,,,,A,8133,9615.0,50588,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",1,N,13302,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL627658,1088.0,BAO_0000218,,,,A,8133,314293.0,22224,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",1,U,13303,,Simiiformes,Urine,0,,Autocuration
,,,CHEMBL630428,1088.0,BAO_0000218,,,,A,8133,314293.0,22224,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",1,U,13304,,Simiiformes,Urine,0,,Autocuration
,,,CHEMBL630429,1088.0,BAO_0000218,,,,A,8133,314293.0,22224,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",1,U,13305,,Simiiformes,Urine,0,,Autocuration
,,,CHEMBL630430,1088.0,BAO_0000218,,,,A,8133,314293.0,22224,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",1,U,13306,,Simiiformes,Urine,0,,Autocuration
,,,CHEMBL630431,1088.0,BAO_0000218,,,,A,8133,314293.0,22224,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",1,U,13307,,Simiiformes,Urine,0,,Autocuration
,,,CHEMBL630432,1088.0,BAO_0000218,,,,A,8133,10116.0,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",1,N,13308,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL630433,1088.0,BAO_0000218,,,,A,8133,10116.0,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",1,N,13309,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL630434,1088.0,BAO_0000218,,,,A,8133,10116.0,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",1,N,13310,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL629372,1088.0,BAO_0000218,,,,A,8133,10116.0,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",1,N,13311,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL629553,1088.0,BAO_0000218,,,,A,8133,10116.0,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",1,N,13312,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL629554,1088.0,BAO_0000218,,,,A,8133,10116.0,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",1,N,13313,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL874447,1088.0,BAO_0000218,,,,A,8133,10116.0,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",1,N,13314,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL629555,1088.0,BAO_0000218,,,,A,8133,10116.0,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",1,N,13315,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL629556,1088.0,BAO_0000218,,,,A,8133,10116.0,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",1,N,13316,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL629557,1088.0,BAO_0000218,,,,A,8133,10116.0,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",1,N,13317,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL629558,1088.0,BAO_0000218,,,,A,8133,10116.0,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",1,N,13318,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL629559,1088.0,BAO_0000218,,,,A,8133,10116.0,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",1,N,13319,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL629560,1088.0,BAO_0000218,,,,A,8133,10116.0,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",1,N,13320,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL629561,1088.0,BAO_0000218,,,,A,8133,9615.0,50588,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",1,N,13321,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL629562,1088.0,BAO_0000218,,,,A,8133,9615.0,50588,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",1,N,13322,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL629563,1088.0,BAO_0000218,,,,A,8133,9615.0,50588,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",1,N,13323,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL629564,1088.0,BAO_0000218,,,,A,8133,9615.0,50588,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",1,N,13324,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL629565,1088.0,BAO_0000218,,,,A,8133,9615.0,50588,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",1,N,13325,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL629566,1088.0,BAO_0000218,,,,A,8133,9615.0,50588,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",1,N,13326,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL629567,1088.0,BAO_0000218,,,,A,8133,9615.0,50588,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",1,N,13327,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL629568,1088.0,BAO_0000218,,,,A,8133,9615.0,50588,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",1,N,13328,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL629569,1088.0,BAO_0000218,,,,A,8133,9615.0,50588,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",1,N,13329,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL629570,1088.0,BAO_0000218,,,,A,8133,9615.0,50588,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",1,N,13330,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL629571,1088.0,BAO_0000218,,,,A,8133,314293.0,22224,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",1,U,13331,,Simiiformes,Urine,0,,Autocuration
,,,CHEMBL629572,,BAO_0000218,,,,A,12170,10116.0,22224,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,1,U,13332,In vivo,Rattus norvegicus,,0,,Autocuration
,,,CHEMBL629573,,BAO_0000218,,,,A,12170,10116.0,22224,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,1,U,13333,In vivo,Rattus norvegicus,,0,,Autocuration
,,,CHEMBL629574,,BAO_0000218,,,,A,4985,9347.0,22224,Bioavailability (dose 20 mg/kg),1,U,13334,In vivo,Eutheria,,0,,Autocuration
,,,CHEMBL629575,,BAO_0000218,,,,A,15145,9615.0,22224,Bioavailability in dog,1,U,13335,In vivo,Canis lupus familiaris,,0,,Autocuration
,,,CHEMBL874448,,BAO_0000218,,,,A,14080,10116.0,22224,Bioavailability in rat (Sprague-Dawley) (male),1,U,13336,In vivo,Rattus norvegicus,,0,,Autocuration
,,,CHEMBL629576,,BAO_0000218,,,,A,11219,9443.0,22224,Bioavailability in monkey (dose 10 mg/kg i.d.),1,U,13337,In vivo,Primates,,0,,Autocuration
,,,CHEMBL629577,,BAO_0000218,,,,A,15145,10116.0,22224,Bioavailability in rat,1,U,13338,In vivo,Rattus norvegicus,,0,,Autocuration
,,,CHEMBL629578,,BAO_0000218,,,,A,15145,10116.0,22224,Bioavailability in rat,1,U,13339,In vivo,Rattus norvegicus,,0,,Autocuration
,,,CHEMBL629579,,BAO_0000218,,,,A,1202,9615.0,22224,Bioavailability in dog (dose 3.0 mg/kg p.o.),1,U,13340,In vivo,Canis lupus familiaris,,0,,Autocuration
,,,CHEMBL882958,,BAO_0000218,,,,A,1202,9615.0,22224,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,1,U,13341,In vivo,Canis lupus familiaris,,0,,Autocuration
,,,CHEMBL629580,,BAO_0000218,,,,A,1202,9598.0,50505,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,1,N,13342,In vivo,Pan troglodytes,,1,,Intermediate
,,,CHEMBL629581,,BAO_0000218,,,,A,4026,9347.0,22224,Bioavailability,1,U,13343,In vivo,Eutheria,,0,,Autocuration
,,,CHEMBL629582,,BAO_0000218,,,,A,1492,9520.0,22224,Bioavailability in squirrel monkey,1,U,13344,In vivo,Saimiri,,0,,Autocuration
,,,CHEMBL628522,,BAO_0000218,,,,A,12793,9615.0,50588,Bioavailability was evaluated in dog,1,N,13345,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625432,,BAO_0000218,,,,A,12793,10026.0,100712,Bioavailability was evaluated in hamster,1,N,13346,In vivo,Cricetinae,,1,,Intermediate
,,,CHEMBL625433,,BAO_0000218,,,,A,12793,10116.0,22224,Bioavailability in rat,1,U,13347,In vivo,Rattus norvegicus,,0,,Autocuration
,,,CHEMBL625434,1969.0,BAO_0000218,,,,A,14793,10116.0,50597,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,1,N,13348,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL625435,1969.0,BAO_0000218,,,,A,14793,10116.0,50597,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,1,N,13349,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL625436,,BAO_0000218,,,,A,14793,10116.0,22224,Bioavailability in rat (dose 10 mg/kg p.o.),1,U,13350,In vivo,Rattus norvegicus,,0,,Autocuration
,,,CHEMBL874588,,BAO_0000218,,,,A,14731,9541.0,100710,Bioavailability was measured in cynomolgus monkeys.,1,N,13351,In vivo,Macaca fascicularis,,1,,Intermediate
,,,CHEMBL625437,,BAO_0000218,,,,A,14731,10090.0,50594,Bioavailability was measured in nude mice.,1,N,13352,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL625438,,BAO_0000218,,,,A,12187,9669.0,22224,Bioavailability in ferret (dose 10 mg/kg i.d.),1,U,13353,In vivo,Mustela putorius furo,,0,,Autocuration
,,,CHEMBL625439,,BAO_0000218,,,,A,12187,314293.0,22224,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),1,U,13354,In vivo,Simiiformes,,0,,Autocuration
,,,CHEMBL625440,,BAO_0000218,,,,A,12187,314293.0,22224,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",1,U,13355,In vivo,Simiiformes,,0,,Autocuration
,,,CHEMBL625441,,BAO_0000218,,,,A,12187,314293.0,22224,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),1,U,13356,In vivo,Simiiformes,,0,,Autocuration
,,,CHEMBL625442,,BAO_0000218,,,,A,12187,10116.0,22224,Bioavailability in rat (dose 10 mg/kg i.d.),1,U,13357,In vivo,Rattus norvegicus,,0,,Autocuration
,,,CHEMBL625443,,BAO_0000218,,,,A,12187,10116.0,50597,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",1,N,13358,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625444,,BAO_0000218,,,,A,17431,,22224,Bioavailability was determined; extremely poor,1,U,13359,In vivo,,,0,,Autocuration
,,,CHEMBL625445,,BAO_0000218,,,,A,13318,10090.0,50594,% bioavailability in mice after oral administration of prodrug,1,N,13360,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL625446,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,1,N,13361,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL882960,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,1,N,13362,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625447,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,1,N,13363,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625448,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,1,N,13364,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625449,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,1,N,13365,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL874589,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),1,N,13366,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625450,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,1,N,13367,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625451,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,1,N,13368,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626584,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,1,N,13369,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626585,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,1,N,13370,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626586,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,1,N,13371,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626587,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,1,N,13372,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626588,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,1,N,13373,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626589,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,1,N,13374,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626590,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,1,N,13375,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626591,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,1,N,13376,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL627181,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,1,N,13377,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628083,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,1,N,13378,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628084,,BAO_0000218,,,,A,15173,,22224,IV clearance determined at an peroral dose of 15 mg/kg.,1,U,13379,In vivo,,,0,,Autocuration
,,,CHEMBL628085,,BAO_0000218,,,,F,7732,102285.0,50064,Mouse oral clearance was measured against Hymenolepiasis nana.,1,N,13380,In vivo,Hymenolepis nana,,1,,Expert
,,,CHEMBL628086,,BAO_0000218,,,,F,7732,6339.0,50545,Mouse oral clearance was measured against Nematospiroides dubius,1,N,13381,In vivo,Heligmosomoides polygyrus,,1,,Expert
,,,CHEMBL628087,,BAO_0000218,,,,F,7732,,22224,Mouse oral clearance was measured against N. dubius; NT is Not Tested,1,U,13382,In vivo,,,0,,Autocuration
,,,CHEMBL628088,,BAO_0000218,,,,A,7732,10090.0,50594,Mouse oral clearance was measured against N. nana; NT is Not Tested,1,N,13383,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL628089,,BAO_0000218,,,,B,7732,,22224,Mouse oral clearance was measured against N. nana; NT is Not Tested,1,U,13384,In vivo,,,0,,Autocuration
,,,CHEMBL628090,,BAO_0000218,,,,A,8328,,22224,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,1,U,13385,In vivo,,,0,,Autocuration
,,,CHEMBL628091,,BAO_0000218,,,,A,8328,,22224,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,1,U,13386,In vivo,,,0,,Autocuration
,,,CHEMBL628092,,BAO_0000218,,,,A,8328,,22224,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,1,U,13387,In vivo,,,0,,Autocuration
,,,CHEMBL628093,,BAO_0000218,,,,A,8328,,22224,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,1,U,13388,In vivo,,,0,,Autocuration
,,,CHEMBL875607,,BAO_0000218,,,,A,8328,,22224,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,1,U,13389,In vivo,,,0,,Autocuration
,,,CHEMBL625710,,BAO_0000218,,,,A,8328,,22224,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,1,U,13390,In vivo,,,0,,Autocuration
,,,CHEMBL625711,,BAO_0000218,,,,A,8328,,22224,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,1,U,13391,In vivo,,,0,,Autocuration
,,,CHEMBL625712,,BAO_0000218,,,,A,8328,,22224,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,1,U,13392,In vivo,,,0,,Autocuration
,,,CHEMBL625713,,BAO_0000218,,,,A,8328,,22224,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,1,U,13393,In vivo,,,0,,Autocuration
,,,CHEMBL625714,,BAO_0000218,,,,A,13376,9615.0,50588,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,1,N,13394,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625715,,BAO_0000218,,,,A,13477,9544.0,50797,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,1,N,13395,In vivo,Macaca mulatta,,1,,Intermediate
,,,CHEMBL625716,,BAO_0000218,,,,A,13477,10116.0,50597,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,1,N,13396,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625717,,BAO_0000218,,,,A,13477,10116.0,50597,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,1,N,13397,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625718,,BAO_0000218,,,,A,13313,10116.0,50597,Plasma clearance was determined for the compound in rats,1,N,13398,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625719,,BAO_0000218,,,,A,12504,10116.0,50597,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,1,N,13399,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625720,,BAO_0000218,,,,A,12504,10116.0,50597,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,1,N,13400,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625721,,BAO_0000218,,,,A,12504,10116.0,50597,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,1,N,13401,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625722,,BAO_0000218,,,,A,12504,10116.0,50597,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,1,N,13402,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625723,,BAO_0000218,,,,A,13129,10116.0,50597,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,1,N,13403,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625724,,BAO_0000218,,,,A,7732,6339.0,50545,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,1,N,13404,In vivo,Heligmosomoides polygyrus,,1,,Intermediate
,,,CHEMBL625725,,BAO_0000218,,,,A,7732,6339.0,50545,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,1,N,13405,In vivo,Heligmosomoides polygyrus,,1,,Intermediate
,,,CHEMBL625726,,BAO_0000218,,,,A,7732,6339.0,50545,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,1,N,13406,In vivo,Heligmosomoides polygyrus,,1,,Intermediate
,,,CHEMBL875608,,BAO_0000218,,,,A,7732,6339.0,50545,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,1,N,13407,In vivo,Heligmosomoides polygyrus,,1,,Intermediate
,,,CHEMBL625727,,BAO_0000218,,,,A,7732,6339.0,50545,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,1,N,13408,In vivo,Heligmosomoides polygyrus,,1,,Intermediate
,,,CHEMBL625728,1088.0,BAO_0000218,,,,A,9278,10116.0,22224,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,1,U,13409,In vivo,Rattus norvegicus,Urine,0,,Autocuration
,,,CHEMBL625729,,BAO_0000218,,,,A,9278,10116.0,22224,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,1,U,13410,In vivo,Rattus norvegicus,,0,,Autocuration
,,,CHEMBL625730,,BAO_0000218,,,,A,9278,10116.0,22224,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,1,U,13411,In vivo,Rattus norvegicus,,0,,Autocuration
,,,CHEMBL625731,1088.0,BAO_0000218,,,,A,9278,10116.0,22224,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,1,U,13412,In vivo,Rattus norvegicus,Urine,0,,Autocuration
,,,CHEMBL626417,1088.0,BAO_0000218,,,,A,9278,10116.0,22224,Urinary clearance was determined in rat at 25 mg/kg os dosage,1,U,13413,In vivo,Rattus norvegicus,Urine,0,,Autocuration
,,,CHEMBL626418,1088.0,BAO_0000218,,,,A,9278,9606.0,50587,Urinary clearance was determined at 100 mg/kg oral dosage in human,1,N,13414,In vivo,Homo sapiens,Urine,1,,Intermediate
,,,CHEMBL626419,1088.0,BAO_0000218,,,,A,9278,9615.0,50588,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,1,N,13415,In vivo,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL626592,1969.0,BAO_0000218,,,,A,5932,9615.0,50588,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,1,N,13416,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL626593,1969.0,BAO_0000218,,,,A,5932,10116.0,50597,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,1,N,13417,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626594,,BAO_0000218,,,,A,5182,10116.0,50597,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,1,N,13418,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625035,,BAO_0000218,,,,A,10499,9615.0,50588,Clearance rate in dogs,1,N,13419,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625036,,BAO_0000019,,,,A,6051,,22224,Compound was measured for intrinsic clearance,1,U,13420,In vitro,,,0,,Autocuration
,,,CHEMBL625037,,BAO_0000100,,,,P,17508,,22229,Calculated partition coefficient (clogP),1,U,13421,,,,0,,Autocuration
,,,CHEMBL625038,,BAO_0000100,,,,P,6228,,22229,Calculated partition coefficient (clogP),1,U,13422,,,,0,,Autocuration
,,,CHEMBL625039,,BAO_0000100,,,,P,6231,,22229,Calculated partition coefficient (clogP),1,U,13423,,,,0,,Autocuration
,,,CHEMBL625040,,BAO_0000100,,,,P,17740,,22229,Calculated partition coefficient (clogP),1,U,13424,,,,0,,Autocuration
,,,CHEMBL625041,,BAO_0000100,,,,P,6495,,22229,Calculated partition coefficient (clogP),1,U,13425,,,,0,,Autocuration
,,,CHEMBL625042,,BAO_0000100,,,,P,2171,,22229,Calculated partition coefficient (clogP),1,U,13426,,,,0,,Autocuration
,,,CHEMBL874411,,BAO_0000019,,,,A,3255,,22224,Partition coefficient of the compound,1,U,13427,,,,0,,Autocuration
,,,CHEMBL625043,,BAO_0000019,,,,A,6821,,22224,Permeability,1,U,13428,,,,0,,Autocuration
,,,CHEMBL625044,,BAO_0000100,,,,P,2685,,22229,Calculated partition coefficient (clogP),1,U,13429,,,,0,,Autocuration
,,,CHEMBL625045,,BAO_0000019,,,,A,17584,,22224,Partition coefficient (logD),1,U,13430,,,,0,,Autocuration
,,,CHEMBL625046,,BAO_0000100,,,,P,13824,,22229,Calculated partition coefficient (clogP) (CLOGP3 V3.4),1,U,13431,,,,0,,Autocuration
,,,CHEMBL625047,,BAO_0000100,,,,P,13824,,22229,Calculated partition coefficient (clogP) (CLOGP3 V3.4),1,U,13432,,,,0,,Autocuration
,,,CHEMBL625048,,BAO_0000100,,,,P,16479,,22229,Calculated partition coefficient (clogP),1,U,13433,,,,0,,Autocuration
,,,CHEMBL625049,,BAO_0000100,,,,P,11997,,22229,Calculated partition coefficient (clogP),1,U,13434,,,,0,,Autocuration
,,,CHEMBL625050,,BAO_0000100,,,,P,2988,,22229,Calculated logarithm of partition coefficient (P) was determined,1,U,13435,,,,0,,Autocuration
,,,CHEMBL625051,,BAO_0000100,,,,P,931,,22229,Calculated partition coefficient (clogP),1,U,13436,,,,0,,Autocuration
,,,CHEMBL874412,,BAO_0000100,,,,P,4381,,22229,Calculated partition coefficient (clogP),1,U,13437,,,,0,,Autocuration
,,,CHEMBL625052,,BAO_0000100,,,,P,4397,,22229,Calculated partition coefficient (clogP),1,U,13438,,,,0,,Autocuration
,,,CHEMBL625053,,BAO_0000100,,,,P,5889,,22229,Calculated partition coefficient (clogP),1,U,13439,,,,0,,Autocuration
,,,CHEMBL623250,,BAO_0000019,,,,A,6154,,22224,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,1,U,13440,,,,0,,Autocuration
,,,CHEMBL623251,,BAO_0000019,,,,A,6154,,22224,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,1,U,13441,,,,0,,Autocuration
,,,CHEMBL623252,,BAO_0000019,,,,A,6154,,22224,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,1,U,13442,,,,0,,Autocuration
,,,CHEMBL623253,,BAO_0000019,,,,A,6154,,22224,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,1,U,13443,,,,0,,Autocuration
,,,CHEMBL623254,,BAO_0000019,,,,A,6154,,22224,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,1,U,13444,,,,0,,Autocuration
,,,CHEMBL623255,,BAO_0000019,,,,A,6154,,22224,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,1,U,13445,,,,0,,Autocuration
,,,CHEMBL626831,,BAO_0000019,,,,A,6887,,22224,Percent degradation of compound at a pH of 1 over a 18 hr period,1,U,13446,,,,0,,Autocuration
,,,CHEMBL877494,,BAO_0000019,,,,A,6887,,22224,Percent degradation of compound at pH of 1 over an 18 hr period,1,U,13447,,,,0,,Autocuration
,,,CHEMBL626832,,BAO_0000019,,,,A,14116,,22224,Delta Logarithm of Partition Coefficient value was determined.,1,U,13448,,,,0,,Autocuration
,,,CHEMBL626833,,BAO_0000019,,,,A,11137,,22224,Delta logPoct-cyc,1,U,13449,,,,0,,Autocuration
,,,CHEMBL626834,,BAO_0000100,,,,P,7230,,22224,Lipophilicity estimated on reversed phase TLC,1,U,13450,,,,0,,Autocuration
,,,CHEMBL626835,,BAO_0000019,,,,A,15741,,22224,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,1,U,13451,,,,0,,Autocuration
,,,CHEMBL626836,,BAO_0000019,,,,A,9663,,22224,Delta logPoct-cyc,1,U,13452,,,,0,,Autocuration
,,,CHEMBL626837,,BAO_0000100,,,,P,9663,,22229,Change in logarithm of partition coefficient of the compound,1,U,13453,,,,0,,Autocuration
,,,CHEMBL626838,,BAO_0000019,,,,A,13807,,22224,Delta logD (pH 6.5),1,U,13454,,,,0,,Autocuration
,,,CHEMBL626839,,BAO_0000100,,,,P,13807,,22224,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",1,U,13455,,,,0,,Autocuration
,,,CHEMBL626840,,BAO_0000019,,,,A,17425,,22224,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,1,U,13456,,,,0,,Autocuration
,,,CHEMBL626841,,BAO_0000019,,,,A,12143,,22224,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),1,U,13457,,,,0,,Autocuration
,,,CHEMBL626842,,BAO_0000219,,,,A,12608,,22224,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,1,U,13458,,,,0,,Autocuration
,,,CHEMBL626843,,BAO_0000219,,,,A,12608,,22224,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,1,U,13459,,,,0,,Autocuration
,,,CHEMBL626844,,BAO_0000218,,,,A,8649,10116.0,50597,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,1,N,13460,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL877495,,BAO_0000218,,,,A,8649,10116.0,50597,Amount of deuterium retained was reported after normal workup in rats,1,N,13461,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626845,,BAO_0000218,,,,A,8649,10116.0,50597,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,1,N,13462,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626846,,BAO_0000218,,,,A,8649,10116.0,50597,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,1,N,13463,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626847,,BAO_0000218,,,,A,8649,10116.0,50597,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,1,N,13464,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628677,,BAO_0000218,,,,A,8649,10116.0,50597,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,1,N,13465,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628678,,BAO_0000218,,,,A,8649,10116.0,50597,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,1,N,13466,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628679,,BAO_0000019,,,,A,9659,,22224,Compound was subjected to electrochemical oxidation,1,U,13467,,,,0,,Autocuration
,,,CHEMBL628680,,BAO_0000019,,,,A,9659,,22224,Compound was subjected to photochemical oxidation,1,U,13468,,,,0,,Autocuration
,,,CHEMBL628681,,BAO_0000019,,,,A,9659,,22224,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,1,U,13469,,,,0,,Autocuration
,,,CHEMBL628682,,BAO_0000019,,,,A,9659,,22224,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,1,U,13470,,,,0,,Autocuration
,,,CHEMBL628683,,BAO_0000019,,,,A,9659,,22224,Oxidation of compound by methemoglobin in presence of hydroperoxide,1,U,13471,,,,0,,Autocuration
,,,CHEMBL628684,,BAO_0000218,,,,A,9607,10116.0,50597,Percent diffusion through fuzzy rat skin after 48 h of incubation,1,N,13472,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL877501,,BAO_0000100,,,,P,7057,,22229,Dissociation constant (pKa),1,U,13473,,,,0,,Autocuration
,,,CHEMBL628685,,BAO_0000100,,,,P,7057,,22224,Dissociation constant value of the compound; ND means not determined.,1,U,13474,,,,0,,Autocuration
,,,CHEMBL628686,178.0,BAO_0000218,,,,A,7911,10116.0,50597,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,1,N,13475,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL628687,178.0,BAO_0000218,,,,A,7911,10116.0,50597,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,1,N,13476,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL628688,,BAO_0000218,,,,A,7911,10116.0,50597,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,1,N,13477,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628689,,BAO_0000218,,,,A,7911,10116.0,50597,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,1,N,13478,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628690,2107.0,BAO_0000218,,,,A,7911,10116.0,50597,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,1,N,13479,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL629363,2107.0,BAO_0000218,,,,A,7911,10116.0,50597,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,1,N,13480,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL629364,2106.0,BAO_0000218,,,,A,7911,10116.0,50597,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,1,N,13481,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL629365,2106.0,BAO_0000218,,,,A,7911,10116.0,50597,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,1,N,13482,,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL629366,,BAO_0000218,,,,A,7911,10116.0,50597,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,1,N,13483,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629367,1088.0,BAO_0000218,,,,A,7911,10116.0,50597,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,1,N,13484,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL629368,1988.0,BAO_0000218,,,,A,7911,10116.0,50597,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,1,N,13485,,Rattus norvegicus,Feces,1,,Intermediate
,,,CHEMBL877502,1088.0,BAO_0000218,,,,A,7911,10116.0,50597,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,1,N,13486,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL629369,2037.0,BAO_0000218,,,,A,13792,10090.0,50594,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,1,N,13487,,Mus musculus,Cerebellum,1,,Intermediate
,,,CHEMBL629370,955.0,BAO_0000218,,,,A,13792,10090.0,50594,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,1,N,13488,,Mus musculus,Brain,1,,Intermediate
,,,CHEMBL629371,1088.0,BAO_0000218,,,,A,8133,314293.0,22224,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",1,U,13489,,Simiiformes,Urine,0,,Autocuration
,,,CHEMBL626276,1088.0,BAO_0000218,,,,A,8133,314293.0,22224,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",1,U,13490,,Simiiformes,Urine,0,,Autocuration
,,,CHEMBL626277,1088.0,BAO_0000218,,,,A,8133,314293.0,22224,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",1,U,13491,,Simiiformes,Urine,0,,Autocuration
,,,CHEMBL631250,1088.0,BAO_0000218,,,,A,8133,314293.0,22224,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",1,U,13492,,Simiiformes,Urine,0,,Autocuration
,,,CHEMBL631251,1088.0,BAO_0000218,,,,A,8133,10116.0,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",1,N,13493,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631252,1088.0,BAO_0000218,,,,A,8133,10116.0,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",1,N,13494,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631253,1088.0,BAO_0000218,,,,A,8133,10116.0,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",1,N,13495,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631254,1088.0,BAO_0000218,,,,A,8133,10116.0,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",1,N,13496,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631255,1088.0,BAO_0000218,,,,A,8133,10116.0,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",1,N,13497,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631256,1088.0,BAO_0000218,,,,A,8133,10116.0,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",1,N,13498,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631257,1088.0,BAO_0000218,,,,A,8133,10116.0,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",1,N,13499,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628009,1088.0,BAO_0000218,,,,A,8133,10116.0,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",1,N,13500,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628010,1088.0,BAO_0000218,,,,A,8133,10116.0,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",1,N,13501,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628011,1088.0,BAO_0000218,,,,A,8133,10116.0,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",1,N,13502,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628012,1088.0,BAO_0000218,,,,A,8133,10116.0,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",1,N,13503,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628013,1088.0,BAO_0000218,,,,A,8133,10116.0,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",1,N,13504,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628014,1088.0,BAO_0000218,,,,A,8133,10116.0,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",1,N,13505,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628015,1088.0,BAO_0000218,,,,A,8133,9615.0,50588,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",1,N,13506,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL628016,1088.0,BAO_0000218,,,,A,8133,9615.0,50588,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",1,N,13507,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL874461,1088.0,BAO_0000218,,,,A,8133,9615.0,50588,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",1,N,13508,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL628017,1088.0,BAO_0000218,,,,A,8133,9615.0,50588,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",1,N,13509,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL628018,1088.0,BAO_0000218,,,,A,8133,9615.0,50588,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",1,N,13510,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL628019,1088.0,BAO_0000218,,,,A,8133,9615.0,50588,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",1,N,13511,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL628020,1088.0,BAO_0000218,,,,A,8133,9615.0,50588,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",1,N,13512,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL628021,1088.0,BAO_0000218,,,,A,8133,9615.0,50588,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",1,N,13513,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL628022,1088.0,BAO_0000218,,,,A,8133,9615.0,50588,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",1,N,13514,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL628023,1088.0,BAO_0000218,,,,A,8133,9615.0,50588,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",1,N,13515,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL628024,1088.0,BAO_0000218,,,,A,8133,314293.0,22224,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",1,U,13516,,Simiiformes,Urine,0,,Autocuration
,,,CHEMBL628025,1088.0,BAO_0000218,,,,A,8133,314293.0,22224,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",1,U,13517,,Simiiformes,Urine,0,,Autocuration
,,,CHEMBL628026,1088.0,BAO_0000218,,,,A,8133,314293.0,22224,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",1,U,13518,,Simiiformes,Urine,0,,Autocuration
,,,CHEMBL628027,1088.0,BAO_0000218,,,,A,8133,314293.0,22224,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",1,U,13519,,Simiiformes,Urine,0,,Autocuration
,,,CHEMBL628028,1088.0,BAO_0000218,,,,A,8133,314293.0,22224,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",1,U,13520,,Simiiformes,Urine,0,,Autocuration
,,,CHEMBL628029,1088.0,BAO_0000218,,,,A,8133,10116.0,50597,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",1,N,13521,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628030,1088.0,BAO_0000218,,,,A,8133,10116.0,50597,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",1,N,13522,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628031,1088.0,BAO_0000218,,,,A,8133,10116.0,50597,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",1,N,13523,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628032,1088.0,BAO_0000218,,,,A,8133,10116.0,50597,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",1,N,13524,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628033,1088.0,BAO_0000218,,,,A,8133,10116.0,50597,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",1,N,13525,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628034,1088.0,BAO_0000218,,,,A,8133,10116.0,50597,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",1,N,13526,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628035,1088.0,BAO_0000218,,,,A,8133,10116.0,50597,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",1,N,13527,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628036,1088.0,BAO_0000218,,,,A,8133,10116.0,50597,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",1,N,13528,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL874462,1088.0,BAO_0000218,,,,A,8133,10116.0,50597,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",1,N,13529,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628037,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,1,N,13530,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628123,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,1,N,13531,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628124,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,1,N,13532,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628125,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,1,N,13533,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628126,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,1,N,13534,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628127,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),1,N,13535,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628128,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,1,N,13536,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628129,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,1,N,13537,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628130,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,1,N,13538,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628131,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,1,N,13539,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628132,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,1,N,13540,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628133,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,1,N,13541,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628134,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,1,N,13542,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628135,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,1,N,13543,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628136,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,1,N,13544,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628137,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,1,N,13545,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628138,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,1,N,13546,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628139,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,1,N,13547,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628140,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,1,N,13548,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628141,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,1,N,13549,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628142,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,1,N,13550,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628143,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,1,N,13551,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628144,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,1,N,13552,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628145,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,1,N,13553,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL628146,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,1,N,13554,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625355,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,1,N,13555,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625356,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,1,N,13556,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625357,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,1,N,13557,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625527,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,1,N,13558,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL875473,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),1,N,13559,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL625528,,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,1,N,13560,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626304,,BAO_0000218,,,,A,9025,10116.0,50597,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,1,N,13561,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL624138,1637.0,BAO_0000218,,,,A,9025,9615.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,1,N,13562,In vivo,Canis lupus familiaris,Artery,1,,Intermediate
,,,CHEMBL624139,,BAO_0000100,,,,P,6448,,22229,Calculated partition coefficient (clogP),1,U,13563,,,,0,,Autocuration
,,,CHEMBL624140,,BAO_0000100,,,,P,17221,,22229,Calculated partition coefficient (clogP),1,U,13564,,,,0,,Autocuration
,,,CHEMBL624141,,BAO_0000100,,,,P,6545,,22229,Calculated partition coefficient (clogP),1,U,13565,,,,0,,Autocuration
,,,CHEMBL624142,,BAO_0000100,,,,P,577,,22229,Calculated partition coefficient (clogP),1,U,13566,,,,0,,Autocuration
,,,CHEMBL624143,,BAO_0000100,,,,P,6285,,22229,Calculated partition coefficient (clogP),1,U,13567,,,,0,,Autocuration
,,,CHEMBL624144,,BAO_0000100,,,,P,6500,,22229,Calculated partition coefficient (clogP),1,U,13568,,,,0,,Autocuration
,,,CHEMBL624145,,BAO_0000100,,,,P,6716,,22229,Calculated partition coefficient (clogP),1,U,13569,,,,0,,Autocuration
,,,CHEMBL624146,,BAO_0000100,,,,P,13658,,22229,Calculated partition coefficient (clogP),1,U,13570,,,,0,,Autocuration
,,,CHEMBL624147,,BAO_0000100,,,,P,6549,,22229,Calculated partition coefficient (clogP),1,U,13571,,,,0,,Autocuration
,,,CHEMBL883123,,BAO_0000100,,,,P,14685,,22229,Calculated partition coefficient (clogP) (MacLogP),1,U,13572,,,,0,,Autocuration
,,,CHEMBL624148,,BAO_0000019,,,,A,6893,,22224,Partition coefficient (logP),1,U,13573,,,,0,,Autocuration
,,,CHEMBL874416,,BAO_0000019,,,,A,3687,,22224,Kinetic parameter was determined,1,U,13574,,,,0,,Autocuration
,,,CHEMBL624149,,BAO_0000100,,,,P,4207,,22229,Calculated partition coefficient (clogP),1,U,13575,,,,0,,Autocuration
,,,CHEMBL624150,,BAO_0000100,,,,P,4626,,22229,Calculated partition coefficient (clogP),1,U,13576,,,,0,,Autocuration
,,,CHEMBL624151,,BAO_0000100,,,,P,1021,,22224,Lipophilicity was determined,1,U,13577,,,,0,,Autocuration
,,,CHEMBL624152,,BAO_0000100,,,,P,3777,,22224,Lipophilicity was determined,1,U,13578,,,,0,,Autocuration
,,,CHEMBL622139,,BAO_0000100,,,,P,17533,,22224,Lipophilicity was determined,1,U,13579,,,,0,,Autocuration
,,,CHEMBL622140,,BAO_0000100,,,,P,6524,,22229,Calculated partition coefficient (clogP),1,U,13580,,,,0,,Autocuration
,,,CHEMBL622141,,BAO_0000100,,,,P,17533,,22224,Lipophilicity was determined,1,U,13581,,,,0,,Autocuration
,,,CHEMBL622142,,BAO_0000100,,,,P,6480,,22224,Lipophilicity in octanol-water,1,U,13582,,,,0,,Autocuration
,,,CHEMBL622143,,BAO_0000100,,,,P,17606,,22229,Calculated partition coefficient (clogP),1,U,13583,,,,0,,Autocuration
,,,CHEMBL622144,,BAO_0000100,,,,P,6863,,22229,Octanol-water partition coefficient was determined,1,U,13584,,,,0,,Autocuration
,,,CHEMBL877473,,BAO_0000019,,,,A,1356,,22224,Partition coefficient (logP),1,U,13585,,,,0,,Autocuration
,,,CHEMBL622145,,BAO_0000100,,,,P,3326,,22229,Calculated partition coefficient (clogP),1,U,13586,,,,0,,Autocuration
,,,CHEMBL622146,,BAO_0000019,,,,A,1356,,22224,Partition coefficient was determined; ND means not determined,1,U,13587,,,,0,,Autocuration
,,,CHEMBL622147,,BAO_0000100,,,,P,12984,,22229,Calculated partition coefficient (clogP),1,U,13588,,,,0,,Autocuration
,,,CHEMBL622148,,BAO_0000019,,,,A,17363,,22224,Partition coefficient of the compound,1,U,13589,,,,0,,Autocuration
,,,CHEMBL883124,,BAO_0000019,,,,A,6827,,22224,Permeability was determined,1,U,13590,,,,0,,Autocuration
,,,CHEMBL622149,,BAO_0000100,,,,P,261,,22229,The compound was evaluated for the partition coefficient,1,U,13591,,,,0,,Autocuration
,,,CHEMBL622150,,BAO_0000019,,,,A,2685,,22224,Partition coefficient (logP),1,U,13592,,,,0,,Autocuration
,,,CHEMBL622151,,BAO_0000100,,,,P,414,,22224,The lipophilicity was reported,1,U,13593,,,,0,,Autocuration
,,,CHEMBL622152,,BAO_0000100,,,,P,15769,,22229,logarithm of the octanol-water partition coefficient for the compound,1,U,13594,,,,0,,Autocuration
,,,CHEMBL622153,,BAO_0000019,,,,A,17248,,22224,Clogp value was determined,1,U,13595,,,,0,,Autocuration
,,,CHEMBL877474,,BAO_0000218,,,,A,16935,,22224,Clp at a dose of 1.5 mg/kg,1,U,13596,In vivo,,,0,,Autocuration
,,,CHEMBL622154,,BAO_0000218,,,,A,16935,,22224,Clp at a dose of 2.0 mg/kg,1,U,13597,In vivo,,,0,,Autocuration
,,,CHEMBL622155,1969.0,BAO_0000218,,,,A,14832,,22224,"Clp, plasma clearance at a dose of 10 mg/kg",1,U,13598,In vivo,,Plasma,0,,Autocuration
,,,CHEMBL622156,1969.0,BAO_0000218,,,,A,14832,,22224,"Clp, plasma clearance at a dose of 50 mg/kg",1,U,13599,In vivo,,Plasma,0,,Autocuration
,,,CHEMBL622157,1969.0,BAO_0000218,,,,A,2399,10116.0,50597,Compound was tested for plasma clearance in rat,1,N,13600,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622158,1969.0,BAO_0000218,,,,A,2399,10116.0,50597,Compound was tested for plasma clearance in rat; Not determined,1,N,13601,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622807,,BAO_0000218,,,,A,6227,10116.0,50597,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,1,N,13602,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622808,,BAO_0000218,,,,A,6227,9544.0,50797,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,1,N,13603,In vivo,Macaca mulatta,,1,,Intermediate
,,,CHEMBL622809,,BAO_0000218,,,,A,5623,,22224,Plasma clearance by iv administration at a dose 0.003 ug/mL,1,U,13604,In vivo,,,0,,Autocuration
,,,CHEMBL622810,,BAO_0000218,,,,A,4854,,22224,Plasma clearance determined,1,U,13605,In vivo,,,0,,Autocuration
,,,CHEMBL876653,,BAO_0000218,,,,A,4493,10026.0,100712,Plasma clearance after iv administration at 3 mg/kg in hamster,1,N,13606,In vivo,Cricetinae,,1,,Intermediate
,,,CHEMBL622811,,BAO_0000218,,,,A,4493,10026.0,100712,Plasma clearance after iv administration at 4 mg/kg in hamster,1,N,13607,In vivo,Cricetinae,,1,,Intermediate
,,,CHEMBL622986,,BAO_0000218,,,,A,14956,10116.0,50597,Rate of clearance in rat was determined,1,N,13608,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622987,1969.0,BAO_0000218,,,,A,15372,10116.0,50597,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,1,N,13609,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622988,1969.0,BAO_0000218,,,,A,15372,10116.0,50597,Total plasma clearance after iv dose of 5.10 mg/kg in rats,1,N,13610,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622989,1969.0,BAO_0000218,,,,A,15372,10116.0,50597,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,1,N,13611,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622990,1969.0,BAO_0000218,,,,A,15372,10116.0,50597,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,1,N,13612,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622991,1969.0,BAO_0000218,,,,A,15604,314293.0,22224,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,1,U,13613,In vivo,Simiiformes,Plasma,0,,Autocuration
,,,CHEMBL622227,1969.0,BAO_0000218,,,,A,15604,10116.0,50597,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,1,N,13614,In vivo,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL622228,1969.0,BAO_0000218,,,,A,15604,9615.0,50588,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,1,N,13615,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL622229,,BAO_0000218,,,,A,14964,10116.0,50597,Clpl value in rat,1,N,13616,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622230,,BAO_0000218,,,,A,15240,10141.0,50512,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,1,N,13617,In vivo,Cavia porcellus,,1,,Intermediate
,,,CHEMBL622231,,BAO_0000218,,,,A,16449,10116.0,50597,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,1,N,13618,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL622232,,BAO_0000218,,,,A,16449,9541.0,100710,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,1,N,13619,In vivo,Macaca fascicularis,,1,,Intermediate
,,,CHEMBL622233,,BAO_0000218,,,,A,12902,,22224,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,1,U,13620,In vivo,,,0,,Autocuration
,,,CHEMBL622234,,BAO_0000218,,,,A,12902,,22224,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,1,U,13621,In vivo,,,0,,Autocuration
,,,CHEMBL622235,,BAO_0000218,,,,A,12902,,22224,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,1,U,13622,In vivo,,,0,,Autocuration
,,,CHEMBL622236,,BAO_0000218,,,,A,12902,,22224,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,1,U,13623,In vivo,,,0,,Autocuration
,,,CHEMBL622237,,BAO_0000218,,,,A,12902,,22224,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,1,U,13624,In vivo,,,0,,Autocuration
,,,CHEMBL877482,,BAO_0000218,,,,A,12902,,22224,Cmax in minutes at a po dose of 10.0(pmol/g/h).,1,U,13625,In vivo,,,0,,Autocuration
,,,CHEMBL622238,,BAO_0000218,,,,A,12902,,22224,Cmax in minutes at a po dose of 20.0(pmol/g/h).,1,U,13626,In vivo,,,0,,Autocuration
,,,CHEMBL622239,,BAO_0000218,,,,A,12902,,22224,Cmax in minutes at a po dose of 40.0(pmol/g/h).,1,U,13627,In vivo,,,0,,Autocuration
,,,CHEMBL622240,178.0,BAO_0000218,,,,A,11149,,22224,Cmax was calculated as maximum concentration reached in the blood,1,U,13628,In vivo,,Blood,0,,Autocuration
,,,CHEMBL622241,178.0,BAO_0000218,,,,A,11149,,22224,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,1,U,13629,In vivo,,Blood,0,,Autocuration
,,,CHEMBL631013,,BAO_0000218,,,,A,5669,10116.0,50597,Cmax was determine after peroral administration at 10 mpk in Rat,1,N,13630,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631014,,BAO_0000218,,,,A,5669,9544.0,50797,Cmax was determine after peroral administration at 10 mpk in Rhesus,1,N,13631,In vivo,Macaca mulatta,,1,,Intermediate
,,,CHEMBL631015,,BAO_0000218,,,,A,5669,9615.0,50588,Cmax was determine after peroral administration at 10 mpk in dog,1,N,13632,In vivo,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL631016,,BAO_0000218,,,,A,5669,10116.0,50597,Cmax was determine after peroral administration at 160 mpk in Rat,1,N,13633,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631017,,BAO_0000218,,,,A,5669,10116.0,50597,Cmax was determine after peroral administration at 20 mpk in Rat,1,N,13634,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631018,,BAO_0000218,,,,A,5669,10116.0,50597,Cmax was determine after peroral administration at 50 mpk in Rat,1,N,13635,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631019,,BAO_0000218,,,,A,4236,,22224,Cmax was determined,1,U,13636,In vivo,,,0,,Autocuration
,,,CHEMBL875761,955.0,BAO_0000218,,,,A,13792,10090.0,50594,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,1,N,13637,,Mus musculus,Brain,1,,Intermediate
,,,CHEMBL631020,955.0,BAO_0000218,,,,A,13792,10090.0,50594,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,1,N,13638,,Mus musculus,Brain,1,,Intermediate
,,,CHEMBL631669,955.0,BAO_0000218,,,,A,13792,10090.0,50594,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,1,N,13639,,Mus musculus,Brain,1,,Intermediate
,,,CHEMBL631670,955.0,BAO_0000218,,,,A,13792,10090.0,50594,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,1,N,13640,,Mus musculus,Brain,1,,Intermediate
,,,CHEMBL631671,2435.0,BAO_0000218,,,,A,13792,10090.0,50594,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,1,N,13641,,Mus musculus,Striatum,1,,Intermediate
,,,CHEMBL631672,178.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,1,N,13642,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631673,178.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,1,N,13643,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631856,178.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,1,N,13644,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631857,178.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,1,N,13645,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631858,178.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,1,N,13646,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631859,178.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,1,N,13647,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631860,178.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,1,N,13648,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631861,178.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,1,N,13649,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631862,178.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,1,N,13650,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631863,178.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,1,N,13651,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631864,178.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,1,N,13652,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631865,178.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,1,N,13653,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631866,178.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,1,N,13654,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL629360,178.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,1,N,13655,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL629361,178.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,1,N,13656,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL629362,178.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,1,N,13657,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL630740,178.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,1,N,13658,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL630741,178.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,1,N,13659,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL630742,178.0,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,1,N,13660,,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL630743,,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,1,N,13661,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630744,,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,1,N,13662,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630745,,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,1,N,13663,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630746,,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,1,N,13664,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630747,,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,1,N,13665,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630748,,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,1,N,13666,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL632056,,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,1,N,13667,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL632057,,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,1,N,13668,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL632058,,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,1,N,13669,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL632059,,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,1,N,13670,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL632060,,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,1,N,13671,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL632061,,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,1,N,13672,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629207,,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,1,N,13673,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629208,,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,1,N,13674,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629209,,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,1,N,13675,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629210,,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,1,N,13676,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629211,,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,1,N,13677,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629212,,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,1,N,13678,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629213,,BAO_0000218,,,,A,8418,10116.0,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,1,N,13679,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629214,1088.0,BAO_0000218,,,,A,8133,10116.0,50597,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",1,N,13680,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL629215,1088.0,BAO_0000218,,,,A,8133,10116.0,50597,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",1,N,13681,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL635154,1088.0,BAO_0000218,,,,A,8133,10116.0,50597,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",1,N,13682,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL629216,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),1,N,13683,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629217,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,1,N,13684,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629218,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),1,N,13685,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629219,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),1,N,13686,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629220,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),1,N,13687,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629221,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),1,N,13688,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631127,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),1,N,13689,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631128,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,1,N,13690,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631129,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),1,N,13691,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631130,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),1,N,13692,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631131,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),1,N,13693,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631132,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),1,N,13694,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631133,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),1,N,13695,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631134,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,1,N,13696,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL875120,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),1,N,13697,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631135,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),1,N,13698,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631136,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),1,N,13699,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631137,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),1,N,13700,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631138,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),1,N,13701,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631139,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,1,N,13702,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631140,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),1,N,13703,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631141,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),1,N,13704,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631142,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),1,N,13705,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631143,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),1,N,13706,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631144,,BAO_0000218,,,,A,6996,10116.0,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),1,N,13707,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631145,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,1,N,13708,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL631146,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),1,N,13709,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL631147,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,1,N,13710,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL631148,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),1,N,13711,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL631149,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),1,N,13712,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL631150,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),1,N,13713,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL631151,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),1,N,13714,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL631152,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),1,N,13715,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL631443,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),1,N,13716,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL631444,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),1,N,13717,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL631445,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),1,N,13718,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL631446,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),1,N,13719,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL631447,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),1,N,13720,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL631448,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),1,N,13721,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL631449,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,1,N,13722,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL631450,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),1,N,13723,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL629724,,BAO_0000218,,,,A,6996,9615.0,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),1,N,13724,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL629725,14.0,BAO_0000218,,,,A,9716,10090.0,50594,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,N,13725,In vivo,Mus musculus,Zone of skin,1,,Intermediate
,,,CHEMBL629726,14.0,BAO_0000218,,,,A,9716,10090.0,50594,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,N,13726,In vivo,Mus musculus,Zone of skin,1,,Intermediate
,,,CHEMBL629727,2106.0,BAO_0000218,,,,A,9716,10090.0,50594,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,N,13727,In vivo,Mus musculus,Spleen,1,,Intermediate
,,,CHEMBL630404,2106.0,BAO_0000218,,,,A,9716,10090.0,50594,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,N,13728,In vivo,Mus musculus,Spleen,1,,Intermediate
,,,CHEMBL630405,2106.0,BAO_0000218,,,,A,9716,10090.0,50594,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,N,13729,In vivo,Mus musculus,Spleen,1,,Intermediate
,,,CHEMBL630406,2106.0,BAO_0000218,,,,A,9716,10090.0,50594,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,N,13730,In vivo,Mus musculus,Spleen,1,,Intermediate
,,,CHEMBL630407,945.0,BAO_0000218,,,,A,9716,10090.0,50594,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,N,13731,In vivo,Mus musculus,Stomach,1,,Intermediate
,,,CHEMBL630573,945.0,BAO_0000218,,,,A,9716,10090.0,50594,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,N,13732,In vivo,Mus musculus,Stomach,1,,Intermediate
,,,CHEMBL630574,945.0,BAO_0000218,,,,A,9716,10090.0,50594,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,N,13733,In vivo,Mus musculus,Stomach,1,,Intermediate
,,,CHEMBL630575,945.0,BAO_0000218,,,,A,9716,10090.0,50594,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,N,13734,In vivo,Mus musculus,Stomach,1,,Intermediate
,,,CHEMBL630576,,BAO_0000218,,,,A,9716,10090.0,50594,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,N,13735,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL630577,,BAO_0000218,,,,A,9716,10090.0,50594,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,N,13736,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL630578,,BAO_0000218,,,,A,9716,10090.0,50594,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,N,13737,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL630579,,BAO_0000218,,,,A,9716,10090.0,50594,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,N,13738,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL630580,2113.0,BAO_0000218,,,,A,12192,10090.0,50594,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),1,N,13739,,Mus musculus,Kidney,1,,Intermediate
,,,CHEMBL630581,2113.0,BAO_0000218,,,,A,12192,10090.0,50594,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,1,N,13740,,Mus musculus,Kidney,1,,Intermediate
,,,CHEMBL630582,2113.0,BAO_0000218,,,,A,12192,10090.0,50594,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),1,N,13741,,Mus musculus,Kidney,1,,Intermediate
,,,CHEMBL630583,,BAO_0000218,,,,A,12192,10090.0,50594,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,1,N,13742,,Mus musculus,,1,,Intermediate
,,,CHEMBL630584,,BAO_0000218,,,,A,12192,10090.0,50594,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),1,N,13743,,Mus musculus,,1,,Intermediate
,,,CHEMBL630585,,BAO_0000218,,,,A,12192,10090.0,50594,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,1,N,13744,,Mus musculus,,1,,Intermediate
,,,CHEMBL630586,,BAO_0000218,,,,A,12192,10090.0,50594,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),1,N,13745,,Mus musculus,,1,,Intermediate
,,,CHEMBL630587,,BAO_0000218,,,,A,12192,10090.0,50594,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,1,N,13746,,Mus musculus,,1,,Intermediate
,,,CHEMBL630588,,BAO_0000218,,,,A,12192,10090.0,50594,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),1,N,13747,,Mus musculus,,1,,Intermediate
,,,CHEMBL630589,,BAO_0000218,,,,A,12192,10090.0,50594,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,1,N,13748,,Mus musculus,,1,,Intermediate
,,,CHEMBL630590,,BAO_0000218,,,,A,12192,10090.0,50594,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),1,N,13749,,Mus musculus,,1,,Intermediate
,,,CHEMBL630591,1988.0,BAO_0000019,,,,A,12192,,22224,Removal of 238-Plutonium(IV) in feces at 24 h,1,U,13750,,,Feces,0,,Autocuration
,,,CHEMBL630592,1988.0,BAO_0000019,,,,A,12192,,22224,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),1,U,13751,,,Feces,0,,Autocuration
,,,CHEMBL630593,,BAO_0000019,,,,A,12192,,22224,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,1,U,13752,,,,0,,Autocuration
,,,CHEMBL630594,,BAO_0000019,,,,A,12192,,22224,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),1,U,13753,,,,0,,Autocuration
,,,CHEMBL630595,1088.0,BAO_0000019,,,,A,12192,,22224,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),1,U,13754,,,Urine,0,,Autocuration
,,,CHEMBL630596,1088.0,BAO_0000019,,,,A,12192,,22224,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),1,U,13755,,,Urine,0,,Autocuration
,,,CHEMBL630597,1088.0,BAO_0000019,,,,A,12192,,22224,Removal of 238-Plutonium(IV) in urine after 0-24 h,1,U,13756,,,Urine,0,,Autocuration
,,,CHEMBL630598,1088.0,BAO_0000019,,,,A,12192,,22224,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),1,U,13757,,,Urine,0,,Autocuration
,,,CHEMBL630599,1088.0,BAO_0000019,,,,A,12192,,22224,Removal of 238-Plutonium(IV) in urine after 0-4 h,1,U,13758,,,Urine,0,,Autocuration
,,,CHEMBL630600,1088.0,BAO_0000019,,,,A,12192,,22224,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),1,U,13759,,,Urine,0,,Autocuration
,,,CHEMBL630601,1088.0,BAO_0000019,,,,A,12192,,22224,Removal of 238-Plutonium(IV) in urine after 4-24 h,1,U,13760,,,Urine,0,,Autocuration
,,,CHEMBL630602,1088.0,BAO_0000019,,,,A,12192,,22224,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),1,U,13761,,,Urine,0,,Autocuration
,,,CHEMBL630603,1088.0,BAO_0000019,,,,A,12192,,22224,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),1,U,13762,,,Urine,0,,Autocuration
,,,CHEMBL630604,1088.0,BAO_0000019,,,,A,12192,,22224,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),1,U,13763,,,Urine,0,,Autocuration
,,,CHEMBL624869,178.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,13764,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL624870,178.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,13765,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL623189,178.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,N,13766,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL623190,178.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,13767,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL623191,178.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,13768,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL623192,,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,13769,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623193,,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,13770,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623194,,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,N,13771,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623195,,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,13772,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623196,,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,13773,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623197,,BAO_0000218,,,,A,11836,10116.0,50597,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,1,N,13774,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623198,,BAO_0000218,,,,A,11836,10116.0,50597,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,1,N,13775,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623199,,BAO_0000218,,,,A,11836,10116.0,50597,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,1,N,13776,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623200,2385.0,BAO_0000218,,,,A,11836,10116.0,50597,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,1,N,13777,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL623201,2385.0,BAO_0000218,,,,A,11836,10116.0,50597,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,1,N,13778,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL623202,2385.0,BAO_0000218,,,,A,11836,10116.0,50597,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,1,N,13779,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL623203,2385.0,BAO_0000218,,,,A,11836,10116.0,50597,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,1,N,13780,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL623204,2385.0,BAO_0000218,,,,A,11836,10116.0,50597,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,1,N,13781,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL623205,2385.0,BAO_0000218,,,,A,11836,10116.0,50597,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,1,N,13782,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL623206,2385.0,BAO_0000218,,,,A,11836,10116.0,50597,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,1,N,13783,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL623207,2385.0,BAO_0000218,,,,A,11836,10116.0,50597,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,1,N,13784,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL623208,2385.0,BAO_0000218,,,,A,11836,10116.0,50597,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,1,N,13785,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL623209,2385.0,BAO_0000218,,,,A,11836,10116.0,50597,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,1,N,13786,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL623210,2385.0,BAO_0000218,,,,A,11836,10116.0,50597,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,1,N,13787,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL623211,,BAO_0000218,,,,A,11836,10116.0,50597,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,1,N,13788,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623212,995.0,BAO_0000218,,,,A,11836,10116.0,50597,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,1,N,13789,,Rattus norvegicus,Uterus,1,,Intermediate
,,,CHEMBL623213,,BAO_0000019,,,,A,12640,,22224,Tested in vitro for intrinsic activity relative to quinpirole,1,U,13790,,,,0,,Autocuration
,,,CHEMBL623214,,BAO_0000019,,,,A,14218,,22224,"Relative ion enhancement, determined in pulsed ultrafiltration",1,U,13791,,,,0,,Autocuration
,,,CHEMBL623215,,BAO_0000019,,,,A,11296,,22224,% ionization at the pH 7.4 at 37 degree Centigrade,1,U,13792,,,,0,,Autocuration
,,,CHEMBL623216,,BAO_0000019,,,,A,10929,,22224,Percentage ionization was measured,1,U,13793,,,,0,,Autocuration
,,,CHEMBL623217,,BAO_0000218,,,,A,13841,9913.0,50591,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,1,N,13794,,Bos taurus,,1,,Intermediate
,,,CHEMBL623218,,BAO_0000019,,,,A,10431,,22224,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,1,U,13795,,,,0,,Autocuration
,,,CHEMBL623913,,BAO_0000019,,,,A,10431,,22224,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,1,U,13796,,,,0,,Autocuration
,,,CHEMBL623914,,BAO_0000019,,,,A,10431,,22224,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,1,U,13797,,,,0,,Autocuration
,,,CHEMBL623915,,BAO_0000100,,,,P,8826,,22229,Compound was evaluated for the partition coefficient in octanol/water,1,U,13798,,,,0,,Autocuration
,,,CHEMBL624080,,BAO_0000100,,,,P,8826,,22229,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),1,U,13799,,,,0,,Autocuration
,,,CHEMBL624081,,BAO_0000019,,,,A,9884,,22224,Equilibrium constant measured by the pulse radiolysis at pH 7,1,U,13800,,,,0,,Autocuration
,,,CHEMBL624082,,BAO_0000218,,,,A,9827,9606.0,50587,In vitro hydrolytic rate constant determined in human blood,1,N,13801,,Homo sapiens,,1,,Intermediate
,,,CHEMBL625054,,BAO_0000218,,,,A,10009,9606.0,50587,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,1,N,13802,,Homo sapiens,,1,,Intermediate
,,,CHEMBL877485,,BAO_0000019,,,,A,10009,,22224,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,1,U,13803,,,,0,,Autocuration
,,,CHEMBL625055,,BAO_0000218,,,,A,10009,10090.0,50594,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,1,N,13804,,Mus musculus,,1,,Intermediate
,,,CHEMBL625056,,BAO_0000218,,,,A,10009,10090.0,50594,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,1,N,13805,,Mus musculus,,1,,Intermediate
,,,CHEMBL625057,,BAO_0000218,,,,A,10009,9606.0,50587,In vitro oxidation of compound in presence of human plasma,1,N,13806,,Homo sapiens,,1,,Intermediate
,,,CHEMBL625058,,BAO_0000019,,,,A,10009,,22224,In vitro oxidation of compound in presence of hydrogen peroxide,1,U,13807,,,,0,,Autocuration
,,,CHEMBL625059,,BAO_0000218,,,,A,10009,10090.0,50594,In vitro oxidation of compound in presence of mouse brain homogenate,1,N,13808,,Mus musculus,,1,,Intermediate
,,,CHEMBL629536,,BAO_0000218,,,,A,10009,10090.0,50594,In vitro oxidation of compound in presence of mouse liver homogenate,1,N,13809,,Mus musculus,,1,,Intermediate
,,,CHEMBL629537,,BAO_0000218,,,,A,11510,10116.0,50597,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,1,N,13810,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629538,,BAO_0000218,,,,A,11510,10116.0,50597,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,1,N,13811,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629539,,BAO_0000218,,,,A,11510,10116.0,50597,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,1,N,13812,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL874445,,BAO_0000218,,,,A,11510,10116.0,50597,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,1,N,13813,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629540,,BAO_0000218,,,,A,11510,10116.0,50597,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,1,N,13814,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629541,,BAO_0000218,,,,A,11510,10116.0,50597,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,1,N,13815,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629542,,BAO_0000218,,,,A,11510,10116.0,50597,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,1,N,13816,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630243,,BAO_0000218,,,,A,11510,10116.0,50597,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,1,N,13817,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630244,,BAO_0000218,,,,A,11510,10116.0,50597,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,1,N,13818,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630245,,BAO_0000218,,,,A,11510,10116.0,50597,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,1,N,13819,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630246,,BAO_0000218,,,,A,11510,10116.0,50597,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,1,N,13820,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630247,,BAO_0000218,,,,A,11510,10116.0,50597,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,1,N,13821,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630248,,BAO_0000218,,,,A,11510,10116.0,50597,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,1,N,13822,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630249,178.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat blood at 240 minutes after dose administration.,1,N,13823,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL630250,178.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat blood at 30 minutes after dose administration.,1,N,13824,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL630251,178.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat blood at 360 minutes after dose administration.,1,N,13825,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL630252,178.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat blood at 3 hr after dose administration.,1,N,13826,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL630408,178.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat blood at 60 minutes after dose administration.,1,N,13827,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL630409,2037.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat cerebellum at 120 minutes after dose administration.,1,N,13828,In vivo,Rattus norvegicus,Cerebellum,1,,Intermediate
,,,CHEMBL874446,2037.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,1,N,13829,In vivo,Rattus norvegicus,Cerebellum,1,,Intermediate
,,,CHEMBL630410,2037.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat cerebellum at 15 minutes after dose administration.,1,N,13830,In vivo,Rattus norvegicus,Cerebellum,1,,Intermediate
,,,CHEMBL630411,2037.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat cerebellum at 240 minutes after dose administration.,1,N,13831,In vivo,Rattus norvegicus,Cerebellum,1,,Intermediate
,,,CHEMBL630412,2037.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat cerebellum at 30 minutes after dose administration.,1,N,13832,In vivo,Rattus norvegicus,Cerebellum,1,,Intermediate
,,,CHEMBL630413,2037.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat cerebellum at 360 minutes after dose administration.,1,N,13833,In vivo,Rattus norvegicus,Cerebellum,1,,Intermediate
,,,CHEMBL630414,2037.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat cerebellum at 3 hr after dose administration.,1,N,13834,In vivo,Rattus norvegicus,Cerebellum,1,,Intermediate
,,,CHEMBL630415,2037.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat cerebellum at 60 minutes after dose administration.,1,N,13835,In vivo,Rattus norvegicus,Cerebellum,1,,Intermediate
,,,CHEMBL630416,,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat cortex at 120 minutes after dose administration.,1,N,13836,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630417,,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat cortex at 1440 minutes after dose administration.,1,N,13837,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630418,,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat cortex at 15 minutes after dose administration.,1,N,13838,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630419,,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat cortex at 240 minutes after dose administration.,1,N,13839,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630420,,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat cortex at 30 minutes after dose administration.,1,N,13840,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630421,,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat cortex at 360 minutes after dose administration.,1,N,13841,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630422,,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat cortex at 3 hr after dose administration.,1,N,13842,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630423,,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat cortex at 60 minutes after dose administration.,1,N,13843,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630424,948.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat heart at 120 minutes after dose administration.,1,N,13844,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL630425,948.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat heart at 15 minutes after dose administration.,1,N,13845,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL629462,948.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat heart at 240 minutes after dose administration.,1,N,13846,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL630426,948.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat heart at 30 minutes after dose administration.,1,N,13847,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL630427,948.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat heart at 360 minutes after dose administration.,1,N,13848,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL625877,948.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat heart at 3 hr after dose administration.,1,N,13849,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL625878,948.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat heart at 60 minutes after dose administration.,1,N,13850,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL625879,10000000.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,1,N,13851,In vivo,Rattus norvegicus,Hippocampus,1,,Intermediate
,,,CHEMBL625880,10000000.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat hippocampus at 240 minutes after dose administration.,1,N,13852,In vivo,Rattus norvegicus,Hippocampus,1,,Intermediate
,,,CHEMBL625881,10000000.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat hippocampus at 30 minutes after dose administration.,1,N,13853,In vivo,Rattus norvegicus,Hippocampus,1,,Intermediate
,,,CHEMBL625882,10000000.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat hippocampus at 360 minutes after dose administration.,1,N,13854,In vivo,Rattus norvegicus,Hippocampus,1,,Intermediate
,,,CHEMBL625883,10000000.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat hippocampus at 15 minutes after dose administration.,1,N,13855,In vivo,Rattus norvegicus,Hippocampus,1,,Intermediate
,,,CHEMBL625884,2113.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat kidney at 120 minutes after dose administration.,1,N,13856,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL625885,2113.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat kidney at 1440 minutes after dose administration.,1,N,13857,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL628649,2113.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat kidney at 15 minutes after dose administration.,1,N,13858,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL628650,2113.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat kidney at 240 minutes after dose administration.,1,N,13859,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL628651,2113.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat kidney at 30 minutes after dose administration.,1,N,13860,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL628652,2113.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat kidney at 360 minutes after dose administration.,1,N,13861,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL628653,2113.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat kidney at 60 minutes after dose administration.,1,N,13862,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL628654,2107.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat liver at 120 minutes after dose administration.,1,N,13863,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL628655,2107.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat liver at 1440 minutes after dose administration.,1,N,13864,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625238,2107.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat liver at 15 minutes after dose administration.,1,N,13865,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625239,2107.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat liver at 240 minutes after dose administration.,1,N,13866,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625240,2107.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat liver at 30 minutes after dose administration.,1,N,13867,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625241,2107.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat liver at 360 minutes after dose administration.,1,N,13868,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625242,2107.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat liver at 60 minutes after dose administration.,1,N,13869,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL874587,2048.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat lung at 120 minutes after dose administration.,1,N,13870,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL625405,2048.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat lung at 1440 minutes after dose administration.,1,N,13871,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL625406,2048.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat lung at 15 minutes after dose administration.,1,N,13872,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL625407,2048.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat lung at 240 minutes after dose administration.,1,N,13873,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL625408,2048.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat lung at 30 minutes after dose administration.,1,N,13874,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL625409,2048.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat lung at 360 minutes after dose administration.,1,N,13875,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL625410,1515.0,BAO_0000218,,,,A,12361,10116.0,50597,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,1,N,13876,,Rattus norvegicus,Thoracic aorta,1,,Intermediate
,,,CHEMBL625411,1515.0,BAO_0000218,,,,A,12361,10116.0,50597,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,1,N,13877,,Rattus norvegicus,Thoracic aorta,1,,Intermediate
,,,CHEMBL625412,1515.0,BAO_0000218,,,,A,12361,10116.0,50597,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,1,N,13878,,Rattus norvegicus,Thoracic aorta,1,,Intermediate
,,,CHEMBL625413,1515.0,BAO_0000218,,,,A,12361,10116.0,50597,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,1,N,13879,,Rattus norvegicus,Thoracic aorta,1,,Intermediate
,,,CHEMBL625414,1515.0,BAO_0000218,,,,A,12361,10116.0,50597,Percent of maximal contractile response to compound in rat thoracic aorta strips v,1,N,13880,,Rattus norvegicus,Thoracic aorta,1,,Intermediate
,,,CHEMBL625415,1515.0,BAO_0000218,,,,A,12361,10116.0,50597,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,1,N,13881,,Rattus norvegicus,Thoracic aorta,1,,Intermediate
,,,CHEMBL625416,1515.0,BAO_0000218,,,,A,12361,10116.0,50597,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,1,N,13882,,Rattus norvegicus,Thoracic aorta,1,,Intermediate
,,,CHEMBL625417,1088.0,BAO_0000218,,,,A,12712,10116.0,50597,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,1,N,13883,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL625418,1988.0,BAO_0000218,,,,A,7415,10116.0,50597,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,1,N,13884,,Rattus norvegicus,Feces,1,,Intermediate
,,,CHEMBL625419,1088.0,BAO_0000218,,,,A,7415,10116.0,50597,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,1,N,13885,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL625420,,BAO_0000218,,,,A,7415,10116.0,50597,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,1,N,13886,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626996,,BAO_0000218,,,,A,7415,10116.0,50597,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,1,N,13887,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626997,1988.0,BAO_0000218,,,,A,7415,10116.0,50597,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",1,N,13888,,Rattus norvegicus,Feces,1,,Intermediate
,,,CHEMBL626998,1088.0,BAO_0000218,,,,A,7415,10116.0,50597,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",1,N,13889,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL626999,,BAO_0000218,,,,A,7415,10116.0,50597,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",1,N,13890,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627000,,BAO_0000218,,,,A,8050,10090.0,50594,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,1,N,13891,,Mus musculus,,1,,Intermediate
,,,CHEMBL627001,,BAO_0000218,,,,A,8050,10090.0,50594,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,1,N,13892,,Mus musculus,,1,,Intermediate
,,,CHEMBL627002,,BAO_0000218,,,,A,8050,10090.0,50594,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,1,N,13893,,Mus musculus,,1,,Intermediate
,,,CHEMBL627003,,BAO_0000218,,,,A,8050,10090.0,50594,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,1,N,13894,,Mus musculus,,1,,Intermediate
,,,CHEMBL627004,1088.0,BAO_0000218,,,,A,8050,10090.0,50594,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,1,N,13895,,Mus musculus,Urine,1,,Intermediate
,,,CHEMBL627005,1088.0,BAO_0000218,,,,A,8050,10090.0,50594,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,1,N,13896,,Mus musculus,Urine,1,,Intermediate
,,,CHEMBL874594,1088.0,BAO_0000218,,,,A,8050,10090.0,50594,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,1,N,13897,,Mus musculus,Urine,1,,Intermediate
,,,CHEMBL627006,1088.0,BAO_0000218,,,,A,8050,10090.0,50594,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,1,N,13898,,Mus musculus,Urine,1,,Intermediate
,,,CHEMBL627007,1088.0,BAO_0000218,,,,A,8050,10090.0,50594,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,1,N,13899,,Mus musculus,Urine,1,,Intermediate
,,,CHEMBL627884,1088.0,BAO_0000218,,,,A,8050,10090.0,50594,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,1,N,13900,,Mus musculus,Urine,1,,Intermediate
,,,CHEMBL627885,1088.0,BAO_0000218,,,,A,8050,10090.0,50594,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,1,N,13901,,Mus musculus,Urine,1,,Intermediate
,,,CHEMBL627886,1088.0,BAO_0000218,,,,A,8050,10090.0,50594,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,1,N,13902,,Mus musculus,Urine,1,,Intermediate
,,,CHEMBL627887,1088.0,BAO_0000218,,,,A,8050,10090.0,50594,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,1,N,13903,,Mus musculus,Urine,1,,Intermediate
,,,CHEMBL627888,1088.0,BAO_0000218,,,,A,8050,10090.0,50594,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,1,N,13904,,Mus musculus,Urine,1,,Intermediate
,,,CHEMBL628057,1088.0,BAO_0000218,,,,A,8050,10090.0,50594,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,1,N,13905,,Mus musculus,Urine,1,,Intermediate
,,,CHEMBL627405,1088.0,BAO_0000218,,,,A,8050,10090.0,50594,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,1,N,13906,,Mus musculus,Urine,1,,Intermediate
,,,CHEMBL627406,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,1,N,13907,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL627407,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,1,N,13908,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL627408,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,1,N,13909,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL627409,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,1,N,13910,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL875486,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,1,N,13911,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL627410,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,1,N,13912,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL627411,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,1,N,13913,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL627412,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,1,N,13914,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL627413,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,1,N,13915,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL627414,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,1,N,13916,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL627415,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,1,N,13917,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL627416,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,1,N,13918,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL627417,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,1,N,13919,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL627418,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,1,N,13920,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL627419,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,1,N,13921,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL627320,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,1,N,13922,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL627321,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,1,N,13923,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL627322,2113.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,13924,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL627323,2113.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,13925,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL627491,2113.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,N,13926,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL627492,2113.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,13927,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL627493,2113.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,13928,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL627494,2107.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,13929,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL627495,2107.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,13930,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL627496,2107.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,N,13931,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL627497,2107.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,13932,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL627498,2107.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,13933,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL627499,2048.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,13934,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627500,2048.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,13935,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627501,2048.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,N,13936,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL625616,2048.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,13937,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL625617,2048.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,13938,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL625618,2385.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,13939,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL625619,2385.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,13940,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL625620,2385.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,N,13941,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL625621,2385.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,13942,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL625622,2385.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,13943,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL625788,2106.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,13944,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL625789,2106.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,13945,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL625790,2106.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,N,13946,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL625791,2106.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,13947,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL622334,2106.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,13948,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL622335,2046.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,13949,In vivo,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL622336,2046.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,13950,In vivo,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL622337,2046.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,N,13951,In vivo,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL622338,2046.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,13952,In vivo,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL622339,2046.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,13953,In vivo,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL624153,,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,13954,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628430,,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,13955,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628431,,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,N,13956,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628432,,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,13957,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628433,,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,13958,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628434,2106.0,BAO_0000218,,,,A,12017,10116.0,50597,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",1,N,13959,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL626789,2106.0,BAO_0000218,,,,A,12017,10116.0,50597,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",1,N,13960,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL626790,2106.0,BAO_0000218,,,,A,12017,10116.0,50597,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",1,N,13961,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL626791,2106.0,BAO_0000218,,,,A,12017,10116.0,50597,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",1,N,13962,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL626792,2106.0,BAO_0000218,,,,A,12017,10116.0,50597,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",1,N,13963,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL626793,2106.0,BAO_0000218,,,,A,12017,10116.0,50597,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",1,N,13964,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL627436,,BAO_0000218,,,,A,11510,10116.0,50597,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,1,N,13965,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627437,,BAO_0000218,,,,A,11510,10116.0,50597,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,1,N,13966,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627438,,BAO_0000218,,,,A,11510,10116.0,50597,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,1,N,13967,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627439,,BAO_0000218,,,,A,11510,10116.0,50597,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,1,N,13968,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627440,,BAO_0000218,,,,A,11510,10116.0,50597,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,1,N,13969,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627602,,BAO_0000218,,,,A,11510,10116.0,50597,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,1,N,13970,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627603,,BAO_0000218,,,,A,11510,10116.0,50597,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,1,N,13971,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627604,,BAO_0000218,,,,A,11510,10116.0,50597,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,1,N,13972,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627605,,BAO_0000218,,,,A,11510,10116.0,50597,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,1,N,13973,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627606,,BAO_0000218,,,,A,11510,10116.0,50597,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,1,N,13974,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627607,,BAO_0000218,,,,A,11510,10116.0,50597,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,1,N,13975,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627608,,BAO_0000218,,,,A,11510,10116.0,50597,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,1,N,13976,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627609,,BAO_0000218,,,,A,11510,10116.0,50597,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,1,N,13977,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627610,,BAO_0000218,,,,A,11510,10116.0,50597,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,1,N,13978,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627611,,BAO_0000218,,,,A,11510,10116.0,50597,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,1,N,13979,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627612,,BAO_0000218,,,,A,11510,10116.0,50597,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,1,N,13980,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627613,,BAO_0000100,,,,P,8362,,22229,Octanol:water partition coefficient is evaluated,1,U,13981,,,,0,,Autocuration
,,,CHEMBL627614,,BAO_0000100,,,,P,8257,,22224,Partition coefficient in 1-octanol/water system,1,U,13982,,,,0,,Autocuration
,,,CHEMBL627615,,BAO_0000100,,,,P,8257,,22224,Partition coefficient in 1-octanol/water system measured using radio active compounds,1,U,13983,,,,0,,Autocuration
,,,CHEMBL627616,,BAO_0000100,,,,P,9468,,22224,Partition coefficient in octanol/water system was determined,1,U,13984,,,,0,,Autocuration
,,,CHEMBL627617,,BAO_0000100,,,,P,9468,,22224,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,1,U,13985,,,,0,,Autocuration
,,,CHEMBL627618,,BAO_0000019,,,,A,10568,,22224,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,1,U,13986,,,,0,,Autocuration
,,,CHEMBL627619,,BAO_0000019,,,,A,10568,,22224,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",1,U,13987,,,,0,,Autocuration
,,,CHEMBL627620,,BAO_0000019,,,,A,15359,,22224,Pseudo-first-order rate constant of the compound,1,U,13988,,,,0,,Autocuration
,,,CHEMBL627621,,BAO_0000019,,,,A,15359,,22224,Pseudo-first-order rate constant with 1-min time point,1,U,13989,,,,0,,Autocuration
,,,CHEMBL627622,,BAO_0000019,,,,A,15359,,22224,Pseudo-first-order rate constant without 1-min time point,1,U,13990,,,,0,,Autocuration
,,,CHEMBL627623,,BAO_0000019,,,,A,10431,,22224,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,1,U,13991,,,,0,,Autocuration
,,,CHEMBL627624,,BAO_0000019,,,,A,10431,,22224,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,1,U,13992,,,,0,,Autocuration
,,,CHEMBL627625,,BAO_0000019,,,,A,10431,,22224,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,1,U,13993,,,,0,,Autocuration
,,,CHEMBL628523,,BAO_0000019,,,,A,15704,,22224,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,1,U,13994,,,,0,,Autocuration
,,,CHEMBL628524,,BAO_0000019,,,,A,15287,,22224,The alkaline hydrolysis second order rate constant(K OH) of the compound,1,U,13995,,,,0,,Autocuration
,,,CHEMBL628525,,BAO_0000019,,,,A,7516,,22224,The efflux rate constant of the compound,1,U,13996,,,,0,,Autocuration
,,,CHEMBL625732,,BAO_0000019,,,,A,12973,,22224,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,1,U,13997,,,,0,,Autocuration
,,,CHEMBL625733,,BAO_0000019,,,,A,12973,,22224,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,1,U,13998,,,,0,,Autocuration
,,,CHEMBL625734,,BAO_0000019,,,,F,12973,,22224,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,1,U,13999,,,,0,,Autocuration
,,,CHEMBL625913,,BAO_0000019,,,,A,12973,,22224,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,1,U,14000,,,,0,,Autocuration
,,,CHEMBL625914,,BAO_0000019,,,,A,8696,,22224,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,1,U,14001,,,,0,,Autocuration
,,,CHEMBL625915,,BAO_0000019,,,,A,15052,,22224,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,1,U,14002,,,,0,,Autocuration
,,,CHEMBL625916,,BAO_0000019,,,,A,15052,,22224,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,1,U,14003,,,,0,,Autocuration
,,,CHEMBL625917,,BAO_0000019,,,,A,10503,,22224,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),1,U,14004,,,,0,,Autocuration
,,,CHEMBL625918,,BAO_0000019,,,,A,8354,,22224,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,U,14005,,,,0,,Autocuration
,,,CHEMBL625919,,BAO_0000019,,,,A,8354,,22224,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,U,14006,,,,0,,Autocuration
,,,CHEMBL625920,,BAO_0000019,,,,A,8354,,22224,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,U,14007,,,,0,,Autocuration
,,,CHEMBL874453,,BAO_0000019,,,,A,8354,,22224,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,U,14008,,,,0,,Autocuration
,,,CHEMBL625921,,BAO_0000019,,,,A,8354,,22224,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",1,U,14009,,,,0,,Autocuration
,,,CHEMBL625922,,BAO_0000019,,,,A,10503,,22224,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,1,U,14010,,,,0,,Autocuration
,,,CHEMBL625923,,BAO_0000019,,,,A,8354,,22224,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,U,14011,,,,0,,Autocuration
,,,CHEMBL625924,,BAO_0000019,,,,A,8354,,22224,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,U,14012,,,,0,,Autocuration
,,,CHEMBL625925,,BAO_0000019,,,,A,8354,,22224,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,U,14013,,,,0,,Autocuration
,,,CHEMBL625926,,BAO_0000019,,,,A,8354,,22224,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,U,14014,,,,0,,Autocuration
,,,CHEMBL627704,2048.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat lung at 60 minutes after dose administration.,1,N,14015,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL627705,,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,1,N,14016,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627706,,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,1,N,14017,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627707,,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,1,N,14018,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627708,,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,1,N,14019,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628361,,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,1,N,14020,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628362,,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,1,N,14021,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628363,2435.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat striatum at 120 minutes after dose administration.,1,N,14022,In vivo,Rattus norvegicus,Striatum,1,,Intermediate
,,,CHEMBL628364,2435.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat striatum at 1440 minutes after dose administration.,1,N,14023,In vivo,Rattus norvegicus,Striatum,1,,Intermediate
,,,CHEMBL628365,2435.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat striatum at 15 minutes after dose administration.,1,N,14024,In vivo,Rattus norvegicus,Striatum,1,,Intermediate
,,,CHEMBL874454,2435.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat striatum at 240 minutes after dose administration.,1,N,14025,In vivo,Rattus norvegicus,Striatum,1,,Intermediate
,,,CHEMBL628531,2435.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat striatum at 30 minutes after dose administration.,1,N,14026,In vivo,Rattus norvegicus,Striatum,1,,Intermediate
,,,CHEMBL628532,2435.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat striatum at 360 minutes after dose administration.,1,N,14027,In vivo,Rattus norvegicus,Striatum,1,,Intermediate
,,,CHEMBL628533,2435.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat striatum at 3 hr after dose administration.,1,N,14028,In vivo,Rattus norvegicus,Striatum,1,,Intermediate
,,,CHEMBL628534,2435.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat striatum at 60 minutes after dose administration.,1,N,14029,In vivo,Rattus norvegicus,Striatum,1,,Intermediate
,,,CHEMBL628535,2046.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat thyroid at 120 minutes after dose administration.,1,N,14030,In vivo,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL628536,2046.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat thyroid at 1440 minutes after dose administration.,1,N,14031,In vivo,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL628537,2046.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat thyroid at 15 minutes after dose administration.,1,N,14032,In vivo,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL628538,2046.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat thyroid at 240 minutes after dose administration.,1,N,14033,In vivo,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL628539,2046.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat thyroid at 30 minutes after dose administration.,1,N,14034,In vivo,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL630297,2046.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat thyroid at 360 minutes after dose administration.,1,N,14035,In vivo,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL630298,2046.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rat thyroid at 60 minutes after dose administration.,1,N,14036,In vivo,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL630299,955.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rest of brain of rat 120 minutes after dose administration.,1,N,14037,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL628094,955.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,1,N,14038,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL628095,955.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,1,N,14039,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL874648,955.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,1,N,14040,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL628096,955.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,1,N,14041,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL628097,955.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,1,N,14042,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL628098,955.0,BAO_0000218,,,,A,13100,10116.0,50597,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,1,N,14043,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL628099,,BAO_0000019,,,,A,13331,,22224,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",1,U,14044,,,,0,,Autocuration
,,,CHEMBL628100,,BAO_0000019,,,,A,13331,,22224,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",1,U,14045,,,,0,,Autocuration
,,,CHEMBL628101,,BAO_0000019,,,,A,13331,,22224,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),1,U,14046,,,,0,,Autocuration
,,,CHEMBL628102,,BAO_0000019,,,,A,13331,,22224,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",1,U,14047,,,,0,,Autocuration
,,,CHEMBL628103,,BAO_0000019,,,,A,13331,,22224,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",1,U,14048,,,,0,,Autocuration
,,,CHEMBL628104,,BAO_0000019,,,,A,13331,,22224,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",1,U,14049,,,,0,,Autocuration
,,,CHEMBL628105,,BAO_0000019,,,,A,13331,,22224,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",1,U,14050,,,,0,,Autocuration
,,,CHEMBL628106,,BAO_0000019,,,,A,13331,,22224,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",1,U,14051,,,,0,,Autocuration
,,,CHEMBL628107,1088.0,BAO_0000218,,,,A,10086,10116.0,50597,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,1,N,14052,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628108,1088.0,BAO_0000218,,,,F,10086,,22224,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,1,U,14053,,,Urine,0,,Autocuration
,,,CHEMBL628109,1088.0,BAO_0000218,,,,A,10086,10116.0,50597,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,1,N,14054,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL625299,1088.0,BAO_0000218,,,,F,10086,,22224,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,1,U,14055,,,Urine,0,,Autocuration
,,,CHEMBL625300,1088.0,BAO_0000218,,,,A,10086,10116.0,50597,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,1,N,14056,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL625301,1088.0,BAO_0000218,,,,A,10086,10116.0,50597,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,1,N,14057,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL625302,1088.0,BAO_0000218,,,,A,10086,10116.0,50597,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,1,N,14058,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL874649,1088.0,BAO_0000218,,,,A,10086,10116.0,50597,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,1,N,14059,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL625303,,BAO_0000218,,,,A,13248,10116.0,50597,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,1,N,14060,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625463,,BAO_0000218,,,,A,13248,10116.0,50597,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,1,N,14061,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625464,2107.0,BAO_0000218,,,,A,14527,9606.0,50587,In vitro metabolism in human liver microsomes,1,N,14062,,Homo sapiens,Liver,1,,Intermediate
,,,CHEMBL625465,,BAO_0000218,,,,A,3008,9606.0,50587,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,1,N,14063,,Homo sapiens,,1,,Intermediate
,,,CHEMBL625466,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,1,N,14064,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL625467,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,1,N,14065,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL625468,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,1,N,14066,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL625469,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,1,N,14067,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL625470,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,1,N,14068,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL632418,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,1,N,14069,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL627250,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,1,N,14070,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL627251,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,1,N,14071,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL627252,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,1,N,14072,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL627253,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,1,N,14073,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL627254,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,1,N,14074,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL875471,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,1,N,14075,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL627255,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,1,N,14076,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL627256,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,1,N,14077,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL627257,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,1,N,14078,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL627258,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,1,N,14079,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL627259,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,1,N,14080,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL627260,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,1,N,14081,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL623256,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,1,N,14082,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL874413,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,1,N,14083,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL623257,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,1,N,14084,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL623258,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,1,N,14085,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL623259,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,1,N,14086,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL623260,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,1,N,14087,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL623261,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,1,N,14088,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL623262,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,1,N,14089,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL623263,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,1,N,14090,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL623264,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,1,N,14091,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL623265,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,1,N,14092,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL623266,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,1,N,14093,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL623267,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,1,N,14094,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL623268,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,1,N,14095,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL623269,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,1,N,14096,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL623270,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,1,N,14097,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL623271,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,1,N,14098,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL623272,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,1,N,14099,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL623273,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,1,N,14100,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL623274,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,1,N,14101,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL874414,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,1,N,14102,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL623275,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,1,N,14103,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL629150,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,1,N,14104,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL623276,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,1,N,14105,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL623277,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,1,N,14106,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL623112,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,1,N,14107,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL623113,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,1,N,14108,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL623800,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,1,N,14109,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL623801,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,1,N,14110,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL623802,2106.0,BAO_0000218,,,,A,12017,10116.0,50597,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",1,N,14111,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL623803,995.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14112,In vivo,Rattus norvegicus,Uterus,1,,Intermediate
,,,CHEMBL623970,995.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14113,In vivo,Rattus norvegicus,Uterus,1,,Intermediate
,,,CHEMBL623971,995.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14114,In vivo,Rattus norvegicus,Uterus,1,,Intermediate
,,,CHEMBL623972,178.0,BAO_0000218,,,,A,14045,10116.0,50597,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),1,N,14115,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL623973,178.0,BAO_0000218,,,,A,14045,10116.0,50597,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),1,N,14116,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL623974,178.0,BAO_0000218,,,,A,14045,10116.0,50597,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),1,N,14117,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL623975,178.0,BAO_0000218,,,,A,14045,10116.0,50597,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),1,N,14118,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL623976,955.0,BAO_0000218,,,,A,14045,10116.0,50597,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),1,N,14119,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL623977,955.0,BAO_0000218,,,,A,14045,10116.0,50597,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),1,N,14120,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL623978,955.0,BAO_0000218,,,,A,14045,10116.0,50597,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),1,N,14121,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL623979,955.0,BAO_0000218,,,,A,14045,10116.0,50597,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),1,N,14122,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL623980,,BAO_0000218,,,,A,14045,10116.0,50597,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),1,N,14123,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL623981,,BAO_0000218,,,,A,14045,10116.0,50597,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),1,N,14124,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626278,,BAO_0000218,,,,A,14045,10116.0,50597,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),1,N,14125,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626279,,BAO_0000218,,,,A,14045,10116.0,50597,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),1,N,14126,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626280,,BAO_0000218,,,,A,14045,10090.0,50594,Biodistribution in mice bladder plus excreted urine was determined,1,N,14127,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL626281,,BAO_0000218,,,,A,14045,10090.0,50594,"Percentage biodistribution in mouse blood, 10 minutes post injection",1,N,14128,,Mus musculus,,1,,Intermediate
,,,CHEMBL626282,,BAO_0000218,,,,A,14045,10090.0,50594,"Percentage biodistribution in mouse blood, 30 minutes post injection",1,N,14129,,Mus musculus,,1,,Intermediate
,,,CHEMBL626283,,BAO_0000218,,,,A,14045,10090.0,50594,"Percentage biodistribution in mouse blood, 5 minutes post injection",1,N,14130,,Mus musculus,,1,,Intermediate
,,,CHEMBL626284,,BAO_0000218,,,,A,14045,10090.0,50594,"Percentage biodistribution in mouse blood, 60 minutes post injection",1,N,14131,,Mus musculus,,1,,Intermediate
,,,CHEMBL626285,955.0,BAO_0000218,,,,A,14045,10090.0,50594,"Percentage biodistribution in mouse brain, 10 minutes post injection",1,N,14132,,Mus musculus,Brain,1,,Intermediate
,,,CHEMBL626286,955.0,BAO_0000218,,,,A,14045,10090.0,50594,"Percentage biodistribution in mouse brain, 30 minutes post injection",1,N,14133,,Mus musculus,Brain,1,,Intermediate
,,,CHEMBL626287,955.0,BAO_0000218,,,,A,14045,10090.0,50594,"Percentage biodistribution in mouse brain, 5 minutes post injection",1,N,14134,,Mus musculus,Brain,1,,Intermediate
,,,CHEMBL626288,955.0,BAO_0000218,,,,A,14045,10090.0,50594,"Percentage biodistribution in mouse brain, 60 minutes post injection",1,N,14135,,Mus musculus,Brain,1,,Intermediate
,,,CHEMBL626289,,BAO_0000218,,,,A,14045,10090.0,50594,"Percentage biodistribution in mouse heart, 10 minutes post injection",1,N,14136,,Mus musculus,,1,,Intermediate
,,,CHEMBL626290,,BAO_0000218,,,,A,14045,10090.0,50594,"Percentage biodistribution in mouse heart, 30 minutes post injection",1,N,14137,,Mus musculus,,1,,Intermediate
,,,CHEMBL626291,,BAO_0000218,,,,A,14045,10090.0,50594,"Percentage biodistribution in mouse heart, 5 minutes post injection",1,N,14138,,Mus musculus,,1,,Intermediate
,,,CHEMBL839888,,BAO_0000218,,,,A,14045,10090.0,50594,"Percentage biodistribution in mouse heart, 60 minutes post injection",1,N,14139,,Mus musculus,,1,,Intermediate
,,,CHEMBL626292,160.0,BAO_0000218,,,,A,14045,10090.0,50594,"Percentage biodistribution in mouse intestine, 10 minutes post injection",1,N,14140,,Mus musculus,Intestine,1,,Intermediate
,,,CHEMBL626293,160.0,BAO_0000218,,,,A,14045,10090.0,50594,"Percentage biodistribution in mouse intestine, 30 minutes post injection",1,N,14141,,Mus musculus,Intestine,1,,Intermediate
,,,CHEMBL626294,160.0,BAO_0000218,,,,A,14045,10090.0,50594,"Percentage biodistribution in mouse intestine, 5 minutes post injection",1,N,14142,,Mus musculus,Intestine,1,,Intermediate
,,,CHEMBL626295,160.0,BAO_0000218,,,,A,14045,10090.0,50594,"Percentage biodistribution in mouse intestine, 60 minutes post injection",1,N,14143,,Mus musculus,Intestine,1,,Intermediate
,,,CHEMBL627659,2107.0,BAO_0000218,,,,A,14045,10090.0,50594,"Percentage biodistribution in mouse liver, 10 minutes post injection",1,N,14144,,Mus musculus,Liver,1,,Intermediate
,,,CHEMBL627660,2107.0,BAO_0000218,,,,A,14045,10090.0,50594,"Percentage biodistribution in mouse liver, 30 minutes of post injection",1,N,14145,,Mus musculus,Liver,1,,Intermediate
,,,CHEMBL627661,2107.0,BAO_0000218,,,,A,14045,10090.0,50594,"Percentage biodistribution in mouse liver, 5 minutes post injection",1,N,14146,,Mus musculus,Liver,1,,Intermediate
,,,CHEMBL627662,2107.0,BAO_0000218,,,,A,14045,10090.0,50594,Biodistribution in mice liver at 60 minutes of post injection,1,N,14147,In vivo,Mus musculus,Liver,1,,Intermediate
,,,CHEMBL627663,2048.0,BAO_0000218,,,,A,14045,10090.0,50594,Biodistribution in mice lungs at 10 min of post injection,1,N,14148,In vivo,Mus musculus,Lung,1,,Intermediate
,,,CHEMBL627664,,BAO_0000218,,,,A,14045,10090.0,50594,"Percentage biodistribution in mouse lung, 30 minutes post injection",1,N,14149,,Mus musculus,,1,,Intermediate
,,,CHEMBL627665,,BAO_0000218,,,,A,14045,10090.0,50594,"Percentage biodistribution in mousee lung, 5 minutes post injection",1,N,14150,,Mus musculus,,1,,Intermediate
,,,CHEMBL627666,2048.0,BAO_0000218,,,,A,14045,10090.0,50594,Biodistribution in mice lungs at 60 min of post injection,1,N,14151,In vivo,Mus musculus,Lung,1,,Intermediate
,,,CHEMBL627667,2106.0,BAO_0000218,,,,A,14045,10090.0,50594,Percentage biodistribution in mouse spleen,1,N,14152,,Mus musculus,Spleen,1,,Intermediate
,,,CHEMBL627668,945.0,BAO_0000218,,,,A,14045,10090.0,50594,Percentage biodistribution in mouse stomach,1,N,14153,,Mus musculus,Stomach,1,,Intermediate
,,,CHEMBL627669,1088.0,BAO_0000218,,,,A,11745,10090.0,50594,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,1,N,14154,,Mus musculus,Urine,1,,Intermediate
,,,CHEMBL627670,1255.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,1,U,14155,In vivo,,Urinary bladder,0,,Autocuration
,,,CHEMBL627671,178.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,1,U,14156,In vivo,,Blood,0,,Autocuration
,,,CHEMBL627672,1474.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,1,U,14157,In vivo,,Bone element,0,,Autocuration
,,,CHEMBL627673,,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,1,U,14158,In vivo,,,0,,Autocuration
,,,CHEMBL627674,2113.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,1,U,14159,In vivo,,Kidney,0,,Autocuration
,,,CHEMBL627675,2107.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,1,U,14160,In vivo,,Liver,0,,Autocuration
,,,CHEMBL627676,2048.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,1,U,14161,In vivo,,Lung,0,,Autocuration
,,,CHEMBL627677,2385.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,1,U,14162,In vivo,,Muscle tissue,0,,Autocuration
,,,CHEMBL627678,,BAO_0000019,,,,A,8354,,22224,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",1,U,14163,,,,0,,Autocuration
,,,CHEMBL627679,1977.0,BAO_0000218,,,,A,7095,10116.0,50597,Affinity for protein binding expressed as association constant in fresh rat serum,1,N,14164,,Rattus norvegicus,Serum,1,,Intermediate
,,,CHEMBL627680,,BAO_0000019,,,,A,12185,,22224,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,1,U,14165,,,,0,,Autocuration
,,,CHEMBL627681,,BAO_0000019,,,,A,12185,,22224,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,1,U,14166,,,,0,,Autocuration
,,,CHEMBL627682,,BAO_0000019,,,,A,12185,,22224,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,1,U,14167,,,,0,,Autocuration
,,,CHEMBL627683,,BAO_0000019,,,,A,12185,,22224,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,1,U,14168,,,,0,,Autocuration
,,,CHEMBL627684,,BAO_0000019,,,,A,12686,,22224,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,1,U,14169,,,,0,,Autocuration
,,,CHEMBL874441,,BAO_0000019,,,,A,12686,,22224,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",1,U,14170,,,,0,,Autocuration
,,,CHEMBL627685,,BAO_0000019,,,,A,12686,,22224,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,1,U,14171,,,,0,,Autocuration
,,,CHEMBL627686,,BAO_0000019,,,,A,12686,,22224,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",1,U,14172,,,,0,,Autocuration
,,,CHEMBL627687,,BAO_0000019,,,,A,8057,,22224,Apparent rate constant Koff for inactivation of dTMP synthase.,1,U,14173,,,,0,,Autocuration
,,,CHEMBL627688,,BAO_0000019,,,,A,15778,,22224,The irreversible inhibitor activity by second order rate equation.,1,U,14174,,,,0,,Autocuration
,,,CHEMBL628038,,BAO_0000218,,,,A,12375,10116.0,50597,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,1,N,14175,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628039,,BAO_0000218,,,,A,12375,10116.0,50597,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,1,N,14176,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628040,,BAO_0000218,,,,A,12375,10116.0,50597,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,1,N,14177,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628041,,BAO_0000019,,,,A,13588,,22224,Dissociation rate calculated from the first-order equation using t1/2 value,1,U,14178,,,,0,,Autocuration
,,,CHEMBL630226,,BAO_0000019,,,,A,15039,,22224,The compound was tested for Binding constant against DNA,1,U,14179,,,,0,,Autocuration
,,,CHEMBL628042,,BAO_0000019,,,,A,9500,,22224,First order rate constant for cyclization of the compound,1,U,14180,,,,0,,Autocuration
,,,CHEMBL625232,,BAO_0000019,,,,A,10014,,22224,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,1,U,14181,,,,0,,Autocuration
,,,CHEMBL625233,,BAO_0000019,,,,A,10014,,22224,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,1,U,14182,,,,0,,Autocuration
,,,CHEMBL625979,,BAO_0000019,,,,A,568,,22224,Hydrolysis rate constant was determined,1,U,14183,,,,0,,Autocuration
,,,CHEMBL625980,,BAO_0000019,,,,A,10026,,22224,Observed first order rate constant,1,U,14184,,,,0,,Autocuration
,,,CHEMBL625981,,BAO_0000019,,,,A,10281,,22224,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,1,U,14185,,,,0,,Autocuration
,,,CHEMBL625982,,BAO_0000019,,,,A,10281,,22224,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,1,U,14186,,,,0,,Autocuration
,,,CHEMBL625983,,BAO_0000019,,,,A,9680,,22224,Second-order rate constant for attack on PNPA at 25 degree Centigrade,1,U,14187,,,,0,,Autocuration
,,,CHEMBL625984,,BAO_0000019,,,,A,13028,,22224,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,1,U,14188,,,,0,,Autocuration
,,,CHEMBL625985,,BAO_0000019,,,,A,13028,,22224,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,1,U,14189,,,,0,,Autocuration
,,,CHEMBL625986,,BAO_0000019,,,,A,13028,,22224,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,1,U,14190,,,,0,,Autocuration
,,,CHEMBL625987,,BAO_0000019,,,,A,13028,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,U,14191,,,,0,,Autocuration
,,,CHEMBL625988,,BAO_0000019,,,,A,13028,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,U,14192,,,,0,,Autocuration
,,,CHEMBL625989,,BAO_0000019,,,,A,13028,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,U,14193,,,,0,,Autocuration
,,,CHEMBL625990,,BAO_0000019,,,,A,13028,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,U,14194,,,,0,,Autocuration
,,,CHEMBL625991,,BAO_0000019,,,,A,13028,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,U,14195,,,,0,,Autocuration
,,,CHEMBL625992,,BAO_0000019,,,,A,13028,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,U,14196,,,,0,,Autocuration
,,,CHEMBL625993,,BAO_0000019,,,,A,13028,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,U,14197,,,,0,,Autocuration
,,,CHEMBL631973,,BAO_0000019,,,,A,13028,,22224,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,1,U,14198,,,,0,,Autocuration
,,,CHEMBL632143,,BAO_0000019,,,,A,13028,,22224,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,1,U,14199,,,,0,,Autocuration
,,,CHEMBL632144,,BAO_0000019,,,,A,13028,,22224,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,1,U,14200,,,,0,,Autocuration
,,,CHEMBL632145,,BAO_0000019,,,,A,13028,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,U,14201,,,,0,,Autocuration
,,,CHEMBL632146,,BAO_0000019,,,,A,13028,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,U,14202,,,,0,,Autocuration
,,,CHEMBL632147,,BAO_0000019,,,,A,13028,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,U,14203,,,,0,,Autocuration
,,,CHEMBL632148,,BAO_0000019,,,,A,13028,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,U,14204,,,,0,,Autocuration
,,,CHEMBL632149,,BAO_0000019,,,,A,13028,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,U,14205,,,,0,,Autocuration
,,,CHEMBL632150,,BAO_0000019,,,,A,13028,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,U,14206,,,,0,,Autocuration
,,,CHEMBL632151,,BAO_0000019,,,,A,13028,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,U,14207,,,,0,,Autocuration
,,,CHEMBL632152,,BAO_0000218,,,,A,3008,9606.0,50587,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,1,N,14208,,Homo sapiens,,1,,Intermediate
,,,CHEMBL632153,,BAO_0000218,,,,A,4509,9606.0,50587,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,1,N,14209,,Homo sapiens,,1,,Intermediate
,,,CHEMBL632154,,BAO_0000218,,,,A,4509,9606.0,50587,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,1,N,14210,,Homo sapiens,,1,,Intermediate
,,,CHEMBL632155,,BAO_0000218,,,,A,8613,10298.0,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,1,N,14211,,Human herpesvirus 1,,1,,Intermediate
,,,CHEMBL632156,,BAO_0000218,,,,A,8613,10298.0,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,1,N,14212,,Human herpesvirus 1,,1,,Intermediate
,,,CHEMBL632157,,BAO_0000218,,,,A,8613,10298.0,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,1,N,14213,,Human herpesvirus 1,,1,,Intermediate
,,,CHEMBL632158,,BAO_0000218,,,,A,8613,10298.0,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,1,N,14214,,Human herpesvirus 1,,1,,Intermediate
,,,CHEMBL632159,,BAO_0000218,,,,A,8613,10298.0,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,1,N,14215,,Human herpesvirus 1,,1,,Intermediate
,,,CHEMBL626305,,BAO_0000218,,,,A,8613,10298.0,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,1,N,14216,,Human herpesvirus 1,,1,,Intermediate
,,,CHEMBL626306,,BAO_0000218,,,,A,8613,10298.0,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,1,N,14217,,Human herpesvirus 1,,1,,Intermediate
,,,CHEMBL626307,,BAO_0000218,,,,A,8613,10298.0,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,1,N,14218,,Human herpesvirus 1,,1,,Intermediate
,,,CHEMBL626308,,BAO_0000218,,,,A,8613,10298.0,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,1,N,14219,,Human herpesvirus 1,,1,,Intermediate
,,,CHEMBL626479,,BAO_0000218,,,,A,8613,10298.0,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,1,N,14220,,Human herpesvirus 1,,1,,Intermediate
,,,CHEMBL626480,,BAO_0000218,,,,A,8613,10298.0,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,1,N,14221,,Human herpesvirus 1,,1,,Intermediate
,,,CHEMBL626481,,BAO_0000100,,,,P,6021,,22229,Calculated partition coefficient (clogP) (MlogP),1,U,14222,,,,0,,Autocuration
,,,CHEMBL626482,,BAO_0000019,,,,A,9348,,22224,Equipotent potent ratio relative to carbachol (nicotinic activity),1,U,14223,,,,0,,Autocuration
,,,CHEMBL626483,,BAO_0000218,,,,A,15592,9615.0,50588,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",1,N,14224,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626484,,BAO_0000218,,,,A,15592,9615.0,50588,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",1,N,14225,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL626485,,BAO_0000100,,,,P,15592,,22229,Solubility at pH 7.4 in micro g/mL;NA denotes available,1,U,14226,,,,0,,Autocuration
,,,CHEMBL626486,,BAO_0000100,,,,P,15592,,22229,Solubility at pH 7.4 in micro g/mL;NA denotes not available,1,U,14227,,,,0,,Autocuration
,,,CHEMBL626487,,BAO_0000100,,,,P,15592,,22229,Solubility at pH 7.4 in ug/mL;NA denotes not available,1,U,14228,,,,0,,Autocuration
,,,CHEMBL626488,1969.0,BAO_0000218,,,,A,15592,9615.0,50588,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,1,N,14229,In vivo,Canis lupus familiaris,Plasma,1,,Intermediate
,,,CHEMBL626489,1977.0,BAO_0000218,,,,A,7095,10116.0,50597,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,1,N,14230,,Rattus norvegicus,Serum,1,,Intermediate
,,,CHEMBL626490,,BAO_0000019,,,,A,16618,,22224,Area under the MAP curve measured over 5 min; ND means Not determined,1,U,14231,,,,0,,Autocuration
,,,CHEMBL626491,,BAO_0000100,,,,P,16835,,22224,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,1,U,14232,,,,0,,Autocuration
,,,CHEMBL626492,,BAO_0000100,,,,P,15284,,22229,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,1,U,14233,,,,0,,Autocuration
,,,CHEMBL626493,,BAO_0000019,,,,A,15750,,22224,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,1,U,14234,,,,0,,Autocuration
,,,CHEMBL626494,,BAO_0000218,,,,A,16618,10116.0,50597,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,1,N,14235,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626495,,BAO_0000218,,,,A,16618,,22224,Half life after oral tested,1,U,14236,In vivo,,,0,,Autocuration
,,,CHEMBL626496,1969.0,BAO_0000218,,,,A,15812,10116.0,50597,Half life was determined in plasma of rat; NT indicates not tested,1,N,14237,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626497,,BAO_0000218,,,,A,16618,10116.0,50597,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,1,N,14238,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626498,,BAO_0000218,,,,A,16618,,22224,Oral bioavailability after oral tested,1,U,14239,In vivo,,,0,,Autocuration
,,,CHEMBL626499,,BAO_0000218,,,,A,13098,10116.0,50597,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),1,N,14240,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626500,,BAO_0000218,,,,A,13098,10116.0,50597,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),1,N,14241,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626501,1969.0,BAO_0000218,,,,A,15812,10116.0,50597,half life was determined in plasma of rat; NT indicates not tested,1,N,14242,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626502,1969.0,BAO_0000218,,,,A,15812,10116.0,50597,half life was determined in plasma of rat; NT means not tested,1,N,14243,,Rattus norvegicus,Plasma,1,,Intermediate
,,,CHEMBL626503,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,1,N,14244,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626504,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats (Control/Drug treatment value); inactive,1,N,14245,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626505,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,1,N,14246,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626506,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,1,N,14247,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626507,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,1,N,14248,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626508,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,1,N,14249,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626509,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,1,N,14250,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL875480,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,1,N,14251,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626510,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,1,N,14252,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626511,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,1,N,14253,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626512,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,1,N,14254,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628208,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,1,N,14255,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628209,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,1,N,14256,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628210,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,1,N,14257,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628211,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,1,N,14258,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628212,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,1,N,14259,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628213,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,1,N,14260,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628214,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,1,N,14261,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628215,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,1,N,14262,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628216,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,1,N,14263,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL626595,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,1,N,14264,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL626596,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,1,N,14265,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL626597,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,1,N,14266,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL626598,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,1,N,14267,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL622242,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,1,N,14268,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL622243,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,1,N,14269,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL622244,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,1,N,14270,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL622245,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,1,N,14271,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL622246,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,1,N,14272,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL622247,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,1,N,14273,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL622248,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,1,N,14274,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL877483,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,1,N,14275,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL622249,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,1,N,14276,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL622250,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,1,N,14277,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL622251,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,1,N,14278,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL622252,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,1,N,14279,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL622253,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,1,N,14280,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL622254,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,1,N,14281,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL622255,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,1,N,14282,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL622256,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,1,N,14283,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL622257,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,1,N,14284,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL622258,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,1,N,14285,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL622259,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,1,N,14286,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL622927,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,1,N,14287,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL622928,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,1,N,14288,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL622929,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,1,N,14289,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL623182,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,1,N,14290,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL623183,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,1,N,14291,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL623184,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,1,N,14292,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL623185,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,1,N,14293,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL877484,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,1,N,14294,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL627274,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,1,N,14295,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL623186,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,1,N,14296,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL623187,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,1,N,14297,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL623188,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,1,N,14298,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628055,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,1,N,14299,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628056,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,1,N,14300,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628200,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,1,N,14301,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628201,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,1,N,14302,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628202,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,1,N,14303,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628203,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,1,N,14304,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628204,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,1,N,14305,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628205,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,1,N,14306,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628206,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,1,N,14307,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628207,2367.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),1,U,14308,In vivo,,Prostate gland,0,,Autocuration
,,,CHEMBL627220,2367.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,1,U,14309,In vivo,,Prostate gland,0,,Autocuration
,,,CHEMBL627221,2385.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,1,U,14310,In vivo,,Muscle tissue,0,,Autocuration
,,,CHEMBL627222,2367.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),1,U,14311,In vivo,,Prostate gland,0,,Autocuration
,,,CHEMBL627223,,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,1,U,14312,In vivo,,,0,,Autocuration
,,,CHEMBL632062,2385.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,1,U,14313,In vivo,,Muscle tissue,0,,Autocuration
,,,CHEMBL632063,2106.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,1,U,14314,In vivo,,Spleen,0,,Autocuration
,,,CHEMBL632064,1255.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,1,U,14315,In vivo,,Urinary bladder,0,,Autocuration
,,,CHEMBL632065,178.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,1,U,14316,In vivo,,Blood,0,,Autocuration
,,,CHEMBL632066,1474.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,1,U,14317,In vivo,,Bone element,0,,Autocuration
,,,CHEMBL632067,,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,1,U,14318,In vivo,,,0,,Autocuration
,,,CHEMBL629188,2113.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,1,U,14319,In vivo,,Kidney,0,,Autocuration
,,,CHEMBL629189,2107.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,1,U,14320,In vivo,,Liver,0,,Autocuration
,,,CHEMBL629190,2048.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,1,U,14321,In vivo,,Lung,0,,Autocuration
,,,CHEMBL629191,2385.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,1,U,14322,In vivo,,Muscle tissue,0,,Autocuration
,,,CHEMBL629192,2367.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),1,U,14323,In vivo,,Prostate gland,0,,Autocuration
,,,CHEMBL629193,2385.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,1,U,14324,In vivo,,Muscle tissue,0,,Autocuration
,,,CHEMBL629194,2367.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),1,U,14325,In vivo,,Prostate gland,0,,Autocuration
,,,CHEMBL629195,,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,1,U,14326,In vivo,,,0,,Autocuration
,,,CHEMBL629373,2385.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,1,U,14327,In vivo,,Muscle tissue,0,,Autocuration
,,,CHEMBL629374,2106.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,1,U,14328,In vivo,,Spleen,0,,Autocuration
,,,CHEMBL629375,2367.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,1,U,14329,In vivo,,Prostate gland,0,,Autocuration
,,,CHEMBL629376,1255.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,1,U,14330,In vivo,,Urinary bladder,0,,Autocuration
,,,CHEMBL629377,178.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,1,U,14331,In vivo,,Blood,0,,Autocuration
,,,CHEMBL629378,1474.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,1,U,14332,In vivo,,Bone element,0,,Autocuration
,,,CHEMBL629379,,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,1,U,14333,In vivo,,,0,,Autocuration
,,,CHEMBL629151,2113.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,1,U,14334,In vivo,,Kidney,0,,Autocuration
,,,CHEMBL629152,2107.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,1,U,14335,In vivo,,Liver,0,,Autocuration
,,,CHEMBL629153,2048.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,1,U,14336,In vivo,,Lung,0,,Autocuration
,,,CHEMBL629154,2385.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,1,U,14337,In vivo,,Muscle tissue,0,,Autocuration
,,,CHEMBL629155,2367.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),1,U,14338,In vivo,,Prostate gland,0,,Autocuration
,,,CHEMBL629156,2367.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,1,U,14339,In vivo,,Prostate gland,0,,Autocuration
,,,CHEMBL629157,2385.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,1,U,14340,In vivo,,Muscle tissue,0,,Autocuration
,,,CHEMBL629158,2367.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),1,U,14341,In vivo,,Prostate gland,0,,Autocuration
,,,CHEMBL629159,,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,1,U,14342,In vivo,,,0,,Autocuration
,,,CHEMBL629160,2385.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,1,U,14343,In vivo,,Muscle tissue,0,,Autocuration
,,,CHEMBL629161,2106.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,1,U,14344,In vivo,,Spleen,0,,Autocuration
,,,CHEMBL629162,1255.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,1,U,14345,In vivo,,Urinary bladder,0,,Autocuration
,,,CHEMBL629163,178.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,1,U,14346,In vivo,,Blood,0,,Autocuration
,,,CHEMBL629164,1474.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,1,U,14347,In vivo,,Bone element,0,,Autocuration
,,,CHEMBL629165,,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,1,U,14348,In vivo,,,0,,Autocuration
,,,CHEMBL629166,2107.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,1,U,14349,In vivo,,Liver,0,,Autocuration
,,,CHEMBL629167,2048.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,1,U,14350,In vivo,,Lung,0,,Autocuration
,,,CHEMBL629168,2385.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,1,U,14351,In vivo,,Muscle tissue,0,,Autocuration
,,,CHEMBL629169,,BAO_0000019,,,,A,2193,,22224,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,1,U,14352,,,,0,,Autocuration
,,,CHEMBL629170,,BAO_0000019,,,,A,2193,,22224,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,1,U,14353,,,,0,,Autocuration
,,,CHEMBL631153,,BAO_0000019,,,,A,2193,,22224,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,1,U,14354,,,,0,,Autocuration
,,,CHEMBL875121,,BAO_0000019,,,,A,2193,,22224,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,1,U,14355,,,,0,,Autocuration
,,,CHEMBL631154,,BAO_0000019,,,,A,2193,,22224,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,1,U,14356,,,,0,,Autocuration
,,,CHEMBL631155,,BAO_0000019,,,,A,2193,,22224,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,1,U,14357,,,,0,,Autocuration
,,,CHEMBL631156,,BAO_0000019,,,,A,568,,22224,Hydrolysis rate constant was determined,1,U,14358,,,,0,,Autocuration
,,,CHEMBL631157,,BAO_0000019,,,,A,9680,,22224,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",1,U,14359,,,,0,,Autocuration
,,,CHEMBL631158,,BAO_0000019,,,,A,9680,,22224,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",1,U,14360,,,,0,,Autocuration
,,,CHEMBL631159,,BAO_0000019,,,,A,9680,,22224,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",1,U,14361,,,,0,,Autocuration
,,,CHEMBL631160,,BAO_0000019,,,,A,10026,,22224,Observed second order rate constant,1,U,14362,,,,0,,Autocuration
,,,CHEMBL631161,,BAO_0000019,,,,A,10281,,22224,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,1,U,14363,,,,0,,Autocuration
,,,CHEMBL631162,,BAO_0000019,,,,A,10014,,22224,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,1,U,14364,,,,0,,Autocuration
,,,CHEMBL630313,,BAO_0000019,,,,A,10014,,22224,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,1,U,14365,,,,0,,Autocuration
,,,CHEMBL630314,,BAO_0000019,,,,A,9680,,22224,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",1,U,14366,,,,0,,Autocuration
,,,CHEMBL630315,,BAO_0000019,,,,A,9680,,22224,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",1,U,14367,,,,0,,Autocuration
,,,CHEMBL630316,,BAO_0000019,,,,A,13028,,22224,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,1,U,14368,,,,0,,Autocuration
,,,CHEMBL630986,,BAO_0000019,,,,A,13028,,22224,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,1,U,14369,,,,0,,Autocuration
,,,CHEMBL630987,,BAO_0000019,,,,A,13028,,22224,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,1,U,14370,,,,0,,Autocuration
,,,CHEMBL630988,,BAO_0000019,,,,A,13028,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,1,U,14371,,,,0,,Autocuration
,,,CHEMBL630989,,BAO_0000019,,,,A,13028,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,U,14372,,,,0,,Autocuration
,,,CHEMBL630990,,BAO_0000019,,,,A,13028,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,U,14373,,,,0,,Autocuration
,,,CHEMBL630991,,BAO_0000019,,,,A,13028,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,U,14374,,,,0,,Autocuration
,,,CHEMBL630992,,BAO_0000019,,,,A,13028,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,U,14375,,,,0,,Autocuration
,,,CHEMBL630993,,BAO_0000019,,,,A,13028,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,U,14376,,,,0,,Autocuration
,,,CHEMBL630994,,BAO_0000019,,,,A,13028,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,U,14377,,,,0,,Autocuration
,,,CHEMBL630995,,BAO_0000218,,,,A,10014,10116.0,50597,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,1,N,14378,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629252,,BAO_0000019,,,,A,9962,,22224,Association constant for compound at 31 degree C was determined,1,U,14379,,,,0,,Autocuration
,,,CHEMBL629253,,BAO_0000019,,,,A,12029,,22224,Calculated antagonist equilibrium dissociation constant of the compound,1,U,14380,,,,0,,Autocuration
,,,CHEMBL629944,,BAO_0000019,,,,A,12029,,22224,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,1,U,14381,,,,0,,Autocuration
,,,CHEMBL629945,3126.0,BAO_0000218,,,,A,10583,10141.0,50512,Dissociation constants vs LTE4 on guinea pig trachea,1,N,14382,,Cavia porcellus,Trachea,1,,Intermediate
,,,CHEMBL629946,,BAO_0000019,,,,A,568,,22224,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",1,U,14383,,,,0,,Autocuration
,,,CHEMBL629947,,BAO_0000019,,,,A,568,,22224,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",1,U,14384,,,,0,,Autocuration
,,,CHEMBL629948,,BAO_0000019,,,,A,568,,22224,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",1,U,14385,,,,0,,Autocuration
,,,CHEMBL856024,,BAO_0000019,,,,A,568,,22224,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",1,U,14386,,,,0,,Autocuration
,,,CHEMBL629949,,BAO_0000019,,,,A,7493,,22224,Affinity constant KD value was derived from TMP,1,U,14387,,,,0,,Autocuration
,,,CHEMBL629950,,BAO_0000019,,,,A,8371,,22224,Apparent dissociation (binding) rate constant was evaluated,1,U,14388,,,,0,,Autocuration
,,,CHEMBL630127,,BAO_0000100,,,,P,13114,,22224,Dissociation constant (KD) of the compound,1,U,14389,,,,0,,Autocuration
,,,CHEMBL630128,,BAO_0000100,,,,P,15515,,22224,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,1,U,14390,,,,0,,Autocuration
,,,CHEMBL630129,,BAO_0000100,,,,P,522,,22224,Dissociation constant from ESR titration experiments,1,U,14391,,,,0,,Autocuration
,,,CHEMBL630130,,BAO_0000019,,,,,13888,,22224,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),1,U,14392,,,,0,,Autocuration
,,,CHEMBL875234,,BAO_0000100,,,,P,2616,,22224,Dissociation constant was evaluated.,1,U,14393,,,,0,,Autocuration
,,,CHEMBL630131,,BAO_0000100,,,,P,3798,,22224,Dissociation constant was reported,1,U,14394,,,,0,,Autocuration
,,,CHEMBL630132,,BAO_0000218,,,,A,8731,10116.0,50597,Dissociation constant was determined in rat pituitary cells.,1,N,14395,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630133,,BAO_0000019,,,,A,11892,,22224,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,1,U,14396,,,,0,,Autocuration
,,,CHEMBL630134,,BAO_0000019,,,,A,11892,,22224,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,1,U,14397,,,,0,,Autocuration
,,,CHEMBL630135,,BAO_0000019,,,,A,2582,,22224,Equilibrium dissociation constant of the compound,1,U,14398,,,,0,,Autocuration
,,,CHEMBL630136,,BAO_0000019,,,,A,11892,,22224,Equilibrium dissociation constant was determined,1,U,14399,,,,0,,Autocuration
,,,CHEMBL630137,,BAO_0000019,,,,A,13396,,22224,Kinetic constant KD was evaluated,1,U,14400,,,,0,,Autocuration
,,,CHEMBL630138,,BAO_0000019,,,,A,603,,22224,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,1,U,14401,,,,0,,Autocuration
,,,CHEMBL630139,,BAO_0000019,,,,A,15673,,22224,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,1,U,14402,,,,0,,Autocuration
,,,CHEMBL630140,,BAO_0000019,,,,A,10368,,22224,Rate constant for hydrolysis in aqueous acetone.,1,U,14403,,,,0,,Autocuration
,,,CHEMBL875235,,BAO_0000019,,,,A,14228,,22224,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,1,U,14404,,,,0,,Autocuration
,,,CHEMBL876439,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,1,N,14405,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630605,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,1,N,14406,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630606,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,1,N,14407,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630607,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,1,N,14408,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630608,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,1,N,14409,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630609,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,1,N,14410,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630610,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,1,N,14411,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630611,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,1,N,14412,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629552,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,1,N,14413,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629733,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,1,N,14414,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629734,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,1,N,14415,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629735,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,1,N,14416,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629736,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,1,N,14417,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629737,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,1,N,14418,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629738,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,1,N,14419,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629739,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,1,N,14420,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629740,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,1,N,14421,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629741,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,1,N,14422,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629742,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,1,N,14423,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629743,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,1,N,14424,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629744,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,1,N,14425,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629745,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,1,N,14426,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629746,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,1,N,14427,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629747,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,1,N,14428,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629748,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,1,N,14429,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629749,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,1,N,14430,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629750,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,1,N,14431,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629751,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,1,N,14432,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629752,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,1,N,14433,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629753,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,1,N,14434,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629754,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,1,N,14435,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629755,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,1,N,14436,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629756,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,1,N,14437,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629757,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,1,N,14438,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629758,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,1,N,14439,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629759,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,1,N,14440,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629760,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,1,N,14441,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL876443,,BAO_0000218,,,,A,11510,10116.0,50597,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,1,N,14442,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629761,,BAO_0000218,,,,A,8310,9615.0,50588,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,1,N,14443,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL629762,,BAO_0000218,,,,A,8310,9615.0,50588,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,1,N,14444,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL629763,,BAO_0000218,,,,A,8310,10090.0,50594,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,1,N,14445,,Mus musculus,,1,,Intermediate
,,,CHEMBL629764,,BAO_0000218,,,,A,8310,10090.0,50594,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,1,N,14446,,Mus musculus,,1,,Intermediate
,,,CHEMBL629765,,BAO_0000218,,,,A,8310,10090.0,50594,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,1,N,14447,,Mus musculus,,1,,Intermediate
,,,CHEMBL629766,,BAO_0000218,,,,A,8310,10090.0,50594,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,1,N,14448,,Mus musculus,,1,,Intermediate
,,,CHEMBL629767,,BAO_0000218,,,,A,8310,10090.0,50594,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,1,N,14449,,Mus musculus,,1,,Intermediate
,,,CHEMBL629768,,BAO_0000218,,,,A,8310,9615.0,50588,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,1,N,14450,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL629769,,BAO_0000218,,,,A,8310,10090.0,50594,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,1,N,14451,,Mus musculus,,1,,Intermediate
,,,CHEMBL629770,,BAO_0000218,,,,A,8310,9615.0,50588,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,1,N,14452,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL629771,,BAO_0000218,,,,A,8310,9615.0,50588,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,1,N,14453,,Canis lupus familiaris,,1,,Intermediate
,,,CHEMBL629772,,BAO_0000218,,,,A,8310,10090.0,50594,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,1,N,14454,,Mus musculus,,1,,Intermediate
,,,CHEMBL629773,,BAO_0000218,,,,A,8310,10090.0,50594,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,1,N,14455,,Mus musculus,,1,,Intermediate
,,,CHEMBL625455,,BAO_0000218,,,,A,8310,10090.0,50594,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,1,N,14456,,Mus musculus,,1,,Intermediate
,,,CHEMBL625456,,BAO_0000218,,,,A,8310,10090.0,50594,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,1,N,14457,,Mus musculus,,1,,Intermediate
,,,CHEMBL625457,,BAO_0000218,,,,A,8310,10090.0,50594,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,1,N,14458,,Mus musculus,,1,,Intermediate
,,,CHEMBL625458,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,1,N,14459,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL625459,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,1,N,14460,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL875483,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,1,N,14461,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL634779,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,1,N,14462,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL625460,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,1,N,14463,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL626117,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,1,N,14464,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL626118,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,1,N,14465,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628342,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,1,N,14466,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628343,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,1,N,14467,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628344,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,1,N,14468,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628345,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,1,N,14469,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628346,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,1,N,14470,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628347,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,1,N,14471,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628348,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,1,N,14472,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628349,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,1,N,14473,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL875611,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,1,N,14474,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628350,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,1,N,14475,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628351,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,1,N,14476,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628352,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,1,N,14477,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628353,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,1,N,14478,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628354,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,1,N,14479,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL626667,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,1,N,14480,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL626668,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,1,N,14481,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL626669,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,1,N,14482,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL626670,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,1,N,14483,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL626671,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,1,N,14484,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL626672,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,1,N,14485,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL626673,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,1,N,14486,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL626674,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,1,N,14487,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL626675,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,1,N,14488,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL626676,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,1,N,14489,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL626677,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,1,N,14490,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL626678,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,1,N,14491,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL626679,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,1,N,14492,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL875612,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,1,N,14493,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL626680,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,1,N,14494,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL626681,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,1,N,14495,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL626682,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,1,N,14496,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL626683,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,1,N,14497,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL626684,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,1,N,14498,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL626685,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,1,N,14499,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL626686,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,1,N,14500,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL626687,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,1,N,14501,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL624978,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,1,N,14502,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL624979,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,1,N,14503,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL624980,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,1,N,14504,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL624981,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,1,N,14505,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL624982,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,1,N,14506,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL627564,2367.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),1,U,14507,In vivo,,Prostate gland,0,,Autocuration
,,,CHEMBL627565,2367.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),1,U,14508,In vivo,,Prostate gland,0,,Autocuration
,,,CHEMBL627566,,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,1,U,14509,In vivo,,,0,,Autocuration
,,,CHEMBL627567,2385.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,1,U,14510,In vivo,,Muscle tissue,0,,Autocuration
,,,CHEMBL627568,2106.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,1,U,14511,In vivo,,Spleen,0,,Autocuration
,,,CHEMBL627569,2113.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,1,U,14512,In vivo,,Kidney,0,,Autocuration
,,,CHEMBL627570,1255.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,1,U,14513,In vivo,,Urinary bladder,0,,Autocuration
,,,CHEMBL627571,178.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,1,U,14514,In vivo,,Blood,0,,Autocuration
,,,CHEMBL627572,1474.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,1,U,14515,In vivo,,Bone element,0,,Autocuration
,,,CHEMBL627573,,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,1,U,14516,In vivo,,,0,,Autocuration
,,,CHEMBL627574,2113.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,1,U,14517,In vivo,,Kidney,0,,Autocuration
,,,CHEMBL627575,2107.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,1,U,14518,In vivo,,Liver,0,,Autocuration
,,,CHEMBL627576,2048.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,1,U,14519,In vivo,,Lung,0,,Autocuration
,,,CHEMBL627577,2385.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,1,U,14520,In vivo,,Muscle tissue,0,,Autocuration
,,,CHEMBL627578,2367.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),1,U,14521,In vivo,,Prostate gland,0,,Autocuration
,,,CHEMBL627579,2367.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,1,U,14522,In vivo,,Prostate gland,0,,Autocuration
,,,CHEMBL627580,2385.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,1,U,14523,In vivo,,Muscle tissue,0,,Autocuration
,,,CHEMBL627581,2367.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),1,U,14524,In vivo,,Prostate gland,0,,Autocuration
,,,CHEMBL627582,,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,1,U,14525,In vivo,,,0,,Autocuration
,,,CHEMBL627583,2385.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,1,U,14526,In vivo,,Muscle tissue,0,,Autocuration
,,,CHEMBL627584,2106.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,1,U,14527,In vivo,,Spleen,0,,Autocuration
,,,CHEMBL627585,2367.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,1,U,14528,In vivo,,Prostate gland,0,,Autocuration
,,,CHEMBL627586,2385.0,BAO_0000218,,,,A,13257,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,1,U,14529,In vivo,,Muscle tissue,0,,Autocuration
,,,CHEMBL627587,,BAO_0000218,,,,A,15413,10116.0,50597,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,1,N,14530,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL627588,,BAO_0000218,,,,A,15413,10116.0,50597,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,1,N,14531,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628250,,BAO_0000218,,,,A,15413,10116.0,50597,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,1,N,14532,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628251,,BAO_0000218,,,,A,15413,10116.0,50597,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,1,N,14533,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628252,10000000.0,BAO_0000218,,,,A,15413,10116.0,50597,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,1,N,14534,In vivo,Rattus norvegicus,Hippocampus,1,,Intermediate
,,,CHEMBL628253,10000000.0,BAO_0000218,,,,A,15413,10116.0,50597,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,1,N,14535,In vivo,Rattus norvegicus,Hippocampus,1,,Intermediate
,,,CHEMBL628254,1898.0,BAO_0000218,,,,A,15413,10116.0,50597,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,1,N,14536,In vivo,Rattus norvegicus,Hypothalamus,1,,Intermediate
,,,CHEMBL877493,1898.0,BAO_0000218,,,,A,15413,10116.0,50597,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,1,N,14537,In vivo,Rattus norvegicus,Hypothalamus,1,,Intermediate
,,,CHEMBL628255,,BAO_0000218,,,,A,15413,10116.0,50597,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,1,N,14538,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628256,,BAO_0000218,,,,A,15413,10116.0,50597,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,1,N,14539,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628257,10000000.0,BAO_0000218,,,,A,15413,10116.0,50597,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,1,N,14540,In vivo,Rattus norvegicus,Hippocampus,1,,Intermediate
,,,CHEMBL628258,1898.0,BAO_0000218,,,,A,15413,10116.0,50597,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,1,N,14541,In vivo,Rattus norvegicus,Hypothalamus,1,,Intermediate
,,,CHEMBL628259,,BAO_0000218,,,,A,15413,10116.0,50597,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,1,N,14542,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628429,,BAO_0000218,,,,A,15413,10116.0,50597,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,1,N,14543,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL626862,10000000.0,BAO_0000218,,,,A,15413,10116.0,50597,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,1,N,14544,In vivo,Rattus norvegicus,Hippocampus,1,,Intermediate
,,,CHEMBL626863,1898.0,BAO_0000218,,,,A,15413,10116.0,50597,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,1,N,14545,In vivo,Rattus norvegicus,Hypothalamus,1,,Intermediate
,,,CHEMBL625886,2037.0,BAO_0000218,,,,A,15413,10116.0,50597,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,1,N,14546,In vivo,Rattus norvegicus,Cerebellum,1,,Intermediate
,,,CHEMBL625887,2037.0,BAO_0000218,,,,A,15413,10116.0,50597,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,1,N,14547,In vivo,Rattus norvegicus,Cerebellum,1,,Intermediate
,,,CHEMBL625888,,BAO_0000218,,,,A,15413,10116.0,50597,Biodistribution of the [11C]-radiolabeled compound in rat cortex,1,N,14548,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625889,,BAO_0000218,,,,A,15413,10116.0,50597,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,1,N,14549,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625890,10000000.0,BAO_0000218,,,,A,15413,10116.0,50597,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,1,N,14550,In vivo,Rattus norvegicus,Hippocampus,1,,Intermediate
,,,CHEMBL625891,10000000.0,BAO_0000218,,,,A,15413,10116.0,50597,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,1,N,14551,In vivo,Rattus norvegicus,Hippocampus,1,,Intermediate
,,,CHEMBL625892,1898.0,BAO_0000218,,,,A,15413,10116.0,50597,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,1,N,14552,In vivo,Rattus norvegicus,Hypothalamus,1,,Intermediate
,,,CHEMBL625893,1898.0,BAO_0000218,,,,A,15413,10116.0,50597,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,1,N,14553,In vivo,Rattus norvegicus,Hypothalamus,1,,Intermediate
,,,CHEMBL625894,2037.0,BAO_0000218,,,,A,15413,10116.0,50597,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,1,N,14554,In vivo,Rattus norvegicus,Cerebellum,1,,Intermediate
,,,CHEMBL625895,,BAO_0000218,,,,A,15413,10116.0,50597,Biodistribution of the [18F]-radiolabeled compound in rat cortex,1,N,14555,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625896,,BAO_0000019,,,,A,12404,,22224,Reaction rate parameter value for phosphate with transfer with respect to ATP,1,U,14556,,,,0,,Autocuration
,,,CHEMBL625897,,BAO_0000019,,,,A,568,,22224,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",1,U,14557,,,,0,,Autocuration
,,,CHEMBL625898,,BAO_0000019,,,,A,568,,22224,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",1,U,14558,,,,0,,Autocuration
,,,CHEMBL625899,,BAO_0000019,,,,A,568,,22224,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",1,U,14559,,,,0,,Autocuration
,,,CHEMBL626124,,BAO_0000019,,,,A,12404,,22224,Reaction rate parameter value for phosphate with transfer with respect to ATP,1,U,14560,,,,0,,Autocuration
,,,CHEMBL628500,,BAO_0000218,,,,A,7624,562.0,50212,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,1,N,14561,,Escherichia coli,,1,,Intermediate
,,,CHEMBL857856,,BAO_0000218,,,,A,7624,10116.0,50597,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",1,N,14562,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628501,,BAO_0000218,,,,A,7624,10116.0,50597,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",1,N,14563,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628502,,BAO_0000019,,,,A,4643,,22224,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",1,U,14564,,,,0,,Autocuration
,,,CHEMBL628503,,BAO_0000019,,,,A,11532,,22224,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,1,U,14565,,,,0,,Autocuration
,,,CHEMBL628504,,BAO_0000019,,,,A,11018,,22224,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,1,U,14566,,,,0,,Autocuration
,,,CHEMBL628505,,BAO_0000019,,,,A,2276,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",1,U,14567,,,,0,,Autocuration
,,,CHEMBL874452,,BAO_0000019,,,,A,2276,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",1,U,14568,,,,0,,Autocuration
,,,CHEMBL628506,,BAO_0000019,,,,A,2276,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",1,U,14569,,,,0,,Autocuration
,,,CHEMBL628507,,BAO_0000019,,,,A,2276,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",1,U,14570,,,,0,,Autocuration
,,,CHEMBL628508,,BAO_0000019,,,,A,2276,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",1,U,14571,,,,0,,Autocuration
,,,CHEMBL628509,,BAO_0000019,,,,A,8949,,22224,Michaelis constant (KM) was evaluated,1,U,14572,,,,0,,Autocuration
,,,CHEMBL628510,,BAO_0000019,,,,A,12404,,22224,Reaction rate parameter value for phosphate with transfer with respect to ATP,1,U,14573,,,,0,,Autocuration
,,,CHEMBL628511,,BAO_0000019,,,,B,7625,,22224,Substrate concentration for half maximal velocity was reported for rat hexokinase I,1,U,14574,,,,0,,Autocuration
,,,CHEMBL628512,,BAO_0000019,,,,B,7625,,22224,Substrate concentration for half maximal velocity was reported for rat hexokinase II,1,U,14575,,,,0,,Autocuration
,,,CHEMBL628513,,BAO_0000019,,,,B,7625,,22224,Substrate concentration for half maximal velocity was reported for rat hexokinase III,1,U,14576,,,,0,,Autocuration
,,,CHEMBL628514,,BAO_0000019,,,,B,7625,,22224,Substrate concentration for half maximal velocity was reported for yeast hexokinase,1,U,14577,,,,0,,Autocuration
,,,CHEMBL628515,,BAO_0000019,,,,A,12908,,22224,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,1,U,14578,,,,0,,Autocuration
,,,CHEMBL628516,,BAO_0000019,,,,A,10368,,22224,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,1,U,14579,,,,0,,Autocuration
,,,CHEMBL628517,,BAO_0000019,,,,A,13108,,22224,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),1,U,14580,,,,0,,Autocuration
,,,CHEMBL628518,,BAO_0000019,,,,A,13108,,22224,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),1,U,14581,,,,0,,Autocuration
,,,CHEMBL628519,,BAO_0000019,,,,A,15217,,22224,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,1,U,14582,,,,0,,Autocuration
,,,CHEMBL628520,,BAO_0000019,,,,A,15217,,22224,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,1,U,14583,,,,0,,Autocuration
,,,CHEMBL628521,,BAO_0000019,,,,A,10933,,22224,Binding constant was determined,1,U,14584,,,,0,,Autocuration
,,,CHEMBL630443,,BAO_0000019,,,,A,2363,,22224,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,1,U,14585,,,,0,,Autocuration
,,,CHEMBL630444,,BAO_0000019,,,,A,2363,,22224,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,1,U,14586,,,,0,,Autocuration
,,,CHEMBL857732,,BAO_0000019,,,,A,2276,,22224,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,1,U,14587,,,,0,,Autocuration
,,,CHEMBL630445,,BAO_0000100,,,,P,14915,,22224,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,1,U,14588,,,,0,,Autocuration
,,,CHEMBL630446,,BAO_0000019,,,,A,8847,,22224,Catalytic rate constant of the compound,1,U,14589,,,,0,,Autocuration
,,,CHEMBL630447,,BAO_0000019,,,,B,15357,,22224,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,1,U,14590,,,,0,,Autocuration
,,,CHEMBL630448,,BAO_0000019,,,,A,2869,,22224,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),1,U,14591,,,,0,,Autocuration
,,,CHEMBL630449,,BAO_0000019,,,,A,3484,,22224,Catalytic rate constant against phospholipase A2 was determined,1,U,14592,,,,0,,Autocuration
,,,CHEMBL630450,,BAO_0000019,,,,A,1373,,22224,"Compound was evaluated for catalytic constant, Kcat",1,U,14593,,,,0,,Autocuration
,,,CHEMBL630451,,BAO_0000019,,,,A,8142,,22224,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,1,U,14594,,,,0,,Autocuration
,,,CHEMBL630452,,BAO_0000019,,,,A,14131,,22224,Kcat calculated from 0.693/T1/2,1,U,14595,,,,0,,Autocuration
,,,CHEMBL630453,,BAO_0000019,,,,A,17269,,22224,Kcat was determined,1,U,14596,,,,0,,Autocuration
,,,CHEMBL630454,,BAO_0000019,,,,A,3485,,22224,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,1,U,14597,,,,0,,Autocuration
,,,CHEMBL630455,,BAO_0000019,,,,A,3485,,22224,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,1,U,14598,,,,0,,Autocuration
,,,CHEMBL631487,,BAO_0000019,,,,A,3485,,22224,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,1,U,14599,,,,0,,Autocuration
,,,CHEMBL631488,,BAO_0000019,,,,A,5962,,22224,Kcat value was determined,1,U,14600,,,,0,,Autocuration
,,,CHEMBL876440,,BAO_0000019,,,,A,3133,,22224,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,1,U,14601,,,,0,,Autocuration
,,,CHEMBL631489,,BAO_0000019,,,,A,3133,,22224,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,1,U,14602,,,,0,,Autocuration
,,,CHEMBL857742,,BAO_0000019,,,,A,2276,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",1,U,14603,,,,0,,Autocuration
,,,CHEMBL631490,,BAO_0000019,,,,A,2276,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",1,U,14604,,,,0,,Autocuration
,,,CHEMBL631491,,BAO_0000019,,,,A,2276,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",1,U,14605,,,,0,,Autocuration
,,,CHEMBL631492,,BAO_0000019,,,,A,2276,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",1,U,14606,,,,0,,Autocuration
,,,CHEMBL631493,,BAO_0000019,,,,A,2276,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",1,U,14607,,,,0,,Autocuration
,,,CHEMBL631494,,BAO_0000019,,,,A,4892,,22224,Kinetic parameter for rate of conversion to PABA was determined,1,U,14608,,,,0,,Autocuration
,,,CHEMBL631495,,BAO_0000019,,,,A,3133,,22224,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,1,U,14609,,,,0,,Autocuration
,,,CHEMBL631496,1988.0,BAO_0000218,,,,A,11488,10116.0,50597,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",1,N,14610,,Rattus norvegicus,Feces,1,,Intermediate
,,,CHEMBL631497,1088.0,BAO_0000218,,,,A,11488,10116.0,50597,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",1,N,14611,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631498,1088.0,BAO_0000218,,,,A,11488,10116.0,50597,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",1,N,14612,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL629776,1088.0,BAO_0000218,,,,A,11488,10116.0,50597,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",1,N,14613,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL629777,1088.0,BAO_0000218,,,,A,11488,10116.0,50597,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",1,N,14614,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL629778,1088.0,BAO_0000218,,,,A,11488,10116.0,50597,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",1,N,14615,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL630456,,BAO_0000218,,,,A,11488,10116.0,50597,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,1,N,14616,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630457,,BAO_0000218,,,,A,11488,10116.0,50597,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,1,N,14617,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630458,,BAO_0000218,,,,A,11488,10116.0,50597,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,1,N,14618,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630459,,BAO_0000218,,,,A,11488,10116.0,50597,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,1,N,14619,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630460,,BAO_0000218,,,,A,11488,10116.0,50597,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,1,N,14620,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL876550,,BAO_0000218,,,,A,11488,10116.0,50597,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,1,N,14621,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630461,,BAO_0000218,,,,A,11488,10116.0,50597,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,1,N,14622,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630462,,BAO_0000218,,,,A,11488,10116.0,50597,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,1,N,14623,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630463,,BAO_0000218,,,,A,11488,10116.0,50597,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,1,N,14624,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630464,,BAO_0000218,,,,A,11488,10116.0,50597,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,1,N,14625,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630465,,BAO_0000218,,,,A,11488,10116.0,50597,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,1,N,14626,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630466,,BAO_0000218,,,,A,11488,10116.0,50597,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,1,N,14627,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630467,,BAO_0000218,,,,A,11488,10116.0,50597,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,1,N,14628,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630633,,BAO_0000218,,,,A,11488,10116.0,50597,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,1,N,14629,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630634,,BAO_0000218,,,,A,11488,10116.0,50597,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,1,N,14630,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630635,,BAO_0000218,,,,A,11488,10116.0,50597,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,1,N,14631,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630636,,BAO_0000218,,,,A,11488,10116.0,50597,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,1,N,14632,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630637,,BAO_0000218,,,,A,11488,10116.0,50597,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,1,N,14633,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630638,1988.0,BAO_0000218,,,,A,7132,9986.0,50592,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",1,N,14634,,Oryctolagus cuniculus,Feces,1,,Intermediate
,,,CHEMBL630639,1988.0,BAO_0000218,,,,A,7132,9986.0,50592,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",1,N,14635,,Oryctolagus cuniculus,Feces,1,,Intermediate
,,,CHEMBL630640,1988.0,BAO_0000218,,,,A,7132,9986.0,50592,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",1,N,14636,,Oryctolagus cuniculus,Feces,1,,Intermediate
,,,CHEMBL876551,1988.0,BAO_0000218,,,,A,7132,9986.0,50592,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",1,N,14637,,Oryctolagus cuniculus,Feces,1,,Intermediate
,,,CHEMBL630641,1088.0,BAO_0000218,,,,A,7132,9986.0,50592,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",1,N,14638,,Oryctolagus cuniculus,Urine,1,,Intermediate
,,,CHEMBL630642,1088.0,BAO_0000218,,,,A,7132,9986.0,50592,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",1,N,14639,,Oryctolagus cuniculus,Urine,1,,Intermediate
,,,CHEMBL630643,1088.0,BAO_0000218,,,,A,7132,9986.0,50592,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",1,N,14640,,Oryctolagus cuniculus,Urine,1,,Intermediate
,,,CHEMBL630644,1088.0,BAO_0000218,,,,A,7132,9986.0,50592,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",1,N,14641,,Oryctolagus cuniculus,Urine,1,,Intermediate
,,,CHEMBL630645,1088.0,BAO_0000218,,,,A,7132,9986.0,50592,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",1,N,14642,,Oryctolagus cuniculus,Urine,1,,Intermediate
,,,CHEMBL625599,1988.0,BAO_0000218,,,,A,7132,9986.0,50592,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",1,N,14643,,Oryctolagus cuniculus,Feces,1,,Intermediate
,,,CHEMBL625600,1988.0,BAO_0000218,,,,A,7132,9986.0,50592,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",1,N,14644,,Oryctolagus cuniculus,Feces,1,,Intermediate
,,,CHEMBL625601,1988.0,BAO_0000218,,,,A,7132,9986.0,50592,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",1,N,14645,,Oryctolagus cuniculus,Feces,1,,Intermediate
,,,CHEMBL625602,1988.0,BAO_0000218,,,,A,7132,9986.0,50592,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",1,N,14646,,Oryctolagus cuniculus,Feces,1,,Intermediate
,,,CHEMBL627470,1088.0,BAO_0000218,,,,A,7132,9986.0,50592,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",1,N,14647,,Oryctolagus cuniculus,Urine,1,,Intermediate
,,,CHEMBL627471,1088.0,BAO_0000218,,,,A,7132,9986.0,50592,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",1,N,14648,,Oryctolagus cuniculus,Urine,1,,Intermediate
,,,CHEMBL627472,1088.0,BAO_0000218,,,,A,7132,9986.0,50592,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",1,N,14649,,Oryctolagus cuniculus,Urine,1,,Intermediate
,,,CHEMBL627473,1088.0,BAO_0000218,,,,A,7132,9986.0,50592,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",1,N,14650,,Oryctolagus cuniculus,Urine,1,,Intermediate
,,,CHEMBL627474,1088.0,BAO_0000218,,,,A,7132,9986.0,50592,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",1,N,14651,,Oryctolagus cuniculus,Urine,1,,Intermediate
,,,CHEMBL627475,178.0,BAO_0000218,,,,A,13925,10116.0,50597,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,N,14652,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627476,178.0,BAO_0000218,,,,A,13925,10116.0,50597,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,N,14653,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL627477,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,1,N,14654,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL627478,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,1,N,14655,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL627479,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,1,N,14656,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL627480,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,1,N,14657,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL627481,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,1,N,14658,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL627482,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,1,N,14659,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL627483,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,1,N,14660,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL875636,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,1,N,14661,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL625764,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,1,N,14662,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL625765,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,1,N,14663,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL625766,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,1,N,14664,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL625767,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,1,N,14665,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL625768,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,1,N,14666,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL625769,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,1,N,14667,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL625770,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,1,N,14668,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL625771,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,1,N,14669,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL625772,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,1,N,14670,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL625773,1088.0,BAO_0000218,,,,A,12582,9615.0,50588,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,1,N,14671,,Canis lupus familiaris,Urine,1,,Intermediate
,,,CHEMBL625774,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,1,N,14672,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL625775,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,1,N,14673,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL625776,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,1,N,14674,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL625777,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,1,N,14675,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL625778,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,1,N,14676,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL625779,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,1,N,14677,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL625780,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,1,N,14678,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL625781,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,1,N,14679,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL875637,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,1,N,14680,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL626473,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,1,N,14681,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL626474,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,1,N,14682,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL626475,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,1,N,14683,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL626476,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,1,N,14684,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL634397,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,1,N,14685,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL626477,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,1,N,14686,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631069,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,1,N,14687,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631070,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,1,N,14688,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631071,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,1,N,14689,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631072,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,1,N,14690,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631073,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,1,N,14691,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631074,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,1,N,14692,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631075,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,1,N,14693,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631725,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,1,N,14694,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631726,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,1,N,14695,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631727,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,1,N,14696,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631728,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,1,N,14697,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631729,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,1,N,14698,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631730,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,1,N,14699,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631731,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,1,N,14700,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631910,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,1,N,14701,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631911,10000000.0,BAO_0000218,,,,A,15413,10116.0,50597,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,1,N,14702,In vivo,Rattus norvegicus,Hippocampus,1,,Intermediate
,,,CHEMBL631912,1898.0,BAO_0000218,,,,A,15413,10116.0,50597,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,1,N,14703,In vivo,Rattus norvegicus,Hypothalamus,1,,Intermediate
,,,CHEMBL631913,1898.0,BAO_0000218,,,,A,15413,10116.0,50597,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,1,N,14704,In vivo,Rattus norvegicus,Hypothalamus,1,,Intermediate
,,,CHEMBL631914,178.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14705,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631915,178.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14706,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL875778,178.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,N,14707,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631916,178.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14708,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631917,178.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14709,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631918,178.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14710,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631919,178.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14711,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631920,178.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,N,14712,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631921,178.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14713,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631922,178.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14714,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631923,178.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,N,14715,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL631924,,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14716,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630234,,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14717,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630235,,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,N,14718,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630236,,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14719,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630237,,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14720,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630238,,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14721,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630239,,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14722,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630303,,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,N,14723,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630304,,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14724,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630305,,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14725,In vivo,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630306,2113.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14726,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL630307,2113.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14727,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL630308,2113.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,N,14728,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL630309,2113.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14729,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL629309,2113.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14730,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL629993,2113.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14731,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL629994,2113.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14732,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL629995,2113.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,N,14733,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL631993,2113.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14734,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL631994,2113.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14735,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL631995,2113.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14736,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL631996,2107.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,N,14737,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL631997,2107.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14738,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL631998,2107.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14739,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL631999,2107.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14740,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL632000,2107.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,N,14741,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL632001,2107.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14742,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL874424,2107.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14743,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL632002,2107.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14744,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL632003,2107.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14745,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL632004,,BAO_0000019,,,,A,3133,,22224,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,1,U,14746,,,,0,,Autocuration
,,,CHEMBL632005,,BAO_0000019,,,,A,2742,,22224,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,1,U,14747,,,,0,,Autocuration
,,,CHEMBL632006,,BAO_0000019,,,,A,2742,,22224,Compound was tested for amidase rate in the presence of N62C screen enzyme,1,U,14748,,,,0,,Autocuration
,,,CHEMBL632007,,BAO_0000019,,,,A,2742,,22224,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,1,U,14749,,,,0,,Autocuration
,,,CHEMBL632008,,BAO_0000019,,,,A,2742,,22224,Compound was tested for amidase rate in the presence of S166C screen enzyme,1,U,14750,,,,0,,Autocuration
,,,CHEMBL632009,,BAO_0000019,,,,A,2742,,22224,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,1,U,14751,,,,0,,Autocuration
,,,CHEMBL632010,,BAO_0000019,,,,A,2742,,22224,Compound was tested for esterase rate in the presence of N62C screen enzyme,1,U,14752,,,,0,,Autocuration
,,,CHEMBL857750,,BAO_0000019,,,,A,2742,,22224,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,1,U,14753,,,,0,,Autocuration
,,,CHEMBL632011,,BAO_0000019,,,,A,2742,,22224,Compound was tested for esterase rate in the presence of S166C screen enzyme,1,U,14754,,,,0,,Autocuration
,,,CHEMBL632012,,BAO_0000019,,,,A,2276,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",1,U,14755,,,,0,,Autocuration
,,,CHEMBL632013,,BAO_0000019,,,,A,2276,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",1,U,14756,,,,0,,Autocuration
,,,CHEMBL632014,,BAO_0000019,,,,A,2276,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",1,U,14757,,,,0,,Autocuration
,,,CHEMBL629622,,BAO_0000019,,,,A,2276,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",1,U,14758,,,,0,,Autocuration
,,,CHEMBL629623,,BAO_0000019,,,,A,2276,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",1,U,14759,,,,0,,Autocuration
,,,CHEMBL629624,,BAO_0000019,,,,A,2276,,22224,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",1,U,14760,,,,0,,Autocuration
,,,CHEMBL629625,,BAO_0000019,,,,A,17269,,22224,Ratio of Kcat to that of Km was determined,1,U,14761,,,,0,,Autocuration
,,,CHEMBL629626,,BAO_0000019,,,,A,2276,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",1,U,14762,,,,0,,Autocuration
,,,CHEMBL629627,,BAO_0000019,,,,A,2276,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",1,U,14763,,,,0,,Autocuration
,,,CHEMBL629628,,BAO_0000019,,,,A,15917,,22224,"Compound was evaluated for constant, Kd",1,U,14764,,,,0,,Autocuration
,,,CHEMBL629629,,BAO_0000019,,,,A,10933,,22224,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,1,U,14765,,,,0,,Autocuration
,,,CHEMBL629630,,BAO_0000019,,,,A,10933,,22224,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,1,U,14766,,,,0,,Autocuration
,,,CHEMBL856030,,BAO_0000019,,,,A,14293,,22224,Dissociation Constant of compound determined,1,U,14767,,,,0,,Autocuration
,,,CHEMBL629631,,BAO_0000019,,,,B,6698,,22224,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,1,U,14768,,,,0,,Autocuration
,,,CHEMBL629632,,BAO_0000019,,,,B,6698,,22224,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,1,U,14769,,,,0,,Autocuration
,,,CHEMBL629633,,BAO_0000100,,,,P,4318,,22224,Dissociation constant of compound with Fructose was determined,1,U,14770,,,,0,,Autocuration
,,,CHEMBL629634,,BAO_0000100,,,,P,4318,,22224,Dissociation constant of compound with Fructose was determined; Not determined,1,U,14771,,,,0,,Autocuration
,,,CHEMBL629635,,BAO_0000100,,,,P,4318,,22224,Dissociation constant of compound with Lactulose was determined,1,U,14772,,,,0,,Autocuration
,,,CHEMBL629636,,BAO_0000100,,,,P,4318,,22224,Dissociation constant of compound with Lactulose was determined; Not determined,1,U,14773,,,,0,,Autocuration
,,,CHEMBL629637,,BAO_0000100,,,,P,14959,,22224,Dissociation constant of the Compound,1,U,14774,,,,0,,Autocuration
,,,CHEMBL629638,,BAO_0000100,,,,P,5913,,22224,Dissociation constant by non-linear regression analysis,1,U,14775,,,,0,,Autocuration
,,,CHEMBL629639,,BAO_0000100,,,,P,14218,,22224,Dissociation constant was determined,1,U,14776,,,,0,,Autocuration
,,,CHEMBL629640,,BAO_0000100,,,,P,10689,,22224,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,1,U,14777,,,,0,,Autocuration
,,,CHEMBL629641,,BAO_0000100,,,,P,13925,,22224,Dissociation constant was determined,1,U,14778,,,,0,,Autocuration
,,,CHEMBL631344,,BAO_0000100,,,,P,16359,,22224,Dissociation constant was determined,1,U,14779,,,,0,,Autocuration
,,,CHEMBL631345,2385.0,BAO_0000218,,,,A,10944,10116.0,50597,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,1,N,14780,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL631346,,BAO_0000019,,,,A,11080,,22224,The dissociation constant determined by fluorescence displacement assay,1,U,14781,,,,0,,Autocuration
,,,CHEMBL631524,,BAO_0000019,,,,A,17805,,22224,kd value surface plasmon resonance (SPR) method,1,U,14782,,,,0,,Autocuration
,,,CHEMBL631525,2385.0,BAO_0000218,,,,A,10944,10116.0,50597,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,1,N,14783,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL631526,,BAO_0000019,,,,F,16645,,22224,First dissociation constant of the binding of compound to V30M TTR,1,U,14784,,,,0,,Autocuration
,,,CHEMBL631527,,BAO_0000019,,,,F,16645,,22224,Second dissociation constant of the binding of compound to V30M TTR,1,U,14785,,,,0,,Autocuration
,,,CHEMBL631528,,BAO_0000019,,,,A,7793,,22224,"Compound was evaluated for equilibrium constant, Ke",1,U,14786,,,,0,,Autocuration
,,,CHEMBL631529,1898.0,BAO_0000019,,,,A,12199,,22224,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,1,U,14787,,,Hypothalamus,0,,Autocuration
,,,CHEMBL631530,1898.0,BAO_0000019,,,,A,12199,,22224,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,1,U,14788,,,Hypothalamus,0,,Autocuration
,,,CHEMBL631531,,BAO_0000019,,,,A,9680,,22224,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,1,U,14789,,,,0,,Autocuration
,,,CHEMBL631532,,BAO_0000019,,,,A,9680,,22224,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,1,U,14790,,,,0,,Autocuration
,,,CHEMBL631533,,BAO_0000019,,,,A,9680,,22224,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,1,U,14791,,,,0,,Autocuration
,,,CHEMBL876552,,BAO_0000218,,,,A,13758,10090.0,50594,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,1,N,14792,,Mus musculus,,1,,Intermediate
,,,CHEMBL631534,,BAO_0000218,,,,A,13758,10090.0,50594,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,1,N,14793,,Mus musculus,,1,,Intermediate
,,,CHEMBL631535,,BAO_0000218,,,,A,13758,10090.0,50594,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,1,N,14794,,Mus musculus,,1,,Intermediate
,,,CHEMBL631536,,BAO_0000218,,,,A,13758,10090.0,50594,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,1,N,14795,,Mus musculus,,1,,Intermediate
,,,CHEMBL631537,,BAO_0000218,,,,A,13758,10090.0,50594,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,1,N,14796,,Mus musculus,,1,,Intermediate
,,,CHEMBL631538,,BAO_0000218,,,,A,13758,10090.0,50594,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,1,N,14797,,Mus musculus,,1,,Intermediate
,,,CHEMBL631539,,BAO_0000218,,,,A,13758,10090.0,50594,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,1,N,14798,,Mus musculus,,1,,Intermediate
,,,CHEMBL631540,,BAO_0000218,,,,A,13758,10090.0,50594,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,1,N,14799,,Mus musculus,,1,,Intermediate
,,,CHEMBL625637,,BAO_0000218,,,,A,14393,10116.0,50597,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,1,N,14800,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625638,,BAO_0000218,,,,A,14393,10116.0,50597,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,1,N,14801,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625639,,BAO_0000218,,,,A,15078,10116.0,50597,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",1,N,14802,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL625640,955.0,BAO_0000218,,,,A,13925,10116.0,50597,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,N,14803,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL625641,955.0,BAO_0000218,,,,A,13925,10116.0,50597,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,N,14804,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL625642,948.0,BAO_0000218,,,,A,13925,10116.0,50597,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,N,14805,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL625643,948.0,BAO_0000218,,,,A,13925,10116.0,50597,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,N,14806,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL625644,2113.0,BAO_0000218,,,,A,13925,10116.0,50597,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,N,14807,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL625645,2113.0,BAO_0000218,,,,A,13925,10116.0,50597,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,N,14808,In vivo,Rattus norvegicus,Kidney,1,,Intermediate
,,,CHEMBL625646,2107.0,BAO_0000218,,,,A,13925,10116.0,50597,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,N,14809,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625647,2107.0,BAO_0000218,,,,A,13925,10116.0,50597,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,N,14810,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625648,2048.0,BAO_0000218,,,,A,13925,10116.0,50597,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,N,14811,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL625649,2048.0,BAO_0000218,,,,A,13925,10116.0,50597,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,1,N,14812,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL625650,2385.0,BAO_0000218,,,,A,13925,10116.0,50597,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,N,14813,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL625651,2385.0,BAO_0000218,,,,A,13925,10116.0,50597,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,N,14814,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL625652,14.0,BAO_0000218,,,,A,13925,10116.0,50597,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,N,14815,In vivo,Rattus norvegicus,Zone of skin,1,,Intermediate
,,,CHEMBL625653,14.0,BAO_0000218,,,,A,13925,10116.0,50597,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,N,14816,In vivo,Rattus norvegicus,Zone of skin,1,,Intermediate
,,,CHEMBL625654,2106.0,BAO_0000218,,,,A,13925,10116.0,50597,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,N,14817,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL625655,2106.0,BAO_0000218,,,,A,13925,10116.0,50597,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,N,14818,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL625656,178.0,BAO_0000218,,,,A,9712,10116.0,50597,Biodistribution of Compound in rat blood after 15 minutes of administration,1,N,14819,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL625657,178.0,BAO_0000218,,,,A,9712,10116.0,50597,Biodistribution of Compound in rat blood after 2 minutes of administration,1,N,14820,In vivo,Rattus norvegicus,Blood,1,,Intermediate
,,,CHEMBL625658,955.0,BAO_0000218,,,,A,9712,10116.0,50597,Biodistribution of Compound in rat brain after 15 minutes of administration,1,N,14821,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL625659,955.0,BAO_0000218,,,,A,9712,10116.0,50597,Biodistribution of Compound in rat brain after 2 minutes of administration,1,N,14822,In vivo,Rattus norvegicus,Brain,1,,Intermediate
,,,CHEMBL625660,948.0,BAO_0000218,,,,A,9712,10116.0,50597,Biodistribution of Compound in rat heart after 15 minutes of administration,1,N,14823,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL625661,948.0,BAO_0000218,,,,A,9712,10116.0,50597,Biodistribution of Compound in rat heart after 2 minutes of administration,1,N,14824,In vivo,Rattus norvegicus,Heart,1,,Intermediate
,,,CHEMBL625662,2107.0,BAO_0000218,,,,A,9712,10116.0,50597,Biodistribution of Compound in rat liver after 15 minutes of administration,1,N,14825,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL625663,2107.0,BAO_0000218,,,,A,9712,10116.0,50597,Biodistribution of Compound in rat liver after 2 minutes of administration,1,N,14826,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL875621,2048.0,BAO_0000218,,,,A,9712,10116.0,50597,Biodistribution of Compound in rat lung after 15 minutes of administration,1,N,14827,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL628382,2048.0,BAO_0000218,,,,A,9712,10116.0,50597,Biodistribution of Compound in rat lung after 2 minutes of administration,1,N,14828,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL628383,2385.0,BAO_0000218,,,,A,9712,10116.0,50597,Biodistribution of Compound in rat muscle after 15 minutes of administration,1,N,14829,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL628384,2385.0,BAO_0000218,,,,A,9712,10116.0,50597,Biodistribution of Compound in rat muscle after 2 minutes of administration,1,N,14830,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL628385,,BAO_0000218,,,,A,13925,10116.0,50597,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,1,N,14831,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL875753,,BAO_0000218,,,,A,13925,10116.0,50597,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,1,N,14832,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628386,,BAO_0000218,,,,A,13925,10116.0,50597,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,1,N,14833,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628387,,BAO_0000218,,,,A,6941,10116.0,50597,Organ distribution in rat blood 2 minutes after intravenous injection,1,N,14834,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628388,,BAO_0000218,,,,A,6941,10116.0,50597,Organ distribution in rat blood 2 hr after intravenous injection,1,N,14835,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628389,,BAO_0000218,,,,A,6941,10116.0,50597,Organ distribution in rat blood 30 minutes after intravenous injection,1,N,14836,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL632756,,BAO_0000218,,,,A,6941,10116.0,50597,Organ distribution in rat blood 30 min after intravenous injection,1,N,14837,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL628390,,BAO_0000218,,,,A,6941,10116.0,50597,Organ distribution in rat brain 2 minutes after intravenous injection,1,N,14838,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631811,,BAO_0000218,,,,A,6941,10116.0,50597,Organ distribution in rat brain 2 hr after intravenous injection,1,N,14839,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631812,,BAO_0000218,,,,A,6941,10116.0,50597,Organ distribution in rat brain 30 minutes after intravenous injection,1,N,14840,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631813,,BAO_0000218,,,,A,6941,10116.0,50597,Organ distribution in rat heart 2 minutes after intravenous injection,1,N,14841,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631814,,BAO_0000218,,,,A,6941,10116.0,50597,Organ distribution in rat heart 2 hr after intravenous injection,1,N,14842,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631815,,BAO_0000218,,,,A,6941,10116.0,50597,Organ distribution in rat heart 30 minutes after intravenous injection,1,N,14843,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631816,,BAO_0000218,,,,A,6941,10116.0,50597,Organ distribution in rat kidney 2 minutes after intravenous injection,1,N,14844,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL875758,,BAO_0000218,,,,A,6941,10116.0,50597,Organ distribution in rat kidney 2 hr after intravenous injection,1,N,14845,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631817,,BAO_0000218,,,,A,6941,10116.0,50597,Organ distribution in rat kidney 30 minutes after intravenous injection,1,N,14846,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631818,2107.0,BAO_0000218,,,,A,6941,10116.0,50597,Organ distribution in rat liver 2 minutes after intravenous injection,1,N,14847,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL631819,2107.0,BAO_0000218,,,,A,6941,10116.0,50597,Organ distribution in rat liver 2 hr after intravenous injection,1,N,14848,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL631820,2107.0,BAO_0000218,,,,A,6941,10116.0,50597,Organ distribution in rat liver 30 minutes after intravenous injection,1,N,14849,,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL631821,,BAO_0000218,,,,A,6941,10116.0,50597,Organ distribution in rat lung 2 minutes after intravenous injection,1,N,14850,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631822,,BAO_0000218,,,,A,6941,10116.0,50597,Organ distribution in rat lung 2 hr after intravenous injection,1,N,14851,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631823,,BAO_0000218,,,,A,6941,10116.0,50597,Organ distribution in rat lung 30 minutes after intravenous injection,1,N,14852,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL631824,2385.0,BAO_0000218,,,,A,6941,10116.0,50597,Organ distribution in rat muscle 2 minutes after intravenous injection,1,N,14853,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL631825,2385.0,BAO_0000218,,,,A,6941,10116.0,50597,Organ distribution in rat muscle 2 hr after intravenous injection,1,N,14854,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL631826,2385.0,BAO_0000218,,,,A,6941,10116.0,50597,Organ distribution in rat muscle 30 minutes after intravenous injection,1,N,14855,,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL631827,,BAO_0000218,,,,A,14439,10090.0,50594,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),1,N,14856,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL631828,,BAO_0000218,,,,A,14439,10090.0,50594,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),1,N,14857,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL631829,,BAO_0000218,,,,A,14439,10090.0,50594,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),1,N,14858,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL875759,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,1,N,14859,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631830,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,1,N,14860,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631831,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,1,N,14861,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631832,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,1,N,14862,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631833,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,1,N,14863,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631834,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,1,N,14864,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631835,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,1,N,14865,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631836,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,1,N,14866,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631837,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,1,N,14867,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631838,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,1,N,14868,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631839,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,1,N,14869,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631840,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,1,N,14870,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631841,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,1,N,14871,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631842,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,1,N,14872,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631843,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,1,N,14873,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631844,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,1,N,14874,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631845,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,1,N,14875,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631846,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,1,N,14876,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL875760,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,1,N,14877,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL632199,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,1,N,14878,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631847,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,1,N,14879,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL631848,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,1,N,14880,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628707,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,1,N,14881,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628708,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,1,N,14882,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628709,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,1,N,14883,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628710,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,1,N,14884,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628711,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,1,N,14885,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628712,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,1,N,14886,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628713,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,1,N,14887,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628714,1088.0,BAO_0000218,,,,A,12582,10116.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,1,N,14888,,Rattus norvegicus,Urine,1,,Intermediate
,,,CHEMBL628715,,BAO_0000218,,,,A,7415,10116.0,50597,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",1,N,14889,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL629179,,BAO_0000019,,,,A,7313,,22224,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,1,U,14890,,,,0,,Autocuration
,,,CHEMBL629180,,BAO_0000019,,,,A,7313,,22224,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,1,U,14891,,,,0,,Autocuration
,,,CHEMBL875108,,BAO_0000019,,,,A,7313,,22224,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,1,U,14892,,,,0,,Autocuration
,,,CHEMBL629181,1235.0,BAO_0000019,,,,A,7570,,22224,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,1,U,14893,,,Adrenal cortex,0,,Autocuration
,,,CHEMBL629182,1235.0,BAO_0000019,,,,A,7570,,22224,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,1,U,14894,,,Adrenal cortex,0,,Autocuration
,,,CHEMBL629183,,BAO_0000019,,,,A,7570,,22224,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,1,U,14895,,,,0,,Autocuration
,,,CHEMBL629184,,BAO_0000019,,,,A,7570,,22224,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,1,U,14896,,,,0,,Autocuration
,,,CHEMBL629185,1235.0,BAO_0000019,,,,A,7570,,22224,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,1,U,14897,,,Adrenal cortex,0,,Autocuration
,,,CHEMBL629186,1235.0,BAO_0000019,,,,A,7570,,22224,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,1,U,14898,,,Adrenal cortex,0,,Autocuration
,,,CHEMBL629187,,BAO_0000019,,,,A,7570,,22224,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,1,U,14899,,,,0,,Autocuration
,,,CHEMBL629887,,BAO_0000019,,,,A,7570,,22224,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,1,U,14900,,,,0,,Autocuration
,,,CHEMBL629888,,BAO_0000019,,,,A,7570,,22224,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,1,U,14901,,,,0,,Autocuration
,,,CHEMBL629889,,BAO_0000019,,,,A,7570,,22224,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,1,U,14902,,,,0,,Autocuration
,,,CHEMBL629890,1235.0,BAO_0000019,,,,A,7570,,22224,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,1,U,14903,,,Adrenal cortex,0,,Autocuration
,,,CHEMBL629891,,BAO_0000019,,,,A,7570,,22224,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,1,U,14904,,,,0,,Autocuration
,,,CHEMBL629892,,BAO_0000019,,,,A,7570,,22224,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,1,U,14905,,,,0,,Autocuration
,,,CHEMBL629893,1235.0,BAO_0000019,,,,A,7570,,22224,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,1,U,14906,,,Adrenal cortex,0,,Autocuration
,,,CHEMBL629894,,BAO_0000019,,,,A,7570,,22224,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,1,U,14907,,,,0,,Autocuration
,,,CHEMBL629895,,BAO_0000019,,,,A,7570,,22224,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,1,U,14908,,,,0,,Autocuration
,,,CHEMBL875109,,BAO_0000218,,,,A,14122,9615.0,22224,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",1,U,14909,In vivo,Canis lupus familiaris,,0,,Autocuration
,,,CHEMBL629896,,BAO_0000218,,,,A,16449,9541.0,22224,Absolute bioavailability in male cynomolgus monkeys,1,U,14910,In vivo,Macaca fascicularis,,0,,Autocuration
,,,CHEMBL629897,,BAO_0000218,,,,A,16449,10116.0,22224,Absolute bioavailability in maleSprague-Dawley rats,1,U,14911,In vivo,Rattus norvegicus,,0,,Autocuration
,,,CHEMBL629898,2107.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,N,14912,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL630057,2107.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14913,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL630058,2107.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14914,In vivo,Rattus norvegicus,Liver,1,,Intermediate
,,,CHEMBL630059,2048.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14915,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL630060,2048.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14916,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL630061,2048.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,N,14917,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL630062,2048.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14918,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL630063,2048.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14919,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL630064,2048.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14920,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL630065,2048.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14921,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL630066,2048.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,N,14922,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL630067,2048.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14923,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL630068,2048.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14924,In vivo,Rattus norvegicus,Lung,1,,Intermediate
,,,CHEMBL631113,2385.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14925,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL631114,2385.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14926,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL631115,2385.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,N,14927,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL631116,2385.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14928,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL630528,2385.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14929,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL630529,2385.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14930,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL630530,2385.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14931,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL630531,2385.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,N,14932,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL630532,2385.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14933,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL630533,2385.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14934,In vivo,Rattus norvegicus,Muscle tissue,1,,Intermediate
,,,CHEMBL630534,178.0,BAO_0000218,,,,A,15045,10090.0,50594,Biodistribution in normal mice blood after 120 hr,1,N,14935,In vivo,Mus musculus,Blood,1,,Intermediate
,,,CHEMBL630535,178.0,BAO_0000218,,,,A,15045,10090.0,50594,Biodistribution in normal mice blood after 24 hr,1,N,14936,In vivo,Mus musculus,Blood,1,,Intermediate
,,,CHEMBL630536,178.0,BAO_0000218,,,,A,15045,10090.0,50594,Biodistribution in normal mice blood after 4 hr,1,N,14937,In vivo,Mus musculus,Blood,1,,Intermediate
,,,CHEMBL630537,10000001.0,BAO_0000218,,,,A,15045,10090.0,50594,Biodistribution in normal mice bone after 120 hr,1,N,14938,In vivo,Mus musculus,Bone,1,,Intermediate
,,,CHEMBL630538,10000001.0,BAO_0000218,,,,A,15045,10090.0,50594,Biodistribution in normal mice bone after 24 hr,1,N,14939,In vivo,Mus musculus,Bone,1,,Intermediate
,,,CHEMBL630539,10000001.0,BAO_0000218,,,,A,15045,10090.0,50594,Biodistribution in normal mice bone after 4 hr,1,N,14940,In vivo,Mus musculus,Bone,1,,Intermediate
,,,CHEMBL630540,948.0,BAO_0000218,,,,A,15045,10090.0,50594,Biodistribution in normal mice heart after 120 hr,1,N,14941,In vivo,Mus musculus,Heart,1,,Intermediate
,,,CHEMBL630541,948.0,BAO_0000218,,,,A,15045,10090.0,50594,Biodistribution in normal mice heart after 24 hr,1,N,14942,In vivo,Mus musculus,Heart,1,,Intermediate
,,,CHEMBL630542,948.0,BAO_0000218,,,,A,15045,10090.0,50594,Biodistribution in normal mice heart after 4 hr,1,N,14943,In vivo,Mus musculus,Heart,1,,Intermediate
,,,CHEMBL630543,2113.0,BAO_0000218,,,,A,15045,10090.0,50594,Biodistribution in normal mice kidney after 120 hr,1,N,14944,In vivo,Mus musculus,Kidney,1,,Intermediate
,,,CHEMBL630544,2113.0,BAO_0000218,,,,A,15045,10090.0,50594,Biodistribution in normal mice kidney after 24 hr,1,N,14945,In vivo,Mus musculus,Kidney,1,,Intermediate
,,,CHEMBL630545,2113.0,BAO_0000218,,,,A,15045,10090.0,50594,Biodistribution in normal mice kidney after 4 hr,1,N,14946,In vivo,Mus musculus,Kidney,1,,Intermediate
,,,CHEMBL630546,2107.0,BAO_0000218,,,,A,15045,10090.0,50594,Biodistribution in normal mice liver after 120 hr,1,N,14947,In vivo,Mus musculus,Liver,1,,Intermediate
,,,CHEMBL630547,2107.0,BAO_0000218,,,,A,15045,10090.0,50594,Biodistribution in normal mice liver after 24 hr,1,N,14948,In vivo,Mus musculus,Liver,1,,Intermediate
,,,CHEMBL630548,2107.0,BAO_0000218,,,,A,15045,10090.0,50594,Biodistribution in normal mice liver after 4 hr,1,N,14949,In vivo,Mus musculus,Liver,1,,Intermediate
,,,CHEMBL630549,2106.0,BAO_0000218,,,,A,15045,10090.0,50594,Biodistribution in normal mice spleen after 120 hr,1,N,14950,In vivo,Mus musculus,Spleen,1,,Intermediate
,,,CHEMBL630550,2106.0,BAO_0000218,,,,A,15045,10090.0,50594,Biodistribution in normal mice spleen after 24 hr,1,N,14951,In vivo,Mus musculus,Spleen,1,,Intermediate
,,,CHEMBL876426,2106.0,BAO_0000218,,,,A,15045,10090.0,50594,Biodistribution in normal mice spleen after 4 hr,1,N,14952,In vivo,Mus musculus,Spleen,1,,Intermediate
,,,CHEMBL630551,2106.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14953,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL630552,2106.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14954,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL630553,2106.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,N,14955,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL630554,2106.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14956,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL630555,2106.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14957,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL630556,2106.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14958,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL630557,2106.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14959,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL630558,2106.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,N,14960,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL630559,2106.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14961,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL630560,2106.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14962,In vivo,Rattus norvegicus,Spleen,1,,Intermediate
,,,CHEMBL876427,2046.0,BAO_0000218,,,,A,12017,10116.0,50597,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,N,14963,In vivo,Rattus norvegicus,Thyroid gland,1,,Intermediate
,,,CHEMBL630561,,BAO_0000218,,,,A,14941,10116.0,50597,The Kel values in female wistar rats.,1,N,14964,,Rattus norvegicus,,1,,Intermediate
,,,CHEMBL630562,,BAO_0000019,,,,A,4646,,22224,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,1,U,14965,,,,0,,Autocuration
,,,CHEMBL630563,,BAO_0000019,,,,A,8847,,22224,Hydrolysis rate constant of the compound,1,U,14966,,,,0,,Autocuration
,,,CHEMBL629673,,BAO_0000100,,,,P,11778,,22229,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,1,U,14967,,,,0,,Autocuration
,,,CHEMBL629674,,BAO_0000019,,,,A,2363,,22224,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",1,U,14968,,,,0,,Autocuration
,,,CHEMBL629675,,BAO_0000019,,,,A,2363,,22224,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",1,U,14969,,,,0,,Autocuration
,,,CHEMBL629676,,BAO_0000019,,,,A,2363,,22224,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",1,U,14970,,,,0,,Autocuration
,,,CHEMBL629677,,BAO_0000019,,,,A,2363,,22224,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",1,U,14971,,,,0,,Autocuration
,,,CHEMBL629678,,BAO_0000019,,,,A,8371,,22224,Apparent inactivation rate constant was evaluated,1,U,14972,,,,0,,Autocuration
,,,CHEMBL629679,,BAO_0000019,,,,A,14883,,22224,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,1,U,14973,,,,0,,Autocuration
,,,CHEMBL629680,,BAO_0000019,,,,A,14883,,22224,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,1,U,14974,,,,0,,Autocuration
,,,CHEMBL629681,,BAO_0000019,,,,A,4643,,22224,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,1,U,14975,,,,0,,Autocuration
,,,CHEMBL629682,,BAO_0000019,,,,A,3519,,22224,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,1,U,14976,,,,0,,Autocuration
,,,CHEMBL629683,,BAO_0000019,,,,A,10600,,22224,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,1,U,14977,,,,0,,Autocuration
,,,CHEMBL629684,,BAO_0000019,,,,F,8501,,22224,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,1,U,14978,,,,0,,Autocuration
,,,CHEMBL629685,,BAO_0000100,,,,P,8505,,22224,Dissociation constant was determined,1,U,14979,,,,0,,Autocuration
,,,CHEMBL629686,,BAO_0000100,,,,P,9778,,22224,Dissociation constant was determined,1,U,14980,,,,0,,Autocuration
,,,CHEMBL872932,,BAO_0000100,,,,P,9778,,22224,Dissociation constant at pH 7.4,1,U,14981,,,,0,,Autocuration
,,,CHEMBL629687,,BAO_0000100,,,,P,9778,,22224,Dissociation constant in presence of 1 mM dithiothreitol,1,U,14982,,,,0,,Autocuration
,,,CHEMBL872931,,BAO_0000019,,,,A,13007,,22224,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,1,U,14983,,,,0,,Autocuration
,,,CHEMBL628151,,BAO_0000019,,,,A,13007,,22224,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,1,U,14984,,,,0,,Autocuration
,,,CHEMBL628152,,BAO_0000019,,,,A,13007,,22224,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,1,U,14985,,,,0,,Autocuration
,,,CHEMBL628153,,BAO_0000019,,,,A,13007,,22224,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,1,U,14986,,,,0,,Autocuration
,,,CHEMBL628154,,BAO_0000019,,,,A,11482,,22224,Kinetic constant for aromatization of androstenedione,1,U,14987,,,,0,,Autocuration
,,,CHEMBL628155,,BAO_0000019,,,,A,11482,,22224,Kinetic constant for aromatization of testosterone,1,U,14988,,,,0,,Autocuration
,,,CHEMBL628156,,BAO_0000019,,,,A,2303,,22224,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,1,U,14989,,,,0,,Autocuration
,,,CHEMBL628157,,BAO_0000019,,,,A,11964,,22224,Local inhibition constant was determined,1,U,14990,,,,0,,Autocuration
,,,CHEMBL857533,,BAO_0000218,,,,A,3140,4932.0,50347,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,1,N,14991,,Saccharomyces cerevisiae,,1,,Intermediate
,,,CHEMBL628158,,BAO_0000100,,,,P,10650,,22224,Dissociation constant value of the compound,1,U,14992,,,,0,,Autocuration
,,,CHEMBL628159,964.0,BAO_0000019,,,,A,4667,,22224,In vitro permeability through cornea without epithelium,1,U,14993,,,Cornea,0,,Autocuration
,,,CHEMBL875616,964.0,BAO_0000019,,,,A,4667,,22224,In vitro permeability through intact cornea,1,U,14994,,,Cornea,0,,Autocuration
,,,CHEMBL628160,964.0,BAO_0000218,,,,A,9199,9986.0,50592,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,1,N,14995,,Oryctolagus cuniculus,Cornea,1,,Intermediate
,,,CHEMBL628161,,BAO_0000019,,,,A,11966,,22224,Rate of enzyme inactivation for the compound was determined,1,U,14996,,,,0,,Autocuration
,,,CHEMBL628162,964.0,BAO_0000019,,,,A,4667,,22224,In vitro permeability through cornea without epithelium,1,U,14997,,,Cornea,0,,Autocuration
,,,CHEMBL628163,964.0,BAO_0000019,,,,A,4667,,22224,In vitro permeability through intact cornea,1,U,14998,,,Cornea,0,,Autocuration
,,,CHEMBL628164,,BAO_0000019,,,,A,8354,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,U,14999,,,,0,,Autocuration
,,,CHEMBL628165,,BAO_0000019,,,,A,8354,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,U,15000,,,,0,,Autocuration
,,,CHEMBL628166,,BAO_0000019,,,,A,8354,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,U,15001,,,,0,,Autocuration
,,,CHEMBL628167,,BAO_0000019,,,,A,8354,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,U,15002,,,,0,,Autocuration
,,,CHEMBL628168,,BAO_0000019,,,,A,8354,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,U,15003,,,,0,,Autocuration
,,,CHEMBL628169,,BAO_0000019,,,,A,8354,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,U,15004,,,,0,,Autocuration
,,,CHEMBL628170,,BAO_0000019,,,,A,8354,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,U,15005,,,,0,,Autocuration
,,,CHEMBL628171,,BAO_0000019,,,,A,8354,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,U,15006,,,,0,,Autocuration
,,,CHEMBL627434,,BAO_0000019,,,,A,8354,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,U,15007,,,,0,,Autocuration
,,,CHEMBL627435,,BAO_0000019,,,,A,8354,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,U,15008,,,,0,,Autocuration
,,,CHEMBL628110,,BAO_0000019,,,,A,8354,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,U,15009,,,,0,,Autocuration
,,,CHEMBL628111,,BAO_0000019,,,,A,8354,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,U,15010,,,,0,,Autocuration
,,,CHEMBL628112,,BAO_0000019,,,,A,8354,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,U,15011,,,,0,,Autocuration
,,,CHEMBL628260,,BAO_0000019,,,,A,8354,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,U,15012,,,,0,,Autocuration
,,,CHEMBL628261,,BAO_0000019,,,,A,8354,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,U,15013,,,,0,,Autocuration
,,,CHEMBL628262,,BAO_0000218,,,,A,14439,10090.0,50594,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),1,N,15014,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL628263,,BAO_0000218,,,,A,14439,9606.0,50587,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,1,N,15015,In vivo,Homo sapiens,,1,,Intermediate
,,,CHEMBL628264,,BAO_0000218,,,,A,14439,10090.0,50594,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),1,N,15016,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL628265,,BAO_0000218,,,,A,14439,10090.0,50594,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),1,N,15017,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL628266,,BAO_0000218,,,,A,14439,10090.0,50594,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),1,N,15018,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL628267,,BAO_0000218,,,,A,14439,10090.0,50594,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),1,N,15019,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL628268,,BAO_0000218,,,,A,14439,10090.0,50594,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,1,N,15020,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL628269,,BAO_0000218,,,,A,14439,10090.0,50594,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),1,N,15021,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL628270,,BAO_0000218,,,,A,14439,10090.0,50594,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),1,N,15022,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL628271,,BAO_0000218,,,,A,14439,10090.0,50594,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),1,N,15023,In vivo,Mus musculus,,1,,Intermediate
,,,CHEMBL628272,,BAO_0000218,,,,A,14439,10090.0,50594,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),1,N,15024,In vivo,Mus musculus,,1,,Intermediate
